10-K

UNITED STATESSECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-32846

CRH public limited company (Exact name of registrant as specified in its charter)

Ireland	98-0366809
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

Stonemason’s Way, Rathfarnham, Dublin 16, D16 KH51, Ireland

+353 1 404 1000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class:	Trading Symbol:	Name of Each Exchange on Which Registered:
Ordinary Shares of €0.32 each	CRH	New York Stock Exchange
5.200% Guaranteed Notes due 2029	CRH/29	New York Stock Exchange
5.125% Guaranteed Notes due 2030	CRH/30	New York Stock Exchange
6.400% Notes due 2033	CRH/33A	New York Stock Exchange
5.400% Guaranteed Notes due 2034	CRH/34	New York Stock Exchange
5.500% Guaranteed Notes due 2035	CRH/35	New York Stock Exchange
5.875% Guaranteed Notes due 2055	CRH/55	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

☒ Yes ☐ No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. ☐ Yes ☒ No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes Oxley Act (15 U.S.C 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒ Yes ☐ No

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. □

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

The aggregate market value of the voting shares held by non-affiliates of the registrant, computed by reference to the closing price as reported on the New York Stock Exchange, as of the last business day of CRH plc’s most recently completed second fiscal quarter (June 28, 2024), was $51,283,330,098. CRH plc has no non-voting common equity.

As of February 13, 2025, the number of outstanding ordinary shares was 676,475,037 (excluding Treasury stock of 40,944,153 shares).

Documents Incorporated by Reference: Portions of CRH plc’s proxy statement to be prepared in connection with its 2025 Annual General Meeting (the 'Proxy Statement') are incorporated by reference into Part III of this Annual Report on Form 10-K. CRH plc intends to file the Proxy Statement with the SEC no later than 120 days following December 31, 2024.

EXPLANATORY NOTE

CRH plc (together with its consolidated subsidiaries, the 'Company’, 'CRH’, the ‘Group’, ‘we’, ‘us’ or ‘our’), a corporation organized under the laws of the Republic of Ireland, previously determined, as of June 30, 2024 (including as a result of more than 50% of its ordinary shares being held by U.S. residents), that it will no longer qualify as a foreign private issuer as defined under the U.S. Securities Exchange Act of 1934 (the ‘Exchange Act’).

Effective as of January 1, 2025, CRH is a U.S. domestic issuer.

TABLE OF CONTENTS

PART I		PAGE
Item 1	Business	6
Item 1A	Risk Factors	13
Item 1B	Unresolved Staff Comments	19
Item 1C	Cybersecurity	20
Item 2	Properties	21
Item 3	Legal Proceedings	27
Item 4	Mine Safety Disclosures	27
PART II
Item 5	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	28
Item 6	Reserved	30
Item 7	Management's Discussion and Analysis of Financial Condition and Results of Operations	31
Item 7A	Quantitative and Qualitative Disclosuresabout Market Risk	50
Item 8	Financial Statements and Supplementary Data	51
Item 9	Changes in and Disagreementswith Accountants on Accounting and Financial Disclosure	99
Item 9A	Controls and Procedures	99
Item 9B	Other Information	100
Item 9C	Disclosures Regarding Foreign Jurisdictions that Prevent Inspections	100
PART III
Item 10	Directors, Executive Officers and Corporate Governance	101
Item 11	Executive Compensation	101
Item 12	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	101
Item 13	Certain Relationships and Related Transactions, and Director Independence	101
Item 14	Principal Accountant Fees and Services	101
PART IV
Item 15	Exhibits and Financial Statement Schedules	102
Item 16	Form 10-K Summary	103
Signatures		104

CRH Form 10-K 4

Forward-Looking Statements – Safe Harbor Provisions Under The Private Securities Litigation Reform Act Of 1995

In order to utilize the “Safe Harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, CRH is providing the following cautionary statement.

This document contains statements that are, or may be deemed to be, forward-looking statements with respect to the financial condition, results of operations, business, viability and future performance of CRH and certain of the plans and objectives of CRH. These forward-looking statements may generally, but not always, be identified by the use of words such as “will”, “anticipates”, “should”, “could”, “would”, “targets”, “aims”, “may”, “continues”, “expects”, “is expected to”, “estimates”, “believes”, “intends” or similar expressions. These forward-looking statements include all matters that are not historical facts or matters of fact at the date of this document.

In particular, the following, among other statements, are all forward-looking in nature: plans and expectations regarding customer demand, pricing, costs, underlying drivers for growth in infrastructure, residential and non-residential activity, and macroeconomic and other trends in CRH’s markets, including onshoring, regulatory trends, and investment in technology, clean energy and manufacturing; plans and expectations regarding government funding initiatives and priorities, including the timing and amount of government funding and its effects on CRH’s business; plans and expectations regarding CRH’s strategy, expansionary capital expenditures, competitive advantages, growth opportunities, innovation, research and development and acquisitions and divestitures, including the timing for completion, tax and accounting effects and expected commercial benefits; plans and expectations regarding the outcome of pending legal proceedings and provisions for environmental and remediation costs; plans and expectations regarding the timing and amount of share buybacks and dividends, including the Board’s policy of consistent long-term dividend growth; expectations regarding taxation of U.S. holders of our shares, including applicability of Irish Dividend Withholding Tax (DWT) and Irish stamp duty; expectations regarding the Company’s income tax reserves and returns; plans and expectations regarding equity incentive plans and pension plans; plans and expectations regarding CRH’s balance sheet, capital allocation, financial capacity, accounting policies, cash flows and working capital; expectations regarding CRH’s ability to fund its long-term contractual obligations, maturing debt obligations, capital expenditures, and other liquidity requirements; plans and expectations regarding the Share Option Schemes; plans and expectations regarding CRH’s inclusion on certain equity indices; plans and expectations regarding the effect of existing and future laws, rules and regulations on CRH’s business; plans and expectations regarding human capital initiatives, workplace safety, sustainability and climate change, CRH’s decarbonization targets, sustainability-related initiatives and business opportunities, including investments, and the delivery of and consumer demand for sustainable solutions and products; and plans and expectations regarding the potential impact and evolving nature of risks and CRH’s management of such risks.

By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future and reflect the Company’s current expectations and assumptions as to such future events and circumstances that may not prove accurate. You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this document. The Company expressly disclaims any obligation or undertaking to publicly update or revise these forward-looking statements other than as required by applicable law.

A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, certain of which are beyond our control, and which include, among other factors: economic and financial conditions, including changes in interest rates, inflation, price volatility and/or labor and materials shortages; demand for infrastructure, residential and non-residential construction and our products in geographic markets in which we operate; increased competition and its impact on prices and market position; increases in energy, labor and/or other raw materials costs; adverse changes to laws and regulations, including in relation to climate change; the impact of unfavorable weather; investor and/or consumer sentiment regarding the importance of sustainable practices and products; availability of public sector funding for infrastructure programs; political uncertainty, including as a result of political and social conditions in the jurisdictions CRH operates in, or adverse political developments, including the ongoing geopolitical conflicts in Ukraine and the Middle East; failure to complete or successfully integrate acquisitions or make timely divestitures; cyber-attacks and exposure of associates, contractors, customers, suppliers and other individuals to health and safety risks, including due to product failures. Additional factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those expressed by the forward-looking statements in this report including, but not limited to, the risks and uncertainties described herein and in “Risk Factors” in Part 1, Item 1A of this Annual Report on Form 10-K for the year ended December 31, 2024 (the ‘Annual Report on Form 10-K’).

CRH Form 10-K 5

Item 1. Business

Overview

CRH is a leading provider of building materials that build, connect and improve our world. In 2024, the Company generated $35.6 billion of revenues, $3.5 billion of net income and $6.9 billion of Adjusted EBITDA*.1Since formation in 1970, CRH has evolved from being a supplier of base materials to solving complex construction challenges for our customers.

CRH’s differentiated solutions strategy uniquely integrates materials, products and services across the construction value chain, better serving our customers’ needs and driving repeat business while making construction simpler, safer and more sustainable.

The Company integrates essential materials (aggregates and cement), value-added building products as well as construction services, to provide our customers with complete connected solutions. CRH’s capabilities, innovation and technical expertise enable it to be a valuable partner for transportation and critical infrastructure projects, complex non-residential construction and outdoor living solutions.

CRH’s business addresses the needs of customers across infrastructure, non-residential and residential construction markets. In 2024, approximately 35% of revenues came from infrastructure (such as highways, streets, roads and bridges), 30% from non-residential construction (including construction and maintenance of critical water, energy and telecommunications projects, in addition to manufacturing, commercial, warehouse and data center facilities) and 35% from residential construction. Approximately 60% of revenues came from sales to new-build construction, while 40% of revenues came from repair and remodel activity.

Operating in 28 countries, the Company has market leadership positions in North America, Europe and Australia. In 2024, approximately 72% of net income and 74% of Adjusted EBITDA* was generated in North America. The United States is expected to be a key driver of future growth for CRH due to continued economic expansion, a growing population and significant public investment in construction. In 2024, approximately 28% of net income and 26% of Adjusted EBITDA* was generated by our International Division. Our International businesses, which benefit from strong economic and construction growth prospects as well as recurring repair and remodel demand, are an important strategic part of the Company. CRH intends to continue to expand its North American and International operations given significant government support for infrastructure and increasing demand for customer-connected solutions in major infrastructure and commercial projects.

CRH has a proven track record in value creation through acquisition which over the last decade has accounted for approximately 60% of the Company’s growth. We achieve this by acquiring businesses at attractive valuations and creating value by integrating them with our existing operations and generating synergies. The Company takes an active approach to portfolio management and continuously reviews the competitive landscape for attractive investment and divestiture opportunities to deliver further growth and value creation for shareholders. In 2024, CRH completed 40 acquisitions for a total consideration of $5.0 billion compared with $0.7 billion in 2023. The largest acquisition in 2024 was in our Americas Materials Solutions segment where the Company completed the acquisition of a portfolio of cement and readymixed concrete operations and assets in Texas. The Company also completed the acquisition of a majority stake (57%) in the Australian building materials business Adbri Ltd (Adbri) within our International Solutions segment.

CRH has a primary listing on the New York Stock Exchange (NYSE) and an international secondary listing on the London Stock Exchange (LSE) for its ordinary shares, each listing represented by the ticker symbol “CRH”. References to the 'Ordinary Shares' and 'Common Shares' refer to our ordinary shares of €0.32 each.

Effective as of January 1, 2025, CRH is a U.S. domestic issuer.

Customer-Connected Solutions

CRH’s strategy integrates building materials, products and services by providing them to customers as complete solutions that solve complex challenges across the built environment.

Essential Materials

Essential Materials, consisting of aggregates and cement, are the foundation of CRH’s strategy. Our vertically integrated businesses manufacture and supply these materials for use extensively in a wide range of construction applications, ranging from major road and infrastructure projects to the development and refurbishment of commercial buildings, private residences, public spaces and communities. Our deep materials and market knowledge, along with our extensive network of locations and assets, drive our performance and helps us deliver value to our customers. Customers typically range from national, regional and local governments to contractors and other construction product and service providers.

Road Solutions

CRH is a leading provider of solutions for sustainable road construction in North America and Europe. With our capabilities in manufacturing, installation, maintenance and circularity, we deliver a range of innovative solutions for our customers to better connect our communities, from major public highway infrastructure projects to residential roads, airports and parking lots. As responsible operators considerate of our environmental impact, we optimize the use of recycled materials in our paving services, thereby reducing waste, emissions and energy consumption. Fully integrated with our Essential Materials businesses, we have developed our Road Solutions offering to provide customers with quality, flexibility, speed, expertise and convenience through our deep market knowledge and highly capable team of professionals.

Building and Infrastructure Solutions

Our Building & Infrastructure Solutions connect, protect and transport critical water, energy and telecommunications infrastructure to help solve complex construction challenges. We integrate design, materials, products and engineering to enable the transition to a more sustainable and resilient built environment. Our products have a particular focus on the below-ground built environment where we are a leading provider of multi-material infrastructure that connects and protects the critical projects that enhance the daily lives of millions of people.

* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.1

CRH Form 10-K 6

Outdoor Living Solutions

CRH’s Outdoor Living Solutions integrate specialized materials, products and design features to enhance the quality of private and public spaces. We help our customers in residential and commercial markets create unique outdoor settings by providing solutions for repair, remodel and new construction projects. Our business is closely connected to our customers through a broad geographic network as well as a comprehensive suite of products and services spanning hardscapes, masonry, fencing, railing, packaged lawn and garden products, pool finishes and composite decking. We place a strong focus on anticipating the needs of our customers and constantly strive to exceed their expectations. We do this by continually enhancing our offering through innovation, portfolio expansion and multifaceted collaboration.

Innovation and Sustainability

We are accelerating investment in innovation to develop a higher-performing and more sustainable built environment. Through our $250 million Venturing and Innovation Fund we are supporting the development of new technologies and innovative solutions to meet the increasingly complex needs of customers and evolving trends in construction. Our CRH Ventures platform partners with and invests strategically in construction and climate technology start-ups across the entire construction value chain, to pilot and scale cutting-edge and innovative technologies. Our ability to replicate and scale our innovation and technical expertise between geographies provides us with opportunities for further growth. Through our Innovation Center for Sustainable Construction (iCSC), we have a global network of experts across our businesses collaborating in the research, development and replication of innovative solutions.

Sustainability is deeply embedded in all aspects of our business and sustainability leadership is a key pillar of CRH’s purpose. CRH’s building materials solutions play an important role in shaping a more sustainable built environment and, in 2024, revenues from products with enhanced sustainability attributes1 was $14.6 billion, an increase of 5% compared with 2023 and an increase of 16% compared with 2022.

Our sustainability framework identifies three global challenges for society and the built environment: water, circularity and decarbonization. Our strategy focuses on transforming essential materials into value-added and innovative solutions to address these global challenges. By uniquely integrating our materials, products and services, we are positioned to capture further value and accelerate growth across CRH.

•Water: We are advancing solutions to address global water challenges by enhancing flood resilience and improving water management. This includes upgrading water infrastructure, improving wastewater treatment, recharging groundwater and conserving water across the supply chain.

•Circularity: We are reimagining the way materials are used to enable a more circular economy. Our efforts include preserving natural resources, recycling and reusing construction and waste materials, facilitating resource-efficient buildings and infrastructure and building more circular supply chains.

•Decarbonization: We are developing innovative solutions to support a low-carbon future. Our goals include reducing our absolute carbon emissions, minimizing operational carbon from our products and creating energy-efficient solutions to facilitate a clean energy transition.

In 2024, we continued to enhance our capabilities to meet these challenges through investment in innovative technologies. Two recent examples include our investment in FIDO AI, supporting the development of artificial intelligence leak detection software to accelerate our water infrastructure solutions in North America, as well as our strategic investment partnership with Sublime Systems, a U.S.-based company operating in the field of sustainable cement production. Through these efforts, we continue to develop and deliver innovative, climate-resilient solutions for our customers.

By continuing to meet the changing needs of our customers and society, we aim to drive further growth and value creation. In addition, we are striving to create a positive impact on the natural world, helping our people and communities to thrive. We stand out as a responsible business by collaborating to ensure a more sustainable supply chain and embedding responsible conduct at each level throughout our organization.

Business Segment Information

During the fourth quarter of 2024, the Company’s segments changed to three segments across two divisions. Refer to Note 20 “Segment information” in Item 8. “Financial Statements and Supplementary Data” for additional information.

Americas Division

CRH’s Americas Division comprises two segments: Americas Materials Solutions and Americas Building Solutions. The North American market’s positive fundamentals, including strong population growth and significant public investment in construction, is driving demand for CRH’s connected portfolio of materials, products and services. Over several decades, CRH has established difficult to replicate, leading positions of scale across the United States and Canada. The Division employs approximately 47,400 people at 2,008 locations across 48 states of the United States and seven Canadian provinces.

Americas Materials Solutions

Americas Materials Solutions provides building materials for the construction and maintenance of public infrastructure and commercial and residential buildings in North America. The primary materials produced by this segment include aggregates, cement, readymixed concrete and asphalt. This segment also provides paving and construction services for customers.

In 2024, this segment accounted for approximately 45% of CRH’s total revenues and 54% of Adjusted EBITDA. Approximately 50% of segment revenues came from infrastructure, 30% from non-residential construction and 20% from residential construction. New-build construction accounts for approximately 60% of segment revenues while the remaining 40% came from repair and remodel activity.

The Americas Materials Solutions segment leverages our benefits of scale, strong market knowledge, deep industry expertise and extensive array of essential materials to implement CRH’s strategy, offering value-added solutions which combine different types of materials, products and services to satisfy multiple customer needs. In turn, this enables CRH to provide a value-enhancing, differentiated experience, saving time and reducing logistical challenges for customers. Through this customer-connected approach CRH aims to reduce lead times and complexity, deepening relationships, driving repeat business and increasing the share of customer wallet spent on CRH products and services.

Vertical integration is a defining characteristic within this segment, enabling us to optimize production throughout the supply chain and to capture greater value. In order to support its operations, the Company has established a network of long-term reserves at quarry locations, predominantly adjacent to urban areas where demand for its materials and products is strongest.

1 Revenues from products with enhanced sustainability attributes is defined as revenues derived from those products that incorporate any, or a combination of: recycled materials; are produced using alternative energy and fuel sources; have a lower carbon footprint as compared to those products using traditional manufacturing processes; and are designed to specifically benefit the environment.

CRH Form 10-K 7

Americas Building Solutions

Americas Building Solutions manufactures, supplies and delivers high-quality, value-added, innovative solutions for the built environment in communities across North America. Products in this segment are highly specified, designed and engineered thereby adding value for the customer. This segment serves complex critical infrastructure (such as water, energy, transportation and telecommunications projects) and outdoor living solutions for enhancing private and public spaces.

In 2024, Americas Building Solutions accounted for approximately 20% of CRH’s total revenues and 20% of Adjusted EBITDA. Approximately 65% of segment revenues came from sales to residential, 25% to non-residential and 10% to infrastructure markets. Repair and remodel activity accounted for approximately 60% of segment revenues, with the remaining 40% from new-build construction.

This segment analyzes market trends, including increasing urbanization, demand for more sustainable construction and evolving customer preferences to devise high-quality, effective building product solutions. CRH’s ability to provide solutions which are tailored to the specific requirements of individual customer projects helps to drive competitive advantage and deliver sustainable growth in this segment.

International Division

CRH’s International Division, which comprises one segment, International Solutions, is a leading provider of integrated building solutions primarily across Europe and Australia. During the fourth quarter of 2024, the former Europe Materials Solutions and Europe Building Solutions segments were combined into this International Solutions segment reflecting how the business is managed. In Eastern Europe and Australia we see higher-growth potential through strong economic activity, while in Western Europe, CRH’s businesses operate in attractive markets backed by significant public infrastructure spending and region- wide programs that support construction activity. In these regions, CRH is experiencing increasing demand for its customer-connected solutions offering. The Division employs approximately 32,400 people at 1,808 locations across 27 countries.

International Solutions

International Solutions integrates building materials, products and services for the construction and renovation of public infrastructure, critical networks, commercial and residential buildings, and outdoor living spaces. CRH has established itself as a leader in its markets, enabling strong value creation through commercial excellence and performance improvement initiatives, while serving growing demand across the construction value chain for innovative and value-added products and services.

In 2024, this segment accounted for approximately 35% of CRH’s total revenues and 26% of Adjusted EBITDA. Approximately 35% of segment revenues came from infrastructure, 35% from residential construction, and 30% from non-residential construction. New-build construction accounted for approximately 70% of segment revenues, with the remaining 30% from repair and remodel activity.

Materials and Products

The following materials and products are produced and supplied by CRH’s connected portfolio of businesses.

Aggregates

Aggregates are naturally occurring mineral deposits such as granite, limestone and sandstone. CRH extracts these deposits and processes them for sale as aggregates products such as crushed stone, sand and gravel. Typically, aggregates are used in road and rail infrastructure, building foundations and in the production of products including concrete and asphalt. Annualized aggregates sales volumes2 in 2024 for the Americas Division and International Division were 229.8 million tons and 143.1 million tons, respectively.

Cement

Cement is produced from limestone reserves and is the primary binding agent in the production of concrete products, including readymixed concrete and mortars, which are used extensively throughout the built environment. Annualized cement sales volumes2 in 2024 for the Americas Division and International Division were 13.9 million tons and 35.7 million tons, respectively.

Concrete

Concrete is a highly versatile building material, comprised of aggregates bound together with cement and water. Readymixed concrete is the most commonly used form of concrete. It forms the foundations of buildings and homes, roads, tunnels and bridges, water management systems and clean energy structures. While readymixed concrete is supplied to customers for on-site casting, CRH’s infrastructural concrete businesses produce and supply precast and pre-stressed concrete products such as floor and wall elements, beams and vaults, pipes and manholes. These products are delivered to, and assembled at, construction sites where they are used throughout the modern built environment. Annualized readymixed concrete sales volumes2 in 2024 for the Americas Division and International Division were 17.4 million cubic yards and 21.1 million cubic yards, respectively.

Asphalt

Asphalt consists of aggregates bound together with bitumen and is widely used as a surface material in roads, bridges, airport runways, sidewalks and other amenities. In recent years, the use of recycled materials in asphalt has increased considerably. Using materials from existing road surfaces to produce new asphalt reduces the demand for virgin material, extends the life of our aggregates reserves and contributes to reducing the carbon footprint of the product. Recycled Asphalt Pavement (RAP) and Recycled Asphalt Shingles (RAS) are used extensively by CRH businesses to produce new asphalt products for road and other surfaces. Annualized asphalt sales volumes2 in 2024 for the Americas Division and International Division were 52.2 million tons and 10.0 million tons, respectively.

Building Products

CRH’s strategy of vertical integration utilizes our essential materials to produce a range of value-added building products and solutions. These include the manufacturing of concrete and polymer-based products such as underground vaults, drainage systems, enclosures and modular precast structures which are typically supplied to the water, energy, telecommunications and railroad markets. CRH also provides a range of engineered steel and polymer-based anchoring, fixing and connecting solutions for a variety of new-build construction applications.

2 Annualized sales volumes reflect the full-year impact of acquisitions and divestitures during the year and may vary from actual volumes sold. This includes volumes which are used internally (e.g. aggregates supplied internally for cement production).

CRH Form 10-K 8

Further, CRH manufactures a variety of concrete masonry, hardscape and related products including pavers, blocks and curbs, retaining walls and slabs. CRH also produces fencing and railing systems, composite decking, lawn and garden products and packaged concrete mixes. These products are supplied to residential, commercial and do-it-yourself (DIY) construction markets.

Key Trends and Opportunities

Key trends affecting the development of CRH's businesses include:

•Population growth and urbanization driving increasing demand for construction;

•Economic development and further investment in infrastructure, commercial and residential projects; and

•Recurring need to repair, maintain and upgrade the built environment as existing buildings and infrastructure age and wear.

In addition, there are several industry-specific trends that are shaping how CRH evolves to meet the needs of its customers:

•Unprecedented levels of funding support for critical infrastructure and the onshoring of manufacturing activity;

•An evolving regulatory landscape driving increasing customer demand for innovative, connected solutions to deliver a more resilient and sustainable built environment; and

•Supply-side dynamics, such as labor constraints, driving increasing investment in automation, technology and digital solutions.

Environmental and Governmental

Regulations

Our operations in the United States are subject to federal, state and local laws, while our European operations are subject to national environmental laws and regulations stemming primarily from European Union (EU) directives and regulations. Our operations elsewhere are typically subject to both national and local regulatory requirements.

Compliance and Costs

Compliance with applicable regulations requires capital investment and ongoing expenditures for the operation and maintenance of systems and implementation of improvement programs. These include investments in licensing, permitting and monitoring, waste and water management plans, reductions in air emissions and energy consumption, promotion and protection of biodiversity, education and training, as well as employment of environmental specialists within CRH. These capital investments and expenditures were not material to CRH’s earnings, results of operations or financial condition in 2024 and 2023.

Management believes that its current provision for environmental and remediation costs is reasonable and that any potential non-compliance at its operations and facilities with applicable environmental laws and regulations is not likely to have a material adverse effect on CRH’s operations or financial condition. See Item 3. “Legal Proceedings" and Note 13 “Asset retirement obligations” in Item 8. “Financial Statements and Supplementary Data”.

Land and Environmental Management

We generally own or lease the real estate on which our main raw materials, aggregates and other minerals are located. As part of our vertically integrated business model, we have established an extensive global network of extractive sites comprised of 1,296 properties, of which 246,058 acres of land are owned and 129,818 acres are leased. These extractive sites provide us with the raw materials to manufacture various primary building materials, such as aggregates, cement, asphalt, readymixed concrete and concrete products. We offer these products directly for sale and integrate them into our downstream products and services. Materials produced by our aggregates and cement businesses, for example, can be supplied to our downstream businesses for use in our Road Solutions, Building & Infrastructure Solutions and Outdoor Living Solutions businesses.

Our operations are typically required to comply with government land use plans and zoning requirements. We are required by government authorities to obtain permits to operate certain workplaces, such as quarries, mines, production and distribution facilities, including water rights required to operate many of our sites. The terms and general availability of government permits required to conduct our business influence the scope of our operations on the respective sites. We are also required to obtain permits and adhere to applicable restrictions, often including establishing appropriate environmental management systems, to minimize the risk that necessary permits are revoked, modified or not renewed.

CRH is also subject to multiple laws that require the Company, as a mine operator, to reclaim and restore properties after mining activities have ceased. As a result, we are required to record reasonable provisions for such reclamation in our Consolidated Financial Statements.

From time to time, we are required by law and/or contractual obligations to investigate and remediate releases of hazardous substances at our manufacturing sites and at sites where hazardous substances from our operations may have been disposed of. Where we have been required to incur such expenses, we are required to record reasonable provisions for such remediation in our Consolidated Financial Statements.

The Clean Air Act in the United States and similar laws elsewhere require that certain of our facilities, including our cement plants, obtain and maintain air emissions permits that subject them to pollution control requirements and require pre-approval for constructing certain facilities. CRH is also required to comply with laws designed to promote biodiversity and protect ecosystems. From time to time, CRH may be required to install additional equipment or technologies to remain in compliance with such environmental regulations.

Climate Change

We believe the transition to a more sustainable built environment represents a significant commercial opportunity for CRH. We are well-positioned to support the increased demand for more sustainable products, which is underpinned by robust funding programs and regulatory policies in the geographies in which we operate. In addition, extreme weather events are increasing the need for more climate-resilient infrastructure.

CRH Form 10-K 9

CRH has an absolute carbon dioxide (CO2) emissions reduction target of 30% by 2030 (from a 2021 base year) inclusive of organic business growth. The Science Based Targets initiative (SBTi) has validated our targets3 in line with a 1.5°C trajectory. A significant portion of the actions required to deliver on the 2030 roadmap are based on known technologies, well-established operational excellence programs and activities in which CRH has a proven track record of delivery. CRH’s roadmap includes incremental capital expenditure of approximately $150 million per annum on average, which is subject to strict internal investment criteria and the net business benefit is expected to increase revenues and profitability.

In 2024, our Scope 1 and 2 absolute carbon emissions decreased by 4%, from 31.0 million tonnes4 in 2023 to 29.7 million tonnes in 2024, as we made further progress implementing the key levers in our decarbonization roadmap which offset the impact of an increase in emissions arising from changes in our business portfolio. Our cement-specific net CO2 emissions per tonne of cementitious product reduced to 537kg (562kg in 2023). We are also continuing to advance our contribution to the circular economy, preserving scarce natural resources and using more recycled materials in construction. In 2024, we recycled 44.7 million tonnes of by-products and wastes, sourced internally and from other industries, for use as alternative materials and fuels in our products and processes (43.9 million tonnes in 2023).

Supply Chain

CRH employs a dedicated global purchasing team and its supply chain combines vertical integration as well as external suppliers and service providers to deliver products to customers in various markets.

As outlined on page 9, CRH owns or leases the real estate on which its main raw materials are located and has established an extensive global network of quarries. As part of its vertically integrated business model, the raw materials from these quarries are used to manufacture primary building materials, such as aggregates, cement, asphalt, readymixed concrete and concrete products, which are offered directly for sale or integrated into downstream products and services.

CRH is a significant purchaser of certain materials and resources important to its business, including cement, bitumen, steel, supplementary cementitious materials and energy supplies, all of which it acquires at market rates. CRH is not dependent on any one source for the supply of these materials and resources, other than in certain jurisdictions with regard to the supply of gas and electricity.

CRH also utilizes various external suppliers and service providers throughout its business in addition to its internal supply chains, which enables it to economically source various raw materials, equipment and other inputs and to transport finished product to customers. The Company is committed to establishing a sustainable and resilient supply chain. The Company takes an active approach to monitoring the resilience of its supply chain and ensures that it has access to a satisfactory level of required inputs at all times.

Seasonality

Activity in the construction industry is dependent to a considerable extent on the seasonal impact of weather on the Company’s operating locations, with periods of higher activity in some markets during spring and summer which may reduce significantly in winter due to inclement conditions and extreme weather events. In addition to impacting demand for our products and services, adverse weather can negatively impact the production processes for a variety of reasons. For example, workers may not be able to work outdoors in sustained high temperatures and heavy rainfall and/or other unfavorable weather conditions.

Competitive Environment

CRH is a market leader in many of the construction markets it operates in across North America, Europe and Australia. CRH prioritizes investment in markets with attractive fundamentals including population and economic growth, which drive demand for construction. Many of the markets in which CRH operates are highly fragmented, and as a result, CRH products and services face strong competition. The Company’s profits are sensitive to changes in volumes and prices which are impacted from time to time by competitive conditions experienced in different markets.

Pricing for products is impacted by macroeconomic conditions, the number of competitors, the degree of utilization of production capacity, the specifics of product demand, innovation and differentiation, among other factors.

Fragmented markets continue to offer focused growth opportunities for CRH. Similarly, competitors may seek to expand their existing positions or enter new markets and the Company may experience competition for potential acquisitions identified by CRH management.

3 The SBTi’s Target Validation Team has determined that CRH’s target ambition for Scope 1 and Scope 2, as well as Scope 3 for purchased clinker and cement, is in line with a 1.5°C trajectory.

4 Note all sustainability metrics are presented in metric tonnes. Scope 1, 2 and 3 absolute CO2 emissions were 47.1 million tonnes in 2024 (44.1 million tonnes in 2023).

CRH Form 10-K 10

Intellectual Property and Research & Development

CRH relies on a combination of intellectual property laws, confidentiality procedures and contractual provisions to protect its proprietary assets and brands. CRH has registered or applied for registration of trademarks, service marks and internet domain names, both domestically and internationally, where appropriate.

CRH engages in ongoing research & development projects to improve existing and develop new technologies that will empower more sustainable forms of construction in the future. The Company’s research initiatives include:

•A $250 million Venturing and Innovation Fund to support the development of new technologies and innovative solutions. To date, research initiatives across the Company include hydrogen use, CO2 mineralization projects, novel cements, artificial intelligence technology and Carbon Capture Usage and Storage (CCUS);

•CRH Ventures, the Company’s venture capital arm, invests in, and partners with, construction technology and climate technology companies across the construction value chain to pilot and scale new technologies and innovations that will enable safer, smarter and more sustainable construction; and

•iCSC, CRH’s global center of excellence provides expertise and leadership to identify and analyze global market and construction trends and new growth opportunities to maximize the value of sustainable innovation. The iCSC incorporates a global network of laboratories and experts at CRH’s operating companies collaborating to advance research on sustainable building materials and processes, such as low-carbon cement and concrete.

Through these initiatives, CRH is supporting the development of new technologies and innovative solutions to meet the increasingly complex needs of customers and evolving trends in construction.

Human Capital Resources

People are our priority, and we believe that building a safe and inclusive work environment that empowers and inspires our global workforce is core to our success. In 2024, we employed approximately 79,800 people at 3,816 locations in 28 countries, of which approximately 47,400 were in the Americas Division and 32,400 in the International Division. Some of our businesses are seasonal in nature which results in peaks and troughs in employment numbers across certain sections of our workforce. These changes are managed through fair and flexible hiring practices.

Safety and Well-Being

The safety and well-being (including physical and mental health) of our employees, contractors and other stakeholders is embedded in CRH’s values. Our ambition is to have a culture of safety and wellness working towards zero harm, with a target of zero fatalities in any year. The Safety, Environment & Social Responsibility Committee, a Board committee, receives regular reports in relation to safety indicators.

CRH invests substantial time, effort and financial resources to comply with applicable regulations and ensure a safe workplace. In 2024, 94% of our locations had zero accidents and we achieved a lost time incident rate of 0.22 based on the number of incidents per 200,000 work hours for employees and contractors globally. We continue to monitor near misses, prioritizing those high potential learning events to achieve our goal of zero harm. We also invest in initiatives and programs across CRH, including training, technologies and our equipment to increase the standard of safety across our operations and reduce risks. CRH further supports our employees through our health and well-being programs providing tools, social support and strategies for physical and mental health.

Our mining operations, manufacturing facilities and other operations are subject to a variety of worker health and safety requirements, including laws and regulations administered by the United States’ Occupational Safety and Health Administration (OSHA) and Mine Safety and Health Administration (MSHA) and their state-level and foreign equivalents. Failure to comply with these applicable workplace health and safety requirements can result in sanctions and claims for personal injury and property damage and/or the closure of sites.

Employee Engagement

Employee engagement is critical in generating insights regarding CRH’s performance culture, training and career development opportunities, safety culture, corporate purpose, initiatives to support inclusion and overall strategy. The Board has delegated responsibility for the management of employee engagement to the Nomination & Corporate Governance Committee. Through employee engagement, we gain a better understanding of what matters most to our employees. We continue to adapt engagement strategies, ways of working and leadership development approaches based on employee feedback.

Working with the executive leadership team (Global Leadership Team), CRH develops action plans based on the results of these engagements. The proximity of our senior leaders to daily operations across CRH is a key reason for the Company's continued success and enables dynamic engagement across our operations.

We operate both unionized and non-unionized workplaces.

Learning and Development

We are focused on creating a global workforce that will drive performance now and for years to come. Learning and development is integral to embedding our culture and values, ensuring compliance with policies and attracting, retaining and developing top talent. We invest in talent development throughout our businesses, empowering our employees across all levels of education and employment to grow their careers through personal and professional development opportunities to ensure we have a pipeline of talent in place for the next generation of leaders at CRH. We continue to roll out our Frontline Leadership Program, which provides leadership development training for frontline supervisors across CRH, advancing the skills of our employees across a range of programs such as management, inclusive leadership and safety. We have also established multiple training and compliance programs to support appropriate conduct, including mandatory annual trainings regarding anti-bribery, anti-fraud and anti-theft topics.

Inclusion and Engagement

At CRH, we want to enhance and sustain a culture where fairness, inclusion and belonging are achievable for everyone. The Board and management team are committed to building a respectful and inclusive culture where talented people of all backgrounds have opportunities and can perform at their best. CRH has an engagement strategy which is built on, among other things, a firm commitment to nurture respect and inclusion as a core capability.

CRH promoted our inclusion and engagement goals through a range of initiatives and developments in 2024, including the development of new toolkits, forums and supports for our Employee Resource Groups (ERGs). Our ERGs are voluntary, employee-led groups, open to all employees including allies. Their aim is to foster an inclusive workplace by strengthening communication, community and employee experience.

CRH Form 10-K 11

Available Information

The Company maintains an internet address at www.crh.com and makes available free of charge through its website its annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and amendments thereto, if any, filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, which are available as soon as reasonably practicable after CRH files or furnishes such information to the SEC. The Company also posts its proxy statements on its corporate website. Investors may also access such documents via the SEC’s website at www.sec.gov.

References in this document to other documents on the CRH website are included only as an aid to their location and are not incorporated by reference into this Annual Report on Form 10-K. CRH’s website provides the full text of earnings updates, and copies of presentations to analysts and investors.

Further, copies of CRH’s key corporate governance policies and other reports, including its Code of Business Conduct, Sustainability Performance Report and the charters for Committees of the Board, may be found on the CRH website.

The Company undertakes no obligation to update any statements contained in this Annual Report on Form 10-K or the documents incorporated by reference herein for revisions or changes after the filing date of this Annual Report on Form 10‐K, other than as required by law.

We post on our website news releases, announcements and other statements about our business performance, results of operations and sustainability matters, some of which may contain information that may be deemed material to investors. Additionally, we use our LinkedIn account (www.linkedin.com/company/crh), as well as our other social media channels from time to time, to post announcements that may contain information that may be deemed material to investors. Our executive officers may use similar social media channels to disclose public information. We encourage investors, the media and others interested in CRH to review the business and financial information we or our executive officers post on our website and the social media channels identified above. Information on CRH’s website or such social media channels does not form part of, and is not incorporated into, this Annual Report on Form 10-K.

CRH Form 10-K 12

Item 1A. Risk Factors

In addition to the other information contained in this Annual Report on Form 10-K, you should carefully consider the following risk factors before investing in our ordinary shares. The risks and uncertainties we describe below are not the only ones we face. Additional risks and uncertainties of which we are not aware or that we currently believe are immaterial may also adversely affect the business, financial condition and results of operations of the Company. If any of the possible events described below were to occur, the business, financial condition and results of operations of the Company could be materially and adversely affected. If that happens, the market price of our ordinary shares could decline, and holders of our ordinary shares could lose all or part of their investment.

This Annual Report on Form 10-K also contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including the risks described below and elsewhere in this Annual Report on Form 10-K.

Risks Related To Our Industry And Our Business

Industry Cyclicality and Economic Conditions

CRH’s business depends on construction demand, and construction activity is inherently cyclical and influenced by multiple factors, including global and national economic circumstances (particularly those affecting the infrastructure and construction markets), monetary policy, consumer sentiment, swings in fuel and other input costs, and weather conditions that may, individually or collectively, disrupt outdoor construction activity.

Given the nature of our core products, many of which cannot be transported on a cost-effective basis over long distances, our operations are particularly sensitive to the economic conditions in the local markets in which we operate. In general, economic uncertainty and rising interest rates can exacerbate negative trends in construction activity, including when current and/or prospective customers are unable to obtain credit or issue bonds, which can lead to the postponement, delay and/or cancellation of projects, and an associated negative impact on demand for building materials and related services. With a significant proportion of construction activity undertaken outside (e.g. highway construction), demand for and the utilization of the Company's products and services such as aggregates, asphalt and concrete can be highly seasonal in line with customer demand, and may additionally be impacted by acute and/or chronic changes in global and/or localized weather events/conditions.

In addition, CRH may also be negatively impacted by fluctuations in the price of fuel and principal energy-related raw materials, which accounted for approximately 10% of total revenues in 2024, compared to 11% in 2023, with no guarantee that the Company will continue to be able to absorb these inflationary pressures.

Government Infrastructure Spending

CRH’s financial performance may be adversely impacted by reductions or delays in government infrastructure spending.

A significant percentage of the Company’s products and/or services is consumed by public infrastructure projects, including the construction of highways and bridges. Accordingly, demand for our products may be impacted by adverse changes in public policy, as well as the financial resources and investment strategy of government bodies in our markets. The allocation of government funding for public infrastructure programs is a key driver for our markets, such as the infrastructure elements of the Infrastructure Investment and Jobs Act (IIJA) in the United States, and large European infrastructure initiatives.

However, government budget deficits might reduce government infrastructure investment and reduce demand for the Company’s products. Similarly, any significant delay and/or adverse change in investment strategy by policy makers in any of the Company’s key markets could reduce market demand, adversely impacting financial performance.

Adverse Geopolitical Change/Environment

Adverse public policy, economic, social and political situations in any country in which the Company operates could lead to a number of risks including health and safety risks for the Company's people, a fall in demand for the Company’s products, business interruption, restrictions on repatriation of earnings and/or a loss of plant access.

CRH primarily operates across North America, Europe and Australia. The economies of these countries in which we operate are broadly stable. However, they are at varying stages of development, which presents multiple risks and uncertainties that could adversely affect the Company’s operations and financial results. These risks and uncertainties include:

•Changes in political, social or economic conditions;

•New or strengthened trade protection measures, currency controls or import or export licensing requirements;

•Political unrest and currency shocks;

•Social activism and civil disturbance, terrorist events or outbreak of armed conflict, among other potential causes;

•Labor and procurement practices which contravene ethical considerations and regulatory requirements;

•Unexpected changes in regulatory and tax requirements; and

•Lockdowns or other restrictions due to public health emergencies, such as pandemics.

In addition, CRH has people, assets and operations in Ukraine and neighboring countries, which face physical risk due to the ongoing conflict. The Board and management are actively monitoring the situation in Ukraine, as uncertainty continues to exist due to the ongoing conflict in the region.

CRH Form 10-K 13

Health and Safety Performance

CRH’s businesses operate in an industry with inherent health and safety risks, including the operation of heavy vehicles, working at height, use of mechanized processes, and handling of substances and materials potentially hazardous to people, animal life and/or the environment. Any failure to ensure safe workplaces could result in a deterioration in CRH’s safety performance and related adverse regulatory action or legal liability. Health and safety incidents could significantly impact CRH’s operational and financial performance, as well as its reputation.

CRH’s safety risks extend to sites not wholly within our control, including outdoor paving and construction sites. This environment presents a complex challenge which requires safe behaviors and engagement from employees as well as robust Company policies and procedures. A high number of accidents may pose additional challenges in recruiting new employees, ensuring operational continuity and maintaining licenses and permits.

Further, CRH is subject to a broad and stringent range of existing and evolving laws, regulations, standards and best practices with respect to health and safety in each of the jurisdictions in which it operates. Should CRH’s health and safety frameworks, processes and controls fail to comply with such regulations, the Company could be exposed to significant potential legal liabilities and penalties. Any failure resulting in the discharge or release of hazardous substances to the environment (e.g. storage tank leaks, or explosions) could in addition expose CRH to significant liability remediation costs and/or penalties that impact our financial position.

In addition, potential issues with products could lead to health, safety and other issues for our broad range of stakeholders including our employees, contractors, customers and communities.

The recurrence of Covid-19 and/or similarly disruptive/dangerous pandemics could materially endanger our workers and/or contractors.

People Management

CRH may not achieve its strategic objectives if it is not successful in attracting, engaging, retaining and developing employees with the required skill sets, planning for leadership succession, developing an engaged and inclusive workforce, and building constructive relationships with collective representation groups.

The identification and subsequent assessment, management, development and deployment of talented individuals is of major importance in continuing to deliver on the Company’s strategy and in ensuring that succession planning objectives for key executive roles throughout its international operations are satisfied. As well as ensuring the Company identifies, hires, integrates, engages, develops and promotes talent, the Company must attract and retain a broad workforce representing diversity of thought and perspective and maintain an inclusive working environment. Our ability to achieve these objectives depends on the availability of a pool of workers with the required training and skills, and the attractiveness of our employer value proposition compared with competing employers.

The Company operates in a labor-intensive industry and can face frontline labor shortages that impact its ability to produce goods, operate facilities and install products. Additionally, any significant loss of employee resources for a sustained period of time (e.g. due to sickness or a public health emergency) could impact the Company’s ability to maintain operations.

The Company must also maintain constructive relationships with the trade/labor unions that represent certain employees under collective agreements. Failure to do so could mean that the Company cannot renegotiate on appropriate terms the relevant collective agreements upon expiration and may face strikes or work stoppages as a consequence. Poor labor relations could create reputational risk for the Company and/or disrupt our businesses, raise costs and reduce revenues and earnings from the affected locations, with potential adverse effects on the results of operations and financial condition of the Company.

Strategic Mineral Reserves and Permitting

Failure of CRH to maintain access to mineral resources and reserves, plan for reserve depletion and secure or maintain permits for its mining operations may result in operation stoppages, adversely impacting financial performance.

Continuity of the cash flows derived from the production and sale of certain building materials depends on satisfactory reserves planning, including appropriate long-term arrangements for their replacement. The high weight-to-price ratio of the aggregates we consume generally makes it uneconomical to transport them over long distances, and accordingly it is important to secure high quality mineral resources local to our markets or adjacent to appropriate logistical hubs (e.g. rail infrastructure). Any failure to adequately plan for reserve depletion, or accurately forecast future growth markets, could lead to a failure to maintain, and/or acquire and develop required sites, especially given long development lead times, and associated operational stoppages that adversely impact financial performance and cash flows.

Appropriate reserves are increasingly scarce, and licenses and permits required for operations are also becoming harder to secure (e.g. due to increasing resistance from communities that have expanded around potential attractive reserves). In addition, the Company cannot guarantee that it will continue to satisfy the many terms and conditions under which such licenses and permits are granted and/or renewed.

Reserve estimates and projections of production rates of the minerals used in the Company’s products inherently contain numerous assumptions and uncertainties, that, for example, may depend upon geological interpretation, and statistical inferences or assumptions drawn from drilling and sampling analysis. If such interpretations, inferences or assumptions are subsequently proven incorrect and differ materially from actual geological conditions and/or production rates, we may exhaust reserves more quickly than anticipated over the long-term.

The failure to plan adequately for current and future extraction and utilization or to ensure ongoing compliance with requirements of issuing authorities could lead to operational disruptions and negatively affect our long-term financial results. For additional information on the Company’s reserves position, see pages 22 to 26.

Climate Change and Policy

The impact of climate change may adversely affect CRH’s operations and cost base and the stability of markets in which the Company operates. Risks related to climate change that could affect the Company’s operations and financial performance include both physical risks (such as acute and chronic changes in weather) and transitional risks (such as technological development, policy and regulation change and market and economic responses).

Risks related to climate change that could affect the Company’s operations and/or financial performance are discussed as follows:

Physical

Acute weather events such as hurricanes or flooding, and chronic events such as increased precipitation, rising sea levels and/or temperatures may have an adverse effect on the Company’s business and operations. Operational productivity and demand for the Company’s products may be reduced during these weather events leading to reduced financial performance. Changing population demographics and other macro events arising from climate change may also impact demand for our products in significantly affected areas.

CRH Form 10-K 14

Transition

•Legal and Regulatory: As stakeholder expectations with regard to climate change continue to evolve, and various governmental bodies in our markets propose changes to laws and regulations covering emissions, carbon allowances and taxation, we may be exposed to increased operational, compliance and litigation related risks and costs. Efforts to address climate change through laws and regulations, for example by requiring reductions in emissions of greenhouse gases (GHG) such as CO2 can create economic risks and uncertainties for the Company’s businesses. Such risks could include the introduction of more extensive carbon emissions caps and associated carbon costs, additional costs of installing equipment to reduce emissions to comply with GHG limits, and higher costs from the imposition of legislative and/or regulatory controls. There is a risk of reduced competitiveness due to any failure of equalization measures to level costs between domestic producers and importers from countries with lower enforced environmental regulations/GHG constraints.

•Technology: The Company has publicly set itself carbon emission reduction goals and ambitions, the delivery of which may depend on the rapid advancement of technologies, such as CCUS, that are still in early prototype or development phases. If our assumptions as to technology development timelines and/or our ability to economically access them prove inaccurate, we may be unable to deliver our emissions targets.

•Reputational: Any failure to reduce emissions arising from our operations or meet investor and other stakeholder groups’ expectations with regard to emissions reductions may adversely impact the Company's reputation and/or increase the likelihood of associated stakeholder litigation. In addition, the Company may incur materially increased costs related to increases in the cost of carbon, requirements to make further capital investments, reduced access to capital, challenges in retaining and/or attracting talent, local community opposition to operating facilities, and any inability to secure licensing permits.

Portfolio Management

CRH engages in acquisition and divestiture activity as part of active portfolio management, and this portfolio management activity presents risks around due diligence, execution and integration of assets. Additionally, the Company may be liable for liabilities of companies it has acquired or divested. Failure to efficiently identify and execute deals may limit the Company’s growth potential and impact financial performance.

The Company’s acquisition strategy depends on successfully identifying and acquiring suitable assets at prices that satisfy our stringent cash flow and return on investment criteria. The Company may not be able to identify such companies, and, even if identified, may not be able to acquire them because of a variety of factors including the outcome of due diligence processes, the ability to raise required funds on acceptable terms, regulatory approvals (including in certain instances from competition authorities) and competition for transactions from peers and other entities acquiring companies in the building materials sector. In addition, situations may arise where the Company may be liable for the past acts, omissions or liabilities of acquired companies, or may remain liable in cases of divestiture (including for potential environmental liabilities or potential on-going information technology (IT) support).

In addition, the Company’s ability to realize the expected benefits from acquisitions depends in part on its ability to integrate newly-acquired businesses. If the Company fails to integrate acquisitions, it may not achieve expected growth synergies or financial, operating or other benefits, and it may incur write-downs, impairment charges or unforeseen liabilities that could negatively affect its operating results or financial position or could otherwise harm its business. Further, integrating an acquired business, products, or technology, or remediating post-acquisition underperformance and associated operational challenges, could divert management time and resources from other matters.

The Company may decide to use shares of its common stock to complete an acquisition and/or make strategic investments in other companies, which may dilute the ownership interests of existing shareholders and adversely impact the price of our stock.

Early Stage Business/Technology Investment

CRH’s venture capital unit may fail to achieve expected commercial success and financial returns, and CRH may lose all or part of its investments in early-stage companies.

CRH, through its $250 million Venturing and Innovation Fund, makes investments in early stage ventures focused on construction, sustainability and digitalization technology whose products and services may offer us future competitive advantage.

Investing in early-stage businesses and/or technologies presents inherent risks, with the potential that we may lose all or part of our investment if they fail to achieve anticipated strategic, technological and financial returns. If we realize losses on our venture investments, our results of operations and financial condition may be adversely impacted.

Sustainable Products and Innovation

If CRH fails to develop new sustainable products that meet customer needs, we may fall behind our competitors and our financial performance may be adversely impacted.

We operate in competitive markets with customers continuously pushing suppliers to deliver new, innovative products and solutions that enable them to work more efficiently, reduce their environmental footprint and realize greater cost savings. This is especially so in relation to changing customer preferences and demands for high-performance sustainability solutions with enhanced emissions and/or circularity profiles, including those with greater recycled content and/or innovations to existing products, that help them to deliver on their own climate and/or emissions-related commitments.

The failure to keep up with the pace of technological change may lead to increased operational costs and financial loss through the inability to supply products to customers who require innovative and low-carbon sustainable solutions. Failure to leverage innovation and other sustainability initiatives, for example transitioning to innovative lower-carbon products such as RAP, permeable paving solutions, lower-carbon cements and other high-performance sustainability solutions, may shorten product life cycles or give rise to early product obsolescence thus impairing financial performance and/or future value creation.

CRH Form 10-K 15

Commodity Products and Substitution

CRH manufactures and supplies a large number of commodity products into highly competitive markets. Failure by CRH to maintain pricing in an inflationary environment and to differentiate its products from its competitors could adversely impact our financial performance.

Many of the Company’s products are commodities that face strong volume and price competition, with pricing impacted by macroeconomic conditions, the competitive environment, the degree of utilization of production capacity and the specifics of product demand, among other factors. In addition, the Company’s local competitors are increasingly innovative and cost competitive, and our products may also face competition from substitute products, including new products, that the Company does not produce. Any significant shift in demand preference to these alternate products could adversely impact market share and results of operations.

The Company may experience downward pricing pressure from time to time across its different markets and may not always be able to raise prices to offset increased operating expenses and inflationary pressures. The Company’s profits are particularly sensitive to changes in volume, as the cement business is capital-intensive and thus has significant fixed and semi-fixed costs.

Any failure to maintain strong customer relationships could result in an inability to respond to changing consumer preferences and approaches to construction. Failure to differentiate and innovate could lead to market share decline, with adverse impacts on financial performance.

Enabling Business Technology

CRH depends on multiple types of information and operational technologies, and failure to properly manage and maintain such technologies could adversely impact our ability to operate.

The Company makes significant capital investments in information and operational technology, and systems to promote operational efficiency and maintain competitive advantage. Some of these investments relate to complex, multi-year technology deployments that require specialist customization and project management to deliver expected value (including Enterprise Reporting Program (ERP) and industrial control systems deployments and upgrades). The Company maintains a complex operating environment in relation to both information and operating technology, that includes on-premises, hybrid and cloud technologies supported by a mixture of third-party outsourced service providers and internal resources. Any failure to properly manage the customization and/or deployment of these systems or this complex operating environment may result in additional costs being incurred, and/or delayed or eroded benefit realization. If we fail to make the required technological investments at the right time, we may lose competitive advantage and/or inhibit our ability to comply with evolving laws and/or regulations.

Given the specific nature of the technology that the Company implements, it often relies on the support of specialist third-parties; any failure to secure appropriately skilled and experienced third-parties may result in an increased risk of unsuccessful implementations, time delays and/or increased costs.

Major Business Interruption

CRH depends on the continued availability of people, production equipment, processes and systems, and our production could be materially disrupted by operational failures, which would have a negative impact on our profitability.

Given the capital-intensive nature of some of our product lines, with significant fixed and semi-fixed costs, the Company's profits are particularly sensitive to changes in volume, creating an exposure to any natural and/or human events that could disrupt production.

The ongoing, efficient operation of our facilities is often dependent on important pieces of equipment and IT networks/infrastructure. These can present single points of failure and can be difficult to quickly and/or easily replace due to long supply chain lead times and high associated capital costs. It is possible we could experience periodic disruption to equipment availability for a variety of reasons, including accidents, mechanical failures, fires/explosions and extreme weather conditions.

In addition to damaging equipment, extreme weather events could also disrupt operations through delaying project start dates, extending product curing times, and/or disrupting infrastructure on which we depend including power and water networks. In addition, the manual nature of some of our manufacturing processes and infrastructure projects, including highway construction and maintenance, creates a high level of dependency on our highly skilled workforce. Any event that materially inhibits our people from being able to work, including an inability to get to our facilities and/or customer sites or widespread sickness/pandemic, could materially disrupt our operations, with adverse impacts on financial performance.

Cybersecurity

CRH depends on multiple information and operational technology systems, including certain systems for which third-parties are in whole or in part responsible. We may be unable to protect our assets and data against increasingly sophisticated cybersecurity attacks. Security breaches, IT interruptions or data loss could result in significant business disruption, loss of production, reputational damage and/or regulatory penalties.

The Company has not been subject to a cyber-attack that has had a material impact on our operations or financial results. However, we have faced attempted cyber-attacks and may face future cyber-attacks, including malware or ransomware attacks, or suffer other human or technological errors that have a material impact. Breaches, significant IT interruptions or errors could disrupt production software, permit manipulation of financial data, and could lead to corruption or theft of sensitive data that we collect and retain about our customers, suppliers, employees and business performance. Following a material cybersecurity incident, the Company may incur significant remediation costs, may face regulatory proceedings and/or private litigation, and may suffer damage to our reputation and customer confidence in our operations.

Our businesses rely on information and operational technologies to support critical business processes and activities, and failures or breaches of such technologies could lead to production curtailment and/or other operational disruptions. We rely on specialist third-parties to provide many of our information and operational technology systems, and vulnerabilities within such third-party systems could have a material negative effect on us. The third-parties on whom we rely may themselves be affected by cybersecurity breaches or failures, which could lead to operational disruption or other negative consequences that could adversely impact our own business and financial condition.

In addition, the Company regularly engages in acquisition activity as part of its active portfolio management. Many newly-acquired companies rely on different information and operational technology systems to the rest of the Company and may not have cybersecurity protections comparable to those implemented throughout the existing Company. Integrating newly-acquired companies and assets and implementing appropriate cybersecurity controls may be more resource-intensive and time-consuming than anticipated. Failure to appropriately integrate new acquisitions into our cybersecurity and IT systems can lead to vulnerabilities and make our systems more complex to secure. Further, the global nature of our operations and diverse information and operational technologies used across the Company may result in potential delays in the detection and reporting of cyber incidents. In addition, as cybersecurity threats evolve, the Company is increasingly required to expend additional resources to enhance our cybersecurity protection measures and may be required to expend additional resources to investigate and remediate identified vulnerabilities.

CRH Form 10-K 16

Supply Chain Failure

CRH’s ability to maintain production capacity and/or quality depends on the reliable and economic sourcing of various input materials, and failure to manage any material disruption in our supply chains could adversely impact our ability to service our customers and result in a deterioration in operational and/or financial performance.

The Company must reliably and economically source various raw materials, equipment and other inputs from many third-party suppliers and then transport finished products to satisfy customer demands and meet contractual requirements. Our ability to balance maintaining resilient supply chains with optimizing our working capital and inventory levels is critical to the continuity and strong financial returns of our operations. Any failure to manage any material disruption in our supply chains, including where we do not hold adequate buffer stocks and/or are unable to source adequate alternatives within acceptable timelines and at reasonable cost, could adversely impact our ability to service our customers and result in a deterioration in operational and/or financial performance, and reputational damage.

Some of the raw materials, equipment, transport and other inputs that the Company requires are limited to a small number of suppliers from which the Company can economically and/or practically source, which often have long lead times. Any of our suppliers may experience temporary, prolonged or even permanent operational disruption and/or capacity in the market may fall below required levels (e.g. for haulage capacity), which could have an adverse impact on the Company’s operations, financial performance and reputation. In addition, in certain markets in which the Company operates, including markets for steel, cement, bitumen and supplementary cementitious materials, contracted market demand can far outstrip supply, which may restrict the Company’s ability to obtain alternative suppliers or additional volumes where necessary. Our focus on responsible sourcing practices and other Environmental & Social Governance (ESG) considerations may also limit the pool of acceptable suppliers from which we may choose to source.

Construction Contracts

A number of our projects/contracts are complex, spanning multiple parties, years and/or products, and our future financial results may be adversely affected if we incorrectly forecast project budgets, deliver projects that do not meet contracted standards, or fail to deliver on time.

Across the Company’s business lines, we enter into contracts for complex, multi-year projects that comprise multiple product lines and as such are exposed to inherent risks related to forecasting and budgeting, project management and delivery, and quality control.

Any failure to manage these risks may reduce the Company’s profitability and/or damage its reputation, with associated impacts on our ability to bid for and/or win future contracts.

Risks Related To Financial, Regulatory And Reporting Environment

Laws, Regulations and Business Conduct

CRH is subject to a wide variety of local and international laws and regulations. CRH may face adverse operational and financial effects and reputational damage, including significant fines, debarment or other sanctions, due to litigation or investigations in connection with breaches or perceived breaches of such laws and regulations or otherwise. In addition, we are governed by the Irish Companies Act, which differs from laws generally applicable to U.S. companies.

As an Irish incorporated company, with a primary listing on the NYSE and an international secondary listing on the LSE, CRH must comply with a wide variety of local and international laws and regulations, including the Irish Companies Act, U.S. securities laws and regulations, NYSE listing requirements, the Market Abuse Regulation, the Disclosure Guidance and Transparency Rules, and other relevant legislation and regulation. The Company is also subject to various statutes, regulations and laws affecting land usage, zoning, labor and employment practices, competition/anti-trust, financial reporting, taxation, anti-fraud and theft, anti-bribery, anti-corruption, governance, data protection and data privacy and security, environmental, health and safety, and international trade and sanctions laws, among other matters.

There can be no assurance that the Company’s policies and procedures will afford adequate protection against compliance failures or other fraudulent and/or corrupt activities. Any failure to comply with the requirements of any of these laws and/or regulations could have a material adverse effect on the Company’s business, results of operations, financial condition, prospects and/or reputation, with resultant litigation or investigations, the imposition of significant fines, sanctions, debarment from operating in key markets, and/or reputational damage. Where subject to litigation, we establish reserves in line with the requirements of the relevant accounting standards, where there is a clearly defined past event, when the loss is assessed as probable and we can reasonably estimate the amount. These estimated reserves are based on the facts and circumstances known to the Company at the time of estimation and subsequent reporting and subsequent developments related to these matters may affect our assessment and estimates.

In addition, we are incorporated under Irish law, which treats interested director and officer transactions and shareholder lawsuits differently than the laws generally applicable to U.S.-incorporated corporations and our shareholders may thus have more difficulty protecting their interests than would shareholders of a corporation incorporated in a jurisdiction of the United States. As we are an Irish company, the duties of our directors and officers are generally owed to CRH plc. Our shareholders will generally not have a personal right of action against our directors or officers and in limited circumstances only may exercise rights of action on behalf of the Company.

Financial Instruments

CRH uses financial instruments throughout its businesses giving rise to interest rate and leverage, foreign currency, counterparty, credit rating and liquidity risks. A downgrade of the Company’s credit ratings may give rise to increases in future funding costs and may impair the Company’s ability to raise funds on acceptable terms. In addition, insolvency of the financial institutions with which the Company conducts business may adversely impact the Company’s financial position.

Risks related to Company financing that could affect its operations and/or financial performance are discussed as follows:

Interest rate and leverage risks

As at December 31, 2024, the Company had outstanding gross indebtedness, including overdrafts, finance lease liabilities and the impact of derivatives, of approximately $14.3 billion, compared to $11.8 billion in 2023, and cash and cash equivalents and restricted cash of approximately $3.8 billion, compared to $6.4 billion in 2023. The Company uses interest rate swaps to manage its interest rate profile. While current leverage is low, acquisition activity could adversely impact operating and financial flexibility as well as financial position. There can be no assurance that the Company will not be adversely impacted by increases in borrowing costs in the future.

CRH Form 10-K 17

Foreign currency risks

If the Company’s reporting currency weakens relative to the basket of foreign currencies in which Net Debt*5is denominated (including the euro, Pound Sterling, Canadian Dollar, Australian Dollar, Philippine Peso, Polish Zloty, and Swiss Franc), the Net Debt* balance would increase; the converse would apply if the Company’s reporting currency was to strengthen. Where economically feasible, Net Debt* is maintained in the same relative ratio as capital employed to act as an economic hedge of the underlying currency assets.

Counterparty risks

Insolvency of the financial institutions with which the Company conducts business or a downgrade in their credit ratings may lead to losses in the cash balances that the Company holds with such financial institutions or losses in derivative transactions that the Company has entered into with these parties and may render it more difficult for the Company to utilize existing debt capacity or otherwise obtain financing for operations. The Company holds significant cash and cash equivalents and restricted cash on deposit and derivative transactions with a variety of highly rated financial institutions which at December 31, 2024, totaled $3.8 billion and $27 million, compared to $6.4 billion and $37 million, respectively, in 2023. In addition, certain of the Company’s activities give rise to significant amounts receivable from counterparties at the balance sheet date; at December 31, 2024, this balance was $4.4 billion and in 2023 this balance was $4.1 billion.

Credit rating risks

A downgrade of the Company’s credit ratings may give rise to increases in funding costs in respect of future debt and may, among other matters, impair its ability to access debt markets or otherwise raise funds or enter into lines of credit, for example, on acceptable terms. Such a downgrade may result from factors specific to the Company, including increased indebtedness stemming from acquisition activity, or from other factors such as general economic or sector specific weakness, Central Bank monetary policy, governmental fiscal policy or sovereign credit rating ceilings. In addition, any downgrade, suspension or withdrawal of one or more of our ratings could result in the market price, yield or marketability of our securities being adversely affected.

Liquidity risks

The principal liquidity risks stem from the maturation of debt obligations and derivative transactions. The Company aims to achieve flexibility in funding sources through a variety of means including; (i) maintaining cash and cash equivalents with a number of highly rated counterparties; (ii) meeting the bulk of debt requirements through debt capital markets or other term financing; (iii) limiting the annual maturity of such balances; and (iv) having surplus committed bank lines of credit. However, market or economic conditions may make it difficult at times to realize this objective. In addition, continued focus on climate change by investors and lenders may affect their preferences and sentiments, potentially impacting the Company’s access to and cost of capital, and investment attractiveness.

Taxation Charge and Balance Sheet Provisioning

CRH is exposed to uncertainties stemming from governmental actions in respect of taxes paid or payable in the future in all jurisdictions of operation. In addition, various assumptions are made in the computation of the overall tax charge and in balance sheet provisions which may need to be adjusted over time. Changes in tax regimes or assessment of additional tax liabilities in future tax audits could result in incremental tax liabilities which could have a material adverse effect on cash flows and the financial results of operations.

The Company’s income tax charge is based on reported profits and statutory tax rates, which reflect various allowances and reliefs and tax efficiencies available to the Company in the multiple tax jurisdictions in which it operates. The determination of the Company’s provision for income tax requires certain judgments and estimates in relation to matters where the ultimate tax outcome may not be certain. The recognition of deferred tax assets also requires judgment as it involves an assessment of the future recoverability of those assets. In addition, the Company is subject to tax audits which can involve complex issues that could require extended periods to conclude, the resolution of which is often not within its control. Although management believes that the estimates included in the Consolidated Financial Statements and the Company’s tax return positions are reasonable, there can be no assurance that the final outcome of these matters will equal the estimates reflected in the Company’s historical income tax provisions and accruals.

As a multinational corporation, the Company is subject to various taxes in all jurisdictions in which it operates. Economic and political conditions, tax rates and the interpretation of tax rules in these jurisdictions may be subject to significant change, particularly during periods of administrative change or fiscal deficit. In addition, the Company’s future effective income tax rate could be affected (positively or negatively) by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets or changes in tax laws or their interpretation.

Finally, changes to international tax principles, for example at an EU level, could adversely affect the Company’s effective tax rate or result in higher cash tax liabilities. If the Company’s effective income tax rate was to increase, its cash flows and the financial results of operations could be adversely affected.

Foreign Currency Translation

A proportion of CRH’s revenues are in currencies other than its reporting currency, and adverse changes in exchange rates could negatively affect retained earnings.

The principal foreign exchange risks to which the Consolidated Financial Statements are exposed pertain to (i) adverse movements in reported results when translated into the reporting currency; and (ii) declines in the reporting currency value of net investments which are denominated in a wide basket of currencies other than the reporting currency.

Given the geographic spread of the Company, a significant proportion of its revenues, expenses, assets and liabilities are denominated in currencies other than the Company’s reporting currency, including the euro, Pound Sterling, Canadian Dollar, Australian Dollar, Philippine Peso, Polish Zloty, and Swiss Franc. From year to year, adverse changes in the exchange rates used to translate these and other foreign currencies into the reporting currency have impacted and will continue to impact consolidated results.

5** Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.

CRH Form 10-K 18

Goodwill Impairment

CRH may be required to write-down its goodwill, which could have an adverse impact on the Company’s retained earnings.

Significant underperformance in any of the Company’s major reporting units or the divestiture of businesses in the future may give rise to a material write-down of goodwill. While a non-cash item, a material write-down of goodwill could have a substantial impact on the Company’s retained earnings.

Under U.S. GAAP, goodwill and indefinite-lived intangible assets are subject to annual impairment testing, or more frequently if events or circumstances change in a manner that would more likely than not reduce the fair value of a reporting unit below its carrying value. A detailed discussion of the impairment testing process, the key assumptions used, the results of that testing and the related sensitivity analysis is contained in section “Critical Accounting Estimates” of Item 7. “Management's Discussion and Analysis of Financial Condition and Results of Operations” on page 46.

Accounting Estimates

CRH’s financial reporting requires the use of accounting estimates for a number of significant items.

The accounting standards used in preparation of our audited Consolidated Financial Statements are complex and involve the making of significant estimates and assumptions in their interpretation and application that are inherently uncertain and/or require subjective judgments. In the event these assumptions and/or judgments prove incorrect or different values were to be applied (e.g. through the adoption of different methods of calculation), our reported financial results could be materially higher or lower. We make accounting estimates in relation to a wide range of matters that are relevant to our business, such as impairment of long-lived assets, business combinations, impairment of goodwill, pension and other postretirement benefits, tax matters and litigation, including self-insurance and environmental compliance costs.

Any changes to accounting standards previously applied in the preparation of our audited Consolidated Financial Statements could affect future reported results compared with prior years, and/or see the revision of prior reporting where any retrospective application is required.

Self-Insurance

CRH may elect or be required to self-insure specific risk exposures, and failure or inability to obtain appropriate insurance coverage could result in increased insurance and claims costs that adversely affects our financial results.

CRH elects to self-insure up to certain limits through one or more of its wholly-owned captive insurance companies (captives). The Company’s captives provide coverage in respect of multiple lines of insurance to the Company’s operating and non-operating entities up to certain designated limits, both each-and-every and in the annual aggregate. Where insurable losses exceed those limits, CRH would need to rely on external insurance and/or reinsurance from global institutions of appropriate credit standing, and such external insurance and/or reinsurance may not be available at an appropriate cost or at all.

Risks Related To Our Common Stock

Payment of Dividends/Share Repurchase Program

CRH may not pay dividends or make other returns of capital to shareholders in the future, and our current share repurchase program may not enhance long-term shareholder value.

We cannot guarantee that we will pay or maintain dividends at their current level, or effect other future returns of capital (including, without limitation, share repurchases). Our ability to pay dividends or effect other returns of capital depends on factors such as our financial performance, cash flow requirements, business outlook, working capital requirements, interest expenses, economic climate, regulatory considerations, and any other factors deemed significant by the Board in exercising its discretion to return capital. In addition, under Irish law dividends may only be paid, and share repurchases and redemptions must generally be funded only, out of distributable reserves.

In addition, we cannot guarantee that our share repurchase program of our ordinary shares will be fully consummated or that it will enhance long-term shareholder value. The timing and actual number of shares repurchased/redeemed will depend on a variety of factors including the price, cash availability and other market conditions; the share repurchase program does not oblige us to repurchase/redeem any specific dollar amount or to acquire/redeem any specific number of shares, and may be suspended or terminated at any time, which may adversely affect the trading price of our ordinary shares. The existence of our share repurchase program could also cause increased volatility in the price of our ordinary shares or increase the price of our ordinary shares and thus reduce their liquidity. Additionally, repurchases and redemptions under our share repurchase program will diminish our cash reserves, which may adversely affect our financial position.

Relocation of Primary Listing

CRH faces risks associated with the relocation of our primary listing.

On September 25, 2023, CRH relocated the primary listing of its ordinary shares from the LSE to the NYSE. The Company has an international secondary listing on the LSE and accordingly our ordinary shares are now listed on both exchanges. As a result of the relocation of the primary listing CRH has ceased to be eligible for inclusion in certain UK and European equity indices.

Following the transition to the NYSE, CRH has been added to the MSCI USA Equity Index, the S&P TMI Index and the Russell 1000 Equity Index. The Company aims to be included in other relevant equity indices for which it believes it is eligible, including the S&P 500 Index. Inclusion is however at the discretion of the respective index providers. There is a risk that the Company may not be admitted, which may adversely affect the price and liquidity of the ordinary shares.

Item 1B. Unresolved Staff Comments

None.

CRH Form 10-K 19

Item 1C. Cybersecurity

Cybersecurity Risk Management and Strategy

CRH leverages its Enterprise Risk Management (ERM) framework, which accords with internationally recognized standards, to identify, assess, respond, monitor and report material cybersecurity risks facing the Company. CRH manages cybersecurity risk at multiple levels within the Company. Given CRH’s wide geographic spread, the frequency and possible scale of acquisition activity, the diversity of the types of IT systems operated by CRH companies and the decentralized nature of its operations, CRH implements an amalgam of centralized and decentralized processes for IT management. Under this model, Company-level management and the management of CRH’s operating companies and business units share responsibility for cybersecurity management and collaborate on assessing, identifying, and managing material risks.

CRH’s operating companies and business units use a variety of tools and processes to identify and manage material cybersecurity risks. CRH utilizes multiple monitoring tools and practices to identify and detect unusual activities and/or potential cybersecurity incidents, including potential system breaches, and to verify the effectiveness of protective measures. CRH’s operating companies and business units implement various risk mitigation strategies, including continuously strengthening security measures, improving incident response plans through post-incident evaluations and assessments, investing in security technologies, providing regular and focused employee training, and transferring risk through cybersecurity insurance.

At the Group level, CRH conducts a semi-annual bottom-up risk assessment focused on CRH’s operating companies and business units, including cybersecurity-related risks, which evaluates the impact and likelihood of the identified cyber risks and the effectiveness of existing security measures, policies, and procedures. CRH also requires that each operating company completes a self-assessment regarding its cyber controls and risk, including user awareness training, email security protection, multi-factor authentication, system patch management, identity management, network segregation, antivirus and web protections, asset inventory, privileged access management, logging, monitoring, and incident response capabilities.

As described further below under “Cybersecurity Governance”, CRH’s Board and senior management receive regular briefings on cybersecurity risks facing CRH and are closely involved in identifying cybersecurity risks, developing CRH’s plan for managing such risks, and continuously refining CRH’s cyber defenses in response to the information gathered through the above-mentioned risk assessments.

To manage the risk of a material impact on CRH’s operations or financial performance due to a cybersecurity incident, CRH has implemented a mandatory Cybersecurity Incident Escalation Standard as part of its Company-wide Information Security Policy. This Standard, which is supported by relevant guidelines and procedural documentation, provides a structured approach adapted to the systems of each CRH operating company and business unit to manage the incident response process through a series of pre-defined phases, including triage, containment, eradication, recovery, and post-incident analysis.

CRH also provides regular and focused training to aid employees in understanding and complying with relevant Company policies and applicable regulations, including those related to cybersecurity.

Assessment and management of cybersecurity risks is a key component of CRH’s broader risk governance processes as cybersecurity is a core risk facing the Company. Identification of cybersecurity risks is integrated into CRH’s overall ERM framework, with a focus on risks related to information systems, data security, operational technology and technology infrastructure.

CRH works closely with multiple external advisors specializing in cybersecurity to improve its ability to identify and detect, protect against, and recover from, cybersecurity incidents. In addition, CRH leverages certain managed service providers to aid in triaging and monitoring potentially malicious activities. CRH is dependent upon third-party service providers for certain IT-related services, and has systems of oversight to evaluate potential risks in certain critical third-parties on whom CRH has a material dependency. These systems would include the use of vendor security questionnaires, vulnerability assessments and annual audits.

CRH has not been subject to a cyber-attack that has had a material impact on our operations or financial results. For additional information, please refer to Item 1A. “Risk Factors”.

Cybersecurity Governance

Our Board is responsible for strategy, risk and governance, including oversight of risks from cybersecurity threats. The Board has delegated to the Audit Committee primary responsibility for oversight of cybersecurity risk management and the associated internal control systems. The Audit Committee is currently made up of six independent directors with a range of relevant cybersecurity, information technology and operational technology experience.

The Audit Committee receives updates at least annually from the Chief Information Security Officer (CISO) on the design and progress of key information security initiatives in addition to regular briefings on cybersecurity and management of cybersecurity-related risks from relevant members of management, including the Head of ERM and our CISO. Recent updates from the CISO have focused on the Company’s information security strategy, ongoing security assessments and ongoing projects. The Audit Committee is responsible for updating the Board on identified risks related to cybersecurity.

Our Global Leadership Team is responsible for the execution of CRH’s strategy and governance, including implementation and review of our ERM framework, which has identified cybersecurity as a core risk for CRH. CRH has established the role of CISO to provide technical leadership on a day-to-day basis in assessing and managing the Company’s material cybersecurity risks and liaising with the chief information officers of CRH’s Divisions. Our CISO has 25 years of experience working in IT, including more than a decade spent in prior technical and senior management roles related to cybersecurity. The divisional chief information officers have in excess of 20 years of experience, on average, in IT-related and cybersecurity-related roles and, together with the CISO, hold a variety of recognized and specialized credentials related to cybersecurity and IT.

CRH also maintains a Company-wide incident response function centered in our Group Information Security (GIS) team, led by the CISO. GIS responds to potential incidents across CRH in accordance with predetermined severity classifications. In line with CRH’s Cybersecurity Incident Escalation Standard and supporting guidelines and procedural documentation, incidents that are deemed potentially material to the Company and/or which may lead to the exposure of confidential or sensitive data are immediately escalated to GIS for review and, as necessary, mitigation and remediation actions are taken. GIS and the CISO also review regular attestation reports that are required to be prepared by CRH’s operating companies and business units regarding cybersecurity incidents that did not meet the threshold for immediate escalation.

Following cybersecurity incidents, GIS, in conjunction with members of management of CRH’s operating companies and business units as necessary, conduct post-incident analysis and exercises designed to strengthen CRH’s cybersecurity practices. The Risk Committee and Global Leadership Team are briefed on the occurrence, mitigation and remediation of cybersecurity incidents on a regular basis, including ad-hoc briefings covering significant or potentially material incidents.

CRH Form 10-K 20

The Risk Committee, which is made up of our Chief Financial Officer, Group General Counsel, Chief Operating Officer and the Divisional Presidents of CRH Americas and CRH International, is the executive oversight body for risk management, including cybersecurity risks and the work of the CISO, GIS and related teams. The Risk Committee meets quarterly with the Head of ERM to assess risks facing CRH, and, on an as-needed basis, meets with other members of CRH management regarding cybersecurity risks and developments. The Risk Committee also reviews the half-yearly risk updates that are provided to the Audit Committee prior to dissemination.

Item 2. Properties

As of February 13, 2025, we had a total of 3,816 operating locations:

	Americas Materials Solutions	Americas Building Solutions	International Solutions
United States	1,608	307	10
Europe	–	4	1,587
Rest of World	66	23	211
Total	1,674	334	1,808

Our building materials operating locations include product production facilities, mobile plants and retail facilities. Some of these operating locations are located on the same sites as our mining properties described below under the heading “Mineral Reserves and Resources: Background”. Significant building materials operating locations for CRH’s subsidiaries, as of December 31, 2024, are the cement facilities in the United States, Canada, United Kingdom, Ireland, France, Poland, Ukraine, Romania, Slovakia, Australia and the Philippines. These facilities include plant and equipment such as kilns, crushers, calciners, coolers, and silos used to process limestone and other raw materials into cement as well as equipment used to extract and transport limestone from CRH quarries. The clinker (the key intermediate product in the manufacture of cement) capacity for our significant building material locations is set out in the table below:

	Country	Number of Plants	Average Clinker Capacity<br>(tons per hour)
Americas Materials Solutions
South	United States	4	602
West	United States	6	780
Great Lakes	United States, Canada	2	298
International Solutions
Western Europe	United Kingdom, Ireland, France	8	898
Central & Eastern Europe	Poland, Ukraine, Romania, Slovakia	8	1,712
Australia	Australia	2	204
Philippines	Philippines	5	714

During 2024, CRH’s material cement kilns operated on average at 73% utilization.

Our building solutions businesses have many types of manufacturing facilities including paver, masonry, precast, pipe, dry-mix, fencing and railing and lawn and garden plants. These facilities include plant and equipment such as automated presses, batching systems, packaging equipment, kilns, coolers and silos which are used to turn raw materials into finished goods for our cementitious products as well as equipment such as presses, extruders and molds which are used in the fencing, railing, plastic pipe, trench and metals and enclosure businesses.

Other Properties

In addition to the properties described above and those disclosed under the heading “Mineral Reserves and Resources: Background”, CRH has corporate offices in New York, New York (leased) and Dublin, Ireland (owned). The Company also leases administrative offices for each of its two Divisions, including a CRH Americas divisional headquarters in Atlanta, Georgia and a CRH International divisional headquarters in Amsterdam, Netherlands.

CRH also owns and leases, directly or indirectly through third-parties, heavy mobile equipment, trucks and vehicles for production and transportation purposes.

Condition

CRH believes that all the facilities are in good condition, adequate for their purpose and suitably utilized according to the individual nature and requirements of the relevant operations. CRH has a continuing program of improvements and replacements of properties when considered appropriate to meet the needs of the individual operations.

CRH Form 10-K 21

Mineral Reserves And Resources

Background

CRH’s mineral reserves (reserves) and mineral resources (resources) for the production of primary building materials (which encompasses aggregates (crushed stone, sand and gravel), cement and lime, asphalt, readymixed concrete and concrete products) fall into a variety of categories spanning a wide number of rock types and geological classifications. These reserves and resources are found within our extensive network of quarry locations in attractive local markets globally. This disclosure of the Company’s mining properties has been prepared in accordance with the requirements of Subpart 1300 of Regulation S-K (Subpart 1300). As of December 31, 2024, the Company has 1,296 mining properties with 246,058 acres of owned and 129,818 acres of leased land, respectively, as disclosed in the table on page 25 the locations of which are presented by geographic location in the maps on page 26.

None of CRH’s mineral-bearing properties are individually material to the Company as of December 31, 2024. A summary disclosure of CRH’s mining operations is provided on pages 23 to 26.

As of December 31, 2024, the Company’s reserves and resources estimations of 26,685 million tons and 11,573 million tons, respectively, as disclosed on pages 23 to 24, are calculated in accordance with Subpart 1300. The Company’s reserves and resources disclosures may not be comparable to similar disclosures disclosed in accordance with the requirements of other countries and should be read in conjunction with the disclosures that follow on pages 23 to 26.

CRH operates predominantly production stage properties, with a limited number of development and exploration stage properties, as such terms are defined in Subpart 1300. Predominantly, CRH’s production stage properties provide raw materials for on-site modern cement and aggregates producing facilities. Almost exclusively, CRH utilizes surface mining and, with a very limited number of exceptions, CRH and its subsidiaries are the only operators of the properties.

Reserves

Reserves are defined in Subpart 1300 as “an estimate of tonnage and grade or quality of indicated and measured mineral resources that, in the opinion of the qualified person, can be the basis of an economically viable project. More specifically, it is the economically mineable part of a measured or indicated mineral resource, which includes diluting materials and allowances for losses that may occur when the material is mined or extracted”. Reserves are classified into two categories, probable and proven reserves, in order of increasing geological confidence.

The Company’s estimate of 26,685 million tons of reserves, as disclosed on page 23 analyzed by rock type (Hard rock, Sand & Gravel and Other), are of recoverable stone, sand, and gravel of suitable quality for economic extraction, based on drilling and studies by the Company’s geologists and engineers. These estimates also consider reasonable economic and operating constraints as to maximum depth of overburden and stone excavation and are subject to permitting or other restrictions.

The disclosed reserves and resources estimations which include diluting materials and allowances for losses that may occur when the mineral is mined, extracted or processed have been estimated by qualified persons, as such term is defined within Subpart 1300.

Not all minerals that may be on CRH’s mineral-bearing properties have been assessed and such properties may be assessed for mineral reserves or resources in future years, as required by operational needs.

CRH’s properties are subject to a wide variety of permitting procedures and conditions, which vary between jurisdictions. Many of CRH’s properties require separate permits from multiple authorities, including but not limited to environmental, mining, regional and national administrative authorities. The periods of validity and the conditions of these permits may be different.

Resources

A mineral resource is defined in Subpart 1300 as “a concentration or occurrence of material of economic interest in or on the Earth’s crust in such form, grade or quality, and quantity that there are reasonable prospects for economic extraction. A mineral resource is a reasonable estimate of mineralization, taking into account relevant factors such as cut-off grade, likely mining dimensions, location or continuity, that, with the assumed and justifiable technical and economic conditions, is likely to, in whole or in part, become economically extractable”. Resources are classified into three categories, inferred, indicated or measured resources, in order of increasing geological confidence. Indicated or measured resources can be converted to reserves by the application of certain modifying factors which include, but are not limited to, consideration of mining, processing, metallurgical, infrastructure, economic, marketing, legal, environmental compliance, plans, negotiations, or agreements with local individuals or groups, and governmental factors. There is no certainty that any of the resources disclosed on page 24 will be converted into reserves. Resources have not been fully assessed using modifying factors, however, an initial assessment has been completed in accordance with Subpart 1300.

Internal Controls

CRH has established appropriate governance processes to support the publication of our 2024 reserves and resources disclosures. Reserve and resource estimates are subject to annual review by each of the relevant operating companies across the Company in conjunction with the relevant qualified persons. CRH has established and maintains a number of internal controls to address the risks inherent in the mineral reserves and resources reporting process. These internal controls have been embedded into the local control environments and operate across the business, including controls at an operating company, divisional and Group level.

As CRH’s reserves and resources are predominantly in production stage properties, features of the internal controls relating to quality assurance and quality control (QA/QC) include:

•Databases and data repositories for exploration and/or production data that contain accurate and precise data from which reserves and resources can be evaluated, and operational plans can be developed;

•Verification sampling and testing of known mineralization. This is generally required to establish compliance with regulations on product qualities. Verification testing confirms geological maps prepared during earlier exploration programs; and

•In the case of cement raw materials, facility laboratories participate in an externally managed annual review process with ISO 17025 accredited independent laboratories.

CRH Form 10-K 22

When exploration programs are conducted, QA/QC measures include:

•Ensuring that surface or drill sampling results in the highest quality sample possible. This would include down-hole surveying of drill holes as necessary;

•Obtaining pictures of drill sample (e.g. core) for future reference;

•Geological core logging, where the geological description of each sample interval is recorded prior to laboratory analysis;

•Ensuring the integrity of samples from point of origin to analytical laboratory; and

•Using nationally or regionally accredited laboratories for all analyses and tests for exploration programs in properties containing aggregates.

In addition, to provide further assurance over the Company’s mineral reserves and resources reporting process, the Company’s Internal Audit function completed a limited scope review across a sample of material reporting entities on the operation of these internal controls as of December 31, 2024.

The table below presents, by segment and geographic location, the tons of proven and probable aggregates, cement and lime mineral reserves at December 31, 2024, and the related percentages by rock type.

				Reserves
				Proven								Probable								Total Reserves (i) (ii)
		Country		Tons (iii)		Grade: % by rock type						Tons (iii)		Grade: % by rock type						Tons (iii)		Grade: % by rock type
						Hard Rock		Sand & Gravel		Other				Hard Rock		Sand & Gravel		Other				Hard Rock		Sand & Gravel		Other
Aggregates
Americas Materials Solutions		United States		8,067		76%		16%		8%		9,745		86%		8%		6%		17,812		81%		12%		7%
	Canada		456		70%		30%		–		169		84%		16%		–		625		74%		26%		–
International Solutions		Western Europe (UK, IE, FR, ES, DK, FI) (iv)		1,993		82%		18%		–		1,262		93%		7%		–		3,255		86%		14%		–
	Central & Eastern Europe (PL, RO, SK, CH, HU) (iv)		267		82%		18%		–		232		51%		49%		–		499		68%		32%		–
	Australia		476		89%		11%		–		227		95%		5%		–		703		91%		9%		–
	Philippines		54		100%		–		–		5		100%		–		–		59		100%		–		–
Subtotal				11,313		78%		17%		5%		11,640		86%		9%		5%		22,953		82%		13%		5%
Cement
Americas Materials Solutions		United States		745		98%		–		2%		272		100%		–		–		1,017		98%		–		2%
	Canada		159		100%		–		–		22		100%		–		–		181		100%		–		–
International Solutions		Western Europe (UK, IE, FR, ES) (iv)		407		96%		–		4%		151		94%		–		6%		558		96%		–		4%
	Central & Eastern Europe (DE, PL, RO, RS, SK, CH, UA) (iv)		695		95%		1%		4%		563		85%		3%		12%		1,258		91%		2%		7%
	Australia		145		100%		–		–		1		–		–		100%		146		99%		–		1%
	Philippines		455		69%		7%		24%		58		84%		–		16%		513		70%		6%		24%
Subtotal				2,606		92%		2%		6%		1,067		91%		1%		8%		3,673		92%		1%		7%
Lime
International Solutions		Australia		30		30%		70%		–		29		94%		6%		–		59		61%		39%		–
Subtotal				30		30%		70%		–		29		94%		6%		–		59		61%		39%		–
Total				13,949		80%		14%		6%		12,736		86%		8%		6%		26,685		83%		11%		6%

(i)    CRH has no individually material mineral-bearing properties requiring individual property disclosure under Subpart 1300.

(ii)    CRH’s point of reference for the estimation of the Company’s mineral reserves is “in-situ” reserves.

(iii)    All reserves quantities are quoted in millions of short tons.

(iv)    The country and their respective codes are Denmark: DK, Finland: FI, France: FR, Germany: DE, Hungary: HU, Ireland: IE, Poland: PL, Romania: RO, Serbia: RS, Slovakia: SK, Spain: ES, Switzerland: CH, Ukraine: UA, United Kingdom: UK.

CRH’s mineral reserves and resources are used predominantly for the production and sale of aggregates, cement and lime. The average sales price for the period January 1, 2024, to October 31, 2024, for aggregates and cement was $18.5 and $135.4 per ton, respectively, for our Americas Materials Solutions’ businesses and $12.0 and $119.3 per ton, respectively, for our International Solutions’ businesses. The average sales price for lime within our International Solutions' businesses over this time period was $165.6 per ton. These prices, which are used for estimation of both mineral reserves and resources, are impacted by product mix, geographic location and foreign currency.

CRH Form 10-K 23

The table below presents, by segment and geographic location, the tons of measured, indicated and inferred aggregates, cement and lime resources as of December 31, 2024, and the related percentage of these resources by rock type. CRH’s mineral resources in the table below are disclosed exclusive of mineral reserves.

Resources
				Measured								Indicated								Total Measured & Indicated								Inferred								Total Resources<br>(i) (ii)
		Country		Tons (iii)		Grade: % by rock type						Tons (iii)		Grade: % by rock type						Tons (iii)		Grade: % by rock type						Tons (iii)		Grade: % by rock type
						Hard Rock		Sand & Gravel		Other				Hard Rock		Sand & Gravel		Other				Hard Rock		Sand & Gravel		Other				Hard Rock		Sand & Gravel		Other
Aggregates
Americas Materials Solutions		United States		1,014		92%		5%		3%		1,583		82%		17%		1%		2,597		86%		12%		2%		4,333		75%		23%		2%		6,930
	Canada		354		94%		6%		–		—		—		—		—		354		94%		6%		–		96		100%		–		–		450
International Solutions		Western Europe (UK, IE, FR, ES, DK, FI) (iv)		331		20%		80%		–		571		80%		19%		1%		902		58%		42%		–		403		92%		8%		–		1,305
	Central & Eastern Europe (RO, SK, CH) (iv)		248		76%		24%		–		52		78%		22%		–		300		76%		24%		–		16		14%		86%		–		316
	Australia		26		100%		–		–		347		67%		33	%	–		373		70%		30	%	–		516		100	%	–		–		889
Subtotal				1,973		79%		19%		2%		2,553		79%		20%		1%		4,526		79%		20%		1%		5,364		78%		20%		2%		9,890
Cement
Americas Materials Solutions		United States		38		85%		–		15%		40		93%		–		7%		78		89%		–		11%		316		100%		—		–		394
	Canada		49		89%		–		11%		—		—		–		—		49		89%		–		11%		—		—		—		–		49
International Solutions		Western Europe (UK, IE, FR, ES) (iv)		138		100%		–		–		62		90%		–		10%		200		97%		–		3%		47		95%		5%		–		247
	Central & Eastern Europe (DE, RO, SK, UA) (iv)		347		57%		–		43%		205		71%		–		29%		552		62%		–		38%		115		100%		–		–		667
	Australia		2		100%		–		–		–		–		–		–		2		100%		–		–		2		100%		–		–		4
	Philippines		–		–		–		–		–		–		–		–		–		–		–		–		32		99%		1%		–		32
Subtotal				574		72%		–		28%		307		78%		–		22%		881		74%		–		26%		512		100%		–		–		1,393
Lime
International Solutions		Australia		71		82%		18%		–		218		48%		52%		–		289		56%		44%		–		1		–		100%		–		290
Subtotal				71		82%		18%		–		218		48%		52%		–		289		56%		44%		–		1		–		100%		–		290
Total				2,618		78%		15%		7%		3,078		77%		20%		3%		5,696		77%		18%		5%		5,877		80%		18%		2%		11,573

(i)    CRH has no individually material mineral-bearing properties requiring individual property disclosure under Subpart 1300.

(ii)    CRH’s point of reference for the estimation of the Company’s mineral resources is “in-situ” resources.

(iii)    All resources quantities are quoted in millions of short tons.

(iv)    The country and their respective codes are Denmark: DK, Finland: FI, France: FR, Germany: DE, Hungary: HU, Ireland: IE, Poland: PL, Romania: RO, Slovakia: SK, Spain: ES, Switzerland: CH, Ukraine: UA, United Kingdom: UK.

CRH Form 10-K 24

The table below outlines the number of facilities by segment and geographic location along with the annualized extraction (in millions of tons) for each of the three years ending December 31, 2024.

		Country		No. of Quarries /pits		Surface acreage (acres) (i)				Annualized extraction<br>(millions of tons)						Years to Depletion<br>(ii)
						Owned		Leased		2022		2023		2024
Aggregates
Americas Materials Solutions		United States		719		138,464		71,662		203.2		211.6		207.1		86
	Canada		33		14,129		1,717		20.5		20.3		17.1		32
International Solutions		Western Europe (UK, IE, FR, ES, DK, FI) (iii)		394		40,870		24,117		85.8		79.6		76.3		40
	Central & Eastern Europe (PL, RO, SK, CH, HU) (iii)		38		2,807		1,213		11.3		10.9		12.3		43
	Australia		24		9,518		1,858		–		–		10.4		67
	Philippines		1		–		440		–		–		–		–
Subtotal				1,209		205,788		101,007		320.8		322.4		323.2
Cement
Americas Materials Solutions		United States		11		22,233		2,647		10.1		11.6		11.8		91
	Canada		2		1,053		17		2.2		3.4		2.2		70
International Solutions		Western Europe (UK, IE, FR, ES) (iii)		18		7,060		556		14.2		15.2		10.8		42
	Central & Eastern Europe (DE, PL, RO, RS, SK, CH, UA) (iii)		29		3,131		4,595		16.5		17.1		18.1		73
	Australia		12		3,632		1,127		–		–		2.8		53
	Philippines		5		2,469		531		7.2		7.7		7.0		70
Subtotal				77		39,578		9,473		50.2		55.0		52.7
Lime
International Solutions		Australia		10		692		19,338		–		–		3.7		47
Subtotal				10		692		19,338		–		–		3.7
Total				1,296		246,058		129,818		371.0		377.4		379.6

(i)    The disclosures in the table above include the surface area of infrastructure, process plants, waste piles, water storage, water treatment plants and boundary areas of CRH’s mineral-bearing properties. Remote properties such as offices, distribution facilities and readymixed concrete plants are not included.

(ii)     Years to depletion is based on the average of the three years’ 2022 to 2024 annualized extraction.

(iii)    The country and their respective codes are Denmark: DK, Finland: FI, France: FR, Germany: DE, Hungary: HU, Ireland: IE, Poland: PL, Romania: RO, Serbia: RS, Slovakia: SK, Spain: ES, Switzerland: CH, Ukraine: UA, United Kingdom: UK.

CRH Form 10-K 25

CRH Mineral-Bearing Locations

l	Represents the location of CRH’s mineral-bearing properties

CRH Form 10-K 26

Item 3. Legal Proceedings

The Company is from time to time a party to various legal proceedings that arise in the ordinary course of business. We do not believe any pending legal proceeding to which the Company is a party will have a material effect on our financial condition, results of operations or liquidity.

CRH has elected to use a $1 million threshold for disclosing certain proceedings under environmental laws to which a governmental authority is a party. Applying this threshold, there were no relevant legal proceedings to disclose for this period.

Item 4. Mine Safety Disclosures

The information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd‐Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S‐K (17 CFR 229.104) is included in Exhibit 95 to this Annual Report on Form 10‐K.

CRH Form 10-K 27

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

CRH has a primary listing on the NYSE and an international secondary listing on the LSE of its ordinary shares, each represented by the ticker symbol ‘CRH’. As of February 13, 2025, there were approximately 15,000 holders of record of our ordinary shares.

Irish Taxation of U.S. Holders

The following is a general summary of the main Irish tax considerations applicable to the purchase, ownership and disposition of our ordinary shares by U.S. holders. This description is based on Irish law and practices as of the latest practicable date, and administrative or judicial changes may modify the tax consequences described below. The statements do not constitute tax advice and are intended only as a general guide.

Withholding Tax on Dividends: Dividends on our ordinary shares would generally be subject to Irish DWT at the rate of 25%, unless an exemption applies. Dividends on our ordinary shares that are owned by residents of the United States and held beneficially through the Depositary Trust Company (DTC), will not be subject to DWT provided that the address of the beneficial owner of the ordinary shares in the records of the broker is in the United States. Dividends on our ordinary shares that are owned by residents of the United States and held directly (outside of DTC) will not be subject to DWT provided that the shareholder has completed the appropriate Irish DWT form and this form remains valid. Such shareholders must provide the appropriate Irish DWT form to our Transfer Agent, Computershare Trust Company N.A., before the record date for the first dividend payment to which they are entitled. If any shareholder who is resident in the United States receives a dividend subject to DWT, he or she should generally be able to apply for a refund from the Irish Revenue Commissioners. The Double Taxation Treaty between Ireland and the United States contains provisions regarding withholding tax, but it is generally not necessary for U.S. resident shareholders to rely on the treaty due to the wide scope of DWT exemptions under Irish law.

Income Tax on Dividends: A shareholder who is neither resident nor ordinarily resident in Ireland and who is entitled to an exemption from DWT generally has no liability for Irish income tax or for the Irish universal social charge on CRH dividends, unless he or she holds his or her ordinary shares through a branch or agency in Ireland which carries out a trade on his or her behalf.

Capital Gains Tax: A shareholder who is neither resident nor ordinarily resident in Ireland and does not hold our ordinary shares in connection with a trade or business carried on by such shareholder in Ireland through a branch or agency should not be subject to Irish tax on capital gains on a disposal of our ordinary shares.

Capital Acquisitions Tax: Irish capital acquisitions tax (CAT) is comprised principally of gift tax and inheritance tax. CAT could apply to a gift or inheritance of our ordinary shares irrespective of the place of residence, ordinary residence or domicile of the parties. The person who receives the gift or inheritance has primary liability for CAT. CAT is levied at a rate of 33% above certain tax-free thresholds. Shareholders in the United States should consult their own tax advisers as to whether CAT is creditable or deductible in computing U.S. tax liabilities.

Stamp Duty: Transfer of our ordinary shares other than via transfer of book-entry interests in the DTC may be subject to Irish stamp duty. Transfers of our ordinary shares via transfer of book entry interests in the DTC will not be subject to Irish stamp duty. However, if a shareholder holds our ordinary shares directly rather than beneficially through DTC, any transfer of shares could be subject to Irish stamp duty (currently at the rate of 1% of the higher of the price paid or the market value of the shares acquired). Payment of Irish stamp duty is generally a legal obligation of the transferee. The potential for stamp duty could adversely affect the price of our ordinary shares.

Other Shareholder Matters

There are no legislative or other legal provisions currently in force in Ireland or arising under our Articles that restrict the payment of dividends or distributions to holders of our ordinary shares not resident in Ireland, except for Irish laws and regulations that restrict the remittance of dividends, distributions and other payments in compliance with the sanctions laws of the Security Council of the United Nations, the European Union (and any of its members), the United Kingdom and the United States.

Dividend Policy

CRH has paid dividends on its ordinary shares each fiscal year since the formation of the Company in 1970. Dividends are paid to shareholders on the Register of Members on the record date for the dividend. The Board continues to believe that a policy of consistent long-term dividend growth is appropriate for the Company. In line with this dividend growth strategy, and our strong financial position, the Board approved dividends totaling $1.40 per share in respect of 2024, a 5% increase on the prior year (2023: $1.33), broken into quarterly dividends of $0.35 per share being paid on April 17, 2024, June 26, 2024, September 25, 2024, and December 18, 2024, respectively. It is proposed to pay a quarterly dividend of $0.37 per share on April 16, 2025 to shareholders registered at the close of business on March 14, 2025 in respect of the first quarter of 2025.

Dividends are paid wholly in cash. The default payment currency is U.S. Dollar for shareholders who hold their ordinary shares through a DTC participant. It is also U.S. Dollar for shareholders holding their ordinary shares in registered form, unless a currency election is registered with CRH’s Transfer Agent, Computershare Trust Company N.A. in advance of the applicable record date. The default payment currency for shareholders holding their ordinary shares in the form of Depository Interests is euro. Such shareholders can elect to receive dividends in U.S. Dollar or Pound Sterling by providing their instructions to the Company’s Depositary Interest provider, Computershare Investor Services plc, in advance of the applicable record date.

Securities Authorized For Issuance Under Equity Compensation Plans

Our equity compensation plan information required by this item is incorporated by reference to the information in Part III, Item 12. “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” of this Annual Report on Form 10-K.

CRH Form 10-K 28

Share Performance Graph

The performance graph below compares the five-year cumulative total shareholder return of our ordinary shares from December 31, 2019, to December 31, 2024, with the cumulative total return for the same period of the S&P 500 Index and the S&P 500 Materials Index. The graph assumes that the initial investment in our ordinary shares and each index was $100, with reinvestment of dividends.

Performance data for the Company is provided as of the last trading day of each relevant fiscal year. The share price performance graph is not indicative of future share price performance.

Comparative Total Return ($)	2019	2020	2021	2022	2023	2024
CRH plc	100.00	109.10	138.65	107.72	195.14	265.20
S&P 500	100.00	118.39	152.34	124.73	157.48	196.85
S&P 500 Materials	100.00	120.73	153.67	134.80	151.71	151.66

The performance graph above is being furnished solely to accompany this Annual Report on Form 10-K pursuant to Item 201(e) of Regulation S-K. It is not being filed for purposes of Section 18 of the Exchange Act, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Recent Sales Of Unregistered Securities

None.

CRH Form 10-K 29

Issuer Purchases of Equity Securities

Period	(a)<br>Total Number of Shares Purchased	(b)<br>Average Price Paid per Share	(c)<br>Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (i)	(d)<br>Maximum Number of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs
October 1 – October 31, 2024	1,073,950	$91.62	1,073,950	51,818,930
November 1 – November 30, 2024	796,638	$99.93	796,638	49,385,302
December 1 – December 31, 2024	802,015	$97.82	802,015	48,583,287
Total	2,672,603		2,672,603

(i)     In May 2018, CRH announced its intention to introduce a share repurchase program to repurchase ordinary shares (the ‘Program’). In the fourth quarter of 2024, the Company returned a further $0.3 billion of cash to shareholders through the repurchase of 2,672,603 ordinary shares (equivalent to 0.4% of the Company’s issued share capital). This brought total cash returned to shareholders under the Program to $8.4 billion since its commencement in May 2018. The purchases in the fourth quarter of 2024 were completed under the following tranches:

Date Announced		Max Amount to be Repurchased <br>(in $ millions)	Expiry Date
August 8, 2024	(Tranche 22)	300	November 6, 2024
November 7, 2024	(Tranche 23)	300	February 26, 2025

Item 6. Reserved

CRH Form 10-K 30

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to convey management’s perspective regarding operational and financial performance for fiscal years 2024, 2023 and 2022. This MD&A should be read in conjunction with the Consolidated Financial Statements in Item 8. “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K.

The following discussion contains trend information and forward-looking statements. Actual results could differ materially from those discussed in these forward-looking statements, as well as from our historical performance, due to various factors, including, but not limited to, those discussed in Item 1A “Risk Factors” and “Forward-Looking Statements – Safe Harbor Provisions Under The Private Securities Litigation Reform Act Of 1995” and elsewhere in this Annual Report on Form 10-K. Our operating results depend upon economic cycles, seasonal and other weather‐related conditions, and trends in government expenditures, among other factors. Accordingly, financial results for any year presented, or year‐to‐year comparisons of reported results, may not be indicative of future operating results.

Overview

CRH is a leading provider of building materials that build, connect and improve our world. Since formation in 1970, CRH has evolved from being a supplier of base materials to solving complex construction challenges for our customers. CRH’s differentiated solutions strategy uniquely integrates materials, products and services across the construction value chain, better serving our customers’ needs and driving repeat business. This customer-connected approach is making construction simpler, safer and more sustainable.

CRH integrates essential materials (aggregates and cement), value-added building products as well as construction services, to provide our customers with complete solutions. CRH’s capabilities, innovation and technical expertise enable it to be a valuable partner for transportation and critical infrastructure projects, complex non-residential construction and outdoor living solutions.

Financial performance highlights:

CRH delivered another record performance in 2024 resulting in the following performance highlights (compared to 2023 and 2022):

•Total revenues increased to $35.6 billion, compared with $34.9 billion in 2023 and $32.7 billion in 2022;

•Net income increased to $3.5 billion compared with $3.1 billion in 2023, primarily due to higher gross profit along with higher gains on disposal of long-lived assets and divestitures. Net income was $3.9 billion in 2022. Adjusted EBITDA* increased to $6.9 billion in 2024 from $6.2 billion in 2023. In 2022 Adjusted EBITDA* was $5.4 billion;

•Net income margin was 9.9% in 2024, 8.8% in 2023 and 11.9% in 2022. Adjusted EBITDA margin* was 19.5% in 2024, an increase of 180 basis points (bps) compared with an Adjusted EBITDA margin* of 17.7% in 2023. In 2022, the Adjusted EBITDA margin* was 16.5%;

•Operating cash flow5 of $5.0 billion was in line with 2023 operating cash flow of $5.0 billion and ahead of 2022 operating cash flow of $3.8 billion; 6

•Return on Net Segment Assets was 15.3% in 2024, 14.4% in 2023 and 13.1% in 2022. Return on Net Assets (RONA)* increased by 20bps to 15.5% in 2024, from 15.3% in 2023. RONA* was 13.3% in 2022; and

•Basic Earnings Per Share (EPS) from continuing operations in 2024 was $5.06 compared with $4.36 in 2023 and $3.58 in 2022. Basic EPS pre-impairment* from continuing operations was $5.48 in 2024, $4.65 in 2023 and $3.58 in 2022.

Capital allocation highlights:

•Cash paid to shareholders in 2024 through dividends was $1.7 billion and through share buybacks was $1.3 billion, compared with $0.9 billion and $3.0 billion, respectively, in 2023, and $0.9 billion and $1.2 billion, respectively, in 2022;

•Full year dividend per share increase of 5% resulting in a dividend per share of $1.40 in 2024, from $1.33 in 2023 and $1.27 in 2022;

•Ongoing share buyback program in 2024 repurchased approximately 15.9 million ordinary shares for a total consideration of $1.3 billion, compared with $3.0 billion in 2023 and $1.2 billion in 2022; and

•40 acquisitions completed for a total consideration of $5.0 billion in 2024, compared with $0.7 billion in 2023 and $3.3 billion in 2022. A further $2.6 billion was invested in development and replacement capital expenditure projects in 2024, compared with $1.8 billion and $1.5 billion in 2023 and 2022, respectively.

Delivering On Our Vision

CRH continues to evolve its business to improve performance, deliver for its stakeholders and respond to the ever-changing needs of its customers. Our strategy enables CRH to realize our vision to develop sustainable solutions that build, connect and improve our world. CRH has a specific set of capabilities in the markets in which it operates along with decades of experience and deep customer relationships. CRH leverages its scale and best practices across the Company to provide value-added materials, products and services as construction solutions that solve complex problems for its customers.

These solutions allow us to create further value for our customers by combining our products, materials and services which drive commercial and operational benefits. This connected portfolio allows us to leverage production and logistics efficiencies to drive increased profitability and asset utilization. We can reduce waste and advance the sustainability of construction. We believe it also makes our business less capital intensive and drives a higher rate of return delivering superior long-term value and higher growth for shareholders.

* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.

5 Operating cash flow refers to net cash provided by operating activities as reported in the Consolidated Statements of Cash Flows on pages 56 to 57.6

CRH Form 10-K 31

A business optimized for industry-leading performance

Through the successful execution of its strategy, CRH has shaped its business to capitalize on the attractive fundamentals driving demand in higher-growth construction markets in North America, Europe and Australia.

Customer-connected solutions strategy: Our differentiated strategy is focused on uniquely integrating materials, products and services across the construction value chain. We leverage our scale, expertise and best practices to provide sustainable solutions that solve complex problems for our customers. We utilize specific expertise in areas such as materials science, design and engineering to innovate and create new products. This allows us to do more for our customers and help deliver a higher performing and more sustainable built environment.

Performance-focused operator: CRH has the ability to leverage its connected portfolio of assets in the most attractive markets and this has resulted in our record 2024 results with 12% increase in Adjusted EBITDA*, 180 bps increase in Adjusted EBITDA margin* and 16% higher basic EPS from continuing operations, with basic EPS from continuing operations on a pre-impairment*7basis 18% higher. These results are underpinned by a differentiated strategy delivered by an experienced management team with deep industry knowledge and a proven track record of consistent financial and operational delivery.

Strong and flexible balance sheet: At December 31, 2024, total short-term and long-term debt was $14.0 billion, cash and cash equivalents and restricted cash were $3.8 billion and Net Debt* was $10.5 billion. We believe our strong and flexible balance sheet provides CRH with significant financial capacity for long-term value creation through accretive acquisitions, expansionary capital expenditure and cash returns to shareholders through dividends and share buybacks.

Focused growth

Our customers have an increasing need for more holistic solutions and CRH maximizes its overall growth potential by focusing on its ability to deliver solutions that meet this growing need. We are focused on delivering our customer-connected solutions strategy and to do so we are working to better connect our people, capabilities, assets and customers across businesses, markets, and geographies. We acquire businesses at attractive valuations and create value by integrating them with our existing operations and realizing synergies in areas including procurement, operational excellence, human resources, technology and sales.

Development review

In 2024, CRH completed 40 acquisitions for a total consideration of $5.0 billion.

The largest acquisition in 2024 was in Americas Materials Solutions where CRH acquired an attractive portfolio of cement and readymixed concrete operations and assets in Texas, for a total consideration of $2.1 billion. In addition, Americas Materials Solutions completed a further 20 acquisitions and Americas Building Solutions completed 10 acquisitions for a total 2024 spend in the Americas of $3.8 billion. International Solutions completed nine acquisitions for a total 2024 spend of $1.2 billion, including the acquisition of a majority stake in Adbri, a market leader in cement and aggregates in Australia.

CRH completed 10 divestitures and realized proceeds from divestitures and disposal of long-lived assets (including deferred divestiture consideration received) of $1.4 billion, primarily related to the divestiture of the European Lime operations.

In 2023, CRH completed 22 acquisitions for a total consideration of $0.7 billion. On the divestitures front, CRH realized proceeds from divestitures and disposal of long-lived assets (including deferred divestiture consideration received) of $0.1 billion.

The largest acquisition in 2023 was in Americas Building Solutions where the Company completed the acquisition of Hydro International, a leading provider of stormwater products, wastewater treatment products, wastewater services, and data solutions in North America and Europe. In addition, Americas Building Solutions completed a further four acquisitions and Americas Materials Solutions completed eight acquisitions in the United States, for a total 2023 spend in the Americas of $0.4 billion. International Solutions completed nine acquisitions for a total 2023 spend of $0.3 billion.

In 2022, CRH completed 29 acquisitions for a total consideration of $3.3 billion.

The largest acquisition in 2022 was in Americas Building Solutions where the Company completed its acquisition of Barrette Outdoor Living, Inc. (Barrette) for $1.9 billion. In addition, Americas Building Solutions completed a further seven acquisitions and Americas Materials Solutions completed 10 acquisitions for a total 2022 spend in the Americas of $3.1 billion. International Solutions completed 11 acquisitions for a total 2022 spend of $0.2 billion.

The largest divestiture in 2022 was the Building Envelope business for cash proceeds of $3.5 billion (enterprise value of $3.8 billion including lease liabilities transferred of $0.3 billion). A further eight divestitures were completed across CRH, realizing total proceeds of $0.2 billion and $0.2 billion was realized from the disposal of long-lived assets and deferred divestiture consideration.

Outlook

We expect positive underlying demand across our key end-use markets in 2025, underpinned by significant public investment in critical infrastructure, combined with increased re-industrialization activity in key non-residential segments. This backdrop is expected to support overall demand levels and further positive pricing across our business.

Our North American businesses expect continued positive momentum in infrastructure activity, supported by robust state and federal funding. Non-residential activity continues to benefit from secular tailwinds in key growth areas. Although the residential sector continues to be supported by strong long-term demand fundamentals, the new-build segment is expected to remain subdued while repair and remodel activity remains resilient.

In our International operations, we expect infrastructure activity to be underpinned by government and EU funding. Non-residential construction continues to be aided by onshoring of supply chains and industrial manufacturing activity. Residential markets are expected to stabilize with structural demand fundamentals supporting a gradual recovery.

Assuming normal seasonal weather patterns and absent any major dislocations in the political or macroeconomic environment, CRH’s leading positions of scale in attractive higher-growth markets, together with our strong and flexible balance sheet, are expected to underpin another year of growth and value creation in 2025.

7* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.

CRH Form 10-K 32

Market Backdrop

CRH’s results can be impacted by trends and factors in the wider construction markets it is exposed to. The principal construction markets, for all segments, are infrastructure, including highways, streets, roads and bridges; non-residential, including construction and maintenance of critical infrastructure, manufacturing, commercial, warehouse and data center facilities; and residential, including new-build construction, and repair and remodel activity, of single and multi-family housing. See ‘Business Segment Information’ in Item 1. “Business” for details by segment.

Infrastructure

In 2024, approximately 35% of revenues were derived from infrastructure.

Americas

Our North American businesses expect positive momentum in infrastructure activity, underpinned by robust state and federal funding, and supported by the IIJA which was signed into law in November 2021. This provides expected federal highway funding of approximately $350 billion over five years, including $110 billion in new funding for roads, bridges, and other infrastructure projects. Aided by the IIJA, U.S. highway contract awards remained at elevated levels in 2024, underpinning a positive outlook for 2025 as state budgets reflect the need for increased public infrastructure funding for highways and bridges.

International

After a resilient 2024, the outlook for 2025 in our International markets remains underpinned by government and EU funding for the infrastructure sector, which typically fluctuates less than residential and non-residential sectors. In this sector the impact of the business cycle is mitigated by long-term projects and a high share of activities financed by the public sector, with multinational EU funds a stabilizing factor in some of our larger markets.

Non-Residential

In 2024, approximately 30% of revenues were derived from non-residential construction.

Americas

In Americas, a key driver of demand in the non-residential sector is the onshoring of critical manufacturing. Large, multi-year construction projects (data centers, semiconductor chips, liquefied natural gas facilities) are underpinned by initiatives such as the U.S. CHIPS and Science Act, a $280 billion bill with the aim to bolster the United States’ semiconductor capacity. In addition, critical infrastructure is expecting to receive significant funding from the IIJA – water (approximately $48 billion), energy (approximately $79 billion) and technology (approximately $65 billion).

International

The non-residential sector outlook remains mixed in our International markets in 2025. Having declined in 2024, construction activity is expected to grow in Eastern Europe, underpinned by improving economic fundamentals. In the United Kingdom, construction confidence improved steadily through 2024 although sentiment remains subdued in other markets. Non-residential activity in the Division remains supported by increased efforts to onshore manufacturing activity via government stimulus measures.

Residential

In 2024, approximately 35% of revenues were derived from residential construction.

Americas

The residential sector’s recent performance has been influenced by affordability constraints with inflation challenges, rising home prices and high mortgage rates. While residential construction activity continues to be supported by long-term demand fundamentals, the new-build segment is expected to remain subdued. As a result of the aging U.S. housing stock, repair and remodel activity is expected to be less subdued than new-build activity in the near-term.

International

Our International businesses are more heavily exposed to the new-build residential sector, which is expected to gradually recover as a lower interest rate environment unfolds.

CRH Form 10-K 33

Results Of Operations

Revenues are derived from a range of products and services across three segments. The Americas Materials Solutions segment utilizes an extensive network of reserve-backed quarry locations to produce and supply a range of materials including aggregates, cement, readymixed concrete and asphalt, as well as providing paving and construction services. The Americas Building Solutions segment manufactures, supplies and delivers high-quality building products and solutions. The International Solutions segment integrates building materials, product and services for the construction and renovation of public infrastructure, critical networks, commercial and residential buildings, and outdoor living spaces.

The table below summarizes CRH’s Consolidated Statements of Income for the periods indicated.

Consolidated Statements of Income8

(in $ millions, except per share data)

For the years ended December 31	2024	2023	2022
Total revenues	35,572	34,949	32,723
Total cost of revenues	(22,871)	(22,986)	(21,908)
Gross profit	12,701	11,963	10,815
Selling, general and administrative expenses	(7,852)	(7,486)	(7,056)
Gain on disposal of long-lived assets	237	66	50
Loss on impairments	(161)	(357)	–
Operating income	4,925	4,186	3,809
Interest income	143	206	65
Interest expense	(612)	(376)	(344)
Other nonoperating income (expense), net	258	(2)	(69)
Income from continuing operations before income tax expense and income from equity method investments	4,714	4,014	3,461
Income tax expense	(1,085)	(925)	(762)
Loss from equity method investments	(108)	(17)	–
Income from continuing operations	3,521	3,072	2,699
Income from discontinued operations, net of income tax expense	–	–	1,190
Net income	3,521	3,072	3,889
Net (income) attributable to redeemable noncontrolling interests	(28)	(28)	(27)
Net (income) loss attributable to noncontrolling interests	(1)	134	–
Net income attributable to CRH	3,492	3,178	3,862
Basic earning per share attributable to CRH from continuing operations	$5.06	$4.36	$3.58
Basic earning per share attributable to CRH from continuing operations - pre-impairment*	$5.48	$4.65	$3.58
Adjusted EBITDA*	6,930	6,176	5,388

Total revenues

2024 versus 2023

Total revenues were $35.6 billion in 2024, an increase of $0.6 billion, or 2%, compared with 2023, with resilient underlying demand in key end-use markets, continued commercial progress and contributions from acquisitions partly offset by lower activity levels in certain regions due to adverse weather and divestitures.

For additional discussion on segment revenues, see “Segments” section on pages 37 to 39.

2023 versus 2022

Total revenues were $34.9 billion, an increase of $2.2 billion, or 7%, compared with 2022, reflecting good underlying demand across key end-use markets, positive pricing and contributions from acquisitions which offset lower volumes compared with the prior year.

Gross profit

2024 versus 2023

Gross profit was $12.7 billion in 2024, an increase of $0.7 billion, or 6%, compared with 2023, reflecting total revenues growth of 2%, with total cost of revenues 1% lower. The gross profit margin of 35.7% increased 150bps from 34.2% in the prior year, driven by commercial progress, ongoing cost control and operational efficiencies. Total cost of revenues decreased primarily as a result of an 18% decrease in energy costs due to a decline in energy prices, lower activity levels and divestitures. These were partly offset by an increase in labor costs of 6% driven by wage inflation and increased headcount due to acquisitions.

8* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.

CRH Form 10-K 34

2023 versus 2022

Gross profit was $12.0 billion in 2023, an increase of $1.2 billion, or 11%, compared with 2022. This reflected total revenues growth of 7%, with total cost of revenues increasing by 5%. The gross profit margin of 34.2%, increased 110bps from 33.1% in the prior year, due to revenue growth exceeding increases in total cost of revenues. Total cost of revenues increased primarily as a result of subcontractor costs and repairs and maintenance increasing 11% and 9%, respectively, due to the impact of cost inflation. Labor costs increased by 8% due to the impact of acquisitions, wage inflation impacted by continued labor shortages and increased headcount. Energy costs were in line with 2022 and raw materials costs decreased by 1% primarily as a result of lower volumes.

Selling, general and administrative expenses

2024 versus 2023

Selling, general and administrative (SG&A) expenses, which are primarily comprised of haulage costs, labor costs, and other selling and administration expenses, were $7.9 billion in 2024, an increase of $0.4 billion, or 5%, compared with 2023. The increase in SG&A expenses was primarily due to labor cost increases of 9%, as a result of increased headcount from acquisitions and wage inflation; partially offset by divestitures.

2023 versus 2022

SG&A expenses were $7.5 billion in 2023, an increase of $0.4 billion, or 6%, compared with 2022. The increase in SG&A expenses primarily reflects labor cost increases of 14%, as a result of increased headcount, impacted by acquisitions and wage inflation; partially offset by lower haulage costs which decreased 4% compared with 2022 as a result of lower volumes and lower fuel costs.

Gain on disposal of long-lived assets

2024 versus 2023

Gain on disposal of long-lived assets was $237 million in 2024, an increase of $171 million compared with 2023. The increase mainly related to the disposal of certain land assets.

2023 versus 2022

Gain on disposal of long-lived assets was $66 million in 2023, an increase of $16 million compared with 2022, primarily due to gains on disposal of plant and equipment.

Loss on impairments

2024 versus 2023

Loss on impairments in 2024 was $161 million, compared with $357 million in 2023, and principally related to the International Solutions segment where an impairment was recognized related to the Architectural Products reporting unit, driven by challenging market conditions.

2023 versus 2022

Loss on impairments in 2023 was $357 million, compared with $nil million in 2022, and was principally in the International Solutions segment where an impairment was recognized related to our business in the Philippines which has been impacted by challenging market conditions.

Interest income

2024 versus 2023

Interest income was $143 million in 2024, a decrease of $63 million compared with 2023, primarily due to lower levels of cash deposits.

2023 versus 2022

Interest income was $206 million in 2023, an increase of $141 million compared with 2022, as a result of higher interest rates on deposits.

Interest expense

2024 versus 2023

Interest expense was $612 million in 2024, an increase of $236 million, or 63%, compared with 2023. The increase was primarily due to higher gross debt balances and increased interest rates. For additional information on new fixed rate debt issuance, see Note 11 “Debt” in Item 8. “Financial Statements and Supplementary Data”.

2023 versus 2022

Interest expense was $376 million in 2023, an increase of $32 million, or 9%, compared with 2022. The increase was primarily due to higher interest rates on floating rate debt, interest rate swaps and new fixed rate debt issued, partially offset by interest on maturing debt.

Other nonoperating income (expense), net

2024 versus 2023

Other nonoperating income (expense), net, was income of $258 million in 2024, an increase of $260 million compared with 2023. Other nonoperating income (expense) net, includes pension and postretirement benefit costs (excluding service costs), gains and losses from divestitures, and other miscellaneous income and expenses. The increase was primarily related to gains on divestitures.

2023 versus 2022

Other nonoperating income (expense), net, was an expense of $2 million in 2023, a decrease of $67 million compared with 2022. The decrease was primarily related to a reduction of loss on divestitures to $nil million in 2023 which was $99 million in 2022, partly offset by pension-related movements of $27 million.

CRH Form 10-K 35

Income tax expense

The Company’s tax rate is driven by the tax rates in jurisdictions in which the Company operates and the relative amount of income earned in each jurisdiction. Income tax expense for the three-year period from 2022 to 2024 is shown below:

in $ millions, except effective tax rate	2024	2023	2022
Income from continuing operations before income tax expense and income from equity method investments	4,714	4,014	3,461
Income tax expense	(1,085)	(925)	(762)
Effective tax rate	23%	23%	22%

2024 versus 2023

In 2024, the Company’s income tax expense was $1.1 billion, an increase of $0.2 billion compared with 2023. The effective tax rate attributable to continuing operations was 23% for 2024, in line with 23% for 2023.

2023 versus 2022

In 2023, the Company’s income tax expense was $0.9 billion, an increase of $0.2 billion compared with 2022. The effective tax rate attributable to continuing operations was 23% for 2023 compared with 22% for 2022. The increase in the effective tax rate compared with the prior year was primarily driven by the impact of impairments not deductible for tax purposes in the year.

Loss from equity method investments

2024 versus 2023

In 2024, a loss of $108 million was recorded in equity method investments, primarily driven by an impairment in the Company’s equity method investment in Yatai Building Materials (YBM) in China, where market conditions remained challenging.

2023 versus 2022

In 2023, a loss of $17 million was recorded in equity method investments, primarily driven by the performance of the Company’s equity method investment in YBM in China, where market conditions remained challenging.

Income from continuing operations

2024 versus 2023

Income from continuing operations in 2024 amounted to $3.5 billion, an increase of $0.4 billion on 2023. This result was primarily driven by higher gross profit along with higher gains on divestitures and disposal of long-lived assets, which offset higher interest and SG&A expenses.

2023 versus 2022

Income from continuing operations in 2023 amounted to $3.1 billion, an increase of $0.4 billion on 2022. This result was primarily driven by an improved operating performance and higher interest income, partially offset by loss on impairments and a higher income tax expense.

Income from discontinued operations, net of income tax expense

2024 versus 2023

Income from discontinued operations, net of income tax expense was $nil million in both 2024 and 2023.

2023 versus 2022

Income from discontinued operations, net of income tax expense was $nil million in 2023, compared with income of $1.2 billion related to the divestiture of the Building Envelope business in 2022.

Net income attributable to CRH and earnings per share

2024 versus 2023

Net income attributable to CRH was $3.5 billion in 2024, an increase of $0.3 billion from 2023. Basic EPS from continuing operations for 2024 was $5.06, an increase of 16% on 2023. Basic EPS pre-impairment* from continuing operations for 2024 was $5.48, an increase of 18% on 2023.9

2023 versus 2022

Net income attributable to CRH was $3.2 billion in 2023, a decrease of $0.7 billion from 2022. Basic EPS from continuing operations for 2023 was $4.36, an increase of 22% on 2022. Basic EPS pre-impairment* from continuing operations for 2023 was $4.65.10

* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.9

10

CRH Form 10-K 36

Segments

During the fourth quarter of 2024, the Company's reportable segments changed to the following three segments: Americas Materials Solutions, Americas Building Solutions, and International Solutions; across two Divisions: CRH Americas and CRH International.

Within CRH’s segments, revenue is disaggregated by principal activities and products and by primary geographic market. Business lines are reviewed and evaluated as follows: (1) Essential Materials, (2) Road Solutions, (3) Building & Infrastructure Solutions, and (4) Outdoor Living Solutions. The vertically integrated Essential Materials businesses manufacture and supply aggregates and cement for use in a range of construction and industrial applications. Road Solutions support the manufacturing, installation and maintenance of public highway infrastructure projects and commercial infrastructure projects. Building & Infrastructure Solutions connect, protect and transport critical water, energy and telecommunications infrastructure and deliver complex commercial building projects. Outdoor Living Solutions integrate specialized materials, products and design features to enhance the quality of private and public spaces.

The Company’s measure of segment profit is Adjusted EBITDA, which is defined as earnings from continuing operations before interest, taxes, depreciation, depletion, amortization, loss on impairments, gain/loss on divestitures and unrealized gain/loss on investments, income/loss from equity method investments, substantial acquisition-related costs and pension expense/income excluding current service cost component.

Americas Materials Solutions

2024

		Analysis of Change
in $ millions	2023	Currency	Acquisitions	Divestitures	Organic	2024	% change
Total revenues	15,435	(22)	+641	(112)	+231	16,173	+5%
Adjusted EBITDA	3,059	(6)	+180	(36)	+548	3,745	+22%
Adjusted EBITDA margin	19.8%					23.2%

Americas Materials Solutions’ total revenues were 5% ahead of the prior year as price increases and contributions from acquisitions offset lower activity levels which were impacted by adverse weather. Organic total revenues* were 1% ahead.

In Essential Materials, total revenues were 5% ahead of the prior year, supported by aggregates and cement pricing, which were ahead by 10% and 8%, respectively. Aggregates volumes declined by 3% while cement volumes increased by 1% compared to 2023.

In Road Solutions, total revenues increased by 5% driven by pricing progression and sustained activity levels through continued state and federal funding support. Asphalt prices increased by 3% while volumes, impacted by weather, declined 2% against 2023. Paving and construction revenues increased 5% versus the prior year. Readymixed concrete pricing was 6% higher than the prior year, while volumes were 1% ahead.

Adjusted EBITDA for Americas Materials Solutions of $3.7 billion was 22% ahead of the prior year with growth across all regions. Positive pricing, disciplined cost management and operational efficiencies along with gains on land asset sales offset lower volumes in certain markets. Organic Adjusted EBITDA* was 18% ahead of 2023. Adjusted EBITDA margin increased by 340bps.

2023

		Analysis of Change
in $ millions	2022	Currency	Acquisitions	Divestitures	Organic	2023	% change
Total revenues	14,324	(44)	+242	–	+913	15,435	+8%
Adjusted EBITDA	2,638	(6)	+42	–	+385	3,059	+16%
Adjusted EBITDA margin	18.4%					19.8%

Americas Materials Solutions’ total revenues were 8% ahead of 2022, 6% ahead on an organic* basis, driven primarily by price progression across all business lines and partly offset by lower activity levels in certain regions.

In Essential Materials total revenues increased by 10%, supported by double-digit pricing growth in both aggregates and cement, which were ahead by 14% and 15%, respectively. Aggregates volumes declined by 1% and cement volumes declined by 3%, impacted by unfavorable weather in certain regions.

In Road Solutions, total revenues increased by 7% driven by increased pricing and positive infrastructure activity underpinned by IIJA funding. Asphalt prices increased by 7% while asphalt volumes were in line with the prior year as improved demand in the South and West during the second half of the year was offset by lower volumes in the Great Lakes and Northeast regions. Paving and construction revenues increased by 6%. Readymixed concrete pricing was 12% higher compared with 2022, however volumes were 2% behind due to lower activity levels in the South.

Adjusted EBITDA in Americas Materials Solutions of $3.1 billion was 16% ahead of 2022 as increased pricing across all lines of business and operational efficiencies mitigated the impact of higher labor and subcontractor costs. Organic Adjusted EBITDA* was 15% ahead of 2022. Adjusted EBITDA margin increased by 140bps.11

11* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.

CRH Form 10-K 37

Americas Building Solutions

2024

		Analysis of Change
in $ millions	2023	Currency	Acquisitions	Divestitures	Organic	2024	% change
Total revenues	7,017	(4)	+193	–	(147)	7,059	+1%
Adjusted EBITDA	1,442	(2)	+34	–	(85)	1,389	(4%)
Adjusted EBITDA margin	20.6%					19.7%

In 2024, Americas Building Solutions' total revenues were 1% ahead of the prior year as positive contributions from acquisitions were partially offset by subdued new-build residential demand and adverse weather. Organic total revenues* were 2% behind the prior year.

In Building & Infrastructure Solutions, total revenues were 2% ahead of the prior year as contributions from acquisitions offset lower activity levels due to adverse weather conditions and subdued new-build residential demand.

In Outdoor Living Solutions, total revenues were flat compared with 2023 as unfavorable weather conditions offset increased sales into the retail channel.

Adjusted EBITDA for Americas Building Solutions was 4% behind 2023 and 6% behind on an organic* basis as adverse weather and subdued new-build residential demand impacted performance. Adjusted EBITDA margin was 90bps behind the prior year.

12

2023

		Analysis of Change
in $ millions	2022	Currency	Acquisitions	Divestitures	Organic	2023	% change
Total revenues	6,188	(14)	+751	–	+92	7,017	+13%
Adjusted EBITDA	1,219	(4)	+153	–	+74	1,442	+18%
Adjusted EBITDA margin	19.7%					20.6%

Americas Building Solutions recorded total revenues growth of 13%, driven by the continued execution of our integrated solutions strategy, good commercial progress through price increases and contributions from prior year acquisitions, primarily Barrette. Organic total revenues* were 1% ahead of 2022.

In Building & Infrastructure Solutions, total revenues growth was 6% due to increased demand in the water and energy sectors as well as contributions from recent acquisitions.

In Outdoor Living Solutions, total revenues growth was 18%, driven by positive pricing, resilient retail demand and the incremental impact of the Barrette acquisition in July 2022.

Adjusted EBITDA in Americas Building Solutions was 18% ahead of the prior year, 6% ahead on an organic* basis, driven by positive pricing and contributions from recent acquisitions which offset the impact of increased labor and raw materials costs. As a result, the Adjusted EBITDA margin was 90bps ahead of the prior year.13

* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.12

13

CRH Form 10-K 38

International Solutions

2024

		Analysis of Change
in $ millions	2023	Currency	Acquisitions	Divestitures	Organic	2024	% change
Total revenues	12,497	+141	+808	(542)	(564)	12,340	(1%)
Adjusted EBITDA	1,675	+17	+100	(136)	+140	1,796	+7%
Adjusted EBITDA margin	13.4%					14.6%

International Solutions’ total revenues were 1% behind the prior year. Organic total revenues* were 4% behind as positive pricing momentum and good volume growth in Central and Eastern Europe were offset by lower volumes in Western Europe as well as lower trading activities in the Building & Infrastructure Solutions and Outdoor Living Solutions businesses.

In Essential Materials, total revenues were 2% behind as continued pricing progress and contributions from acquisitions were offset by the divestiture of the European Lime operations. Aggregates volumes were 3% ahead of 2023 with cement volumes 5% ahead, supported by good growth in Central and Eastern Europe as well as recent acquisitions. Aggregates pricing was 4% ahead and overall cement pricing was 3% ahead of 2023.

In Road Solutions, total revenues were 2% ahead of 2023. Volumes and prices were ahead in the readymixed concrete business by 8% and 3%, respectively, benefiting from volume growth in Central and Eastern Europe as well as acquisitions in the period. Asphalt volumes and pricing declined 2% and 1%, respectively. Paving and construction revenues were behind 2023 due to lower activity levels in Western Europe.

Total revenues in Building & Infrastructure Solutions and Outdoor Living Solutions declined by 6% compared with the prior year, amid continued subdued new-build residential activity.

Adjusted EBITDA in International Solutions was $1.8 billion, 7% ahead of 2023, and 8% ahead on an organic* basis, primarily driven by increased pricing, lower energy costs and operational efficiencies. Adjusted EBITDA margin increased by 120bps compared with 2023.

202314

		Analysis of Change
in $ millions	2022	Currency	Acquisitions	Divestitures	Organic	2023	% change
Total revenues	12,211	+255	+156	(157)	+32	12,497	+2%
Adjusted EBITDA	1,531	+34	+18	(12)	+104	1,675	+9%
Adjusted EBITDA margin	12.5%					13.4%

International Solutions’ performance in 2023 was driven by continued pricing progress which more than offset lower activity levels, resulting in total revenues growth of 2%. Organic* revenues were in line with the prior year.

In Essential Materials, total revenues were 5% ahead of 2022 driven by positive pricing for aggregates and cement which were ahead by 9% and 18%, respectively. Aggregates volumes declined by 7% while cement volumes were 13% behind (10% behind excluding the impact of 2022 divestitures) as activity levels were impacted by lower new-build residential activity and unfavorable weather in several key markets.

In Road Solutions, notwithstanding the impact of adverse weather in the first half of the year, pricing progress across all key markets resulted in total revenues for the year 2% ahead of 2022. Asphalt pricing increased by 10%, while volumes declined by 6%. Paving and construction revenues increased by 10%. Readymixed concrete pricing improved by 17%, while volumes decreased by 14%.

Total revenues in Building & Infrastructure Solutions and Outdoor Living Solutions declined by 2% compared with 2022 as increased infrastructure demand was more than offset by subdued new-build residential activity. Positive pricing and commercial progress was offset by lower activity experienced in several markets of the Precast and Construction Accessories businesses in particular.

In 2023 Adjusted EBITDA in International Solutions was $1.7 billion, 9% ahead of 2022 and 7% ahead on an organic* basis. Adjusted EBITDA growth was primarily driven by positive pricing and lower haulage and raw materials costs, which offset lower volume levels. Adjusted EBITDA margin increased by 90bps compared with 2022.

14* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.

CRH Form 10-K 39

Non-GAAP Reconciliation and Supplementary Information

CRH uses a number of non-GAAP performance measures to monitor financial performance. These measures are referred to throughout the discussion of our reported financial position and operating performance on a continuing operations basis unless otherwise defined and are measures which are regularly reviewed by CRH management. These performance measures may not be uniformly defined by all companies and accordingly may not be directly comparable with similarly titled measures and disclosures by other companies.

Certain information presented is derived from amounts calculated in accordance with U.S. GAAP but is not itself an expressly permitted GAAP measure. The non-GAAP performance measures as summarized below should not be viewed in isolation or as an alternative to the equivalent GAAP measure.

Adjusted EBITDA: Adjusted EBITDA is defined as earnings from continuing operations before interest, taxes, depreciation, depletion, amortization, loss on impairments, gain/loss on divestitures and unrealized gain/loss on investments, income/loss from equity method investments, substantial acquisition-related costs and pension expense/income excluding current service cost component. It is quoted by management in conjunction with other GAAP and non-GAAP financial measures to aid investors in their analysis of the performance of the Company. Adjusted EBITDA by segment is monitored by management in order to allocate resources between segments and to assess performance. Adjusted EBITDA margin is calculated by expressing Adjusted EBITDA as a percentage of total revenues.

Reconciliation to its nearest GAAP measure is presented below:

in millions		2023		2022
Net income		3,072		3,889
Income from discontinued operations, net of income tax expense		–		(1,190)
Loss from equity method investments (i)		17		–
Income tax expense		925		762
(Gain) loss on divestitures and unrealized gains on investments (ii)		–		99
Pension income excluding current service cost component (ii)		(3)		(30)
Other interest, net (ii)		5		–
Interest expense		376		344
Interest income		(206)		(65)
Depreciation, depletion and amortization		1,633		1,552
Loss on impairments (i)		357		–
Substantial acquisition-related costs (iii)		–		27
Adjusted EBITDA		6,176		5,388
Total revenues		34,949		32,723
Net income margin	%	8.8	%	11.9	%
Adjusted EBITDA margin		17.7%		16.5%
(i) For the year ended December 31, 2024, the total impairment loss comprised 0.35 billion, principally related to the Architectural Products reporting unit within International Solutions and the equity method investment in China. For the year ended December 31, 2023, the total impairment loss comprised 62 million within Americas Materials Solutions and 295 million within International Solutions.
(ii) (Gain) loss on divestitures and unrealized gains on investments, pension income excluding current service cost component and other interest, net have been included in Other nonoperating income (expense), net in the Consolidated Statements of Income.
(iii) Represents expenses associated with non-routine substantial acquisitions, which meet the criteria for being separately reported in Note 4 “Acquisitions” of the audited financial statements. Expenses in 2024 and in 2022 primarily include legal and consulting expenses related to these non-routine substantial acquisitions.

All values are in US Dollars.

Return on Net Assets (RONA): Return on Net Assets is a key internal pre-tax and pre-impairment (which is non-cash) measure of operating performance throughout the Company and can be used by management and investors to measure the relative use of assets between CRH’s segments. The metric measures management’s ability to generate income from the net assets required to support that business, focusing on both profit maximization and the maintenance of an efficient asset base; it encourages effective fixed asset maintenance programs, good decisions regarding expenditure on property, plant and equipment and the timely disposal of surplus assets. It also supports the effective management of the Company’s working capital base. RONA is calculated by expressing operating income from continuing operations and operating income from discontinued operations excluding loss on impairments (which is non-cash) as a percentage of average net assets. Net assets comprise total assets by segment (including assets held for sale) less total liabilities by segment (excluding finance lease liabilities and including liabilities associated with assets classified as held for sale) as shown below and detailed in Note 3 “Assets held for sale and discontinued operations” in Item 8. “Financial Statements and Supplementary Data” and excludes equity method investments and other financial assets, Net Debt (as defined on page 42) and tax assets and liabilities. The average net assets for the year is the simple average of the opening and closing balance sheet figures.

CRH Form 10-K 40

Reconciliation to its nearest GAAP measure is presented below:

in millions	2024	2023	2022
Operating income	4,925	4,186	3,809
Operating income from discontinued operations	–	–	89
	4,925	4,186	3,898
Adjusted for loss on impairments (i)	161	357	–
Numerator for RONA computation	5,086	4,543	3,898
Current year
Segment assets (ii)	45,534	38,868	38,504
Segment liabilities (ii)	(9,771)	(10,169)	(8,883)
	35,763	28,699	29,621
Finance lease liabilities	257	117	81
	36,020	28,816	29,702
Assets held for sale (iii)	–	1,268	–
Liabilities associated with assets classified as held for sale (iii)	–	(375)	–
	36,020	29,709	29,702
Prior year
Segment assets (ii)	38,868	38,504	37,951
Segment liabilities (ii)	(10,169)	(8,883)	(9,246)
	28,699	29,621	28,705
Finance lease liabilities	117	81	83
	28,816	29,702	28,788
Assets held for sale (iii)	1,268	–	–
Liabilities associated with assets classified as held for sale (iii)	(375)	–	–
	29,709	29,702	28,788
Denominator for RONA computation - average net assets	32,865	29,706	29,245
Return on net segment assets (A divided by average of B and C)	15.3%	14.4%	13.1%
RONA	15.5%	15.3%	13.3%
Total assets as reported in the Consolidated Balance Sheets	50,613	47,469	45,319
Total liabilities as reported in the Consolidated Balance Sheets	27,763	25,848	22,279
(i) Operating income is adjusted for loss on impairments. For the year ended December 31, 2024, the total impairment loss comprised 161 million within International Solutions. For the year ended December 31, 2023, the total impairment loss comprised 62 million within Americas Materials Solutions and 295 million within International Solutions.
(ii) Segment assets and liabilities as disclosed in Note 20 “Segment information” in Item 8. “Financial Statements and Supplementary Data”.
(iii) Assets held for sale and liabilities associated with assets classified as held for sale as disclosed in Note 3 “Assets held for sale and discontinued operations” in Item 8. “Financial Statements and Supplementary Data”.

All values are in US Dollars.

CRH Form 10-K 41

Net Debt: Net Debt is used by management as it gives additional insight into the Company’s current debt position less available cash. Net Debt is provided to enable investors to see the economic effect of gross debt, related hedges and cash and cash equivalents in total. Net Debt comprises short and long-term debt, finance lease liabilities, cash and cash equivalents and current and noncurrent derivative financial instruments (net).

Reconciliation to its nearest GAAP measure is presented below:

in millions	2023	2022
Short and long-term debt	(11,642)	(9,636)
Cash and cash equivalents (i)	6,390	5,936
Finance lease liabilities	(117)	(81)
Derivative financial instruments (net)	(37)	(86)
Net Debt	(5,406)	(3,867)
(i) 2023 includes 49 million cash and cash equivalents reclassified as held for sale.

All values are in US Dollars.

Organic Revenue and Organic Adjusted EBITDA: CRH pursues a strategy of growth through acquisitions and investments, with total consideration spent on acquisitions and investments of $5.0 billion in 2024, compared with $0.7 billion in 2023. Acquisitions completed in 2024 and 2023 contributed incremental total revenues of $1.6 billion and Adjusted EBITDA of $0.3 billion in 2024. Cash proceeds from divestitures and disposal of long-lived assets (including deferred divestiture consideration received) amounted to $1.4 billion in 2024, compared with $0.1 billion in 2023. The total revenues impact of divestitures in 2024 was a negative $0.7 billion and the impact at an Adjusted EBITDA level was a negative $0.2 billion.

The U.S. Dollar weakened against most major currencies during 2024 resulting in an overall positive currency exchange impact in 2024.

Because of the impact of acquisitions, divestitures, currency exchange translation and other non-recurring items on reported results each year, CRH uses organic revenue and organic Adjusted EBITDA as additional performance indicators to assess performance of pre-existing (also referred to as underlying, like-for-like or ongoing) operations each year.

Organic revenue and organic Adjusted EBITDA are arrived at by excluding the incremental revenue and Adjusted EBITDA contributions from current and prior year acquisitions and divestitures, the impact of exchange translation, and the impact of any one-off items. In the Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section on pages 37 to 39, changes in organic revenue and organic Adjusted EBITDA are presented as additional measures of revenue and Adjusted EBITDA to provide a greater understanding of the performance of the Company. Organic change % is calculated by expressing the organic movement as a percentage of the prior year (adjusted for currency exchange effects). A reconciliation of the changes in organic revenue and organic Adjusted EBITDA to the changes in total revenues and Adjusted EBITDA by segment, is presented with the discussion within each segment’s performance in tables contained in the segment discussion in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” commencing on page 31.

Basic EPS pre‑impairment: Basic EPS pre‑impairment is a measure of the Company's profitability per share from continuing operations excluding any loss on impairments (which is non-cash) and the related tax impact of such impairments. It is used by management to evaluate the Company's underlying profit performance and its own past performance. Basic EPS information presented on a pre‑impairment basis is useful to investors as it provides an insight into the Company's underlying performance and profitability. Basic EPS pre‑impairment is calculated as income from continuing operations adjusted for (i) net (income) attributable to redeemable noncontrolling interests (ii) net loss (income) attributable to noncontrolling interests (iii) adjustment of redeemable noncontrolling interests to redemption value and excluding any loss on impairments (and the related tax impact of such impairments) divided by the weighted average number of common shares outstanding for the year.

Reconciliation to its nearest GAAP measure is presented below:

in millions, except share and per share data	Per Share - basic	2023	Per Share - basic	2022	Per Share - basic
Weighted average common shares outstanding – basic		723.9		758.3
Income from continuing operations	$5.15	3,072	$4.24	2,699	$3.56
Net (income) attributable to redeemable noncontrolling interests	($0.04)	(28)	($0.04)	(27)	($0.03)
Net (income) loss attributable to noncontrolling interests	–	134	$0.19	–	–
Adjustment of redeemable noncontrolling interests to redemption value	($0.05)	(24)	($0.03)	40	$0.05
Income from continuing operations for EPS	$5.06	3,154	$4.36	2,712	$3.58
Impairment of property, plant and equipment and intangible assets	$0.24	224	$0.30	–	–
Impairment of equity method investments (net of tax)	$0.22	–	–	–	–
Tax related to impairment charges	($0.04)	(9)	($0.01)	–	–
Income from continuing operations for EPS – pre-impairment (i)	$5.48	3,369	$4.65	2,712	$3.58
(i) Reflective of CRH’s share of impairment of property, plant and equipment and intangible assets (2024: 161 million; 2023: 224 million), an impairment of equity method investments (2024: 190 million; 2023: nil million) and related tax effect.

All values are in US Dollars.

CRH Form 10-K 42

Liquidity and Capital Resources15

The Company’s primary source of incremental liquidity is cash flows from operating activities, which combined with the year-end cash and cash equivalents balance, the U.S. Dollar and Euro Commercial Paper Programs, and committed credit lines, is expected to be sufficient to meet the Company’s working capital needs, capital expenditures, dividends, share repurchases, upcoming debt maturities, and other liquidity requirements associated with our operations for the foreseeable future. In addition, the Company believes that it will have sufficient ability to fund additional acquisitions via cash flows from internally available cash, cash flows from operating activities and, subject to market conditions, via obtaining additional borrowings and/or issuing additional debt or equity securities.

Total short and long-term debt was $14.0 billion at December 31, 2024, compared with $11.6 billion in 2023 and $9.6 billion in 2022. In January 2024, €600 million 1.875% euro Senior Notes were repaid on maturity. In May 2024, wholly-owned subsidiaries of the Company issued $750 million 5.20% Senior Notes due 2029 and $750 million 5.40% Senior Notes due 2034. In July 2024, as part of the Adbri acquisition $0.5 billion of external debt was acquired. In December 2024, the Company entered into and drew down a $750 million two-year term loan at a fixed rate of 4.91%. For additional information on new fixed rate debt issuance, see Note 11 “Debt” in Item 8. “Financial Statements and Supplementary Data”. Net Debt* at December 31, 2024, was $10.5 billion, compared with $5.4 billion in 2023. The increase in Net Debt* between 2024 and 2023 reflects acquisitions, cash returns to shareholders through dividends and continued share buybacks, as well as the purchase of property, plant and equipment, partially offset by inflows from operating activities and proceeds from divestitures.

CRH continued its ongoing share buyback program in 2024 repurchasing 15.9 million ordinary shares for a total consideration of $1.3 billion, and in 2023 54.9 million ordinary shares were repurchased for total consideration of $3.0 billion. The Company also made cash dividend payments of $1.7 billion in 2024 and $0.9 billion in 2023.

At December 31, 2024, CRH had cash and cash equivalents and restricted cash of $3.8 billion compared with $6.4 billion in 2023 and $5.9 billion in 2022. Total lease liabilities were $1.6 billion compared with $1.5 billion in 2023 and $1.3 billion in 2022.

At December 31, 2024, CRH had $3.8 billion of undrawn committed facilities, $3.6 billion of which is available until May 2029. At December 31, 2024, the weighted average maturity of the term debt (net of cash and cash equivalents) was 7.5 years.

Cash flows

Cash flows from operating activities

	For the years ended December 31
in $ millions	2024	2023	2022
Net cash provided by operating activities	4,989	5,017	3,800

2024 versus 2023

Net cash provided by operating activities was $5.0 billion in 2024, in line with $5.0 billion in 2023. Net cash provided by operating activities in 2024 was primarily from net income of $3.5 billion, adjusted for depreciation, depletion, and amortization of $1.8 billion and loss on impairments of $0.35 billion, partly offset by higher non-operating cash adjustments and working capital outflows.

2023 versus 2022

Net cash provided by operating activities was $5.0 billion in 2023 and $3.8 billion in 2022. Net cash provided by operating activities in 2023 was primarily from net income of $3.1 billion, adjusted for depreciation, depletion, and amortization of $1.6 billion and loss on impairments of $0.4 billion. The primary drivers of the $1.2 billion increase in net cash provided by operating activities in 2023 compared with 2022 were lower non-cash adjustments and positive working capital movements.

Cash flows from investing activities

	For the years ended December 31
in $ millions	2024	2023	2022
Net cash used in investing activities	(6,291)	(2,391)	(917)

2024 versus 2023

Net cash used in investing activities increased to $6.3 billion in 2024 from $2.4 billion in 2023, an increase of $3.9 billion. Capital expenditure totaled $2.6 billion, resulting in an increased outflow of $0.8 billion versus prior year. During 2024, net cash used on acquisitions and divestitures was $3.5 billion as acquisition spend exceeded proceeds from divestitures and disposal of long-lived assets, primarily related to the completed divestiture of the European Lime operations and the divestiture of certain operations in Canada.

2023 versus 2022

Net cash used in investing activities increased to $2.4 billion in 2023 from $0.9 billion in 2022, an increase of $1.5 billion. This increase was primarily driven by a reduction in proceeds from divestitures and increased capital expenditure. In 2022, net cash provided by acquisition and divestiture activity was $0.6 billion as divestiture proceeds more than offset acquisition spend. In 2023, net cash used on acquisitions and divestitures was $0.5 billion as acquisition spend exceeded proceeds from divestitures and disposal of long-lived assets. Net cash used in investing activities also increased as a result of purchases of property, plant and equipment increasing to $1.8 billion in 2023, an increase of $0.3 billion compared with 2022.

*Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42. 15

CRH Form 10-K 43

Cash flows from financing activities

	For the years ended December 31
in $ millions	2024	2023	2022
Net cash used in financing activities	(1,186)	(2,380)	(2,499)

2024 versus 2023

Net cash used in financing activities was $1.2 billion for the year ended December 31, 2024, a decrease of $1.2 billion. Proceeds from debt issuances were $4.0 billion, an increase of $0.8 billion, which was primarily related to the issuance and sale of $750 million 5.20% Senior Notes due 2029 and $750 million 5.40% Senior Notes due 2034, the drawdown of a $750 million fixed rate loan due 2026, as well as the issuance of $1.7 billion under the Company’s commercial paper programs. Payments of debt were $1.9 billion, primarily the repayment of the €600 million 1.875% euro Senior Notes on maturity in January 2024 as well as the repayment of $1.2 billion issued under the Company’s commercial paper programs. Dividends paid were $1.7 billion, an increase of 81% compared with 2023. In 2024, the Company moved to payment of quarterly dividends in addition to the payment of the second interim 2023 dividend while the same period in the prior year saw an outflow related to the final 2022 dividend and the first interim 2023 dividend. Outflows related to the repurchases of common stock were $1.5 billion, compared to $3.1 billion in 2023.

2023 versus 2022

The $0.1 billion decrease in cash used in financing activities between 2023 and 2022 was driven by a number of factors. Payments of debt increased to $1.5 billion from $0.4 billion in 2022. CRH repaid a €750 million euro-denominated Senior Notes on maturity in April 2023 and a €500 million euro-denominated Senior Notes on maturity in November 2023. Offsetting these increases in cash outflows was an increase in proceeds from debt issuances when CRH issued €2 billion of euro-denominated Senior Notes in July 2023 as well as net issuance of $1.0 billion under the Company’s U.S. Dollar Commercial Paper Program. Cash outflows related to repurchases of common stock increased to $3.1 billion compared with $1.2 billion in 2022. Dividends paid in 2023 amounted to $0.9 billion, an increase of 3% compared with 2022.

Debt facilities

The following section summarizes certain material provisions of our debt facilities and long-term debt obligations. The following description is only a summary, does not purport to be complete and is qualified in its entirety by reference to the documents governing such indebtedness (available in the Investors section - www.crh.com).

At December 31, 2024, maturities for the next four quarters and for the next five years are as follows:

2025 Debt Maturities

First Quarter	$1.6 billion
Second Quarter	$1.3 billion
Third Quarter	–
Fourth Quarter	–

2025-2029 Debt Maturities

2025	$2.9 billion
2026	$1.9 billion
2027	$1.4 billion
2028	$1.5 billion
2029	$1.3 billion

Unsecured senior notes

The main sources of Company debt funding are debt capital markets in North America and Europe. See Note 11 “Debt” in Item 8. “Financial Statements and Supplementary Data” for further details regarding our debt obligations.

In May 2024, wholly-owned subsidiaries of the Company completed the issuance and sale of $750 million 5.20% Senior Notes due 2029 and $750 million 5.40% Senior Notes due 2034.

Bank credit facilities

The Company manages its borrowing ability by entering into committed borrowing agreements. The Company has a multi-currency revolving credit facility (the ‘RCF’), dated May 2023, which is made available from a syndicate of lenders, consisting of a €3.5 billion unsecured, revolving loan facility with maturity in May 2029. See Note 11 “Debt” in Item 8. “Financial Statements and Supplementary Data” for further details regarding the RCF. In December 2024, the Company entered into and drew down a $750 million two-year term loan at a fixed rate of 4.91%. At December 31, 2024, the loan was fully drawn.

Interest on drawings on the Company's RCF are based upon Euro Interbank Offer Rate (EURIBOR) for euro drawings, the Secured Overnight Financing Rate (SOFR) for U.S. Dollar drawings, Sterling Overnight Index Average (SONIA) for Pound Sterling drawings and the Swiss Average Rate Overnight (SARON) for Swiss Franc drawings, respectively. At December 31, 2024, and December 31, 2023, the RCF was undrawn.

Guarantees

The Company has given letters of guarantee to secure obligations of subsidiary undertakings as follows: $13.1 billion in respect of loans and borrowings, bank advances and derivative obligations, compared with $11.3 billion in 2023, and $0.4 billion in respect of letters of credit due within one year, compared with $0.4 billion in 2023.

CRH Form 10-K 44

Commercial paper programs

The Company has a $4.0 billion U.S. Dollar Commercial Paper Program and a €1.5 billion Euro Commercial Paper Program. Commercial paper borrowings bear interest at rates determined at the time of borrowing. As of December 31, 2024, there was $1.2 billion of outstanding issued notes on the U.S. Dollar Commercial Paper Program and $0.3 billion of outstanding issued notes on the Euro Commercial Paper Program. The purpose of these programs is to provide short-term liquidity.

Off-balance sheet arrangements

CRH does not have any off-balance sheet arrangements that have, or are reasonably likely to have a current or future effect on CRH’s financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that may be material to investors.

Debt ratings616

Our debt ratings and outlooks at December 31, 2024, are as follows:

	Short-Term	Long-Term	Outlook
S&P	A-2	BBB+	Stable
Moody’s	P-2	Baa1	Stable
Fitch	F1	BBB+	Stable

Contractual obligations

An analysis of the maturity profile of debt, leases capitalized, purchase obligations, deferred and contingent acquisition consideration and pension scheme contribution commitments at December 31, 2024, is as follows:

Payments due by period	Less than 1 year	2-3 years	4-5 years	More than 5 years
in millions
Short and long-term debt (i)	3,018	3,372	2,799	4,851
Lease liabilities (ii)	349	525	321	888
Estimated interest payments on contractually committed debt (iii)	470	765	535	1,731
Deferred and contingent acquisition consideration	44	10	3	1
Purchase obligations (iv)	1,750	439	150	210
Retirement benefit obligation commitments (v)	3	6	4	5
Total (vi)	5,634	5,117	3,812	7,686

All values are in US Dollars.

(i)     Of the $14.0 billion short and long-term debt, $0.5 billion is drawn on revolving facilities which may be repaid and redrawn up to the date of maturity.

(ii)     Lease liabilities are presented on an undiscounted basis as detailed in Note 12 “Leases” in Item 8. “Financial Statements and Supplementary Data”.

(iii)     These interest payments have been estimated on the basis of the following assumptions: (a) no change in variable interest rates; (b) no change in exchange rates; (c) that all debt is repaid as if it falls due from future cash generation; and (d) that none is refinanced by future debt issuance.

(iv)     Purchase obligations include contracted-for capital expenditure. These expenditures for replacement and new projects are in the ordinary course of business and will be financed from internal resources.

(v)     These retirement benefit commitments comprise the contracted payments related to our pension schemes in the United Kingdom.

(vi)     Over the long term, CRH believes that our available cash and cash equivalents, cash from operating activities, along with the access to borrowing facilities will be sufficient to fund our long-term contractual obligations, maturing debt obligations and capital expenditures.

6 A security rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time by the assigning rating organization. Each rating should be evaluated independently of any other rating.16

CRH Form 10-K 45

Critical Accounting Estimates

Impairment of goodwill 17

Goodwill represents the excess of the cost of net assets acquired in business combinations over the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed in a business combination. Goodwill impairment exists when the fair value of a reporting unit is less than its carrying amount. Goodwill is tested for impairment on an annual basis or more frequently whenever events or changes in circumstances would more likely than not reduce the fair value of a reporting unit below its carrying amount. The impairment evaluation is a critical accounting policy because goodwill is material to our total assets (as of December 31, 2024, goodwill represents 22% of total assets), and the evaluation involves the use of significant estimates, key assumptions and judgment. There has been no change to the impairment of goodwill critical accounting estimate in the current financial year.

Goodwill is tested for impairment at the reporting unit level, one level below our reportable segments, with 26 reporting units identified for testing. The Company has the option of either assessing qualitative factors to determine whether it is more likely than not that the carrying value of our reporting units exceeds their respective fair value or proceeding directly to a quantitative test. We elected to perform the quantitative impairment test for all years presented. If the fair value exceeds its carrying value, the goodwill of the reporting unit is not considered impaired. However, if the carrying value of a reporting unit exceeds its fair value, an impairment loss is recognized by writing down the assets to their fair value.

We determine the carrying value of each reporting unit by assigning assets and liabilities, including goodwill, to those reporting units as of the measurement date. We estimate the fair values using a discounted cash flow model which requires management to make significant estimates and judgments regarding the future cash flows expected to be generated by reporting units to which goodwill has been allocated. The cash flow forecasts are primarily based on a five-year strategic plan document formally approved by the Board of Directors. In assessing the fair value, cash flow forecasts are extrapolated using long-term growth rates to determine the basis for an annuity-based terminal value. These net cash flow forecasts reflect volume, price and cost (including the cost of carbon where applicable) assumptions in addition to other cash flow movements. Adjusted EBITDA margin* is deemed an appropriate measure for assessing the estimation uncertainty associated with price and cost assumptions. Future cash flows, including the terminal value, are discounted to their present value using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the future cash flow estimates have not been adjusted. The estimates of future cash flows exclude cash inflows or outflows attributable to financing activities and income tax. Management periodically evaluates and updates the estimates based on the conditions which influence these variables.

As in prior years, the terminal value is based on a 20-year annuity, with the exception of certain long-lived cement assets, where an assumption of a 30-year annuity has been used. Projected cash flows beyond the initial evaluation period have been extrapolated using real growth rates ranging from 1.7% in the Americas, 0.6% to 3.0% in Europe and 3.0% in Asia. Such real growth rates do not exceed the long-term average growth rates for the countries in which each reporting unit operates. The fair value represents the present value of the future cash flows, including the terminal value, discounted at a rate appropriate to each reporting unit.

We also considered the potential impact of a scenario of estimated higher carbon costs past the strategic plan period across our reporting units subject to the European Union and United Kingdom Emissions Trading Systems. These reporting units have sufficient levels of headroom to absorb the estimated higher carbon costs which may not be recovered through pricing.

The assumptions and conditions for determining impairments of goodwill reflect management’s best assumptions and estimates, but these items involve inherent uncertainties described above, many of which are not under management’s control. As a result, the accounting for such items as a change to a reporting unit’s prospects, which may result from a change in market conditions, market trends, interest rates or other factors outside our control, or underperformance relative to historical or forecast projections, could result in a different estimate of the fair value of our reporting unit resulting in an impairment charge in the future.

The results of our annual impairment testing for 2024 indicated that all of our reporting units exceeded their carrying value except for the Architectural Products reporting unit within International Solutions. Its fair value did not exceed carrying value, driven by challenging market conditions which had an impact on growth prospects and as such an impairment loss of $72 million has been recorded, resulting in a goodwill balance of $nil million. A qualitative and quantitative assessment has been performed which resulted in a sensitivity analysis being prepared for two reporting units where their fair values did not substantially exceed their carrying values. This sensitivity analysis represents management’s assessment of the economic environment in which these reporting units operate. The key assumptions, methodology used and values applied to each of the key assumptions for these reporting units are in line with those outlined above (a 30-year annuity period has been used). The two reporting units have an aggregate goodwill of $254 million at the date of testing. The table below identifies the amounts by which each of the following assumptions may either decline or increase to arrive at a zero excess headroom of the present value of future cash flows over the carrying value of net assets in the two reporting units selected for sensitivity analysis disclosures:

	Two reporting units
Reduction in Adjusted EBITDA margin*	1.2% and 2.1%
Reduction in long-term growth rate	1.2% and 1.6%
Increase in pre-tax discount rate	1.0% and 1.3%

Pension and other postretirement benefits

Costs arising in respect of the Company’s defined contribution pension schemes are charged to the Consolidated Statements of Income in the period in which they are incurred. The Company has no legal or constructive obligation to pay further contributions in the event that the fund does not hold sufficient assets to meet its benefit commitments.

The liabilities and costs associated with the Company’s defined benefit pension schemes (both funded and unfunded) are assessed on the basis of the projected unit credit method by professionally qualified actuaries and are arrived at using actuarial assumptions based on market expectations at the balance sheet date.

* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42. 17

CRH Form 10-K 46

	(Favorable) Unfavorable
	0.25 Percentage Point Increase		0.25 Percentage Point Decrease
in $ millions	Inc (Dec) in Benefit Obligation	Inc (Dec) in Annual benefit Cost	Inc (Dec) in Benefit Obligation	Inc (Dec) in Annual Benefit Cost
Actuarial Assumptions
Discount Rates
Pension	(90.3)	(1.7)	95.7	4.1
Other postretirement benefits	(2.8)	(0.2)	2.9	0.3
Expected return on plan assets	–	(7.1)	–	7.1

The assumptions underlying the actuarial valuation of the projected benefit obligation (including discount rates, rates of increase in future compensation levels, mortality rates and healthcare cost trends) from which the amounts recognized in the Consolidated Financial Statements are determined, are updated annually based on current economic conditions and for any relevant changes to the terms and conditions of the pension and postretirement plans. These assumptions can be affected by (i) for the discount rates, changes in the rates of return on high-quality corporate bonds; (ii) for future compensation levels, future labor market conditions; and (iii) for healthcare cost trend rates, the rate of medical cost inflation in the relevant regions.

The assumption underlying the performance of plan assets (expected return on plan assets) is a long-term assumption which is reviewed annually and is used to estimate future asset returns. Once set, the expected return on plan assets assumption is used to determine the Company’s net periodic pension (income)/cost.

The assumptions that are the most significant to the measurement of retirement benefit obligations are the discount rates. The discount rates employed in determining the present value of the schemes’ liabilities are determined by reference to market yields at the balance sheet date on high-quality corporate bonds of a currency and term consistent with the currency and term of the associated postretirement benefit obligations.

While management believes that the assumptions used are appropriate, differences in actual experience or changes in assumptions may affect the obligations and expenses recognized in future accounting periods. The assets and liabilities of defined benefit pension schemes may exhibit significant period-on-period volatility attributable primarily to changes in bond yields and longevity. In addition to future service contributions, significant cash contributions may be required to remediate past service deficits.

For additional information about pension and other postretirement benefits, see Note 21 “Pension and other postretirement benefits” in Item 8. “Financial Statements and Supplementary Data”.

Business Combinations – Allocation of Purchase Price

The purchase price of assets acquired and liabilities assumed is determined based on the fair value of consideration transferred to and liabilities assumed from the seller as of the date of acquisition. The Company allocates the purchase price to the fair values of the tangible and intangible assets acquired, and liabilities assumed as valued at the acquisition date. Any excess of the purchase price over the fair value of the assets acquired and liabilities assumed is recorded as goodwill.

The purchase price allocation is a critical accounting estimate because the estimation of fair values of acquired assets and assumed liabilities is judgmental and requires management to utilize various assumptions. Further, the amounts and useful lives assigned to depreciable and amortizable assets versus amounts assigned to goodwill can affect the results of operations in the period of and for periods after a business combination.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction, and therefore represents an exit price. A fair value measurement assumes the highest and best use of the asset by market participants. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels as described below:

•Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.

•Level 2: Inputs that are derived from, or corroborated by, quoted prices or observable market data.

•Level 3: Inputs that are unobservable and are significant to the fair value of the assets or liabilities.

Level 1 fair values are used to value equity investments and long-term debt.

Level 2 fair values are typically used to value acquired receivables, inventory and equity method investments. Additionally, Level 2 fair values are typically used to value contracts acquired at other than market rates.

Level 3 fair values are used to value acquired property, plant and equipment, mineral-bearing land and other identifiable intangible assets.

An in-use valuation premise is applied for property, plant and equipment, such that the fair value of property, plant and equipment reflects the benefit of permits in place, architect and engineering fees, freight, tax, installation and other direct and indirect costs incurred. This premise assumes that each of the assets will continue to be used as is and as part of the ongoing business in connection with other assets.

To determine the value of plant and equipment, a replacement cost methodology is typically applied, which relies upon identifying a direct replacement cost associated with replacing assets with new assets, and incorporates estimates of obsolescence, and depreciation based on economic useful lives. These estimations are based on management’s historical experience, the use of third-party experts and available market and industry data. For the valuation of land, we engage third-party valuation experts. While we believe these assumptions and estimates are reasonable, they are inherently uncertain.

We may adjust the amounts recognized in an acquisition during a measurement period after the acquisition date. Any such adjustments are the result of subsequently obtaining additional information that existed at the acquisition date regarding the assets acquired or the liabilities assumed. Measurement period adjustments are generally recorded as increases or decreases to goodwill, if any, recognized in the transaction. The cumulative impact of measurement period adjustments on depreciation, amortization and other income statement items are recognized in the period the adjustment is determined. The measurement period ends once we have obtained all necessary information that existed as of the acquisition date but does not extend beyond one year from the acquisition date. Any adjustments to assets acquired or liabilities assumed beyond the measurement period, unless as a result of an error, are recorded through earnings.

For additional information about business combinations and purchase price allocations, including details of provisional purchase price allocations at the balance sheet date, see Note 4 “Acquisitions” in Item 8. “Financial Statements and Supplementary Data”.

CRH Form 10-K 47

Accounting Developments And Changes

Refer to Note 1 “Summary of significant accounting policies” in Item 8. “Financial Statements and Supplementary Data” for a discussion of new accounting developments.

Supplemental Guarantor Information

Guarantor financial information

As of December 31, 2024, CRH plc (the 'Guarantor') has fully and unconditionally guaranteed $300 million 6.400% Senior Notes due 2033 (i) (the '6.400% Notes') issued by CRH America, Inc. (CRH America), $750 million 5.200% Senior Notes due 2029 (the '5.200% Notes') issued by CRH SMW Finance Designated Activity Company (SMW Finance) and $750 million 5.400% Senior Notes due 2034 (the '5.400% Notes') issued by CRH America Finance, Inc. (America Finance), and together with the 6.400% Notes and the 5.200% Notes, (the 'Notes') and together with CRH America and SMW Finance (the 'Issuers').

The Issuers are each 100% owned by CRH plc, directly or indirectly. SMW Finance is an indirect wholly-owned finance subsidiary of CRH plc incorporated under the laws of Ireland and is a financing vehicle for CRH’s group companies. America Finance is an indirect wholly-owned finance subsidiary of CRH plc incorporated under the laws of the State of Delaware and is a financing vehicle for CRH’s U.S. operating companies.

Each series of Notes is unsecured and ranks equally with all other present and future unsecured and unsubordinated obligations of the relevant Issuer and CRH plc, subject to exceptions for obligations required by law. Each series of Notes is fully and unconditionally guaranteed by CRH plc as defined in the respective indenture governing each series of Notes. Each guarantee is a full, irrevocable, and unconditional guarantee of the principal, interest, premium, if any, and any other amounts due in respect of the relevant series of Notes given by CRH plc.

(i) Originally issued in September 2003 as $300 million 6.400% Senior Notes due 2033. CRH subsequently acquired $87 million of the 6.400% Notes in liability management exercises in August 2009 and December 2010.

Basis of presentation

The following summarized financial information reflects, on a combined basis, the Balance Sheet as of December 31, 2024, and the Income Statement for the year ended December 31, 2024, of CRH America and CRH plc, which guarantees the registered debt; collectively the ‘Obligor Group’. Intercompany balances and transactions within the Obligor Group have been eliminated in the summarized financial information overleaf. Amounts attributable to the Obligor Group’s investment in non-obligor subsidiaries have also been excluded. Intercompany receivables/payables and transactions with non-obligor subsidiaries are separately disclosed as applicable. This summarized financial information has been prepared and presented pursuant to Regulation S-X Rule 13-01 and is not intended to present the financial position and results of operations of the Obligor Group in accordance with U.S. GAAP.

CRH Form 10-K 48

The summarized Income Statement information is as follows:

in millions
Income from continuing operations before income tax expense and income from equity method investments (i)
- of which relates to transactions with non-obligor subsidiaries
Net income for the financial year – all of which is attributable to equity holders of the Company
- of which relates to transactions with non-obligor subsidiaries
(i) Revenue and Gross Profit for the Obligor Group for the year ended December 31, 2024, amounted to nil.
The summarized Balance Sheet information is as follows:
Current assets
Current assets – of which is due from non-obligor subsidiaries
Noncurrent assets
Noncurrent assets – of which is due from non-obligor subsidiaries
Current liabilities
Current liabilities – of which is due to non-obligor subsidiaries
Noncurrent liabilities

All values are in US Dollars.

CRH Form 10-K 49

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

CRH is exposed to market risks relating to fluctuations in foreign exchange rates, interest rates, and commodity prices. Changes in those factors could impact the Company’s results of operations and financial condition. Financial risk management at the Company seeks to minimize the negative impact of foreign exchange, interest rate and commodity price fluctuations on the Company’s earnings, cash flows and equity. Management provides oversight for risk management and derivative activities, determines certain of the Company’s financial risk policies and objectives, and provides guidelines for derivative instrument utilization.

To manage these risks, CRH uses various derivative financial instruments, including interest rate swaps, foreign exchange forwards and swaps, and commodity contracts. CRH only uses commonly traded and non-leveraged instruments. These contracts are entered into primarily with major banking institutions and utility companies, while CRH actively monitors its exposure to counterparty risk through the use of counterparty approvals and credit limits, thereby minimizing the risk of counterparty loss.

The following discussion presents the sensitivity of the market value, earnings and cash flows of the Company’s financial instruments to hypothetical changes in interest and exchange rates assuming these changes occurred at December 31, 2024.

Interest Rate Risk

CRH may be impacted by interest rate volatility with respect to existing debt and future debt issuances as well as cash balances. For fixed rate debt instruments, interest rate changes affect the fair market value but do not impact earnings or cash flows. Conversely, for floating rate debt instruments, interest rate changes generally do not affect the fair market value of the instrument but impact future earnings and cash flows, assuming that other factors are held constant. Cash balances are held on short-term deposits and changing interest rates will impact deposit interest income earned. The Company uses interest rate swaps to convert a portion of its fixed rate debt to floating rate and these may be designated and qualify as fair value hedges. Under these arrangements, the Company agrees to exchange, at specified intervals, the difference between fixed and benchmark floating interest rates calculated by reference to an agreed-upon notional principal amount.

At December 31, 2024, the Company had fixed rate debt of $10.8 billion and floating rate debt of $3.5 billion, representing 76% and 24%, respectively, of total debt, including overdrafts, finance leases and the impact of derivatives. At December 31, 2023, the Company had fixed rate debt of $9.1 billion and floating rate debt of $2.7 billion, representing 77% and 23%, respectively, of total debt, including overdrafts, finance leases and the impact of derivatives. The Company’s interest rate swaps at December 31, 2024, whereby the Company swaps from fixed interest rates to floating interest rates, were $1.4 billion, compared to $1.4 billion as of December 31, 2023. The Company’s interest rate swaps at December 31, 2024, whereby the Company swaps from floating interest rates to fixed interest rates, were $0.2 billion, compared to $nil billion as at December 2023. Cash and cash equivalents and restricted cash at December 31, 2024, were $3.8 billion, compared to $6.4 billion at December 31, 2023, which was all held on short-term deposits and investments.

Sensitivity to interest rate moves

At December 31, 2024, the before-tax earnings and cash flows impact of a 100 bps increase in interest rates, including the offsetting impact of derivatives, on the variable rate cash and debt portfolio would be approximately $2 million favorable ($37 million favorable in 2023).

Foreign Exchange Rates Risk18

CRH’s exchange rate exposures result primarily from its investments and ongoing operations in countries outside of the United States and other business transactions such as the procurement of products and equipment from foreign sources. Fluctuations in foreign currency exchange rates may affect (i) the carrying value of the Company’s net investment in foreign subsidiaries; (ii) the translation of foreign currency earnings and (iii) the cash flows related to foreign currency denominated transactions.

Where economically feasible, the Company maintains Net Debt* in the same relative currency ratio as capital employed to act as an economic hedge of the underlying currency assets. Where it is not feasible to do so, the Company may enter into foreign exchange forward contracts to hedge a portion of the net investment against the effect of exchange rate fluctuations. These transactions are designated as net investment hedges.

The Company also enters into foreign exchange forward contracts to hedge against the effect of exchange rate fluctuations on cash flows denominated in foreign currencies. These transactions are designated as cash flow hedges. In addition, the Company may enter into foreign currency contracts that are not designated in hedging relationships to offset, in part, the impacts of changes in value of various non-functional currency denominated items including certain intercompany financing balances. The U.S. Dollar equivalent gross notional amount of the Company’s foreign exchange forward contracts was $4.6 billion at December 31, 2024, compared to $1.6 billion at December 31, 2023.

Holding all other variables constant, if there were a 10% weakening in foreign currency exchange rates versus U.S. Dollar for the portfolio, the fair market value of foreign currency contracts outstanding at December 31, 2024, would decrease by approximately $86 million (at December 31, 2023, would increase by approximately $2 million), which would be largely offset by a loss on the foreign currency fluctuation of the underlying exposure being hedged.

Commodity Price Risk

Some of the Company’s products use significant amounts of commodity-priced materials, predominantly fuel and principal energy-related raw materials such as oil, electricity, coal and carbon credits, which are subject to price changes based upon fluctuations in the commodities market. This price volatility could potentially have a material impact on our financial condition and/or our results of operations. When feasible, the Company manages commodity price risks through negotiated supply contracts and forward contracts to manage operating costs. The Company monitors commodity trends and where possible has alternative sourcing plans in place to mitigate the risk of supplier concentration and passing commodity-related inflation to customers or suppliers.

Where appropriate, the Company also has a number of derivative hedging programs in place to hedge commodity risks, with the aim of the programs being to neutralize variability in the Consolidated Statements of Income arising from changes in associated commodity indices. The timeframe for such programs can be up to four years.

* Represents a non-GAAP measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 40 to 42.18

CRH Form 10-K 50

Item 8. Financial Statements and Supplementary Data

Independent Auditor’s Report

Report of Independent Registered Public Accounting Firm

To the shareholders and the Board of Directors of CRH public limited company (CRH plc)

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of CRH plc and subsidiaries (the Company) as of December 31, 2024, and 2023, the related consolidated statements of income, comprehensive income, changes in equity and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 26, 2025, expressed an unqualified opinion on the Company’s internal control over financial reporting.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the Audit Committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Acquisitions - Valuation of Property, plant and equipment related to the Hunter and Adbri acquisitions - Refer to Notes 1 and 4 to the financial statements

Critical Audit Matter Description

On February 9, 2024, the Company wholly acquired a portfolio of cement and readymixed concrete operations and assets in Texas, United States for a total cash consideration, net of cash acquired, of $2,106 million (the ‘Hunter’ acquisition), and on July 1, 2024, it acquired 57% of the issued share capital of Adbri, a materials business in Australia, for a total cash consideration, net of cash acquired, of $787 million (the ‘Adbri’ acquisition). The Company accounted for these acquisitions as business combinations. Accordingly, the purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. These acquisitions included Property, plant and equipment of $1,069 million and $1,364 million respectively.

We identified the valuation of Property, plant and equipment as a critical audit matter because of the estimates made by management to determine the fair value of these assets for purposes of recording the acquisitions. This required a high degree of auditor judgment and an increased extent of effort, including the need to involve our valuation specialists when performing audit procedures to determine the fair value of acquired Property, plant and equipment under the replacement cost approach. This included estimating the useful lives based on management’s historical experience and expectations as to the period of time over which the assets will be used and estimating the cost to replace or reproduce comparable assets adjusted for the remaining useful lives.

How the Critical Audit Matter was Addressed in the Audit

Our audit procedures related to the fair value of Property, plant and equipment acquired as part of the acquisitions included the following, among others:

•We tested the effectiveness of controls over the purchase price allocation, including management's controls over the assumptions used in the replacement cost approach for Property, plant and equipment and the review of the work of management's third-party specialists.

•We evaluated the underlying terms of the purchase agreements, in order to corroborate our understanding of the substance of the acquisition obtained through inquiry with the Company's management, as well as to assess the completeness of the assets acquired.

•We evaluated the competency, capabilities and objectivity of the third-party specialists engaged by management to perform the valuations.

•We read the third-party valuation reports and, with the assistance of our valuation specialists, we evaluated the appropriateness of the Company's methodology used to estimate the cost to replace or reproduce comparable assets adjusted for the remaining useful lives.

CRH Form 10-K 51

Service revenues - Revenue recognition for certain long-term contracts - Refer to Notes 1 and 2 to the financial statements

Critical Audit Matter Description

The Company recognizes long-term contract revenue over the contract term as the work progresses because transfer of control and the fulfillment of performance obligations to the customer is continuous. Revenue derived from long-term contracts, measured on a percentage of completion basis and in-progress at the balance sheet date involves judgment, particularly as it relates to the process of estimating total forecasted costs of the contracts.

We identified revenue recognition for certain long-term contracts, measured on a percentage of completion basis and in-progress at the balance sheet date as a critical audit matter because of the judgments made by management in estimating total forecasted costs of the contracts. This required extensive audit effort due to the complexity of certain long-term contracts and required a high degree of auditor judgment when performing audit procedures to audit management’s estimates and evaluating the results of those procedures.

How the Critical Audit Matter was Addressed in the Audit

Our audit procedures related to management’s recognition of revenue for certain long-term contracts, measured on a percentage of completion basis and in-progress at the balance sheet date included the following, among others:

•We tested the effectiveness of controls over long-term contract revenue, including management’s controls over the estimates of total forecasted costs.

•We selected a sample of long-term contracts and:

–assessed whether the contracts were properly included in management's calculation of long-term contract revenue based on the terms and conditions of each contract, including whether continuous transfer of control to the customer occurred as progress was made toward fulfilling the performance obligation;

–tested the accuracy and completeness of the costs incurred to date for the performance obligation to supporting documentation;

–evaluated management's ability to estimate total forecasted costs accurately by:

◦comparing costs incurred to date to the costs management estimated, at either the inception of the contract or the start of the reporting period;

◦evaluating management’s ability to accurately estimate the total cost by performing corroborating inquiries with the Company’s project managers, and comparing the estimates to management’s work plans, engineering specifications, and supplier contracts; and

◦comparing management’s estimates for the selected contracts to costs of similar performance obligations, when applicable.

–tested the mathematical accuracy of management’s calculation of revenue, measured on a percentage of completion basis, for the performance obligation.

/s/ Deloitte Ireland LLP

Dublin, Ireland

February 26, 2025

We have served as the Company’s auditor since 2020.

CRH Form 10-K 52

Consolidated Statements of Income

(in $ millions, except share and per share data)

For the years ended December 31	2024	2023	2022
Product revenues	26,699	26,156	24,519
Service revenues	8,873	8,793	8,204
Total revenues	35,572	34,949	32,723
Cost of product revenues	(14,651)	(14,741)	(14,123)
Cost of service revenues	(8,220)	(8,245)	(7,785)
Total cost of revenues	(22,871)	(22,986)	(21,908)
Gross profit	12,701	11,963	10,815
Selling, general and administrative expenses	(7,852)	(7,486)	(7,056)
Gain on disposal of long-lived assets	237	66	50
Loss on impairments	(161)	(357)	–
Operating income	4,925	4,186	3,809
Interest income	143	206	65
Interest expense	(612)	(376)	(344)
Other nonoperating income (expense), net	258	(2)	(69)
Income from continuing operations before income tax expense and income from equity method investments	4,714	4,014	3,461
Income tax expense	(1,085)	(925)	(762)
Loss from equity method investments	(108)	(17)	–
Income from continuing operations	3,521	3,072	2,699
Income from discontinued operations, net of income tax expense	–	–	1,190
Net income	3,521	3,072	3,889
Net (income) attributable to redeemable noncontrolling interests	(28)	(28)	(27)
Net (income) loss attributable to noncontrolling interests	(1)	134	–
Net income attributable to CRH	3,492	3,178	3,862
Basic earnings per share attributable to CRH
Continuing operations	$5.06	$4.36	$3.58
Discontinued operations	–	–	$1.57
Net income	$5.06	$4.36	$5.15
Diluted earnings per share attributable to CRH
Continuing operations	$5.02	$4.33	$3.55
Discontinued operations	–	–	$1.56
Net income	$5.02	$4.33	$5.11
Weighted average common shares outstanding
Basic	683.3	723.9	758.3
Diluted	689.5	729.2	764.1

The accompanying notes form an integral part of the Consolidated Financial Statements.

CRH Form 10-K 53

Consolidated Statements of Comprehensive Income

(in $ millions)

For the years ended December 31	2024	2023	2022
Net income	3,521	3,072	3,889
Other comprehensive (loss) income, net of tax:
Currency translation adjustment	(470)	310	(665)
Net change in fair value of effective portion of cash flow hedges, net of tax of $3 million, $1 million, and $6 million in 2024, 2023, and 2022, respectively	(16)	(28)	(37)
Actuarial gains (losses) and prior service credits (costs) for pension and other postretirement plans, net of tax of $(4) million, $17 million, and $(66) million in 2024, 2023, and 2022, respectively	44	(108)	294
Other comprehensive (loss) income	(442)	174	(408)
Comprehensive income	3,079	3,246	3,481
Comprehensive (income) attributable to redeemable noncontrolling interests	(28)	(28)	(27)
Comprehensive loss attributable to noncontrolling interests	52	131	46
Comprehensive income attributable to CRH	3,103	3,349	3,500

The accompanying notes form an integral part of the Consolidated Financial Statements.

CRH Form 10-K 54

Consolidated Balance Sheets

(in $ millions, except share data)

At December 31	2024	2023
Assets
Current assets:
Cash and cash equivalents	3,720	6,341
Restricted cash	39	–
Accounts receivable, net	4,820	4,507
Inventories	4,755	4,291
Assets held for sale	–	1,268
Other current assets	749	478
Total current assets	14,083	16,885
Property, plant and equipment, net	21,452	17,841
Equity method investments	737	620
Goodwill	11,061	9,158
Intangible assets, net	1,211	1,041
Operating lease right-of-use assets, net	1,274	1,292
Other noncurrent assets	795	632
Total assets	50,613	47,469
Liabilities, redeemable noncontrolling interests and shareholders’ equity
Current liabilities:
Accounts payable	3,207	3,149
Accrued expenses	2,248	2,296
Current portion of long-term debt	2,999	1,866
Operating lease liabilities	265	255
Liabilities held for sale	–	375
Other current liabilities	1,577	2,072
Total current liabilities	10,296	10,013
Long-term debt	10,969	9,776
Deferred income tax liabilities	3,105	2,738
Noncurrent operating lease liabilities	1,074	1,125
Other noncurrent liabilities	2,319	2,196
Total liabilities	27,763	25,848
Commitments and contingencies (Note 24)
Redeemable noncontrolling interests	384	333
Shareholders’ equity
Preferred stock, €1.27 par value, 150,000 shares authorized and 50,000 shares issued and outstanding for 5% preferred stock and 872,000 shares authorized, issued and outstanding for 7% 'A' preferred stock, as of December 31, 2024, and December 31, 2023	1	1
Common stock, €0.32 par value, 1,250,000,000 shares authorized; 718,647,277 and 734,519,598 shares issued and outstanding, as of December 31, 2024, and December 31, 2023, respectively	290	296
Treasury stock, at cost (41,355,384 and 42,419,281 shares as of December 31, 2024, and December 31, 2023, respectively)	(2,137)	(2,199)
Additional paid-in capital	422	454
Accumulated other comprehensive loss	(1,005)	(616)
Retained earnings	24,036	22,918
Total shareholders’ equity attributable to CRH shareholders	21,607	20,854
Noncontrolling interests	859	434
Total equity	22,466	21,288
Total liabilities, redeemable noncontrolling interests and equity	50,613	47,469

The accompanying notes form an integral part of the Consolidated Financial Statements.

CRH Form 10-K 55

Consolidated Statements of Cash Flows

(in $ millions)

For the years ended December 31	2024	2023	2022
Cash Flows from Operating Activities:
Net income	3,521	3,072	3,889
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization	1,798	1,633	1,577
Loss on impairments	161	357	–
Share-based compensation	125	123	101
Gains on disposals from discontinued operations, businesses and long-lived assets, net	(431)	(66)	(1,422)
Deferred tax expense (benefit)	180	(64)	(63)
Loss from equity method investments	108	17	–
Pension and other postretirement benefits net periodic benefit cost	34	31	30
Non-cash operating lease costs	262	293	273
Other items, net	14	68	45
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Accounts receivable, net	(122)	(164)	(226)
Inventories	(224)	(60)	(655)
Accounts payable	48	144	403
Operating lease liabilities	(287)	(276)	(269)
Other assets	(69)	25	(45)
Other liabilities	(86)	(72)	205
Pension and other postretirement benefits contributions	(43)	(44)	(43)
Net cash provided by operating activities	4,989	5,017	3,800
Cash Flows from Investing Activities:
Purchases of property, plant and equipment, and intangibles	(2,578)	(1,817)	(1,523)
Acquisitions, net of cash acquired	(4,900)	(640)	(3,253)
Proceeds from divestitures	1,001	–	3,712
Proceeds from disposal of long-lived assets	272	104	115
Dividends received from equity method investments	44	44	36
Settlements of derivatives	(9)	(1)	(11)
Deferred divestiture consideration received	83	6	52
Other investing activities, net	(204)	(87)	(45)
Net cash used in investing activities	(6,291)	(2,391)	(917)

CRH Form 10-K 56

Consolidated Statements of Cash Flows

(in $ millions)

For the years ended December 31	2024	2023	2022
Cash Flows from Financing Activities:
Proceeds from debt issuances	4,001	3,163	38
Payments on debt	(1,859)	(1,462)	(364)
Settlements of derivatives	(36)	7	(11)
Payments of finance lease obligations	(57)	(26)	(28)
Deferred and contingent acquisition consideration paid	(21)	(22)	(24)
Dividends paid	(1,706)	(940)	(917)
Distributions to noncontrolling and redeemable noncontrolling interests	(53)	(35)	(23)
Transactions involving noncontrolling interests	19	(2)	(3)
Repurchases of common stock	(1,482)	(3,067)	(1,178)
Proceeds from exercise of stock options	8	4	11
Net cash used in financing activities	(1,186)	(2,380)	(2,499)
Effect of exchange rate changes on cash and cash equivalents, including restricted cash	(143)	208	(231)
(Decrease)/increase in cash and cash equivalents, including restricted cash	(2,631)	454	153
Cash and cash equivalents and restricted cash at the beginning of year	6,390	5,936	5,783
Cash and cash equivalents and restricted cash at the end of year	3,759	6,390	5,936
Supplemental cash flow information:
Cash paid for interest (including finance leases)	599	418	329
Cash paid for income taxes	960	959	1,043
Reconciliation of cash and cash equivalents and restricted cash
Cash and cash equivalents presented in the Consolidated Balance Sheets	3,720	6,341	5,936
Restricted cash presented in the Consolidated Balance Sheets	39	–	–
Cash and cash equivalents included in Assets held for sale	–	49	–
Total cash and cash equivalents and restricted cash presented in the Consolidated Statements of Cash Flows	3,759	6,390	5,936

The accompanying notes form an integral part of the Consolidated Financial Statements.

CRH Form 10-K 57

Consolidated Statements of Changes in Equity

(in $ millions, except share and per share data)

For the year ended December 31, 2022

	Preferred stock		Common stock		Treasury stock		Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Total Shareholders' Equity Attributable to CRH Shareholders	Noncontrolling Interests	Total Equity
	Shares	Amount	Shares	Amount	Shares	Amount
Balance at December 31, 2021	0.9	$1	774.1	$309	(3.7)	($195)	$458	($425)	$20,466	$20,614	$632	$21,246
Net income	–	–	–	–	–	–	–	–	3,862	3,862	–	3,862
Other comprehensive loss	–	–	–	–	–	–	–	(362)	–	(362)	(46)	(408)
Share-based compensation	–	–	–	–	–	–	101	–	–	101	–	101
Repurchases of common stock	–	–	–	–	(30.0)	(1,178)	–	–	–	(1,178)	–	(1,178)
Retirement of treasury stock	–	–	(22.0)	(7)	22.0	879	–	–	(872)	–	–	–
Shares issued under employee share plans	–	–	–	–	4.0	197	(116)	–	(70)	11	–	11
Dividends declared on common stock	–	–	–	–	–	–	–	–	(931)	(931)	–	(931)
Distributions to noncontrolling interests	–	–	–	–	–	–	–	–	–	–	(8)	(8)
Transactions involving noncontrolling interests	–	–	–	–	–	–	–	–	–	–	(3)	(3)
Adjustment of redeemable noncontrolling interests to redemption value	–	–	–	–	–	–	–	–	40	40	–	40
Balance at December 31, 2022	0.9	$1	752.1	$302	(7.7)	($297)	$443	($787)	$22,495	$22,157	$575	$22,732

For the year ended December 31, 2022, dividends declared on common stock were $1.27 per common share.

The accompanying notes form an integral part of the Consolidated Financial Statements.

CRH Form 10-K 58

Consolidated Statements of Changes in Equity

(in $ millions, except share and per share data)

For the year ended December 31, 2023

	Preferred stock		Common stock		Treasury stock		Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Total Shareholders' Equity Attributable to CRH Shareholders	Noncontrolling Interests	Total Equity
	Shares	Amount	Shares	Amount	Shares	Amount
Balance at December 31, 2022	0.9	$1	752.1	$302	(7.7)	($297)	$443	($787)	$22,495	$22,157	$575	$22,732
Net income	–	–	–	–	–	–	–	–	3,178	3,178	(134)	3,044
Other comprehensive income	–	–	–	–	–	–	–	171	–	171	3	174
Share-based compensation	–	–	–	–	–	–	123	–	–	123	–	123
Repurchases of common stock	–	–	–	–	(38.2)	(2,019)	–	–	–	(2,019)	–	(2,019)
Repurchases and retirement of common stock	–	–	(17.6)	(6)	–	–	–	–	(1,042)	(1,048)	–	(1,048)
Shares issued under employee share plans	–	–	–	–	3.5	117	(112)	–	(1)	4	–	4
Dividends declared on common stock	–	–	–	–	–	–	–	–	(1,688)	(1,688)	–	(1,688)
Distributions to noncontrolling interests	–	–	–	–	–	–	–	–	–	–	(8)	(8)
Transactions involving noncontrolling interests	–	–	–	–	–	–	–	–	–	–	(2)	(2)
Adjustment of redeemable noncontrolling interests to redemption value	–	–	–	–	–	–	–	–	(24)	(24)	–	(24)
Balance at December 31, 2023	0.9	$1	734.5	$296	(42.4)	($2,199)	$454	($616)	$22,918	$20,854	$434	$21,288

For the year ended December 31, 2023, dividends declared on common stock were $1.33 per common share.

The accompanying notes form an integral part of the Consolidated Financial Statements.

CRH Form 10-K 59

Consolidated Statements of Changes in Equity

(in $ millions, except share and per share data)

For the year ended December 31, 2024

	Preferred stock		Common stock		Treasury stock		Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Total Shareholders' Equity Attributable to CRH Shareholders	Noncontrolling Interests	Total Equity
	Shares	Amount	Shares	Amount	Shares	Amount
Balance at December 31, 2023	0.9	$1	734.5	$296	(42.4)	($2,199)	$454	($616)	$22,918	$20,854	$434	$21,288
Net income	–	–	–	–	–	–	–	–	3,492	3,492	1	3,493
Other comprehensive loss	–	–	–	–	–	–	–	(389)	–	(389)	(53)	(442)
Share-based compensation	–	–	–	–	–	–	125	–	–	125	–	125
Repurchases of common stock	–	–	–	–	(2.6)	(180)	–	–	–	(180)	–	(180)
Repurchases and retirement of common stock	–	–	(15.9)	(6)	–	–	–	–	(1,296)	(1,302)	–	(1,302)
Shares issued under employee share plans	–	–	–	–	3.6	242	(157)	–	(88)	(3)	–	(3)
Dividends declared on common stock	–	–	–	–	–	–	–	–	(956)	(956)	–	(956)
Distributions to noncontrolling interests	–	–	–	–	–	–	–	–	–	–	(30)	(30)
Divestiture of noncontrolling interests	–	–	–	–	–	–	–	–	–	–	(19)	(19)
Noncontrolling interests arising on acquisition	–	–	–	–	–	–	–	–	–	–	507	507
Transactions involving noncontrolling interests	–	–	–	–	–	–	–	–	–	–	19	19
Adjustment of redeemable noncontrolling interests to redemption value	–	–	–	–	–	–	–	–	(34)	(34)	–	(34)
Balance at December 31, 2024	0.9	$1	718.6	$290	(41.4)	($2,137)	$422	($1,005)	$24,036	$21,607	$859	$22,466

For the year ended December 31, 2024, dividends declared on common stock were $1.40 per common share.

The accompanying notes form an integral part of the Consolidated Financial Statements.

CRH Form 10-K 60

Notes To Consolidated Financial Statements

1. Summary of significant accounting policies

1.1. Description of business

CRH plc (the Company) is a multinational company that operates in the building materials industry, providing essential products and services for construction projects worldwide. The Company is a major producer of aggregates, cement, readymixed concrete, and asphalt and a supplier of paving and constructions services, providing solutions to a wide range of customers, including contractors, builders, engineers, infrastructure developers, and the residential market. CRH is one of the largest suppliers of building materials globally.

Effective during the fourth quarter of 2024, the Company's reportable segments changed to the following three segments: Americas Materials Solutions, Americas Building Solutions and International Solutions. See Note 20 for further information.

A summary of significant accounting policies used in the preparation of the accompanying Consolidated Financial Statements follows.

1.2. Basis of presentation and use of estimates

The accompanying Consolidated Financial Statements and notes thereto, including all prior periods presented, have been presented under U.S. GAAP, which requires management to make certain estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities and reported amounts of revenues and expenses. Such estimates include impairment of long-lived assets, impairment of goodwill, pension and other postretirement benefits, tax matters and litigation, including insurance and environmental compliance costs. These estimates and assumptions are based on management’s judgment.

Estimates and underlying assumptions are reviewed on an ongoing basis. Changes in accounting estimates may be necessary if there are changes in the circumstances or experiences on which the estimate was based or as a result of new information.

Changes in estimates, including those resulting from changes in the economic environment, are reflected in the Consolidated Financial Statements for the period in which the change in estimate occurs.

Certain amounts in the prior period have been reclassified to conform with the current period presentation in the Consolidated Statements of Cash Flows. These reclassifications had no effect on the previously reported net cash provided by (used in) operating, investing, or financing activities, or in the Consolidated Balance Sheets or Consolidated Statements of Income.

1.3. Consolidation

The Consolidated Financial Statements include the accounts of CRH plc, and the wholly- and majority-owned subsidiaries of CRH plc, in addition to variable interest entities (VIEs) in which the Company is the primary beneficiary. In evaluating whether the Company has a controlling financial interest, the following are considered: (1) for voting interest entities, the Company consolidates those entities in which they own a majority of the voting interests; and (2) for VIEs, the Company consolidates those entities for which they are the primary beneficiary. All intercompany transactions and accounts have been eliminated.

The Company uses the equity method of accounting for their investments in entities over which the Company has the ability to exercise significant influence over the operating and financial policies or exercise joint control with other investors but does not control and is not the primary beneficiary. Equity method investments are initially recognized at cost and are included within Equity method investments in the Consolidated Balance Sheets. The Company’s proportionate interest in the results of the investment is included within Income (loss) from equity method investments in the Consolidated Statements of Income.

Where the Company is an active party to contractual arrangements that involve a joint operating activity and is exposed to significant risks and rewards that are dependent on the commercial success of the activity, the Company treats such operations as collaborative arrangements. For such operations, the Company accounts for its pro rata share of assets, liabilities, revenues, and costs in the Consolidated Balance Sheets and Consolidated Statements of Income.

The Company evaluates its Equity method investments for other-than-temporary impairment when events or conditions indicate that the carrying amounts of such investments are not recoverable. Challenging market conditions in China have impacted future growth prospects and provided indicators of impairment for the carrying value of the Company's equity method investment in China, which forms part of International Solutions. Accordingly, the Company performed a valuation of its investment in China and identified an impairment charge of $190 million, which reflects the difference between its fair value and carrying value at December 31, 2024. An impairment charge of $nil million and $nil million was recognised for the years ended December 31, 2023 and 2022, respectively. The Company calculated fair value by using a discounted cash flow model, which reflects the value of an investment based on its future cash flows. The impairment charge was recorded within Loss from equity method investments in the Consolidated Statements of Income and as a reduction to the Equity method investments balance in the Consolidated Balance Sheets.

1.4. Noncontrolling interests – nonredeemable and redeemable

Noncontrolling interests represent the portion of the equity of a subsidiary not attributable either directly or indirectly to the Company and are presented separately in the Consolidated Statements of Income and within equity in the Consolidated Balance Sheets, distinguished from Company shareholders’ equity. Acquisitions of noncontrolling interests are accounted for as transactions with equity holders in their capacity as equity holders and therefore no goodwill is recognized as a result of such transactions. Noncontrolling interests are measured initially at fair value.

Noncontrolling interests with redemption features, such as put/call options, that are not solely within the Company’s control (Redeemable noncontrolling interests) are reported separately in the Consolidated Balance Sheets at the greater of carrying value or redemption value. The Redeemable noncontrolling interests primarily comprise of the noncontrolling interests in two of the Company’s North American subsidiaries. The respective shareholders’ agreements for these entities contain put options that provide the noncontrolling shareholders the right to put their shares to the Company at a value based on a calculated formula. The put options are currently exercisable.

See Note 23 for further information.

CRH Form 10-K 61

1.5. Business combinations

Acquisitions are accounted for using the acquisition method, which requires allocation of the purchase price to assets acquired and liabilities assumed based on estimated fair values. The purchase price is determined based on the fair value of consideration transferred to and liabilities assumed from the seller as of the date of acquisition. The Company allocates the purchase price to the fair values of the tangible and identifiable intangible assets acquired and liabilities assumed as of the date of acquisition. Any excess of the purchase price over the fair value of the assets acquired and liabilities assumed is recorded as goodwill.

Determining the fair values of assets acquired and liabilities assumed requires judgment and often involves the use of significant estimates and assumptions. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction, and therefore represents an exit price. A fair value measurement assumes the highest and best use of the asset by market participants.

Allocations of the purchase price are based on preliminary estimates and assumptions at the date of acquisition and are subject to revision based on final information received including appraisals and other analyses which support underlying estimates within the measurement period, a period of no more than one year from the acquisition date. Measurement period adjustments are generally recorded as increases or decreases to goodwill, if any, recognized in the transaction.

See Note 4 for further information.

1.6. Foreign currency translation

The Consolidated Financial Statements are presented in U.S. Dollar, which is the reporting currency of the Company.

Transactions in foreign currencies are recorded at the rate of exchange in effect at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the rate of exchange in effect at the balance sheet date. The Company releases any related cumulative translation adjustment into earnings only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity. Non-monetary items are measured at historical rates.

Results and cash flows of subsidiaries and equity method investments with non-U.S. Dollar functional currencies have been translated into U.S. Dollar at average exchange rates for the periods, and the related balance sheets have been translated at the rates of exchange in effect at the balance sheet date. Adjustments arising on translation of the results and net assets of non-U.S. Dollar subsidiaries and equity method investments are recognized as a component of Accumulated other comprehensive income (loss) and Noncontrolling interests both of which are presented in the Consolidated Balance Sheets.

1.7. Revenue recognition

The Company recognizes revenues in the amount of the price expected to be received for goods and services supplied at a point in time or over time, as contractual performance obligations are fulfilled, and control of goods and services passes to the customer. Revenue excludes trade discounts and value-added tax or sales tax. Trade receivables and construction contract assets are in general receivable within 90 days of the balance sheet date.

Revenues derived from sale of goods (sources other than construction contracts)

The Company manufactures and supplies a diverse range of building materials and products. Revenues from the sale of goods are recognized at a point in time when control of the promised goods is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled to receive in exchange for the goods. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from the goods. Control passes to the customer either upon leaving the Company’s premises or upon delivery to the customer, depending on the terms of the sale. Contracts do not contain multiple performance obligations.

Goods are often sold with discounts or rebates based on cumulative sales over a period. This variable consideration is only recognized when it is probable that it will not be subsequently reversed and is recognized using the most-likely amount or expected value methods, depending on the individual contract terms. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based on the assessment of anticipated performance and all information (historical, current, and forecasted) that is reasonably available to management.

Revenues derived from construction contracts

The Company enters into construction contracts to complete large construction projects. Contracts usually commence and complete within one year and are generally fixed price but may be subject to indexation and/or escalation clauses that can either increase or decrease the final transaction price.

The Company typically recognizes revenue within its construction contract businesses over time as it performs its obligations. The Company believes this best reflects the transfer of control to the customer by providing a faithful depiction of the enhancement of a customer-controlled asset or the construction of an asset with no alternative use.

The percentage-of-completion method is used to recognize revenue when the outcome of a contract can be estimated reliably. The percentage-of-completion is calculated using an input method and based on the proportion of contract costs incurred at the balance sheet date relative to the total estimated costs of the contract. In all construction contract arrangements, the Company has an enforceable right to payment for work and performance obligations completed to date.

Some of the Company’s construction contracts may contain forms of variable consideration that can either increase or decrease the transaction price. Variable consideration is estimated based on the most likely amount or expected value methods (depending on the contract terms) and the transaction price is adjusted to the extent it is probable that a significant reversal of revenue recognized will not occur.

See Note 2 for further information.

CRH Form 10-K 62

1.8. Contract assets and liabilities

A contract asset is recognized when the related performance obligation has been satisfied, but the Company has not yet invoiced the customer and so is not unconditionally entitled to the consideration under the payment terms set out in the contract. Contract assets are classified as Accounts receivable, net, in the Consolidated Balance Sheets.

A contract liability is recognized when a non-refundable payment is received from a customer in advance of work being performed. A contract liability would also be recognized if the Company has an unconditional right to receive non-refundable consideration before the Company recognizes the related revenue. Contract liabilities are classified as Other current liabilities in the Consolidated Balance Sheets.

The Company’s contracts generally are for a duration of less than one year and therefore the Company does not capitalize incremental contract costs; instead these are expensed as incurred, as permitted by the practical expedient.

1.9. Cash and cash equivalents and restricted cash

Cash and cash equivalents include cash on hand and all highly liquid investments with original maturities at the time of purchase of three months or less.

Restricted cash consists of amounts held in escrow designated for exchange of assets under Section 1031 of the U.S. Internal Revenue Code.

1.10. Accounts receivable, net

Accounts receivable are stated at amortized cost. The Company records an allowance for credit losses, which includes an allowance for probable losses based on historical write-offs, adjusted for current conditions as deemed necessary, and a specific reserve for accounts deemed at risk. The allowance is the Company’s estimate for receivables as of the balance sheet date that ultimately will not be collected. Any changes in the allowance are reflected in earnings in the period in which the change occurs. The Company writes off accounts receivable when it becomes probable, based upon customer facts and circumstances, that such amounts will not be collected.

See Note 5 for further information.

1.11. Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method or weighted average method. Net realizable value is the estimated selling price in the ordinary course of business, less estimates for costs of completion, disposal, and transportation.

Materials and other supplies held for use in the production of inventories are not written down below cost if the finished goods, in which they will be incorporated, are expected to be sold at or above cost.

See Note 6 for further information.

1.12. Property, plant and equipment, net

Property, plant and equipment are stated at cost less any accumulated depreciation, depletion, and any accumulated impairments.

Expenditures for additions and improvements that significantly add to the productive capacity or extend the useful life of an asset are capitalized. Repair and maintenance costs that do not substantially expand productive capacity or extend the life of property, plant and equipment are expensed as incurred.

The Company reviews the carrying value of property, plant and equipment for impairment whenever events or circumstances indicate that the carrying value of an asset group may not be recoverable. Such indicators may include, among others, deterioration in general economic conditions, adverse changes in the markets in which an entity operates, increases in input costs that have a negative effect on earnings and cash flows or a trend of negative or declining cash flows over multiple periods. An impairment loss is recognized if the estimated future (undiscounted) cash flows expected to result from the use and eventual disposition of that asset group are less than its carrying value and is measured by the amount by which the carrying value of the asset group exceeds its fair value.

The Company capitalizes interest as part of the cost of capital projects incurred during construction. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, as follows:

•Buildings 40 years; and

•Plant and machinery 5 to 30 years

Mineral-bearing land, less an estimate of its residual value, is depleted over the period of the mineral extraction in the proportion to which product for the year bears to the latest estimates of proven and probable mineral reserves. Land, other than mineral-bearing land, is not depreciated.

See Note 7 for further information.

CRH Form 10-K 63

1.13. Leases

A contract contains a lease if it is enforceable and conveys the right to control the use of a specified asset for a period of time in exchange for consideration, which is assessed at inception. A right-of-use asset and lease liability are recognized at the commencement date for contracts containing a lease.

Leases are evaluated and classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (1) the lease transfers ownership of the asset by the end of the lease term; (2) the lease contains an option to purchase the asset that is reasonably certain to be exercised; (3) the lease term is for a major part of the remaining useful life of the asset; (4) the underlying asset is of such a specialized nature that is expected to have no alternative use to the lessor at the end of the lease term; or (5) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of the above criteria.

The lease liability is initially measured at the present value of the future lease payments, discounted using the incremental borrowing rate or the interest rate implicit in the lease, if this is readily determinable, over the remaining lease term. Lease payments include fixed payments less any lease incentives receivable, variable payments that are dependent on a rate or index known at the commencement date, amounts expected to be paid under residual value guarantees and any payments for an optional renewal period and purchase and termination option payments, if the Company is reasonably certain to exercise those options. The lease term is the non-cancellable period of the lease adjusted for any renewal or termination options which are reasonably certain to be exercised. The Company applies judgment in determining whether it is reasonably certain that a renewal, termination or purchase option will be exercised.

The right-of-use asset for each lease is initially measured at cost, which comprises the lease liability adjusted for any payments made at or before the commencement date, initial direct costs incurred, lease incentives received and an estimate of the cost to dismantle or restore the underlying asset or the site on which it is located at the end of the lease term. The right-of-use asset of finance leases is amortized over the lease term or, where a purchase option is reasonably certain to be exercised, over the useful economic life of the asset in line with depreciation rates for owned property, plant and equipment. The right-of-use asset of operating leases is amortized as a balancing amount that together with the accretion on lease liability produces straight-line total lease expenses.

The amortization of operating lease right-of-use assets and the accretion of operating lease liabilities are reported together as fixed lease expense in the Consolidated Financial Statements. The fixed lease expense is recognized on a straight-line basis over the life of the lease. Interest expense on a finance lease is recognized using the effective interest method over the lease term.

The Company has elected to separate non-lease components in a contract such as maintenance and other service charges from the lease component and expense such components as incurred. Variable lease payments directly linked to sales or usage are also expensed as incurred. Additionally, for short-term leases with an initial lease term of 12 months or less and with purchase options which the Company is reasonably certain not to exercise, the Company has elected not to record the corresponding right-of-use asset or the corresponding lease liability in the Consolidated Balance Sheets and to expense short-term lease payments as incurred.

Incremental borrowing rates are calculated using a portfolio approach, based on the risk profile of the entity holding the lease and the term and currency of the lease.

See Note 12 for further information.

1.14. Asset retirement obligations

The Company records a liability for an asset retirement obligation at fair value in the period in which it is incurred where a legal or contractual obligation exists, and the liability can be reasonably estimated. When the liability is initially recorded, the Company capitalizes the cost by increasing the carrying amount of the related long-lived asset. The liability is accreted over time and the asset is depreciated over the useful life of the related asset.

Upon settlement of the liability, the Company recognizes a gain or loss for any difference between the settlement amount and the liability recorded. Asset retirement obligations consist primarily of quarry closure and post-closure costs.

See Note 13 for further information.

1.15. Derivative financial instruments and hedging practices

The Company enters into various derivative financial instruments to manage its exposure to fluctuating interest rates, currency exchange rates, and commodity pricing. Such instruments primarily include interest rate swap agreements, currency swap agreements, commodity swap agreements, and currency and commodity forward contracts. These instruments are not entered into for trading purposes.

There are three types of derivatives the Company enters into: (i) those relating to fair value exposures; (ii) those relating to cash flow exposures; and (iii) those relating to foreign currency net investment exposures. Fair value exposures relate to recognized assets or liabilities, and firm commitments; cash flow exposures relate to the variability of future cash flows associated with recognized assets or liabilities, or forecasted transactions; and net investment exposures relate to the impact of foreign currency exchange rate changes on the carrying value of net assets denominated in foreign currencies.

When a derivative is executed and hedge accounting is appropriate, it is designated as either a fair value hedge, cash flow hedge, or a net investment hedge. Whether designated as hedges for accounting purposes or not, all derivatives are linked to an appropriate underlying exposure. On an ongoing basis, the Company assesses the hedge effectiveness of all derivatives designated as hedges for accounting purposes to determine if they continue to be highly effective in offsetting changes in fair values or cash flows of the underlying hedged items. If it is determined that the hedge is not highly effective, then hedge accounting will be discontinued prospectively.

Changes in the fair value of derivatives designated as fair value hedges are recognized in earnings as an offset to the change in the fair values of the underlying exposures being hedged. The changes in fair value of derivatives that are designated as cash flow hedges are deferred in Accumulated other comprehensive income (loss) and are reclassified to earnings as the underlying hedged transaction affects earnings. Provided the hedge remains highly effective, any ineffectiveness is deferred in Accumulated other comprehensive income (loss) and is reclassified to earnings as the underlying hedged transaction affects earnings. Hedges of net investments in foreign subsidiaries are recognized in the currency translation adjustment component of Accumulated other comprehensive income (loss) in the Consolidated Balance Sheets to offset translation gains and losses associated with the hedged net investment.

Derivatives that are entered into for risk management purposes and are not designated as hedges are recorded at their fair market values and recognized in net income.

The fair values of the Company's derivatives are not material. The notional amount of the Company’s outstanding fair value hedges, cash flow hedges, and net investment hedges was $1,375 million, $342 million, and $1,371 million at December 31, 2024, respectively, and $1,375 million, $550 million, and $1,187 million at December 31, 2023, respectively. The notional amount of derivatives not designated as hedging instruments was $3,323 million and $338 million at December 31, 2024 and 2023, respectively.

CRH Form 10-K 64

1.16. Debt

Debt is recorded at initial fair value, which normally reflects the proceeds received by the Company, net of debt issuance costs. Debt is subsequently stated at amortized cost. Debt issuance costs are amortized to Interest expense over the term of the debt. Debt issuance discounts and premiums are also amortized to Interest expense using the effective interest rate method over the term of the debt.

Debt issuance costs associated with the Company’s revolving facility are amortized to Interest expense on a straight-line basis over the facility’s term.

1.17. Goodwill

Goodwill represents the excess of the purchase price over the fair value of the assets acquired and liabilities assumed in a business combination. Goodwill is tested for impairment annually at October 1 or more frequently if events or circumstances indicate that an impairment loss may have been incurred, at the reporting unit level, one level below the Company’s operating segments. The Company has the option of either assessing qualitative factors to determine whether it is more likely than not that the carrying value of the reporting units exceeds their respective fair value or proceeding directly to a quantitative test. The Company elected to perform the quantitative impairment test for all years presented. If the fair value exceeds its carrying value, the goodwill of the reporting unit is not considered impaired. However, if the carrying value of a reporting unit exceeds its fair value, an impairment loss is recognized by writing down the assets to their fair value.

See Note 9 for further information.

1.18. Intangible assets, net

Intangible assets acquired in business combinations are stated at their fair value as determined at the date of acquisition. Intangible assets are amortized on a straight-line basis. In general, based on the current composition of definite-lived intangible assets, the useful lives for customer-related intangible assets range from 5 to 20 years and the useful lives for marketing-related intangible assets range from 10 to 30 years. The Company evaluates the recoverability of its intangible assets subject to amortization when facts and circumstances indicate that the carrying value of the asset may not be recoverable. If the carrying value is not recoverable, impairment is measured as the amount by which the carrying value exceeds its estimated fair value.

See Note 8 for further information.

1.19. Pension and other postretirement benefits

The Company sponsors defined benefit retirement plans and also provides other postretirement benefits. The Company recognizes the funded status, defined as the difference between the fair value of plan assets and the benefit obligation, of its pension plans and other postretirement benefits as an asset or liability in the Consolidated Balance Sheets. Actuarial gains or losses that arise during the year are recognized as a component of Accumulated other comprehensive income (loss). Amounts in excess of a corridor are subsequently amortized over the participants’ average remaining service period and recognized as a component of net periodic benefit cost. The corridor represents the excess over 10% of the greater of the projected benefit obligation or pension plan assets and is determined on a plan-by-plan basis.

See Note 21 for further information.

1.20. Insurance

The Company has insurance arrangements which comprise employer’s liability (workers’ compensation in the United States), public and products liability (general liability in the United States), automobile liability, property damage, business interruption and various other insurances. Due to the extended timeframe associated with many of the insurances, a significant proportion of the total liability is subject to periodic actuarial valuation. The projected cash flows underlying the discounting process are established through the application of actuarial triangulations, which are extrapolated from historical claims experience. While the Company believes the assumptions used to calculate these liabilities are appropriate, significant differences in actual experience and/or significant changes in those assumptions may materially affect insurance liabilities.

1.21. Share-based compensation

The Company grants share-based awards, which consist of performance stock units (PSUs) and stock options. All of the share-based compensation awards are classified as equity awards. The Company measures share-based compensation awards using fair value based measurement methods. This results in the recognition of compensation expense for all share-based compensation awards based on their fair value as of the grant date. For performance-based awards, compensation expense is recognized only if it is probable that the performance condition will be achieved. Compensation expense is recognized over the requisite service period for time and performance-based awards, net of estimated forfeitures.

See Note 17 for further information.

1.22. Treasury stock

The Company accounts for Treasury stock under the cost method. When Treasury stock is re-issued at a price higher than its cost, the difference is recorded as a component of Additional paid-in capital in the Consolidated Balance Sheets. When Treasury stock is re-issued at a price lower than its cost, the difference is recorded as a component of Additional paid-in capital to the extent that there are previously recorded gains to offset the losses. If there are no Treasury stock gains in Additional paid-in capital, the losses upon re-issuance of Treasury stock are recorded as a reduction of Retained earnings in the Consolidated Balance Sheets.

1.23. Environmental remediation costs

The Company records an accrual for environmental remediation liabilities in the period in which it is probable that a liability has been incurred and the appropriate amounts can be estimated reasonably. Such accruals are adjusted as further information develops or circumstances change. Generally, these costs are not discounted to their present value or offset for potential insurance or other claims or potential gains from future alternative uses for a site.

CRH Form 10-K 65

1.24. Income taxes

Current tax represents the expected tax payable (or recoverable) on the taxable profit for the year using tax rates enacted for the period. Where items are accounted for outside of profit or loss, the related income tax is recognized either in Other comprehensive (loss) income or directly in equity, as appropriate. Interest and penalties associated with the liability for income tax are classified as Income tax expense. The Company’s policy is to release tax effects from Accumulated other comprehensive income (loss) when the underlying items affect earnings.

Deferred tax is recognized using the liability method on temporary differences arising at the balance sheet date between the tax bases of assets and liabilities and their carrying amounts in the Consolidated Financial Statements. However, deferred tax liabilities are not recognized if they arise from the initial recognition of goodwill. For the most part, no provision has been made for undistributed earnings as the majority of earnings are considered indefinitely reinvested or can be distributed on a tax-free basis. However, a temporary difference has been recognized to the extent that earnings are not permanently reinvested.

Deferred tax is determined using tax rates (and laws) that have been enacted as of the balance sheet date and are expected to apply when the related deferred income tax asset is realized, or the deferred income tax liability is settled. Deferred tax assets are recognized in full and then reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax assets will not be recognized.

The Company’s income tax charge is based on reported profit and enacted statutory tax rates, which reflect various allowances and reliefs available to the Company in the multiple tax jurisdictions in which it operates. The determination of the Company’s provision for income tax requires certain judgments and estimates in relation to matters where the ultimate tax outcome may not be certain. In addition, the Company is subject to tax audits which can involve complex issues that could require extended periods to conclude, the resolution of which is often not within the control of the Company. Although the Company believes that the estimates included in the Consolidated Financial Statements and its tax return positions are reasonable, there is no certainty that the final outcome of these matters will not be different to that which is reflected in the Company’s historical income tax provisions and accruals. The Company evaluates these positions regularly and records a tax benefit only to the extent it is more likely than not that a position will be sustained upon examination by taxing authorities.

See Note 15 for further information.

1.25. New accounting standards

Accounting pronouncements recently adopted

For the year ended December 31, 2024, the Company adopted Accounting Standards Update (ASU) No. 2023-07, Improvements to Reportable Segment Disclosures (Topic 280). This ASU updates reportable segment disclosure requirements by requiring disclosure of significant reportable segment expenses that are regularly provided to the Chief Operating Decision Maker (CODM) and included within each reported measure of a segment's profit or loss. This ASU also requires disclosure of the title and position of the individual identified as the CODM and an explanation of how the CODM uses the reported measures of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources. Adoption of the ASU has been applied retrospectively to all prior periods presented in the Consolidated Financial Statements.

Recently issued accounting pronouncements not yet adopted

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The ASU requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the provisions of this ASU and will adopt them for the year ending December 31, 2025.

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40). The ASU requires the disclosure of specified information about certain costs and expenses in the notes to the financial statements. The ASU is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. These amendments should be applied either prospectively to financial statements issued after the effective date or retrospectively to any or all prior periods presented in the financial statements. Early adoption is also permitted. The Company is currently evaluating the provisions of this ASU and will adopt them for the year ending December 31, 2027.

CRH Form 10-K 66

2. Revenue

The Company disaggregates revenue based on its operating and reportable segments. During the fourth quarter of 2024, the Company changed its reportable segments as described in Note 20 Segment Information. The Company’s operating and reportable segments are: (1) Americas Materials Solutions, (2) Americas Building Solutions, and (3) International Solutions.

Revenue is disaggregated by principal activities and products and by primary geographic market. Business lines are reviewed and evaluated as follows: (1) Essential Materials, (2) Road Solutions, (3) Building & Infrastructure Solutions, and (4) Outdoor Living Solutions.

The vertically integrated Essential Materials businesses manufacture and supply aggregates and cement for use in a range of construction and industrial applications.

Road Solutions support the manufacturing, installation and maintenance of public highway infrastructure projects and commercial infrastructure.

Building & Infrastructure Solutions connect, protect and transport critical water, energy and telecommunications infrastructure and deliver complex commercial building projects.

Outdoor Living Solutions integrate specialized materials, products and design features to enhance the quality of private and public spaces.

	For the Year Ended December 31, 2024
in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Principal activities and products
Essential Materials	4,793	–	4,767	9,560
Road Solutions (i)	11,380	–	4,930	16,310
Building & Infrastructure Solutions (ii)	–	2,569	1,998	4,567
Outdoor Living Solutions	–	4,490	645	5,135
Total revenues	16,173	7,059	12,340	35,572
	For the Year Ended December 31, 2023
---	---	---	---	---
in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Principal activities and products
Essential Materials	4,583	–	4,876	9,459
Road Solutions (i)	10,852	–	4,814	15,666
Building & Infrastructure Solutions (ii)	–	2,524	2,174	4,698
Outdoor Living Solutions	–	4,493	633	5,126
Total revenues	15,435	7,017	12,497	34,949
	For the Year Ended December 31, 2022
---	---	---	---	---
in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Principal activities and products
Essential Materials	4,160	–	4,625	8,785
Road Solutions (i)	10,164	–	4,724	14,888
Building & Infrastructure Solutions (ii)	–	2,379	2,252	4,631
Outdoor Living Solutions	–	3,809	610	4,419
Total revenues	14,324	6,188	12,211	32,723

(i)     Revenue from contracts with customers in the Road Solutions principal activities and products category that is recognized over time for the years ended December 31 were:

in $ millions	2024	2023	2022
Americas Materials Solutions	6,426	6,146	5,791
International Solutions	1,880	2,004	1,814
Total revenue from contracts with customers	8,306	8,150	7,605

CRH Form 10-K 67

(ii)     Revenue from contracts with customers in the Building & Infrastructure Solutions principal activities and products category that is recognized over time for the years ended December 31 were:

in $ millions	2024	2023	2022
Americas Building Solutions	81	70	78
International Solutions	486	573	521
Total revenue from contracts with customers	567	643	599
	For the Year Ended December 31, 2024
---	---	---	---	---
in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Primary geographic markets
United States	14,975	6,736	123	21,834
Rest of World (i)	1,198	323	1,199	2,720
United Kingdom	–	–	3,994	3,994
Rest of Europe (ii)	–	–	7,024	7,024
Total revenues	16,173	7,059	12,340	35,572
	For the Year Ended December 31, 2023
---	---	---	---	---
in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Primary geographic markets
United States	14,088	6,692	150	20,930
Rest of World (i)	1,347	325	633	2,305
United Kingdom	–	–	4,312	4,312
Rest of Europe (ii)	–	–	7,402	7,402
Total revenues	15,435	7,017	12,497	34,949
	For the Year Ended December 31, 2022
---	---	---	---	---
in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Primary geographic markets
United States	13,050	5,860	178	19,088
Rest of World (i)	1,274	325	701	2,300
United Kingdom	–	–	4,241	4,241
Rest of Europe (ii)	–	3	7,091	7,094
Total revenues	14,324	6,188	12,211	32,723

(i)    The Rest of World principally includes Australia, Canada and the Philippines.

(ii)    The Rest of Europe principally includes Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Luxembourg, the Netherlands, Poland, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Ukraine. Revenues generated in the Republic of Ireland represented approximately 2%, 3%, and 2% of our consolidated revenues for the years ended December 31, 2024, 2023, and 2022, respectively.

Contract assets were $690 million and $716 million and contract liabilities were $500 million and $439 million, at December 31, 2024 and 2023, respectively. The decrease in contract assets was primarily attributed to revenue recognized on certain contracts partially offset by the timing of billings. The increase in contract liabilities was due to the timing of advance payments and revenue recognized during the period. The Company recognized revenue of $387 million and $308 million for the years ended December 31, 2024 and 2023, respectively, which was previously included in the contract liability balance at December 31, 2023 and 2022, respectively.

Contract assets include unbilled revenue and retentions held by customers in respect of construction contracts at December 31, 2024 and 2023 amounting to $450 million and $240 million, and $471 million and $245 million respectively. Unbilled receivables represent the estimated value of unbilled work for projects with performance obligations recognized over time. Retentions represent amounts that have been billed to customers but payment is withheld until final acceptance of the performance obligation by the customer. Retentions that have been billed, but are not due until completion of performance and acceptance by customers, are generally expected to be collected within one year. The Company applies the practical expedient and does not adjust any of its transaction prices for the time value of money.

On December 31, 2024, the Company had $3,551 million of transaction price allocated to remaining performance obligations. The majority of open contracts at December 31, 2024, are expected to close and revenue to be recognized within 12 months of the balance sheet date.

Revenue from sales to equity method investments for the years ended December 31, 2024, 2023, and 2022 were $296 million, $221 million, and $237 million, respectively.

CRH Form 10-K 68

3. Assets held for sale and discontinued operations

In November 2023, the Company entered into a sales agreement with SigmaRoc plc. to divest of its Lime operations in Europe for consideration of $1.1 billion. The transaction was structured in three phases. The first phase of the transaction, comprising the Company’s Lime operations in Germany, Czech Republic and Ireland, closed on January 1, 2024, and the second phase, comprising the operations in the United Kingdom, closed on March 27, 2024. The third phase, comprising the operations in Poland, closed on August 30, 2024. The divestitures resulted in a pretax gain of $167 million which is included in Other nonoperating income (expense), net. The results of the divested operations and the gain on divestiture are reported in the International Solutions segment.

The disposal of certain cement, aggregates and readymixed concrete operations in Quebec, Canada, previously classified as held for sale, completed during 2024.

The assets associated with these transactions comprised part of the Company’s International Solutions and Americas Materials Solutions segments, respectively. As the businesses were divested in 2024, all opening balances have been reclassified back to the relevant asset and liability categories prior to their divestiture for presentation purposes.

The major classes of assets and liabilities classified as held for sale at December 31 were:

in $ millions	2023
Assets
Cash and cash equivalents	49
Accounts receivable, net	70
Inventories	102
Property, plant and equipment, net	832
Goodwill	201
Operating lease right-of-use assets, net	6
Other assets	8
Assets held for sale	1,268
Liabilities
Accounts payable	59
Accrued expenses	17
Deferred income tax liabilities	148
Operating lease liabilities	6
Other liabilities	145
Liabilities held for sale	375

In April 2022, the Company completed the divestiture of its Building Envelope business, formerly part of the Americas Building Solutions segment. The Company analyzed the quantitative and qualitative factors relevant to the Building Envelope business and determined that the criteria for discontinued operations presentation were met during the year ended 2022. As a result, the operating results of the Building Envelope business were reported separately as discontinued operations, net of income tax expense, in the Consolidated Statements of Income for the period ended December 31, 2022.

CRH Form 10-K 69

The financial results for the Company’s discontinued operations for the year ended December 31 were:

in $ millions	2022
Total revenues	645
Operating income	89
Gain on divestiture before income taxes	1,471
Income from discontinued operations before income tax expense	1,560
Income tax expense	(370)
Income from discontinued operations, net of income tax expense	1,190

The cash flows from discontinued operations included in the accompanying Consolidated Statements of Cash Flows for the year ended December 31 were:

in $ millions	2022
Cash flows from discontinued operations
Net cash used in operating activities (i)	(444)
Net cash provided by investing activities (ii)	3,446
Net cash provided by financing activities	3

(i)     Includes the corporation tax paid on the sale of discontinued operations.

(ii)     Includes the proceeds from the divestiture of discontinued operations.

4. Acquisitions

The Company strategically acquires companies in order to increase its footprint and offer products and services that diversify its existing offerings. These acquisitions are accounted for as business combinations using the acquisition method, whereby the purchase price is allocated to the assets acquired and liabilities assumed, based on their estimated fair values at the date of the acquisition, with the remaining amount recorded in Goodwill.

On February 9, 2024, the Company wholly acquired a portfolio of cement and readymixed concrete operations and assets in Texas, United States (the 'Hunter' acquisition) for a total cash consideration, net of cash acquired, of $2,106 million. The Hunter acquisition is reported in the Americas Materials Solutions segment.

On July 1, 2024, the Company acquired 57% of the issued share capital of Adbri (the 'Adbri' acquisition), a construction materials business in Australia, for a total cash consideration, net of cash acquired, of $787 million. The Adbri acquisition is reported in the International Solutions segment. Due to the size and scale of Adbri, the determination of the fair values of identifiable assets acquired and liabilities assumed as disclosed are provisional.

During 2024, the Company completed the acquisition of 38 other companies in addition to Hunter and Adbri. The total cash consideration for these acquisitions, net of cash acquired, was $2,007 million.

CRH Form 10-K 70

The amounts for assets acquired, liabilities assumed, and consideration related to the acquisitions during the year ended December 31, 2024, were:

in $ millions	Hunter	Adbri (i)	Other acquisitions<br>(i) (ii)	Total
Identifiable assets acquired and liabilities assumed
Assets
Cash and cash equivalents	–	15	38	53
Accounts receivable, net	–	156	152	308
Inventories	70	133	149	352
Other current assets	2	6	8	16
Property, plant and equipment, net	1,069	1,364	850	3,283
Equity method investments	–	366	–	366
Intangible assets, net	2	4	184	190
Operating lease right-of-use assets, net	12	18	85	115
Total assets	1,155	2,062	1,466	4,683
Liabilities
Accounts payable	–	17	54	71
Accrued expenses	6	67	30	103
Operating lease liabilities	12	18	85	115
Long-term debt	–	519	9	528
Deferred income tax liabilities	–	208	27	235
Other liabilities	8	151	57	216
Total liabilities	26	980	262	1,268
Total identifiable net assets at fair value	1,129	1,082	1,204	3,415
Goodwill	977	227	940	2,144
Redeemable noncontrolling interests	–	–	(12)	(12)
Noncontrolling interests	–	(507)	–	(507)
Total consideration	2,106	802	2,132	5,040
Consideration satisfied by:
Cash payments	2,106	802	2,045	4,953
Asset exchange	–	–	41	41
Deferred consideration (stated at net present cost)	–	–	27	27
Contingent consideration	–	–	19	19
Total consideration	2,106	802	2,132	5,040
Acquisitions of businesses, net of cash acquired
Cash consideration	2,106	802	2,045	4,953
Less: cash and cash equivalents acquired	–	(15)	(38)	(53)
Total outflow in the Consolidated Statements of Cash Flows	2,106	787	2,007	4,900

(i)    The estimated fair values of assets acquired and liabilities assumed associated with these acquisitions are provisional (principally in respect of Property, plant and equipment, net, provisions for liabilities and the associated goodwill and deferred tax aspects) and are based on the information that was available as of the reporting date. The Company expects to finalize the valuation and complete the purchase price allocations as soon as practical but no later than one year from the acquisition dates.

(ii)    Other acquisitions are aggregated on the basis of individual immateriality.

As a result of the 2024 acquisitions, the Company recognized $190 million of amortizable intangible assets and $2,144 million of goodwill. Goodwill represents the excess of the consideration paid over the fair value of net assets acquired and includes the expected benefit of cost savings and synergies within the Company’s segments and intangible assets that do not qualify for separate recognition. Of the goodwill recognized in respect of the acquisitions completed in 2024, $1,712 million is expected to be deductible for tax purposes. The amortizable intangible assets will be amortized against earnings over a weighted average of nine years.

CRH Form 10-K 71

During 2023, the Company completed the acquisition of 22 companies. The total cash consideration for these acquisitions, net of cash acquired, was $640 million.

The identifiable assets acquired, liabilities assumed, and consideration related to the acquisitions during the year ended December 31, 2023, were:

in $ millions	Total (i)
Identifiable assets acquired and liabilities assumed
Cash and cash equivalents	19
Accounts receivable, net	71
Inventories	65
Other current assets	8
Property, plant and equipment, net	252
Intangible assets, net	86
Operating lease right-of-use assets, net	35
Accounts payable	56
Accrued expenses	30
Operating lease liabilities	35
Long-term debt	104
Deferred income tax liabilities	30
Other liabilities	6
Total identifiable net assets at fair value	275
Goodwill	398
Total consideration	673
Consideration satisfied by:
Cash payments	659
Deferred consideration (stated at net present cost)	8
Contingent consideration	6
Total consideration	673
Acquisitions of businesses, net of cash acquired
Cash consideration	659
Less: cash and cash equivalents acquired	(19)
Total outflow in the Consolidated Statements of Cash Flows	640

(i)     Total acquisitions are aggregated on the basis of individual immateriality.

As a result of the 2023 acquisitions, the Company recognized $86 million of amortizable intangible assets and $398 million of goodwill. Goodwill represents the excess of the consideration paid over the fair value of net assets acquired and includes the expected benefit of cost savings and synergies within the Company’s segments and intangible assets that do not qualify for separate recognition. Of the goodwill recognized in respect of the acquisitions completed in 2023, $33 million is expected to be deductible for tax purposes. The amortizable intangible assets will be amortized against earnings over a weighted average of six years.

CRH Form 10-K 72

On July 8, 2022, the Company acquired Barrette Outdoor Living, Inc. (Barrette), North America's leading provider of residential fencing and railing solutions headquartered in Middleburg Heights, Ohio, United States, at an effective 100% stake. The total cash consideration for this acquisition, net of cash acquired, was $1,903 million.

During 2022, the Company completed the acquisition of 28 other companies. The total cash consideration for these acquisitions, net of cash acquired, was $1,350 million.

The identifiable assets acquired, liabilities assumed, and consideration related to the acquisitions during the year ended December 31, 2022, were:

in $ millions	Barrette	Other acquisitions (i)	Total
Identifiable assets acquired and liabilities assumed
Cash and cash equivalents	8	14	22
Accounts receivable, net	128	49	177
Inventories	247	128	375
Other current assets	40	10	50
Property, plant and equipment, net	266	539	805
Equity method investments	–	28	28
Intangible assets, net	809	178	987
Operating lease right-of-use assets, net	43	59	102
Accounts payable	26	20	46
Accrued expenses	121	27	148
Operating lease liabilities	43	59	102
Long-term debt	–	8	8
Deferred income tax liabilities	192	55	247
Other liabilities	22	4	26
Total identifiable net assets at fair value	1,137	832	1,969
Goodwill	774	546	1,320
Total consideration	1,911	1,378	3,289
Consideration satisfied by:
Cash payments	1,911	1,364	3,275
Deferred consideration (stated at net present cost)	–	10	10
Contingent consideration	–	4	4
Total consideration	1,911	1,378	3,289
Acquisitions of businesses, net of cash acquired
Cash consideration	1,911	1,364	3,275
Less: cash and cash equivalents acquired	(8)	(14)	(22)
Total outflow in the Consolidated Statements of Cash Flows	1,903	1,350	3,253

(i)     Other acquisitions are aggregated on the basis of individual immateriality.

As a result of the 2022 acquisitions, the Company recognized $987 million of amortizable intangible assets and $1,320 million of goodwill. Goodwill represents the excess of the consideration paid over the fair value of net assets acquired and includes the expected benefit of cost savings and synergies within the Company’s segments and intangible assets that do not qualify for separate recognition. Of the goodwill recognized in respect of the acquisitions completed in 2022, $1,289 million is expected to be deductible for tax purposes. The amortizable intangible assets will be amortized against earnings over a weighted average of 19 years.

CRH Form 10-K 73

Acquisition-related costs

Acquisition-related costs have been included in Selling, general and administrative expenses in the Consolidated Statements of Income. These costs include legal and consulting expenses incurred in connection with acquisitions completed during the applicable period. The Company incurred the following acquisition-related costs for the years ended December 31, 2024, 2023, and 2022:

in $ millions	2024	2023	2022
Acquisition-related costs
Hunter	23	–	–
Adbri	23	–	–
Barrette	–	–	27
Other acquisitions	27	10	12
Total acquisition-related costs	73	10	39

For the period from acquisition date through December 31, 2024, 2023, and 2022, acquisitions contributed $1,387 million, $228 million and $761 million to Revenues and a loss of $23 million, $15 million and $18 million to Net income attributable to CRH, excluding acquisition-related costs that arose in that period and including the effect of interest expense to finance the acquisitions, respectively.

Pro forma results of operations for the current year acquisitions, as if they were combined as of January 1, 2023, have not been presented because they are not material to the Condensed Consolidated Financial Statements.

5. Accounts receivable, net

Accounts receivable, net at December 31 were:

in $ millions	2024	2023
Trade receivables	3,829	3,574
Construction contract assets	690	716
Total accounts receivable	4,519	4,290
Less: allowance for credit losses	(140)	(149)
Other current receivables	441	366
Total accounts receivable, net	4,820	4,507

Of the total Accounts receivable, net balances, $46 million and $27 million at December 31, 2024, and 2023, respectively, were due from equity method investments.

The changes in the allowance for credit losses at December 31 were as follows:

in $ millions	2024	2023	2022
At January 1	149	125	131
Charge-offs	(14)	(18)	(19)
Provision for credit losses	7	39	24
Foreign currency translation and other	(2)	3	(11)
At December 31	140	149	125

6. Inventories

Inventories at December 31 were:

in $ millions	2024	2023
Raw materials	2,074	1,865
Work-in-process	267	186
Finished goods	2,414	2,240
Total inventories	4,755	4,291

CRH Form 10-K 74

7. Property, plant and equipment, net

Property, plant and equipment, net at December 31 were:

in $ millions	2024	2023
Mineral-bearing land	5,159	4,847
Land and buildings	6,609	5,991
Plant and machinery	23,047	20,468
Construction in progress	1,963	1,271
Finance lease right-of-use assets	376	187
Total property, plant and equipment	37,154	32,764
Less: accumulated depreciation, depletion, amortization and impairment	(15,702)	(14,923)
Total property, plant and equipment, net	21,452	17,841

Depreciation, depletion and amortization expense related to property, plant and equipment was $1,646 million, $1,494 million and $1,449 million for the years ended December 31, 2024, 2023 and 2022, respectively. Depreciation, depletion and amortization expense includes amortization of right-of-use assets from finance leases.

Potential impairment of property, plant and equipment is considered by applying a series of external and internal indicators including a limited number of climate change factors.

An impairment charge of $89 million was recognized during the year ended December 31, 2024, principally relating to the write-down of property, plant and equipment in our Architectural Products business in Europe which is part of our International Solutions segment. The fair value did not exceed carrying value, driven by challenging market conditions which had an impact on growth prospects and as such an impairment charge has been recorded. An impairment charge of $30 million was recognized during the year ended December 31, 2023, principally relating to the write-down of property, plant and equipment in our Americas Materials Solutions segment.

8. Intangible assets, net

Intangible assets, net at December 31 were:

in $ millions	2024	2023
Marketing-related	337	310
Customer-related (i)	1,394	1,260
Contract-based	110	101
Software costs	126	–
IT projects in progress	63	–
Total intangible assets, gross	2,030	1,671
Accumulated amortization	(819)	(630)
Total intangible assets, net	1,211	1,041

(i)    The customer-related intangible assets relate predominantly to non-contractual customer relationships.

Amortization of intangibles included predominantly in Selling, general and administrative expenses in the Consolidated Statements of Income for the years ended December 31, 2024, 2023 and 2022 amounted to $152 million, $139 million and $103 million, respectively.

The estimated amortization for intangible assets for the five years subsequent to December 31, 2024, and thereafter is as follows:

in $ millions	2025	2026	2027	2028	2029	2030 and thereafter
Amortization	207	112	116	104	85	587

CRH Form 10-K 75

9. Goodwill

During the fourth quarter of 2024, the Company's operating and reportable segments changed to the following three segments: Americas Materials Solutions; Americas Building Solutions; and International Solutions and existing goodwill was reallocated to each of the new reportable segments and associated reporting units. See Note 20 for further information. The results of this reallocation of goodwill have been recast below, by reportable segment, at December 31, 2023. As a result of this revision to reportable segments and associated reporting units, the Company performed an impairment assessment before and after the reallocation. Both before and after the reallocation, the Company concluded that the fair values of the reporting units affected were above their carrying values and therefore there was no indication of impairment.

The Company uses the present value of estimated future cash flows to establish the estimated fair value of the reporting units at the testing date. This approach includes many assumptions related to future growth rates, discount factors, and tax rates, among other considerations. Changes in economic and operating conditions impacting these assumptions could result in goodwill impairment in future periods. Additionally, the Company uses the market approach to corroborate the estimated fair value.

The changes in the carrying amount of goodwill at December 31 were:

in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Carrying value, December 31, 2022	4,407	2,517	2,275	9,199
Acquisitions	34	240	124	398
Foreign currency translation adjustment	8	(5)	86	89
Impairment charge for the year	(32)	–	(295)	(327)
Reclassified as held for sale	–	–	(201)	(201)
Carrying value, December 31, 2023	4,417	2,752	1,989	9,158
Acquisitions	1,426	333	385	2,144
Foreign currency translation adjustment	(40)	(12)	(114)	(166)
Impairment charge for the year	–	–	(72)	(72)
Divestitures	–	(3)	(201)	(204)
Reclassified from held for sale	–	–	201	201
Carrying value, December 31, 2024	5,803	3,070	2,188	11,061

For the year ended December 31, 2024, the fair value of the Architectural Products reporting unit within International Solutions did not exceed its carrying value. As a result, a goodwill impairment loss of $72 million was recorded in Loss on impairments, driven by challenging market conditions (primarily new build residential) which has had an impact on growth prospects. The assumption underlying the estimated future cash flows resulted in a present value (using a real pre-tax discount rate of 9.1%) of $252 million and a related goodwill impairment being recorded of $72 million.

For the year ended December 31, 2023, the fair value of the Company’s Philippines reporting unit within International Solutions did not exceed its carrying value. As a result, a goodwill impairment loss of $295 million was recorded in Loss on impairments.

Accumulated goodwill impairment losses amount to $1,050 million and $1,001 million at December 31, 2024 and 2023, respectively and relate predominantly to International Solutions.

CRH Form 10-K 76

10. Additional financial information

Other current assets at December 31 were:

in $ millions	2024	2023
Prepayments	303	285
Other financial assets	161	–
Other	285	193
Total other current assets	749	478

Accrued expenses at December 31 were:

in $ millions	2024	2023
Accrued payroll and employee benefits	1,062	1,066
Other accruals	1,186	1,230
Total accrued expenses	2,248	2,296

Other current liabilities at December 31 were:

in $ millions	2024	2023
Dividends payable	–	750
Construction contract liabilities	500	439
Insurance liability	185	171
Income tax payable	97	129
Other	795	583
Total other current liabilities	1,577	2,072

Other noncurrent liabilities at December 31 were:

in $ millions	2024	2023
Income tax payable	726	712
Asset retirement obligations	319	310
Pension liability	223	254
Insurance liability	269	260
Other	782	660
Total other noncurrent liabilities	2,319	2,196

CRH Form 10-K 77

11. Debt

Long-term debt at December 31 was:

in $ millions	Effective interest rate		2024	2023
Long-term debt
(U.S. Dollar denominated unless otherwise noted)
1.875% euro Senior Notes due 2024	2.02	%	–	663
3.875% Senior Notes due 2025	3.93	%	1,250	1,250
1.250% euro Senior Notes due 2026	1.25	%	780	829
3.400% Senior Notes due 2027	3.49	%	600	600
4.000% euro Senior Notes due 2027	4.13	%	520	553
3.950% Senior Notes due 2028	4.07	%	900	900
1.375% euro Senior Notes due 2028	1.42	%	624	663
5.200% Senior Notes due 2029	5.30	%	750	–
4.125% Sterling Senior Notes due 2029	4.22	%	501	509
1.625% euro Senior Notes due 2030	1.72	%	780	829
4.000% euro Senior Notes due 2031	4.10	%	780	829
6.400% Senior Notes due 2033 (i)	6.43	%	213	213
5.400% Senior Notes due 2034	5.52	%	750	–
4.250% euro Senior Notes due 2035	4.38	%	780	829
5.125% Senior Notes due 2045	5.25	%	500	500
4.400% Senior Notes due 2047	4.44	%	400	400
4.500% Senior Notes due 2048	4.63	%	600	600
USD interest bearing loan due 2026	4.96	%	750	–
PHP interest bearing loan due 2027	5.97	%	379	396
AUD interest bearing loan due 2029	5.07	%	478	–
U.S. Dollar Commercial Paper	4.77	%	1,189	1,002
Euro Commercial Paper	3.08	%	347	–
Other			48	37
Unamortized discounts and debt issuance costs			(68)	(67)
Total long-term debt (ii)			13,851	11,535
Less: current portion of long-term debt (iii)			(2,882)	(1,759)
Long-term debt			10,969	9,776

(i)     The $300 million 6.400% Senior Notes were issued in September 2003, and at the time of issuance the Senior Notes were partially swapped to floating interest rates. In August 2009 and December 2010, $87 million of the issued Senior Notes were acquired by CRH as part of liability management exercises undertaken and the interest rate hedge was closed out. The remaining fair value hedge adjustment on the hedged item in the Consolidated Balance Sheets was $27 million and $30 million at December 31, 2024 and 2023, respectively.

(ii)     Of the Company’s nominal fixed rate debt at both December 31, 2024 and December 31, 2023, $1,375 million was hedged to daily compounded Secured Overnight Financing Rate (SOFR) using interest rate swaps. Of the Company’s nominal floating rate debt at December 31, 2024 and December 31, 2023, $140 million and $nil million, respectively, was hedged to fixed rates using interest rate swaps.

(iii)     Excludes borrowings from bank overdrafts of $117 million and $107 million, which are recorded within Current portion of long-term debt in the Consolidated Balance Sheets at December 31, 2024 and 2023, respectively.

Senior Notes:

The Senior Notes are issued by wholly-owned subsidiaries of the Company and carry full and unconditional guarantees from the Company, as defined in the indentures that govern them. These Senior Notes represent senior unsecured obligations of the Company and hold an equal standing in payment priority with the Company's existing and future unsubordinated indebtedness.

With the exception of the 6.400% Senior Notes due 2033, which can be redeemed at any time, all other Senior Notes can be redeemed before their respective par call dates, at a make-whole redemption price. Post par call dates and before the respective maturity dates, the Senior Notes can be redeemed at a price equal to 100% of the principal amount.

In the event of a change-of-control repurchase event, the Company is obligated to offer repurchase options for the 3.875% Senior Notes due in 2025, 3.400% Senior Notes due in 2027, 3.950% Senior Notes due in 2028, 5.200% Senior Notes due 2029, 5.400% Senior Notes due 2034, 5.125% Senior Notes due in 2045, 4.400% Senior Notes due in 2047, and 4.500% Senior Notes due in 2048. This repurchase involves a cash payment equal to 101% of the principal amount, along with any accrued and unpaid interest.

If the Company's credit rating falls below investment-grade, the Company would be required to make an additional coupon step-up payment on the 3.875% Senior Notes due in 2025 and 5.125% Senior Notes due in 2045. The increase is 25 basis points per rating notch per agency, capped at 100 basis points per agency. However, this coupon step-up would reverse if the Company returns to an investment-grade rating.

On January 9, 2024, the Company utilized available cash to fully redeem €600 million of outstanding 1.875% euro Senior Notes due January 2024.

In May 2024, the Company issued $750 million 5.200% Senior Notes due 2029 and $750 million 5.400% Senior Notes due 2034.

CRH Form 10-K 78

Australian (AUD) Debt:

In July 2024, the Company acquired Adbri who have committed credit agreements with a range of banks and credit institutions totaling AUD940 million. The Company does not provide a guarantee for these facilities. The funds drawn from these facilities carry a combination of fixed and floating interest rates.

Philippines (PHP) Debt:

In March 2017, the Company's subsidiary, Republic Cement & Building Materials, Inc., entered a credit arrangement with the Bank of the Philippine Islands. The Company does not provide a guarantee for this facility. The initial credit agreement provided for total commitments of PHP12.5 billion for a 10-year term, which was later expanded to PHP22.5 billion. The funds drawn from this facility carry a combination of fixed and floating interest rates.

Bank Credit:

The Company maintains a multi-currency revolving credit arrangement with a syndicate of lenders (the ‘RCF’). The RCF offers a senior unsecured revolving facility of €3,500 million over five years. Borrowings under the RCF bear interest at rates based upon an underlying base rate, plus a margin determined in accordance with a ratings-based pricing grid. Base rates include SOFR for U.S. Dollar, EURIBOR for euros, SONIA for Sterling, and SARON for Swiss Francs, respectively. The facility entails an annual commitment fee calculated as a percentage of the applicable margin.

During April 2024, the Company completed a one-year extension option on the undrawn committed facilities extending the maturity date to May 11, 2029. The terms of the facility allow for one further plus-one (+1) extension option which, if successfully exercised with the agreement of the Lenders, would extend the maturity to May 11, 2030. The deferred financing costs associated with the RCF were $6 million at December 31, 2024. The total potential credit available through this arrangement is €3,500 million, inclusive of the ability to issue letters of credit.

At December 31, 2024, and 2023, there were no outstanding borrowings or letters of credit issued under this facility and the undrawn committed facility available to be drawn by the Company at December 31, 2024, was $3,639 million (€3,500 million equivalent).

The RCF includes customary terms and conditions for investment-grade borrowers. There are no financial covenants.

In December 2024, the Company entered into a new $750 million two-year fixed rate term loan facility which was fully drawn.

At December 31, 2024, the Company had a $4,000 million U.S. Dollar Commercial Paper Program and a €1,500 million euro Commercial Paper Program. The purpose of these programs is to provide short-term liquidity as required. The Company’s RCF supports the commercial paper programs with a separate €750 million swingline sublimit which allows for same-day drawing in either U.S Dollar or euro. The amount of commercial paper outstanding does not reduce available capacity under the RCF. Commercial paper borrowings may vary during the period, largely as a result of fluctuations in funding requirements.

The long-term debt maturities, net of the unamortized discounts and debt issuance costs, for the periods subsequent to December 31, 2024, are as follows:

in $ millions	2025	2026	2027	2028	2029	2030 and thereafter	Total
Long-term debt maturities	2,882	1,923	1,430	1,506	1,258	4,852	13,851

CRH Form 10-K 79

12. Leases

In the normal course of its business, the Company enters into various leases as the lessee, primarily related to property. The Company also leases plant and machinery, vehicles and equipment.

Lease liabilities at December 31 were:

in $ millions	2024	2023
Current:
Operating lease liabilities	265	255
Finance lease liabilities	67	31
Noncurrent:
Operating lease liabilities	1,074	1,125
Finance lease liabilities	190	86
Total lease liabilities	1,596	1,497

The current portion of finance lease liabilities is included within Other current liabilities and the noncurrent portion of finance lease liabilities is included within Other noncurrent liabilities in the Consolidated Balance Sheets.

The maturity analysis for the discounted and undiscounted lease liability arising from the Company’s leasing activities at December 31, 2024, was:

in $ millions	Operating leases	Finance leases
2025	279	70
2026	230	62
2027	182	51
2028	153	39
2029	107	22
Thereafter	755	133
Total minimum lease payments	1,706	377
Less: lease payments representing interest	(367)	(120)
Present value of future minimum lease payments	1,339	257
Less: current portion of lease liabilities	(265)	(67)
Noncurrent portion of lease liabilities	1,074	190

The projections are based on the foreign exchange rates applied at the end of the relevant financial year and on interest rates (discounted projections only) applicable to the lease portfolio.

The components of lease expense for the years ended December 31 were:

in $ millions	2024	2023	2022
Finance leases
Amortization of right-of-use-assets	45	19	20
Interest on lease liabilities	7	3	3
Operating leases	262	293	255
Short-term leases	301	329	273
Variable leases	80	85	94
Total lease expense (i)	695	729	645

(i)     Income from subleasing transactions were not material for the Company.

CRH Form 10-K 80

The weighted average remaining lease term and discount rates at December 31 were:

	2024		2023
Weighted average remaining lease term (years)
Operating leases	10		12
Finance leases	11		13
Weighted average discount rate (%)
Operating leases	3.86	%	3.63	%
Finance leases	5.10	%	4.07	%

The supplemental cash flow information for the years ended December 31 was:

in $ millions	2024	2023	2022
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	(287)	(276)	(269)
Financing cash flows from finance leases	(57)	(26)	(28)
Non-cash investing and financing activities
Leased assets obtained in exchange for new operating lease liabilities	195	232	130
Leased assets obtained in exchange for new finance lease liabilities	99	51	24

13. Asset retirement obligations

Asset retirement obligations (AROs) are legal obligations associated with the retirement of long-lived assets, including legal obligations for land reclamation. Recognition of a liability for an ARO is required in the period in which it is incurred at its estimated fair value. The associated asset retirement costs are capitalized as part of the carrying amount of the underlying asset and depreciated over the estimated useful life of the asset. The liability is accreted through charges to Cost of revenues. If the ARO is settled for other than the carrying amount of the liability, a gain or loss on settlement is recognized.

ARO costs related to accretion of the Company’s liabilities and the depreciation of the related assets for the years ended December 31 were:

in $ millions	2024	2023	2022
Accretion	9	12	11
Depreciation	12	27	46
Total costs	21	39	57

AROs are reported within Other current liabilities and Other noncurrent liabilities in the Consolidated Balance Sheets. At December 31, 2024 and 2023, the carrying amount of the Company’s AROs were $385 million and $360 million, of which, $66 million and $50 million are current, respectively.

14. Fair value measurement

Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and is measured using inputs in one of the following three categories:

Level 1 measurements are based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation of these items does not entail a significant amount of judgment.

Level 2 measurements are based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active or market data other than quoted prices that are observable for the assets or liabilities.

Level 3 measurements are based on unobservable data that are supported by little or no market activity and are significant to the fair value of the assets or liabilities.

Considerable judgment may be required in interpreting market data used to develop the estimates of fair value.

The carrying values and fair values of the Company’s Long-term debt were $13,851 million and $13,604 million, respectively, at December 31, 2024, and $11,535 million and $11,337 million, respectively, at December 31, 2023. The Company’s Long-term debt obligations are Level 2 instruments whose fair value is derived from quoted market prices.

The Redeemable noncontrolling interests included in the Consolidated Balance Sheets are marked to fair value on a recurring basis using Level 3 inputs. The redemption value of Redeemable noncontrolling interests approximates the fair value and is based on a range of estimated potential outcomes of the expected payment amounts primarily dependent on underlying performance metrics. The unobservable inputs in the valuation include a discount rate determined using a Capital Asset Pricing Model methodology with ranges of between 6.36% and 7.28%.

See Note 23 for the changes in the fair value of Redeemable noncontrolling interests.

The carrying values of the Company’s Cash and cash equivalents, Restricted cash, Accounts receivable, net, Current portion of long-term debt, Accounts payable, Accrued expenses, and Other current liabilities approximate their fair values because of the short-term nature of these instruments.

CRH Form 10-K 81

15. Income taxes

The summary of the Income from continuing operations before income tax expense for the years ended December 31 was:

in $ millions	2024	2023	2022
Income
U.S.	3,069	2,729	2,225
Non-U.S.	1,645	1,285	1,236
Total income	4,714	4,014	3,461

The summary of the Income tax expense from continuing operations for the years ended December 31 was:

in $ millions	2024	2023	2022
Current tax:
U.S. - Federal	466	632	443
U.S. - State	84	67	87
Non-U.S.	355	290	221
Total current tax expense	905	989	751
Deferred tax:
U.S. - Federal	187	(28)	11
U.S. - State	(5)	(12)	(6)
Non-U.S.	(2)	(24)	6
Total deferred tax expense (benefit)	180	(64)	11
Total income tax expense	1,085	925	762

Due to the percentage of global operations subject to tax in the United States, the Company uses the U.S. Federal statutory tax rate in the reconciliation of the effective income tax rate. The reconciliation of the applicable U.S. Federal income tax rate to the effective income tax rates was:

in $ millions	2024		2023		2022
U.S. statutory rate	990		843		727
State tax, net of federal tax benefit	47		38		73
Tax rate differentials	27		(11)		(6)
Uncertain tax positions	62		87		60
Tax credits	(127)		(125)		(96)
Non-deductible goodwill impairment	10		75		–
Non-taxable divestiture of the European Lime operations	(65)		–		–
Other	141		18		4
Total tax expense	1,085		925		762
Effective income tax rate	23	%	23	%	22	%

CRH Form 10-K 82

The significant components of the deferred tax assets and liabilities at December 31 were:

in $ millions	2024	2023
Deferred tax assets:
Company retirement benefit plans	2	38
Revaluation of derivative financial instruments to fair value	4	2
Tax losses, credits and interest deduction carryforwards	1,149	1,052
Share-based compensation	39	41
Accrued expenses	454	420
Lease liabilities	286	292
Total deferred tax assets	1,934	1,845
Less: valuation allowances	(1,059)	(914)
Total deferred tax assets after valuation allowances	875	931
Deferred tax liabilities:
Investment in subsidiaries	146	155
Depreciation, depletion and amortization	3,419	3,109
Leased right-of-use assets	278	274
Rolled-over capital gains	21	21
Other	15	12
Total deferred tax liabilities	3,879	3,571
Total net deferred tax liabilities	3,004	2,640

The net deferred tax assets and liabilities that are included in the Consolidated Balance Sheets at December 31 were:

in $ millions	2024	2023
Deferred income taxes, noncurrent assets	(101)	(98)
Deferred income taxes, noncurrent liabilities	3,105	2,738
Total net deferred tax liabilities	3,004	2,640

At December 31, 2024, the Company had gross loss carryforwards of $1,087 million related to foreign operations and $37 million of state net operating loss carryforwards. $390 million of certain foreign and state loss carryforwards have various expiration dates ranging from 2025 to 2050; $734 million do not expire based on current tax legislation. The Company had gross interest deduction carryforwards of $2,603 million related to foreign operations. $88 million of certain interest carryforwards have various expiration dates ranging from 2025 to 2045, $2,515 million do not expire based on current tax legislation.

The summary of the change in valuation allowance at December 31 was:

in $ millions	2024	2023	2022
Balance at January 1	914	737	578
Acquisitions	12	–	–
Provision for income taxes	188	151	203
Foreign currency and other	(55)	26	(44)
Balance at December 31	1,059	914	737

The Company maintains a valuation allowance on net operating losses and other deferred tax assets if, based on the weight of available evidence, it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. At December 31, 2024, and December 31, 2023, the Company has a valuation allowance on net deferred tax assets of $1,059 million and $914 million, respectively. For the year ended December 31, 2024, the valuation allowance increased due to an increase in interest deduction carryforwards.

A deferred tax liability has been recognized in respect of any undistributed earnings in which the Company is not permanently reinvested. The Company has $18.6 billion of undistributed earnings that are considered permanently reinvested at December 31, 2024, for which no deferred tax liabilities have been recognized. It is not practicable to estimate the amount of tax that would be paid if there was a distribution of these earnings. Participation exemptions and tax credits are available in the majority of jurisdictions in which the Company operates.

CRH Form 10-K 83

The reconciliation of the changes in the unrecognized tax benefits at December 31 was:

in $ millions	2024	2023	2022
Balance at January 1	665	576	547
Increases related to prior periods	–	9	4
Decreases related to prior periods	(50)	(12)	(8)
Increases related to current period	99	148	130
Decreases related to settlements with taxing authorities and lapse of statute of limitations	(65)	(68)	(67)
Foreign currency and other	(15)	12	(30)
Balance at December 31	634	665	576

The Company files income tax returns in Ireland, the United States, the United Kingdom, Germany, Canada, and other various foreign jurisdictions and is subject to ongoing examination by tax authorities throughout the world. In general, the Company is no longer subject to significant income tax examinations by tax authorities in the jurisdictions noted for years before 2016. The Company believes that its income tax reserves are adequately maintained taking into consideration both the technical merits of its tax return positions and ongoing developments in its income tax audits. However, the final determination of the Company's tax return positions, if audited, is uncertain and therefore there is a possibility that the outcomes of such events could cause the Company’s estimate to change in the future. No single position is expected to generate a significant increase or decrease to the liability for unrecognized tax benefits within 12 months of the reporting date. At December 31, 2024, and December 31, 2023, the unrecognized tax benefits that, if recognized, would impact the effective tax rate were $589 million and $627 million, respectively.

The Company’s policy is to accrue interest and penalties related to potential underpayment of income taxes within the provision for income taxes. At December 31, 2024, and December 31, 2023, the Company had accrued interest of $101 million and $84 million, respectively. At December 31, 2024, December 31, 2023, and December 31, 2022, the interest and penalties included in Income tax expense was $20 million, $14 million, and $5 million, respectively.

16. Earnings per share (EPS)

The calculation of basic and diluted earnings per share for the years ended December 31 were:

in $ millions, except share and per share data	2024	2023	2022
Numerator
Income from continuing operations	3,521	3,072	2,699
Net (income) attributable to redeemable noncontrolling interests	(28)	(28)	(27)
Net (income) loss attributable to noncontrolling interests	(1)	134	–
Adjustment of redeemable noncontrolling interests to redemption value	(34)	(24)	40
Income from continuing operations for EPS - basic and diluted	3,458	3,154	2,712
Income from discontinued operations, net of income tax expense	–	–	1,190
Net income attributable to CRH for EPS - basic and diluted	3,458	3,154	3,902
Denominator
Weighted average common shares outstanding – basic (i)	683.3	723.9	758.3
Effect of dilutive employee share awards (ii)	6.2	5.3	5.8
Weighted average common shares outstanding – diluted	689.5	729.2	764.1
Basic earnings per share attributable to CRH
Continuing operations	$5.06	$4.36	$3.58
Discontinued operations	–	–	$1.57
Net income	$5.06	$4.36	$5.15
Diluted earnings per share attributable to CRH
Continuing operations	$5.02	$4.33	$3.55
Discontinued operations	–	–	$1.56
Net income	$5.02	$4.33	$5.11

(i)     The weighted average number of common shares included in the computation of basic and diluted earnings per share has been adjusted to exclude shares repurchased and held by the Company as Treasury stock given that these shares do not rank for dividend.

(ii)     Common shares that would only be issued contingent on certain conditions totaling 2,140,879, 4,677,404 and 4,209,404 at December 31, 2024, 2023 and 2022, respectively, are excluded from the computation of diluted earnings per share where the conditions governing exercisability have not been satisfied as of the end of the reporting period or they are antidilutive for the periods presented.

CRH Form 10-K 84

17. Share-based compensation

Share-based compensation relates primarily to awards granted under the 2014 Performance Share Plan (PSP) and the Company’s Savings-related Share Option Schemes. The expense, net of estimated forfeitures, is reflected in Operating income in the Consolidated Statements of Income.

The share-based compensation for these plans for the years ended December 31 was:

in $ millions	2024	2023	2022
Performance Share Plan expense	123	120	97
Share Option expense	2	3	3
Total share-based compensation	125	123	100

2014 Performance Share Plan

The PSP authorizes the granting of conditional awards or nil-cost options (right to acquire shares during an exercise period without cost to the participant). The number of shares authorized under the PSP during the years ended December 31, 2024, 2023 and 2022 did not exceed 10% of the issued share capital at that time.

Under the PSP, the Company has granted performance stock units (PSUs) to its employees. PSUs provide an employee with the right to receive shares of the Company’s stock, subject to fulfillment of certain market, performance and service conditions over a vesting period. The performance conditions are as follows for the 2024, 2023 and 2022 PSUs: 20% of each award made is subject to Total Shareholder Return (TSR) performance measured against a tailored peer group; 20% is subject to a RONA metric; 15% is subject to ESG metrics; with the remaining 45% subject to a cumulative cash flow metric. Performance for the awards is assessed over a three-year period.

The details of the awards granted under the PSP for the year ended December 31, 2024 were:

	Number of shares	Weighted average grant date fair value
	Shares in whole numbers	Amounts in $	Amounts in €
Outstanding at beginning of year	9,816,619	41.56	37.90
Granted	1,856,679	79.52	73.85
Forfeited	(294,689)	46.12	41.44
Vested	(3,080,029)	40.93	34.97
Outstanding at end of year	8,298,580	50.11	46.89

During fiscal years 2023 and 2022, the weighted average grant date fair values were $48.55 (€45.57) and $36.29 (€34.50), respectively.

The fair value of (i) the portion of awards subject to a cash flow performance metric; (ii) the portion of awards subject to a RONA metric; (iii) the portion of awards subject to ESG metrics; and (iv) the portion of awards with no performance conditions which are subject to a two-year service period; was calculated as the Company’s closing share price at the date the award was granted.

The fair value assigned to the portion of awards subject to a TSR performance metric was calculated using the Monte Carlo simulation model, at the grant date, taking account of peer group TSR, volatilities and correlations together with the following assumptions:

	2024	2023	2022
Risk-free interest rate (%)	4.44	3.16	0.51
Expected volatility (%)	30.3	28.9	36.9

The expected volatility was determined using a historical sample of the Company’s daily share prices over a period equal to the expected term.

The risk-free interest rate is based on the U.S. Treasury bond yield at the grant date with a maturity period equal to the expected term.

During the years ended December 31, 2024, 2023 and 2022, 3,080,029 shares vested having a fair value of $256 million; 2,985,299 shares vested having a fair value of $147 million, and 3,084,926 shares vested having a fair value of $123 million, respectively. At December 31, 2024, unrecognized compensation expense related to the awards was $183 million, which will be recognized over the remaining weighted average vesting period of 1.22 years.

2010 and 2021 Savings-related Share Option Schemes

In April 2021, shareholders approved the adoption of the 2021 Savings-related Share Option Schemes (Share Option Schemes), which replaced the schemes approved by shareholders in May 2010. The number of shares authorized under the Share Option Schemes during the years ended December 31, 2024, 2023 and 2022 did not exceed 10% of the issued share capital at that time.

Under the Share Option Schemes, participants may save up to €500/Stg£500 per month from their net salaries, for a fixed term of three or five years (the savings period). Within a period of six months after the end of the savings period, they have the option to buy shares of the Company at a discount of up to 15% of the market price on the date of invitation of each savings contract.

Under the Share Options Schemes, 236,581, 86,520 and 402,645 shares of the Company were purchased at a weighted average price of $28.68, $26.82 and $25.24 respectively, during the years ended December 31, 2024, 2023, and 2022. At December 31, 2024, the total unrecognized stock-based compensation expense related to the Share Option Schemes was $1 million and is expected to be recognized over a weighted average period of 1.13 years.

The fair values assigned to options issued under the Share Option Schemes were calculated in accordance with the trinomial valuation methodology.

CRH Form 10-K 85

The assumptions used to determine the fair value of the options issued under the Share Options Schemes with three-year and five-year savings periods at December 31 were:

	3-year	5-year
Risk-free interest rate (%)	2.08	2.24
Expected dividend payments over the expected life ()	4.06	7.05
Expected volatility (%)	26.4	24.2
Expected life term (years)	3	5

All values are in Euros.

There were no options granted during the years ended December 31, 2024, and 2023. The expected volatility was determined using a historical sample of 37 month-end Company share prices in respect of the three-year savings-related share options and 61 month-end share prices in respect of the five-year savings-related share options. The expected lives of the options are based on historical data and are therefore not necessarily indicative of exercise patterns that may materialize.

Other than the assumptions listed above, no other features of options grants were factored into the determination of fair value.

The terms of the options issued under the Share Option Schemes do not contain any market conditions.

18. Shareholders' equity

The Company’s capital stock consists of common stock, 5% preferred stock and 7% ‘A’ preferred stock. Holders of the Company’s common stock are entitled to one vote per share.

The holders of the 5% preferred stock are entitled to a fixed preferred dividend at a rate of 5% per annum and priority in a winding-up to repayment of capital but have no further right to participate in profits or assets and are not entitled to be present or vote at general meetings unless their dividend is in arrears. Dividends on the 5% preferred stock are payable half-yearly on April 15 and October 15 in each year. The 5% preferred stock represent 0.03% and 0.03% of the total issued share capital at December 31, 2024, and 2023, respectively.

The holders of the 7% ‘A’ preferred stock are entitled to a fixed preferred dividend at a rate of 7% per annum, and subject to the rights of the holders of the 5% preferred stock, priority in a winding-up to repayment of capital, but have no further right to participate in profits or assets and are not entitled to be present or vote at general meetings unless their dividend is in arrears or unless the business of the meeting includes certain matters. Dividends on the 7% ‘A’ preferred stock are payable half-yearly on April 5 and October 5 in each year. The 7% ‘A’ preferred stock represent 0.48% and 0.47% of the total issued share capital at December 31, 2024 and 2023, respectively.

For the years ended December 31, 2024, 2023, and 2022, dividends declared on 5% preferred stock and 7% ‘A’ preferred stock were all less than $1 million, respectively.

During 2024 and 2023, a total of 15,872,321 and 54,900,928 shares of Common stock (equivalent to 2.21% and 7.47% of the Company’s issued share capital) were repurchased at an average price of $82.01 and $54.92 per share under the share buyback program, respectively. During 2024, all repurchased shares of Common stock were retired on repurchase. During 2023, 17,620,740 shares of Treasury stock (equivalent to 2.40% of the Company’s issued share capital) were retired.

At December 31, 2024 and 2023, 41,355,384 and 42,419,281 shares were held as Treasury stock, equivalent to 5.75% and 5.78% of the Common stock issued, respectively.

CRH Form 10-K 86

19. Accumulated other comprehensive loss

The changes in the balances for each component of Accumulated other comprehensive loss, net of tax, for the years ended December 31 were:

in $ millions	Currency Translation	Cash Flow<br>Hedges	Pension and Other Postretirement Plans	Total
Balance at December 31, 2021	(127)	18	(316)	(425)
Other comprehensive (loss) income before reclassifications	(664)	23	288	(353)
Amounts reclassified from Accumulated other comprehensive loss (i)	(1)	(60)	6	(55)
Net current-period other comprehensive (loss) income	(665)	(37)	294	(408)
Other comprehensive loss attributable to noncontrolling interests	46	–	–	46
Balance at December 31, 2022	(746)	(19)	(22)	(787)
Other comprehensive income (loss) before reclassifications	310	(37)	(104)	169
Amounts reclassified from Accumulated other comprehensive loss (i)	–	9	(4)	5
Net current-period other comprehensive income (loss)	310	(28)	(108)	174
Other comprehensive (income) attributable to noncontrolling interests	(3)	–	–	(3)
Balance at December 31, 2023	(439)	(47)	(130)	(616)
Other comprehensive (loss) income before reclassifications	(431)	(27)	39	(419)
Amounts reclassified from Accumulated other comprehensive loss (i)	(39)	11	5	(23)
Net current-period other comprehensive (loss) income	(470)	(16)	44	(442)
Other comprehensive loss attributable to noncontrolling interests	53	–	–	53
Balance at December 31, 2024	(856)	(63)	(86)	(1,005)

(i)    For the years ended December 31, 2024, 2023, and 2022, $(39) million, $nil million, and $4 million respectively were transferred from currency translation related to (losses) gains on divestitures that were reclassified from Accumulated other comprehensive loss to Other nonoperating income (expense), net. For the year ended December 31, 2022, $(5) million was transferred from currency translation related to losses on divestitures that were reclassified from Accumulated other comprehensive loss to Income from discontinued operations, net of income tax expense.

The amounts reclassified from Accumulated other comprehensive loss to income for the years ended December 31 were:

in $ millions	2024	2023	2022
Cash flow hedges
Cost of product revenues	14	12	(73)
Income tax (benefit) expense	(3)	(3)	13
Total	11	9	(60)
Pension and other postretirement plans
Other nonoperating expense (income), net	9	(7)	8
Income tax (benefit) expense	(4)	3	(2)
Total	5	(4)	6
Reclassifications from Accumulated other comprehensive loss to income	16	5	(54)

20. Segment information

During the fourth quarter of 2024, the Company's reportable segments changed to the following three segments:

Americas Materials Solutions;

Americas Building Solutions; and

International Solutions

The Americas Materials Solutions segment provides building materials for the construction and maintenance of public infrastructure and commercial and residential buildings in North America. The primary materials produced by this segment include aggregates, cement, readymixed concrete and asphalt. This segment also provides paving and construction services for customers.

The Americas Building Solutions segment manufactures, supplies and delivers solutions for the built environment in communities across North America. Our subsidiaries within this segment offer building and infrastructure solutions serving complex critical infrastructure (such as water, energy, transportation and telecommunications projects) and outdoor living solutions for enhancing private and public spaces.

The International Solutions segment provides integrated building solutions primarily across Europe and Australia. The business integrates materials, products, and services to provide complete building solutions for use in the construction and renovation of public infrastructure, critical networks, commercial and residential buildings and outdoor living spaces.

The new segment structure reflects the nature of the financial information reported to and assessed by the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, who are together determined to fulfil the role of CODM. Comparative segment information for 2023 and 2022 has been recast to reflect the change in segments.

The principal factors employed in the identification of the three segments reflected in this note include:

CRH Form 10-K 87

(i)     the Company’s organizational structure in 2024 (during 2024 the Divisional President fulfilled the role of “segment manager”);

(ii)     the nature of the reporting lines to the CODM; and

(iii)     the structure of internal reporting documentation such as management accounts and budgets.

The Company’s reportable segments are the same as the Company’s operating segments and correspond with how the CODM regularly reviews financial information to allocate resources and assess performance under the Company’s organizational structure.

The CODM uses Adjusted EBITDA as part of their review of the monthly operating results on a segment basis. The CODM considers actual monthly results against the budget and the prior year as part of their assessment of the performance of the business and when making decisions regarding resource allocation. Given that Interest expense and Income tax expense are managed on a centralized basis, these items are not allocated between operating segments for the purposes of the information presented to the CODM and are accordingly omitted from the detailed segmental analysis below. There are no asymmetrical allocations to reporting segments which would require disclosure.

Adjusted EBITDA is defined as earnings from continuing operations before interest, taxes, depreciation, depletion, amortization, loss on impairments, gain/loss on divestitures and unrealized gain/loss on investments, income/loss from equity method investments, substantial acquisition-related costs and pension expense/income excluding current service cost component.

The key performance measures and segment expenses for the Company’s reportable segments for the years ended December 31 were:

	2024
in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Revenue	16,173	7,059	12,340	35,572
Less:
Labor	3,493	1,447	2,389	7,329
Energy costs	743	121	983	1,847
Other segment items (i)	8,192	4,102	7,172	19,466
Adjusted EBITDA	3,745	1,389	1,796	6,930
	2023
---	---	---	---	---
in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Revenue	15,435	7,017	12,497	34,949
Less:
Labor	3,274	1,306	2,264	6,844
Energy costs	805	122	1,314	2,241
Other segment items (i)	8,297	4,147	7,244	19,688
Adjusted EBITDA	3,059	1,442	1,675	6,176
	2022
---	---	---	---	---
in $ millions	Americas Materials Solutions	Americas Building Solutions	International Solutions	Total
Revenue	14,324	6,188	12,211	32,723
Less:
Labor	3,009	1,097	2,119	6,225
Energy costs	877	121	1,267	2,265
Other segment items (i)	7,800	3,751	7,294	18,845
Adjusted EBITDA	2,638	1,219	1,531	5,388

(i)    The nature of other segment items is similar for each segment and primarily includes raw materials, haulage costs, subcontractor costs and other Selling, general and administrative expenses. As a result of our integrated building solutions model, the composition of other segment items is such that at a segment level none of these items is individually significant in determining segment performance.

CRH Form 10-K 88

in $ millions	2024	2023	2022
Adjusted EBITDA	6,930	6,176	5,388
Depreciation, depletion and amortization	(1,798)	(1,633)	(1,552)
Loss on impairments (i)	(161)	(357)	–
Interest income	143	206	65
Interest expense	(612)	(376)	(344)
Gain (loss) on divestitures and unrealized gains on investments (ii)	250	–	(99)
Pension income excluding current service cost component (ii)	7	3	30
Other interest, net (ii)	1	(5)	–
Substantial acquisition-related costs	(46)	–	(27)
Income from continuing operations before income tax expense and income from equity method investments	4,714	4,014	3,461

(i)    The total Loss on impairments comprised of $161 million and $295 million within International Solutions for the years ended December 31, 2024 and 2023, respectively and $62 million within Americas Materials Solutions for the year ended December 31, 2023.

(ii)    Gain (loss) on divestitures and unrealized gains on investments, pension income excluding current service cost component and other interest, net have been included in Other nonoperating income (expense), net in the Consolidated Statements of Income.

Depreciation, depletion and amortization for each of the segments for the years ended December 31 were:

in $ millions	2024	2023	2022
Depreciation, depletion and amortization
Americas Materials Solutions	846	781	777
Americas Building Solutions	337	299	236
International Solutions	615	553	539
Total depreciation, depletion and amortization	1,798	1,633	1,552

The Gain (loss) on divestitures and unrealized gains on investments for each of the segments for the years ended December 31 were:

in $ millions	2024	2023	2022
Gain (loss) on divestitures and unrealized gains on investments
Americas Building Solutions	1	–	–
International Solutions	249	–	(99)
Total gain (loss) on divestitures and unrealized gains on investments	250	–	(99)

The segment assets at December 31 were:

in $ millions	2024	2023	2022
Assets
Americas Materials Solutions	21,474	17,534	17,615
Americas Building Solutions	9,049	7,961	7,749
International Solutions	15,011	13,373	13,140
Total assets for reportable segments	45,534	38,868	38,504
Cash and cash equivalents	3,720	6,341	5,936
Restricted cash	39	–	–
Other current assets, excluding segment assets	446	193	134
Equity method investments	737	620	649
Assets held for sale	–	1,268	–
Other noncurrent assets, excluding segment assets	137	179	96
Total assets as reported in the Consolidated Balance Sheets	50,613	47,469	45,319

CRH Form 10-K 89

The segment liabilities at December 31 were:

in $ millions	2024	2023	2022
Liabilities
Americas Materials Solutions	3,154	3,349	2,908
Americas Building Solutions	1,769	1,770	1,567
International Solutions	4,848	5,050	4,408
Total liabilities for reportable segments	9,771	10,169	8,883
Other current liabilities, excluding segment liabilities	163	156	193
Total debt	13,968	11,642	9,636
Deferred income tax liabilities	3,105	2,738	2,885
Liabilities held for sale	–	375	–
Other noncurrent liabilities, excluding segment liabilities	756	768	682
Total liabilities as reported in the Consolidated Balance Sheets	27,763	25,848	22,279

Additions to property, plant and equipment and intangible assets for each of the segments for the years ended December 31 were:

in $ millions	2024	2023	2022
Property, plant and equipment and intangible asset additions (i)
Americas Materials Solutions	1,151	854	715
Americas Building Solutions	480	360	259
International Solutions	1,074	664	559
Total property, plant and equipment and intangible asset additions	2,705	1,878	1,533

(i)     Property, plant and equipment and intangible asset additions exclude asset retirement cost additions.

Long-lived assets by geographic area at December 31 were:

in $ millions	2024	2023	2022
Long-lived assets by geographical area (i)
United Kingdom	1,819	1,786	1,691
United States	13,504	10,821	10,916
Other	7,403	6,526	6,336
Total long-lived assets by geographical area	22,726	19,133	18,943

(i)     Long-lived assets comprise property, plant and equipment and operating lease right-of-use assets.

Information about major customers

There are no material dependencies or concentrations of individual customers that require disclosure. The individual entities within the Company have a large number of customers spread across various activities, end-users and geographies.

21. Pension and other postretirement benefits

The Company operates either defined benefit or defined contribution pension schemes in all of its principal operating areas. The disclosures included below relate to all pension schemes in the Company. The Company operates defined benefit pension schemes in Australia, Belgium, Canada, France, Germany, Italy, the Netherlands, the Philippines, the Republic of Ireland, Romania, Serbia, Slovakia, Switzerland, the United Kingdom, the United States and Ukraine. The Company has a mixture of funded and unfunded defined benefit pension schemes. The net surplus of the funded schemes was $290 million and $218 million at December 31, 2024, and December 31, 2023, respectively. Unfunded obligations (including jubilee, postretirement healthcare obligations and long-term service commitments) comprise of a number of schemes in Canada, France, Germany, Ireland, Italy, the Netherlands, the Philippines, Romania, Serbia, Slovakia, Switzerland, the United States and Ukraine totaling a net liability of $235 million and $260 million at December 31, 2024, and December 31, 2023, respectively.

Funded defined benefit schemes in Australia, the Republic of Ireland, Switzerland and the United Kingdom are administered by separate funds that are legally distinct from the Company under the jurisdiction of Trustees. The Trustees are required by law to act in the best interests of the scheme participants and are responsible for the definition of investment strategy and for scheme administration. Other schemes are also administered in line with the local regulatory environment. The level of benefits available to most members depends on length of service and either their average salary over their period of employment or their salary in the final years leading up to retirement. For Switzerland, the level of benefits depends on salary, level of savings contributions, the interest rate on old age accounts (which cannot be negative) and the annuity conversion factor on retirement. The Company’s pension schemes in Switzerland are contribution-based schemes with guarantees. This means the Company pays an age-dependent fixed contribution percentage but should the invested assets be insufficient to meet the guaranteed benefit obligations, additional contributions might be required.

CRH Form 10-K 90

The change in benefit obligation, change in plan assets, funded status of pension and other postretirement benefit (OPEB) plans, and amounts recognized in the Consolidated Balance Sheets were:

	Pension Plans				OPEB Plans (i)
	2024		2023		2024	2023
in $ millions	U.S.	Non-U.S.	U.S.	Non-U.S.
Change in benefit obligation:
Benefit obligation at beginning of year	496	2,414	497	2,105	105	100
Service cost	2	39	1	31	3	2
Interest cost	24	81	24	86	5	5
Amendments	–	–	–	(1)	–	–
Actuarial (gains) and losses	(24)	(28)	9	178	(10)	3
Benefits paid	(34)	(104)	(35)	(89)	(5)	(5)
Plan participant contributions	–	10	–	9	–	–
Curtailments	–	(4)	–	–	–	–
Settlements	–	(7)	–	(4)	–	–
Net transfer in/(out) (including the effect of any business combinations/divestitures)	–	27	–	–	(1)	–
Foreign currency rate changes	–	(145)	–	99	(2)	–
Benefit obligation at end of year	464	2,283	496	2,414	95	105
Change in plan assets
Fair value of plan assets at beginning of year	449	2,524	446	2,316	–	–
Actual gain on plan assets	17	77	37	143	–	–
Employer contributions	2	36	1	38	5	5
Plan participant contributions	–	10	–	9	–	–
Benefits paid	(34)	(104)	(35)	(89)	(5)	(5)
Settlements	–	(7)	–	(4)	–	–
Net transfer in (including effect of any business combinations/divestitures)	–	82	–	–	–	–
Foreign currency rate changes	–	(155)	–	111	–	–
Fair value of plan assets at end of year	434	2,463	449	2,524	–	–
Reconciliation of funded status:
Fair value of plan assets	434	2,463	449	2,524	–	–
Benefit obligation	464	2,283	496	2,414	95	105
Funded status	(30)	180	(47)	110	(95)	(105)
Accumulated Benefit Obligation	464	2,231	496	2,349
Amounts recognized in the Consolidated Balance Sheets:
Noncurrent assets	–	290	–	271	–	–
Current liabilities	(2)	(4)	(2)	(4)	(6)	(6)
Noncurrent liabilities	(28)	(106)	(45)	(111)	(89)	(98)
Liabilities held for sale	–	–	–	(46)	–	(1)
Funded status at end of year	(30)	180	(47)	110	(95)	(105)
Net actuarial (loss) gain	(45)	(190)	(68)	(225)	42	35
Prior service (cost) credit	(1)	74	(1)	92	2	3
Total accumulated other comprehensive (loss) income	(46)	(116)	(69)	(133)	44	38

(i)    Includes a benefit obligation of $8 million and $11 million related to non-U.S. OPEB plans at December 31, 2024 and 2023, respectively.

CRH Form 10-K 91

The pension and other postretirement plans for which their accumulated benefit obligation, projected benefit obligation or accumulated postretirement benefit obligation exceeds the fair value of their respective plan assets at December 31 were:

	U.S. Plans		Non-U.S. Plans
in $ millions	2024	2023	2024	2023
Pension plans with projected benefit obligations in excess of plan assets:
Projected benefit obligation	464	496	565	580
Fair value of plan assets	434	449	458	421
Pension plans with accumulated benefit obligations in excess of plan assets:
Accumulated benefit obligation	464	496	147	527
Fair value of plan assets	434	449	61	394
Other postretirement plans with accumulated postretirement benefit obligations in excess of plan assets:
Accumulated postretirement benefit obligation	–	–	6	9
Fair value of plan assets	–	–	–	–

Impact on Consolidated Statements of Income

The total retirement benefit expense recognized in the Consolidated Statements of Income for the years ended December 31 were:

in $ millions	2024	2023	2022
Total defined contribution expense	345	320	307
Total defined benefit expense	34	31	30
Total expense within the Consolidated Statements of Income	379	351	337

Components of Net Periodic Benefit Cost (Income)

The components of net periodic benefit cost (income) recognized in the Consolidated Statements of Income for the years ended December 31 were:

	Pension Plans						OPEB Plans (ii)
	U.S.			Non-U.S.
in $ millions	2024	2023	2022	2024	2023	2022	2024	2023	2022
Service cost	2	1	2	39	31	55	3	2	3
Interest cost	24	24	18	81	86	43	5	5	3
Expected return on assets	(21)	(20)	(30)	(87)	(91)	(72)	–	–	–
Amortization of:
Prior service cost (credit)	–	–	1	(12)	(11)	(11)	–	–	–
Actuarial loss (gain)	2	3	2	6	4	15	(2)	(3)	–
Curtailment loss (gain)	–	–	3	(3)	–	–	–	(1)	–
Settlement (gain) loss (i)	–	–	–	(3)	1	(2)	–	–	–
Net periodic benefit cost (income) (iii)	7	8	(4)	21	20	28	6	3	6

(i)    Settlement gain of $3 million relates to pension plans divested as part of the sale of the Company's Lime operations in Europe and is included in gain on divestitures, within Other nonoperating income (expense), net.

(ii)    Includes the net periodic benefit cost of $nil million, $nil million and $1 million related to non-U.S. OPEB plans for the years ended December 31, 2024, 2023, and 2022 respectively.

(iii)    Service cost is included within Cost of revenues and Selling, general and administrative expenses while all other cost components are recorded within Other nonoperating income (expense), net.

CRH Form 10-K 92

The changes in plan assets and benefit obligations that were recognized in Other comprehensive (income) loss for the years ended December 31 were:

	Pension Plans						OPEB Plans (i)
	U.S.			Non-U.S.
in $ millions	2024	2023	2022	2024	2023	2022	2024	2023	2022
Net actuarial (gain) loss	(20)	(8)	(1)	(17)	126	(292)	(10)	3	(32)
Prior service cost (credit)	–	–	2	–	(1)	(2)	–	–	–
Amortization or curtailment recognition of prior service (cost) credit	–	–	(4)	12	11	11	–	–	–
Amortization or settlement recognition of net (loss) gain	(2)	(3)	(2)	(5)	(4)	(13)	2	3	–
Foreign currency exchange effects	–	–	–	(4)	(2)	(27)	–	–	–
Amount recognized in other comprehensive (income) loss (i)	(22)	(11)	(5)	(14)	130	(323)	(8)	6	(32)
Amount recognized in net periodic pension benefit cost (income) and other comprehensive (income) loss	(15)	(3)	(9)	3	150	(295)	(2)	9	(26)

(i)    Includes an amount recognized in Other comprehensive (income) loss of $nil million, $1 million and $(2) million related to non-U.S. OPEB plans for the years ended December 31, 2024, 2023, and 2022, respectively.

The weighted average assumptions used to determine net periodic benefit cost (income) for the years ended December 31 were:

	Pension Plans												OPEB Plans
	U.S.						Non-U.S.
	2024		2023		2022		2024		2023		2022		2024		2023		2022
Discount rate	4.95	%	5.20	%	2.70	%	3.49	%	4.13	%	1.54	%	4.86	%	5.08	%	2.59	%
Rate of compensation increase	N/A		N/A		3.50	%	3.22	%	3.22	%	2.74	%	2.75	%	2.80	%	2.22	%
Expected long‐term rate of return on plan assets	5.50	%	5.50	%	5.50	%	3.62	%	4.04	%	2.54	%	N/A		N/A		N/A
Interest crediting rates	N/A		N/A		N/A		1.60	%	1.50	%	2.25	%	N/A		N/A		N/A

The weighted average assumptions used to determine the benefit obligation at December 31 were:

	Pension Plans								OPEB Plans
	U.S.				Non-U.S.
	2024		2023		2024		2023		2024		2023
Discount rate	5.55	%	4.95	%	3.41	%	3.49	%	5.34	%	4.86	%
Rate of compensation increase	N/A		N/A		2.88	%	3.22	%	2.33	%	2.75	%

The long-term return expectation is developed based on a diversified investment strategy that takes into account historical experience, as well as the impact of portfolio diversification, active portfolio management, and the Company’s view of current and future economic and financial market conditions. In determining the expected rate of return for the plan assets, the Company performs an analysis of investment community forecasts and current market conditions to develop expected returns for each of the asset classes used by the plans, which are weighted to reflect the asset allocation of each plan. As market conditions and other factors change, the Company may adjust targets accordingly, and asset allocations may vary from the target allocations.

The assets of the Company’s pension and other postretirement plans are managed externally for the benefit of the plan members. Consideration is given to the long-term nature of the benefit obligations and the investment strategy is set at plan level, typically to maintain a diversified portfolio of assets with the objective of meeting future obligations and long-term cash requirements as they fall due. Assets are primarily invested in diversified funds that hold equity and debt securities to maintain security while maximizing returns within each plan’s investment policy. The investment policy for each plan specifies the type of investment vehicle, asset allocation guidelines as well as investment monitoring and performance requirements. For the main funded plans, the target allocations to equity/debt are as follows:

(i)    Ireland: Equities 10-20% / Debt 55-65%.

(ii)    U.S.: Equities 10-30% / Debt 65-85%.

(iii)    Switzerland: Equities 25-35% / Debt 25-55%.

(iv)    Other asset classes have a range of smaller % targets.

CRH Form 10-K 93

The target allocation ranges and fair values by asset class at December 31 were:

	Pension Plans
	Target allocation ranges
	U.S. Plans	Non-U.S. Plans
	2024 (%)
Cash and cash equivalents	–	0-5
Equity instruments (i)	10-30	15-25
Debt instruments (ii)	65-85	25-40
Real estate	–	5-10
Derivatives	–	–
Investment funds	0-15	0-5
Assets held by insurance company	–	0-5
Other	–	–

(i)     For U.S. pension plans, equity instruments with a total allocation range of 10-30% are made up of 10-30% in developed markets’ diversified equity instruments and 10-30% in emerging markets’ diversified equity instruments. For non-U.S. pension plans, equity instruments with a total allocation range of 15-25% are made up of 16-24% in developed markets’ diversified equity instruments and 1-2% in emerging markets’ diversified equity instruments.

(ii)    For U.S. pension plans, debt instruments with a total allocation range of 65-85% are made up of 65-85% in non-government debt instruments and 65-85% in government fixed interest instruments. For non-U.S. pension plans, debt instruments with a total allocation range of 25-40% are made up of 24-35% in non-government debt instruments, 32-44% in government fixed interest instruments, 23-31% in government inflation-protected bonds, 9-16% in asset-backed instruments, 9-16% in inflation-protected bonds and 9-16% in structured debt.

The Company’s asset allocations by asset category at December 31 were:

	Pension Plans
	Fair Values
	2024
	U.S. Plans				Non-U.S. Plans
in $ millions	Level 1	Level 2	Level 3	Total	Level 1	Level 2	Level 3	Total
Cash and cash equivalents	3	–	–	3	32	22	–	54
Equity instruments (i)	–	87	–	87	499	59	–	558
Debt instruments (ii)	–	326	–	326	1,226	211	–	1,437
Real estate	–	–	–	–	111	81	8	200
Derivatives	–	–	–	–	8	(23)	–	(15)
Investment funds	16	–	–	16	87	21	–	108
Assets held by insurance company	–	–	–	–	–	2	105	107
Other	–	–	2	2	3	3	8	14
Total	19	413	2	434	1,966	376	121	2,463

(i)    For U.S. pension plans, equity instruments of $87 million are made up of $78 million in developed markets’ diversified equity instruments and $9 million in emerging markets’ diversified equity instruments. For non-U.S. pension plans, equity instruments of $558 million are made up of $521 million in developed markets’ diversified equity instruments and $37 million in emerging markets’ diversified equity instruments.

(ii)    For U.S. pension plans, debt instruments of $326 million are made up of $226 million in non-government debt instruments and $100 million in government fixed interest instruments. For non-U.S. pension plans, debt instruments of $1,437 million are made up of $245 million in non-government debt instruments, $721 million in government fixed interest instruments, $434 million in government inflation-protected bonds and $37 million in asset-backed instruments.

There were no other postretirement plan assets at December 31, 2024.

CRH Form 10-K 94

	Pension Plans
	Fair Values
	2023
	U.S. Plans				Non-U.S. Plans
in $ millions	Level 1	Level 2	Level 3	Total	Level 1	Level 2	Level 3	Total
Cash and cash equivalents	3	–	–	3	50	15	–	65
Equity instruments (i)	–	90	–	90	462	56	–	518
Debt instruments (ii)	–	341	–	341	1,310	179	–	1,489
Real estate	–	–	–	–	97	82	14	193
Derivatives	–	–	–	–	12	2	–	14
Investment funds	11	–	–	11	85	13	–	98
Assets held by insurance company	–	–	–	–	–	2	117	119
Other	–	–	4	4	1	19	8	28
Total	14	431	4	449	2,017	368	139	2,524

(i)     For U.S. pension plans, equity instruments of $90 million are made up of $79 million in developed markets’ diversified equity instruments and $11 million in emerging markets’ diversified equity instruments. For non-U.S. pension plans, equity instruments of $518 million are made up of $486 million in developed markets’ diversified equity instruments and $32 million in emerging markets’ diversified equity instruments.

(ii)    For U.S. pension plans, debt instruments of $341 million are made up of $233 million in non-government debt instruments and $108 million in government fixed interest instruments. For non-U.S. pension plans, debt instruments of $1,489 million are made up of $251 million in non-government debt instruments, $400 million in government fixed interest instruments, $763 million in government inflation-protected bonds, $34 million in asset-backed instruments and $41 million in inflation-protected bonds.

There were no other postretirement plan assets at December 31, 2023.

The Level 3 reconciliation for pension plans by asset class for the years ended December 31, 2024 and 2023 were:

	U.S. Plans
in $ millions	Beginning balance on 1/1/2024	Actual return on plan assets, relating to assets still held at reporting date	Purchases, sales and settlements	Transfer out of Level 3	Change due to exchange rate changes	Ending balance on 12/31/2024
Asset Class
Other	4	–	–	(2)	–	2
Total	4	–	–	(2)	–	2
	Non-U.S. Plans
---	---	---	---	---	---	---
in $ millions	Beginning balance on 1/1/2024	Actual return on plan assets, relating to assets still held at reporting date	Purchases, sales and settlements	Transfer out of Level 3	Change due to exchange rate changes	Ending balance on 12/31/2024
Asset Class
Real estate	14	–	(6)	–	–	8
Assets held by insurance company	117	6	(9)	–	(9)	105
Other	8	–	–	–	–	8
Total	139	6	(15)	–	(9)	121
	U.S. Plans
---	---	---	---
in $ millions	Beginning balance on 1/1/2023	Actual return on plan assets, relating to assets still held at reporting date	Purchases, sales and settlements	Transfer (out of) Level 3	Ending balance on 12/31/2023
Asset Class
Investment funds	11	–	–	(11)	–
Other	8	1	(1)	(4)	4
Total	19	1	(1)	(15)	4

CRH Form 10-K 95

	Non-U.S. Plans
in $ millions	Beginning balance on 1/1/2023	Actual return on plan assets, relating to assets still held at reporting date	Purchases, sales and settlements	Change due to exchange rate changes	Ending balance on 12/31/2023
Asset Class
Real estate	13	–	–	1	14
Assets held by insurance company	113	11	(10)	3	117
Other	6	2	–	–	8
Total	132	13	(10)	4	139

The following is a description of the methods and assumptions used to estimate the fair value of the pension and other postretirement plans’ assets:

Cash and cash equivalents: Cash and all highly liquid securities with original maturities of three months or less are classified as Cash and cash equivalents, primarily consisting of cash deposits in interest bearing accounts, time deposits and money market funds. These assets are classified as Level 1.

Equity instruments: Individual securities that are valued at the closing price or last trade reported on the major market on which they are traded are classed as Level 1. Commingled funds that are publicly traded are based upon market quotes and are classed as Level 1. The fair value of non-publicly traded funds are determined using the Net Asset Value (NAV) provided by the administrator and are classified as Level 2.

Debt instruments: The fair value is determined using market prices (Level 1) or prices derived from observable inputs (Level 2). Level 2 investments may also include commingled funds that have a readily determinable fair value based on observable prices of the underlying securities.

Real estate: Investments in real estate funds that are publicly traded are based upon market quotes and are classed as Level 1. Direct investments in real estate are classed as Level 2 and determined using the NAV provided by the administrator.

Assets held by insurance company: The fair value is based on negotiated value and the underlying investments held in separate account portfolios, as well as the consideration of the creditworthiness of the issuer. The underlying investments are primarily government, asset-backed and fixed income securities. Assets held by insurance company are generally classified as Level 2 or Level 3 depending on the structure of the contract/market pricing information.

The assumed healthcare cost trend rates at December 31 were:

	2024		2023		2022
Healthcare cost trend rate assumed for next year	6.55	%	6.85	%	1.76	%
Rate to which the cost trend rate gradually declines	3.80	%	3.70	%	3.70	%
Year the rate reaches the ultimate rate	2090		2090		2090

The following table presents the expected future benefit payments to be made over the next 10 years:

	Pension plans		OPEB
in $ millions	U.S.	Non-U.S.
2025	37	117	6
2026	37	115	6
2027	37	116	6
2028	37	114	6
2029	36	115	6
2030-2034	175	593	32

The Company expects that it will contribute $2 million to the U.S. pension plans, $36 million to the non-U.S. pension plans and $6 million to the OPEB plans, including minimum funding payments, in 2025.

CRH Form 10-K 96

22. Variable interest entities

The Company’s operations in the Philippines are conducted through a Variable Interest Entity (VIE), wherein the Company holds 40% of the equity share capital and a 55% share of earnings and distributions. The remaining noncontrolling interest of 60% equity share capital and 45% share of earnings and distributions is held by an unrelated party. The Company’s voting rights are not proportional to its share of earnings and distributions, and substantially all of the activities of the Philippines business are conducted on behalf of the Company and controlled by the Company through contractual relationships. The Philippines business meets the definition of a VIE for which the Company is the primary beneficiary and, therefore, is consolidated.

Further, the Company has provided subordinated debt to the intermediate parent of the Philippines business which exposes the Company to the profits and losses of the Philippines business. The debt is repayable only where the shareholder agreement of the intermediate parent of the Philippines business is terminated or where the Company transfers its shares in the intermediate parent to an unrelated entity (i.e. the debt exposure of the Company becomes in substance a residual interest in the intermediate parent).

The carrying amounts of assets and liabilities of the consolidated VIE, reported within the Consolidated Balance Sheets before intragroup eliminations with other CRH companies at December 31 were:

in $ millions	2024	2023
Assets
Current assets:
Cash and cash equivalents	21	19
Accounts receivable, net	38	31
Inventories	96	99
Other current assets	58	51
Total current assets	213	200
Property, plant and equipment, net	846	923
Goodwill	190	200
Intangible assets, net	1	–
Operating lease right-of-use assets, net	5	5
Other noncurrent assets	9	11
Total assets	1,264	1,339
Liabilities
Current liabilities:
Accounts payable	106	92
Accrued expenses	44	36
Current portion of long-term debt	33	98
Operating lease liabilities	1	1
Other current liabilities	25	25
Total current liabilities	209	252
Long-term debt	345	297
Deferred income tax liabilities	94	106
Noncurrent operating lease liabilities	4	5
Other noncurrent liabilities	21	17
Total liabilities	673	677

The operating results of the consolidated VIE, reported within the Consolidated Statements of Income and Consolidated Statements of Cash Flows before intragroup eliminations with other CRH companies for the years ended December 31 were:

in $ millions	2024	2023	2022
Total revenues	359	446	544
Total cost of revenues	(339)	(416)	(479)
Gross profit	20	30	65
Net loss	(40)	(325)	(24)
Net cash provided by operating activities	10	24	12

CRH Form 10-K 97

23. Redeemable noncontrolling interests

The Redeemable noncontrolling interests primarily comprise of the noncontrolling interests in two of the Company’s North American subsidiaries, that are currently redeemable. The Company has the ability to exercise the call option for the noncontrolling interests on or after December 31, 2031. In addition to the call options, the noncontrolling interest holder has the right to sell the noncontrolling interests to the Company, which are currently exercisable. These noncontrolling interests have put and call options and both are redeemable based on multiples of EBITDA. The noncontrolling interests are considered redeemable noncontrolling equity interests, classified as temporary or mezzanine equity, as their redemption is not solely within the Company’s control. The noncontrolling interests were recorded at their respective fair values as of the acquisition dates and are adjusted to their expected redemption values, with an offsetting entry to retained earnings, as of the reporting date as if that date was the redemption date, if those amounts exceed their respective carrying values.

During the year ended December 31, 2024, the Company recognized an addition to redeemable noncontrolling interest, as reflected in Note 4, and adjusted the carrying amount of the redeemable noncontrolling interests to reflect the estimated redemption values as of the balance sheet date. The adjustment was based on the formulaic redemption values, with an offsetting entry to retained earnings.

The rollforward of Redeemable noncontrolling interests at December 31 was:

in millions
Balance at December 31, 2021
Net income attributable to redeemable noncontrolling interests
Adjustment to the redemption value
Dividends paid
Balance at December 31, 2022
Net income attributable to redeemable noncontrolling interests
Adjustment to the redemption value
Dividends paid
Balance at December 31, 2023
Net income attributable to redeemable noncontrolling interests
Acquisitions
Adjustment to the redemption value
Dividends paid
Balance at December 31, 2024

All values are in US Dollars.

24. Commitments and contingencies

Guarantees

The Company has given letters of guarantee to secure obligations of subsidiary undertakings as follows: $13.1 billion and $11.3 billion in respect of loans and borrowings, bank advances and derivative obligations at December 31, 2024, and 2023, respectively, and $0.4 billion and $0.4 billion at December 31, 2024, and 2023, respectively, in respect of letters of credit due within one year.

Contractual commitments

Contractual commitments at December 31, 2024, were:

in $ millions	Unconditional purchase obligations
2025	1,750
Thereafter	799
Total contractual commitments	2,549

Legal Proceedings

The Company is not involved in any proceedings that it believes could reasonably be expected to have a material adverse effect on the Company’s financial condition, results of operations or liquidity.

25. Subsequent events

The Company has evaluated subsequent events occurring through to the date the Consolidated Financial Statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the Consolidated Financial Statements except as noted below.

Issuance of Senior Notes

In January 2025, wholly-owned subsidiaries of the Company completed the issuance and sale of $1.25 billion 5.125% Guaranteed Notes due 2030, $1.25 billion 5.500% Guaranteed Notes due 2035, and $0.5 billion 5.875% Guaranteed Notes due 2055. The first three tranches of debt are fully and unconditionally guaranteed by the Company as to the principal, interest, premium, if any, and any other amounts payable in respect of them.

CRH Form 10-K 98

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Management’s Report on Internal Control over Financial Reporting

In accordance with the requirements of Rule 13a-15 of the Securities Exchange Act 1934, the following report is provided by management in respect of the Company’s internal control over financial reporting. As defined by the SEC, internal control over financial reporting is a process designed by, or under the supervision of, the Company’s principal executive and principal financial officers, or persons performing similar functions, and effected by the Board, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the Consolidated Financial Statements for external purposes in accordance with United States generally accepted accounting principles and includes those policies and procedures that:

•pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;

•provide reasonable assurance that transactions are recorded as necessary to permit preparation of the Consolidated Financial Statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

•provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the Consolidated Financial Statements.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our Company’s published Consolidated Financial Statements for external purposes under generally accepted accounting principles. In connection with the preparation of the Company’s annual Consolidated Financial Statements, management has undertaken an assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2024, based on criteria established in the Internal Control Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission.

As permitted by the SEC, the Company has elected following a qualitative and quantitative review to exclude an assessment of the internal controls of Adbri, one of the substantial acquisitions made during the year. The acquisition of Adbri represented 4.7% and 4.1% of net and total assets, respectively, and 1.7% of revenues. Its profit increased Company profit by less than 1.0% for the financial year ended December 31, 2024.

Management’s assessment included an evaluation of the design of the Company’s internal control over financial reporting and testing of the operational effectiveness of those controls. Based on this assessment, management has concluded and hereby reports that as of December 31, 2024, the Company’s internal control over financial reporting is effective. Our auditor, Deloitte Ireland LLP (PCAOB ID No. 1193), a registered public accounting firm, who have audited the Consolidated Financial Statements for the year ended December 31, 2024, have audited the effectiveness of the Company’s internal controls over financial reporting. Their report, on which an unqualified opinion is expressed thereon, is included below.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the fiscal quarter ended December 31, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Evaluation of Disclosure Controls and Procedures

Management has evaluated the effectiveness of the design and operation of the disclosure controls and procedures as defined in Securities Exchange Act Rule 13a-15(e) as of December 31, 2024. Based on that evaluation, the Chief Executive Officer and the Interim Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of such date at the level of providing reasonable assurance.

In designing and evaluating our disclosure controls and procedures, management, including the Chief Executive Officer and the Interim Chief Financial Officer, recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

Report of Independent Registered Public Accounting Firm

To the shareholders and the Board of Directors of CRH public limited company (CRH plc).

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of CRH plc and subsidiaries (the Company) as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2024, of the Company and our report dated February 26, 2025, expressed an unqualified opinion on those financial statements.

CRH Form 10-K 99

As described in Management’s Report on Internal Control over Financial Reporting, management excluded from its assessment the internal control over financial reporting at Adbri Limited, which was acquired on July 1, 2024, and whose financial statements constitute 4.7% and 4.1% of net and total assets, respectively, 1.7% of revenues, and its profit increased Company profit by less than 1.0% in the consolidated financial statement amounts as of and for the year ended December 31, 2024. Accordingly, our audit did not include the internal control over financial reporting at Adbri Limited.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying management’s report on internal control over financial reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Deloitte Ireland LLP

Dublin, Ireland

February 26, 2025

Item 9B. Other Information

During the three months ended December 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

CRH Form 10-K 100

Item 10. Directors, Executive Officers and Corporate Governance

The information required by this Item 10 will be included in the Proxy Statement and is incorporated herein by reference.

Item 11. Executive Compensation

The information required by this Item 11 will be included in the Proxy Statement and is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this Item 12 will be included in the Proxy Statement and is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information required by this Item 13 will be included in the Proxy Statement and is incorporated herein by reference.

Item 14. Principal Accountant Fees and Services

The information required by this Item 14 will be included in the Proxy Statement and is incorporated herein by reference.

CRH Form 10-K 101

Item 15. Exhibits and Financial Statement Schedules

1. Consolidated Financial Statements

The consolidated financial statements required to be filed in this Form 10-K are included in Part II, Item 8 hereof.

2. Exhibits

3.1	Memorandum and Articles of Association (incorporated by reference to Exhibit 99.1 to the current report on Form 6-K furnished September 25, 2023).
4.1	Indenture, dated as of March 20, 2002, among CRH America, Inc., CRH plc and The Bank of New York Mellon, as successor trustee to JPMorgan Chase Bank, N.A. (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form F-3 filed July 19, 2013).
4.2	Indenture, dated as of May 21, 2024, between CRH plc, CRH America Finance, Inc. and The Bank of New York Mellon (incorporated by reference to Exhibit 4.1 to the current report on Form 8-K filed May 21, 2024).
4.3	Indenture, dated as of May 21, 2024, between CRH plc, CRH SMW Finance DAC and The Bank of New York Mellon (incorporated by reference to Exhibit 4.2 to the current report on Form 8-K filed May 21, 2024).
4.4	Officer’s Certificate of CRH America, Inc. pursuant to Sections 102 and 301 of the Indenture, dated September 29, 2003, setting forth the terms of its 6.400% Notes due 2033 (incorporated by reference to Exhibit 2 to the Registration Statement on Form 8-A filed December 28, 2023).
4.5	Officer’s Certificate of CRH America Finance, Inc. and CRH plc pursuant to Sections 102 and 301 of the Indenture, dated May 2, 2024, setting forth the terms of the 5.400% Guaranteed Notes due May 21, 2034 (incorporated by reference to Exhibit 4.3 to the current report on Form 8-K filed May 21, 2024).
4.6	Officer’s Certificate of CRH SMW Finance DAC and CRH plc pursuant to Sections 102 and 301 of the Indenture, dated May 21, 2024, setting forth the terms of the 5.200% Guaranteed Notes due May 21, 2029 (incorporated by reference to Exhibit 4.4 to the current report on Form 8-K filed May 21, 2024).
4.7	Global Security for the 6.400% Notes due 2033 (incorporated by reference to Exhibit 3 to the Registration Statement on Form 8-A filed December 28, 2023).
4.8	Form of 5.400% Guaranteed Notes due May 21, 2034 (incorporated by reference to Exhibit 4.3 to the current report on Form 8-K filed May 21, 2024).
4.9	Form of 5.200% Guaranteed Notes due May 21, 2029 (incorporated by reference to Exhibit 4.4 to the current report on Form 8-K filed May 21, 2024).
4.10	Description of securities registered under Section 12 of the Exchange Act.
10.1	Multicurrency Facility Agreement, originally dated June 11, 2014, between CRH plc and National Westminster Bank plc (as Agent), as amended and restated by amendment and restatement agreements dated April 7, 2017, April 10, 2019, April 1, 2021 and May 11, 2023 (incorporated by reference to Exhibit 10.1 to the annual report on Form 10-K filed February 29, 2024).
10.2	Amendment and Restatement Agreement, dated May 11, 2023, between CRH plc, Bank of America Europe Designated Activity Company (as Retiring Agent), National Westminster Bank PLC (as Successor Agent) and others (incorporated by reference to Exhibit 10.2 to the annual report on Form 10-K filed February 29, 2024).
10.3*	Rules of the CRH 2021 Savings-Related Share Option Scheme – (Republic of Ireland) (incorporated by reference to Exhibit 4.2 to the registration statement on Form S-8 filed August 22, 2023).
10.4*	Rules of the CRH 2021 Savings-Related Share Option Scheme – (United Kingdom) (incorporated by reference to Exhibit 4.3 to the registration statement on Form S-8 filed August 22, 2023).
10.5*	Rules of the CRH plc 2014 Performance Share Plan (incorporated by reference to Exhibit 4.4 to the registration statement on Form S-8 filed August 22, 2023).
10.6*	Rules of the CRH plc 2014 Deferred Share Bonus Plan (incorporated by reference to Exhibit 10.6 to the quarterly report on Form 10-Q filed August 8, 2024).
10.7*	Rules of the CRH plc 2013 Restricted Share Plan (incorporated by reference to Exhibit 10.7 to the annual report on Form 10-K filed February 29, 2024).
10.8*	Rules of the CRH 2010 Savings-Related Share Option Scheme – (Republic of Ireland) (incorporated by reference to Exhibit 4.7 to the registration statement on Form S-8 filed August 22, 2023).
10.9*	Rules of the CRH 2010 Savings-Related Share Option Scheme – (United Kingdom) (incorporated by reference to Exhibit 4.8 to the registration statement on Form S-8 filed August 22, 2023).
10.10*	Trust Deed and Rules, dated September 6, 1990 of the Roadstone Limited Share Participation Scheme (incorporated by reference to Exhibit 4.9 to the registration statement on Form S-8 filed August 22, 2023).
10.11*	Deed of Amendment, dated November 17, 2009, to the Trust Deed and Rules of the Roadstone Limited Share Participation Scheme (incorporated by reference to Exhibit 4.10 to the registration statement on Form S-8 filed August 22, 2023).
10.12*	Deed of Amendment, dated March 7, 2016, to the Trust Deed and Rules of the Roadstone Limited Share Participation Scheme (incorporated by reference to Exhibit 4.11 to the registration statement on Form S-8 filed August 22, 2023).
10.13*	Trust Deed and Rules, dated December 18, 2019 of the CRH Finance DAC Share Participation Scheme (incorporated by reference to Exhibit 4.12 to the registration statement on Form S-8 filed August 22, 2023).
10.14*	Trust Deed and Rules, dated April 8, 1997 of the CRH Group Services Limited Share Participation Scheme (incorporated by reference to Exhibit 4.13 to the registration statement on Form S-8 filed August 22, 2023).

CRH Form 10-K 102

10.15*	Supplemental Deed, dated June 23, 1997, to the CRH Group Services Limited Share Participation Scheme (incorporated by reference to Exhibit 4.14 to the registration statement on Form S-8 filed August 22, 2023).
10.16*	Agreement, dated June 2, 1998, regarding amendments to the CRH Group Services Limited Share Participation Scheme (incorporated by reference to Exhibit 4.15 to the registration statement on Form S-8 filed August 22, 2023).
10.17*	Trust Deed and Rules, dated October 12, 1989, of the Irish Cement Limited Share Participation Scheme (incorporated by reference to Exhibit 4.16 to the registration statement on Form S-8 filed August 22, 2023).
10.18*	Trust Deed and Rules, dated September 17, 1990 of the Irish Shared Administration Centre Limited Share Participation Scheme (incorporated by reference to Exhibit 4.17 to the registration statement on Form S-8 filed August 22, 2023).
10.19*	Agreement, dated November 27, 1996, regarding amendments to the Irish Shared Administration Centre Limited Share Participation Scheme (incorporated by reference to Exhibit 4.18 to the registration statement on Form S-8 filed August 22, 2023).
10.20*	Deed of Amendment, dated November 18, 2009, to the Irish Shared Administration Centre Limited Share Participation Scheme (incorporated by reference to Exhibit 4.19 to the registration statement on Form S-8 filed August 22, 2023).
10.21*	Deed of Amendment, dated January 7, 2019, to the Irish Shared Administration Centre Limited Share Participation Scheme (incorporated by reference to Exhibit 4.20 to the registration statement on Form S-8 filed August 22, 2023).
10.22*	Trust Deed and Rules, dated October 26, 2018 of the Opterra Wössingen Share Participation Scheme (incorporated by reference to Exhibit 4.21 to the registration statement on Form S-8 filed August 22, 2023).
10.23*	Oldcastle Materials Inc., Retirement Savings Plan, as amended on December 21, 2009 (incorporated by reference to Exhibit 99.1 to the registration statement on Form S-8 filed April 2, 2010).
10.24*	Oldcastle Precast, Inc. Profit Sharing Retirement Plan and Trust, dated February 26, 1970, as amended on January 1, 2010 (incorporated by reference to Exhibit 99.2 to the registration statement on Form S-8 filed April 2, 2010).
10.25*^	Group Chief Executive Officer Service Agreement by and between CRH Group Services Limited and Albert Manifold, dated December 6, 2023.
10.26*^	Letter Agreement by and between CRH plc and Albert Manifold, dated September 23, 2024 (incorporated by referenceExhibit 10.1to the quarterly report on Form 10-Q filed November 7, 2024).
10.27*^	Chief Financial Officer Service Agreement by and between CRH Group Services Limited and Denis James Mintern, dated December 6, 2023.
10.28*^	Group Chief Executive Officer Service Agreement by and between CRH Group Management Limited and Denis James Mintern, dated December 20, 2024.
10.29*^	Employment Agreement by and between CRH Nederland B.V. and Mr. P.J. Buckley, dated February 20, 2024.
10.30*^	Employment Agreement by and between CRH Americas, Inc. and Nathan Creech, dated January 1, 2021.
10.31*^	Employment Agreement by and between CRH Americas, Inc. and Randall Lake, dated January 1, 2021.
19.1	Insider Trading Policy.
21.1	Principal Subsidiary Undertakings.
22.1	List of Guarantors and Subsidiary Issuers of Guaranteed Securities.
23.1	Consent of Independent Registered Public Accounting Firm - Deloitte Ireland LLP.
24.1	Power of Attorney (included on signature page).
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of Chief Executive Officer Pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Chief Financial Officer Pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
95.1	Disclosure of Mine Safety and Health Administration (MSHA) Safety Data.
97.1	Policy Relating to Recovery of Erroneously Awarded Compensation (incorporated by reference to Exhibit 97.1 to the annual report on Form 10-K filed February 29, 2024).
101	Inline eXtensible Business Reporting Language (XBRL).
104	Cover Page Interactive Data File (formatted in iXBRL in Exhibit 101).
*	Management compensation plan or arrangement.
**	Furnished herewith.
^	Certain information in this document has been redacted pursuant to Item 601(a)(6) of Regulation S-K because the disclosure of such information would warrant a clearly unwarranted invasion of personal privacy.

The total amount of long-term debt of the registrant and its subsidiaries authorized under any one instrument does not exceed 10% of the total assets of CRH plc and its subsidiaries on a consolidated basis. The Company agrees to furnish copies of any such instrument to the SEC upon request.

Item 16. Form 10–K Summary

We have chosen not to include an optional summary of the information required by this Annual Report on Form 10‐K.

CRH Form 10-K 103

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CRH public limited company

By /s/ Alan Connolly     Alan Connolly Interim Chief Financial Officer

February 26, 2025

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Alan Connolly and Jim Mintern, and each of them singly, as their true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for them and in their name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Signature	Title	Date
/s/ Richie Boucher<br><br>R. Boucher	(Chairman of the Board)	February 26, 2025
/s/ Jim Mintern<br><br>J. Mintern	(Chief Executive Officer and Director)	February 26, 2025
/s/ Alan Connolly<br><br>A. Connolly	(Interim Chief Financial Officer)	February 26, 2025
/s/ Lamar McKay<br><br>L. McKay	(Non-management Director)	February 26, 2025
/s/ Caroline Dowling<br><br>C. Dowling	(Non-management Director)	February 26, 2025
/s/ Johan Karlström<br><br>J. Karlström	(Non-management Director)	February 26, 2025
/s/ Shaun Kelly<br><br>S. Kelly	(Non-management Director)	February 26, 2025
/s/ Gillian L. Platt<br><br>G.L. Platt	(Non-management Director)	February 26, 2025
/s/ Mary K. Rhinehart<br><br>M.K. Rhinehart	(Non-management Director)	February 26, 2025
/s/ Badar Khan<br><br>B. Khan	(Non-management Director)	February 26, 2025
/s/ Richard Fearon<br><br>R. Fearon	(Non-management Director)	February 26, 2025
/s/ Siobhán Talbot<br><br>S. Talbot	(Non-management Director)	February 26, 2025
/s/ Christina Verchere<br><br>C. Verchere	(Non-management Director)	February 26, 2025

CRH Form 10-K 104

Exhibit 4.10 - Description of Securities Exhibit 4.10

DESCRIPTION OF SECURITIES

REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT

As of December 31, 2024, CRH public limited company (“CRH,” “CRH plc,” the “Company,” “we,”

“us,” and “our”) had the following securities registered pursuant to Section 12(b) of the Securities

Exchange Act of 1934, as amended (the “Exchange Act”):

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Ordinary Shares of €0.32 each	CRH	New York Stock Exchange
5.200% Notes due 2029	CRH/29	New York Stock Exchange
6.400% Notes due 2033	CRH/33A	New York Stock Exchange
5.400% Notes due 2034	CRH/34	New York Stock Exchange

Capitalized terms used but not defined herein have the meanings given to them in CRH’s annual report on

Form 10-K for the fiscal year ended December 31, 2024.

DESCRIPTION OF ORDINARY SHARES

The rights and restrictions to which our Ordinary Shares are subject are prescribed by our Memorandum

and Articles of Association (the “Articles”). This section summarizes the material terms of our Ordinary

Shares, including certain provisions of our Articles and applicable Irish law in effect on the date hereof.

However, the following description is a summary and does not purport to be complete. It is subject to and

qualified in its entirety by reference to the Articles, the Irish Companies Act 2014 (the “Companies Act

2014”) and any other applicable Irish law concerning companies, as amended from time to time.

A copy of the Company’s Articles is included as Exhibit 3.1 to our Annual Report on Form 10-K for the

fiscal year ended December 31, 2023.

General

As of December 31, 2024, the authorized share capital of the Company was €401,297,940, which includes

1,250,000,000 Ordinary Shares of €0.32 each (the “Ordinary Shares”), 150,000 5% Cumulative

Preference Shares of €1.27 each and 872,000 7% “A” Cumulative Preference Shares of €1.27 each

(together the “Preference Shares”). The Preference Shares are not registered pursuant to Section 12(b) of

the Exchange Act. As of December 31, 2024, 718,647,277 Ordinary Shares were issued and outstanding.

All outstanding Ordinary Shares are fully paid.

Transfer of Shares and Registrar

A written instrument of transfer is required under Irish law in order to register on the Company’s share

register any transfer of shares (i) from a person who holds such shares directly to any other person, (ii)

from a person who holds such shares beneficially to a person who holds such shares directly, or (iii) from

a person who holds such shares beneficially to another person who holds such shares beneficially where

the transfer involves a change in the depository or other nominee that is the record owner of the

transferred shares. An instrument of transfer is also required for a shareholder who directly holds shares

in order to transfer those shares into his or her own broker account (or vice versa). The Articles provide

that the Secretary, or any other party designated by the Board of Directors of the Company (the “Board”)

for such purpose from time to time, may sign an instrument of transfer on behalf of the transferor who is

transferring shares in the Company. Notwithstanding the provisions of the Articles, the directors of the

Company (the “Directors”) have the power to permit any class of shares to be held in a settlement

securities system and to implement any arrangements they think fit for such evidencing and transfer

which accord with such the Companies Act 2014.

The foregoing instruments of transfer may give rise to Irish stamp duty. The Company, in its absolute

discretion and insofar as the Companies Act 2014 or any other applicable law permits, may, or may

procure that a subsidiary of the Company shall, pay Irish stamp duty arising on a transfer of shares on

behalf of the transferee of such shares of the Company. If stamp duty resulting from the transfer of shares

in the Company which would otherwise be payable by the transferee is paid by the Company or any

subsidiary of the Company on behalf of the transferee, then in those circumstances, the Company shall,

on its behalf or on behalf of its subsidiary (as the case may be), be entitled to (i) seek reimbursement of

the stamp duty from the transferee, (ii) set off the stamp duty against any dividends payable to the

transferee of those shares; and (iii) to the extent permitted by the Companies Act 2014, claim a first and

paramount lien on the shares on which stamp duty has been paid by the Company or its subsidiaries for

the amount of stamp duty paid, which lien shall extend to all dividends paid on those shares.

The Directors may, in their absolute discretion and without giving any reason, decline to register the

transfer, subject to the limitations specified in the Articles to encourage trading on an open and proper

basis, of (i) a share (other than a fully paid share) to a person of whom they do not approve, or (ii) a share

on which the Company has a lien. The Directors may also decline to register an instrument of transfer

unless the instrument of transfer is accompanied by such evidence as the directors may reasonably require

to show the right of the transferor to make the transfer, the transfer is in respect of one class of shares only

and the instrument of transfer is duly stamped if required and it and such evidence are lodged at the

Company’s office or any other place specified by the Board.

Computershare Trust Company N.A. acts as U.S. transfer agent and registrar for the Ordinary Shares.

Voting Rights

At shareholders’ meetings, holders of Ordinary Shares as of the applicable record date for such meeting

are entitled to one vote per share, either in person or by proxy. No shareholder is entitled to vote at any

general meeting unless all calls or other sums immediately payable in respect of shares in the Company

have been paid.

Dividend Rights

Shareholders may by ordinary resolution declare final dividends and the Directors may declare interim

dividends, but no final dividend may be declared in excess of the amount recommended by the Directors

and no dividend may be paid other than out of profits available for that purpose in accordance with the

Companies Act 2014. There is provision to offer scrip dividend in lieu of cash. The Preference Shares

rank for fixed rate dividends in priority to the Ordinary Shares. Any dividend which has remained

unclaimed for 12 years from the date of its declaration shall, if the Directors so decide, be forfeited and

cease to remain owing by the Company.

Calls on Shares

The Directors may from time to time call upon the shareholders in respect of any moneys unpaid on their

shares (whether on account of the nominal value of the shares or by way of premium) and not by the

conditions of allotment thereof made payable at fixed times.

Liquidation Rights

In the event the Company is being wound up, the liquidator may, with the sanction of a shareholders’

special resolution and any other sanction required by the Companies Act 2014, following the settlement

of all claims of creditors, divide among the holders of the Ordinary Shares the whole or any part of the

assets of the Company available for distribution (after the return of capital and payment of accrued

dividends on the preference shares) in cash or in kind, in proportion to the paid-up par value of the shares

held. The liquidator may, with a like sanction, vest such assets in trust as he thinks fit, but no shareholders

will be compelled to accept any shares or other assets upon which there is any liability.

Issuance of New Shares

Subject to the provisions of the Companies Act 2014 and the Articles, the issuance of new shares is at the

discretion of the Board. The Board requires the authority of the shareholders, by way of ordinary

resolution requiring not less than 50% of the votes cast by the shareholders at a general meeting, to allot

any authorized but unissued Ordinary Share capital of the Company. At the Company’s 2024 Annual

General Meeting on April 25, 2024 (the “2024 General Meeting”), Resolution 4 was approved by the

shareholders authorizing the Board to issue Ordinary Shares up to an amount which represents 20% of the

Company’s issued Ordinary Share capital as at February 15, 2024, being Ordinary Shares with an

aggregate nominal value of €46,815,000. Any allotment exceeding 20% of the issued Ordinary Share

capital as at February 15, 2024 will only be made with the prior approval of the Company in a general

meeting. The authority granted under Resolution 4 expires at the close of business on the earlier of the

date of the Annual General Meeting in 2025 or October 25, 2025.

Pre-emptive Rights

Irish company law provides that issuances of equity shares for cash (and rights to subscribe for or to

convert into equity shares for cash) must be offered, pro rata, to the existing shareholders of equity shares.

The shareholders may, by special resolution (requiring not less than 75% of the votes cast by the

shareholders at a general meeting), eliminate this requirement for periods of up to five years. At the 2024

General Meeting, Resolution 5 was approved by the shareholders to renew the shareholder authorities of

the Directors to disapply statutory pre-emption rights in relation to allotments of Ordinary Shares for cash

in certain circumstances.

Resolution 5 authorizes the Board to allot Ordinary Shares on a non-pre-emptive basis and for cash

(otherwise than in connection with a rights issue or similar pre-emptive issue) up to a maximum of 20%

of the issued Ordinary Share capital of the Company as at February 15, 2024 (being Ordinary Shares with

an aggregate nominal value of €46,815,000). Resolution 5 also allows the Board to disapply pre-

emption rights in a rights issue or other pre-emptive issue in accordance with the Articles. The authority

granted under Resolution 5 expires at the close of business on the earlier of the date of the Annual

General Meeting in 2025 or October 25, 2025.

Disclosure of Shareholders’ Interests

Under the Companies Act 2014, shareholders are required to disclose their interests in, and changes to

interests in, 3% or more of a company’s share capital. Under Article 14 of the Articles, the Board may

give a notice to any shareholder requiring an indication in writing of: (i) the capacity in which the shares

are held or any interest therein; (ii) the persons who have an interest in the shares and the nature of their

interest; or (iii) whether any of the voting rights carried by such shares are the subject of any agreement or

arrangement under which another person is entitled to control the shareholder’s exercise of these rights.

Where such a notice is served by the Company on a person who is or was interested in shares of Company

and that person fails to give the Company the information required within the reasonable time specified,

the Company has the discretion to apply certain restrictions on such person including: (i) no voting rights

shall be exercisable in respect of those shares; (ii) no payment of dividend by the Company of any sums

due from those shares; and/or (iii) any transfer of those shares can be void.

Change of Control

There are no provisions in the Articles which would have an effect of delaying, deferring or preventing a

change in the control of the Company.

Restrictions on Share Ownership

There are no restrictions under the Articles or under Irish law that limit the right of non-Irish residents or

foreign owners to freely hold their Ordinary Shares or to vote their Ordinary Shares.

Variation of Rights

Subject to the provisions of the Companies Act 2014, the rights attached to any class of shares may be

varied with the consent in writing of the holders of not less than three fourths in nominal value of the

issued shares of that class, or with the sanction of a special resolution passed at a separate general meeting

of the holders of those shares.

General Meeting

Shareholder meetings may be convened by majority vote of the Directors or requisitioned by shareholders

holding not less than 5% of the voting rights of the Company. A quorum for a general meeting of the

Company is constituted by two or more shareholders present in person and entitled to vote. The passing of

resolutions at a meeting of the Company, other than special resolutions, requires a simple majority. A

special resolution, in respect of which not less than 21 clear days’ notice in writing must be given,

requires the affirmative vote of at least 75% of the votes cast.

DESCRIPTION OF DEBT SECURITIES

General

The notes listed on the New York Stock Exchange and set forth on the cover page to the Company’s

Annual Report on Form 10-K for the year ended December 31, 2024 were issued pursuant to effective

registration statements and related prospectus and prospectus supplement setting forth the terms of the

respective series of notes.

The following table sets forth the name of the issuer, the date of the registration statement, date of the

base prospectus and date of issuance for each series of notes.

Series	Issuer	Registration<br><br>Statement	Date of Base<br><br>Prospectus	Date of<br><br>Issuance
5.200% Notes due 2029<br><br>(the “2029 Notes”)	CRH SMW Finance<br><br>Designated Activity<br><br>Company	333-279349-02	May 10, 2024	May 21, 2024
6.400% Notes due 2033<br><br>(the “2033 Notes”)	CRH America, Inc.	333-13648	September 6, 2001	September 29,<br><br>2003
5.400% Notes due 2034<br><br>(the “2034 Notes” and<br><br>together with the 2029<br><br>Notes and the 2033 Notes,<br><br>the “Notes”)	CRH America Finance, Inc	333-279349-01	May 10, 2024	May 21, 2024

The following description of the Notes is a summary and does not purport to be complete, and is subject

to and qualified in its entirety by reference to the relevant Indenture (as defined below), the officers’

certificates setting forth the terms of the relevant Notes and the relevant global securities, which are

incorporated by reference as Exhibits 4.1 to 4.9 to the Form 10-K, respectively. We strongly encourage

investors to review the relevant Indenture, officers’ certificate and global securities for additional

information.

A. Terms Applicable to the Notes

The 2029 Notes were issued pursuant to an Indenture dated as of May 21, 2024 (as may be amended and

supplemented from time to time, to the extent that such amendments or supplements apply to the Notes,

the “SMW Indenture”) between CRH SMW Finance Designated Activity Company (“SMW Finance”), as

Issuer, CRH plc, as Guarantor, and The Bank of New York Mellon (the “Trustee”) as trustee.

The 2033 Notes were issued pursuant to an Indenture dated as of March 20, 2002 (as may be amended

and supplemented from time to time, to the extent that such amendments or supplements apply to the

Notes, the “CRH America Indenture”) between CRH America, Inc. (“CRH America”), as Issuer, CRH

plc, as Guarantor, and the Trustee, as successor trustee to J.P. Morgan Chase Bank.

The 2034 Notes were issued pursuant to an Indenture dated as of May 21, 2024 (as may be amended and

supplemented from time to time, to the extent that such amendments or supplements apply to the Notes,

the “AF Indenture” and together with the CRH America Indenture and the SMW Indenture, the

“Indentures”) between CRH America Finance, Inc. (“CRH America Finance”), as Issuer, CRH plc, as

Guarantor, and the Trustee as trustee.

Each series of Notes and each Indenture is governed by, and is to be construed in accordance with, the

laws of the State of New York.

Description of the Notes

Each series of Notes were issued in the aggregate principal amount, and unless previously redeemed and

cancelled will mature on the maturity date and will bear interest at the rate per annum, set forth in the

table below:

	Aggregate Principal<br><br>Amount	Maturity<br><br>Date	Fixed Interest<br><br>Rate
2029 Notes	$750,000,000.00	May 21, 2029	5.200%
2033 Notes	$300,000,000.00	October 15, 2033	6.400%
2034 Notes	$750,000,000.00	May 21, 2034	5.400%

As of December 31, 2024, the aggregate principal amount set forth below was outstanding for each series

of Notes, and each series of Notes was listed and admitted to trading on the NYSE under the trading

symbol set forth below:

	Aggregate<br><br>Principal Amount Outstanding	NYSE<br><br>Trading Symbol
2029 Notes	$750,000,000.00	CRH/29
2033 Notes	$212,555,000.00	CRH/33A
2034 Notes	$750,000,000.00	CRH/34

Interest on each series of the Notes is payable semi-annually in arrears on the interest payment dates,

commencing on the first interest payment date, set forth in the table below:

	Interest Payment Dates	First Interest Payment Date
2029 Notes	May 21 and November 21 of each year	November 21, 2024
2033 Notes	April 15 and October 15 of each year	April 15, 2004
2034 Notes	May 21 and November 21 of each year	November 21, 2024

Each payment of interest due on an interest payment date or the date of maturity includes interest accrued

from and including the last date to which interest has been paid, or made available for payment, or from

the issue date if none has been paid or made available for payment, but excluding the interest payment

date or the date of maturity. Interest on each series of Notes is computed on the basis of a 360-day year of

twelve 30-day months. The regular record dates for each Notes are set forth in the table below:

	Regular Record Dates
2029 Notes	May 6 and November 6 of each year
2033 Notes	April 1 and October 1 of each year
2034 Notes	May 6 and November 6 of each year

The currency in which the payment of the principal of, or any premium, or interest of each series of Notes

is payable is U.S. dollars.

Form and Denomination

The 2033 Notes have been issued in fully registered form in denominations of $1,000 and integral

multiples of $1,000 in excess thereof.

The 2029 Notes and the 2034 Notes have been issued in fully registered form in denominations of

$200,000 and integral multiples of $1,000 in excess thereof.

Each series of Notes are represented by one or more global securities registered in the name of Cede &

Co. as nominee of The Depository Trust Company (the “DTC”). Beneficial interests in a series of Notes

may be held through DTC, and DTC and its direct and indirect participants (including Euroclear and

Clearstream, Luxembourg) who record beneficial interest on their books. Settlement of a series of Notes

occurs through DTC in same day or, in case the case of the 2029 Notes and the 2034 Notes, immediately

available funds.

Trustee, Registrar, Transfer Agent and Paying Agent

The Bank of New York Mellon acts as trustee, registrar, transfer agent and principal paying agent for

each series of Notes. An Issuer may at any time designate additional paying agents or rescind the

designation of paying agents or approve a change in the office through which any paying agent acts. The

Bank of New York Mellon SA/NV, Dublin Branch has been designated as Irish Paying Agent. See also

“B. General Terms Applicable to the Notes — Regarding the Trustee”.

Redemption and Repayment

The relevant Issuer or CRH plc, as applicable, may redeem a series of Notes in whole at any time or in

part from time to time at the applicable redemption price for such series of Notes as further described

below.

In addition, the relevant Issuer or CRH plc, as applicable, may redeem a series of Notes in whole if

certain tax events occur. See “B. General Terms Applicable to the Notes — Optional Tax Redemption”.

See “B. General Terms Applicable to the Notes — Redemption and Repayment” for other terms relating

to redemption of a series of Notes.

Ranking of the Notes

Each series of Notes is the unsecured and unsubordinated indebtedness of the relevant Issuer and ranks

equally with all of such Issuer’s other present and future unsecured and unsubordinated indebtedness.

Each series of Notes rank equally without any preference among themselves and with all of the relevant

Issuer’s present and future unsecured and unsubordinated indebtedness.

See “B. General Terms Applicable to the Notes — Ranking” for further information about the ranking of

the Notes and the guarantees.

B. General Terms Applicable to the Notes

The following terms are applicable to all series of Notes, except where otherwise noted. Where

appropriate, we use parentheses to refer you to the particular sections of the relevant Indenture. Any

reference to particular sections or defined terms of an Indenture in any statement under this heading

qualifies the entire statement and incorporates by reference the applicable section or definition into that

statement.

Guarantee

CRH plc unconditionally and irrevocably guarantees on an unsubordinated basis the due and punctual

payment of the principal, interest, premium, if any, and any other additional amounts payable in respect of

the Notes and the Indenture, when and as any such payments become due and payable, whether at

maturity, upon redemption or declaration of acceleration, or otherwise. (Section 206)

Ranking

The guarantees of the Notes are unsecured, unsubordinated obligations of CRH plc and rank equally with

all other present and future unsecured and unsubordinated indebtedness of CRH plc.

Any payment on a series of Notes is subject to the credit risk of the relevant Issuer, and the credit risk of

CRH plc, as guarantor of each series of Notes.

Further, because CRH America and CRH plc are holding companies, the right of holders to receive

payments on the 2033 Notes and the guarantees of the Notes are effectively subordinated to any

indebtedness of such entities’ subsidiaries. The subsidiaries of CRH America are not guarantors on the

2033 Notes, and the subsidiaries of CRH plc are not guarantors on the Notes, and claims of the creditors

of CRH America or CRH plc’s subsidiaries have priority as to the assets of such subsidiaries over the

claims of CRH America’s or CRH plc’s creditors.

Additional Indebtedness

The Indentures do not limit the aggregate amount of debt securities that any Issuer may issue or the

number of series or the aggregate amount of any particular series. Each Issuer may issue debt securities

and other securities at any time without the consent of the holders and without notifying them. The

Indentures and the Notes also do not limit any Issuer’s ability to incur other indebtedness or to issue other

securities. Also, the Issuers are not subject to financial or similar restrictions by the terms of the Notes,

except as described under “-Covenants-Restriction on Sales and Leasebacks” and “-Covenants-Restriction

on Liens”.

Covenants

Restrictions on Liens

Some of each Issuer’s or CRH plc’s property may be subject to a mortgage or other legal mechanism that

gives their lenders preferential rights in that property over other lenders, including holders of a series of

Notes, or over each Issuer’s and CRH plc’s general creditors if the relevant Issuer or CRH plc fail to pay

them back. These preferential rights are called liens. The Issuers and CRH plc will not become obligated

on any new debt for borrowed money that is secured by a lien on any of the Issuers’ and CRH plc’s

properties, which are described further below, unless an Issuer and CRH plc grant an equivalent or

higher-ranking lien on the same property to direct holders of the Notes.

Neither CRH plc nor any Issuer needs to comply with this restriction if the amount of all debt that would

be secured by liens on such Issuer’s and CRH plc’s properties, which are described further below,

excluding the debt secured by the liens that are listed later, does not exceed (i) with respect to the 2033

Notes, 10% of CRH plc’s consolidated shareholders’ funds and (ii) with respect to the 2029 Notes and the

2034 Notes, 15% of CRH plc’s consolidated shareholders’ funds. (Section 1008)

Consolidated shareholders’ funds refers to:

•The paid-up capital of CRH plc; plus

•The consolidated capital and revenue reserves of CRH plc, capital grants, deferred taxation and

minority shareholders’ interests, but deducting the amount of repayable government grants; minus

•Any revaluation upwards after the end of CRH plc’s latest fiscal year preceding the issuance of

the Notes of plant and machinery.

•This restriction on liens applies only to liens for borrowed money. For example, liens imposed by

operation of law or by order of a court, such as liens to secure statutory obligations for taxes or

workers’ compensation benefits, or liens an Issuer or CRH plc creates to secure obligations to pay

legal judgments or surety bonds, would not be covered by this restriction. This restriction on liens

also does not apply to debt secured by a number of different types of liens, and the Issuers and

CRH plc can disregard this debt when calculating the limits imposed by this restriction. These

types of liens include the following:

•any lien existing on or before the date of the issuance of the Notes.

•any lien over any property that the relevant Issuer or CRH plc acquired as security for, or for

indebtedness incurred, to finance all or part of the price of its acquisition, construction,

development, modification or improvement.

•any lien over any property that the relevant Issuer or CRH plc acquired subject to the lien,

provided the lien was not created in anticipation of the acquisition of that property.

•any lien to secure indebtedness for borrowed money incurred in connection with a specifically

identifiable project where the lien relates to a property involved in the project and that the

relevant Issuer or CRH plc acquired after the date of the issuance of the Notes.

•any lien securing the relevant Issuer’s or CRH plc’s indebtedness for borrowed money incurred in

connection with the financing of accounts receivable.

•any lien incurred or deposits made in the ordinary course of business which do not involve

borrowed money including but not limited to,

•any mechanics’, materialsmen’s, carriers’, workmen’s, vendors’ or similar lien,

•any lien arising in connection with equipment leases,

•any easements or rights-of-way restrictions and other similar charges.

•any lien upon specific items of the relevant Issuer’s or CRH plc’s inventory or other goods and

proceeds securing the relevant Issuer’s or CRH plc’s obligations in respect of bankers’

acceptances issued or created to purchase, ship or store such inventory or other goods.

•any lien or deposits securing the performance of tenders, bids, leases, trade contracts (other than

for borrowed money), statutory obligations, surety bonds, appeal bonds, government contracts,

performance bonds, return-of-money bonds and other similar obligations incurred in the ordinary

course of business.

•any lien securing industrial revenue, development, first mortgage bonds issued to secure other

bonds or similar bonds issued by or for the benefit of the relevant Issuer or CRH plc.

•any lien on the relevant Issuer ’s or CRH plc’s property required by contract or any applicable

laws, rules, regulations or statutes, securing the relevant Issuer’s or CRH plc’s obligations and

payments under a contract with a governmental entity or in relation to a contract entered into at

the request of a governmental entity;

•any statutory or contractual right of set-off, including rights of financial institutions to offset

credit balances in connection with the operation of cash management programs established for the

relevant Issuer’s or CRH plc’s benefit or in connection with the issuance of letters of credit for

their benefit, any lien created on compensating credit balances and any lien created on amounts of

a nature similar to such credit balances held in trust, in each case (other than a statutory right of

set-off) to the extent required by a financial institution as security for financing provided to the

relevant Issuer, CRH plc or any direct or indirect subsidiary of CRH plc;

•any lien securing liabilities under agreements with the Exports Credit Guarantee Department of

the British government, or similar forms of credit, over sums due under any contract for the

purchase, supply or installation of plant and/or machinery;

•any lien constituted by a right of set-off or right over a margin call account or any form of cash or

cash collateral or any similar arrangement for obligations related to the hedging or management

of risks under transactions involving any currency or interest rate swap, cap or collar

arrangements, forward exchange transaction, option, warrant, forward rate agreement, futures

contract or other derivative instrument of any kind;

•any lien arising out of title retention or like provisions in connection with the purchase of goods

and equipment in the ordinary course of business;

•any lien securing taxes or assessments or other applicable governmental charges or levies;

•any lien securing reimbursement obligations under letters of credit, guaranties and other forms of

credit enhancement given in connection with the purchase of goods and equipment in the ordinary

course of business;

•any lien in favor of CRH plc or any subsidiary of CRH plc.

•any extension, renewal or replacement, as a whole or in part, of any lien included earlier in this

list; and

•the amount does not exceed the principal amount of the borrowed money secured by the lien

which is to be so extended, renewed or replaced; and

•the extension, renewal, or replacement lien is limited to all or part of the same property, including

improvements that secured the lien to be extended, renewed or replaced. (Section 1008)

Restrictions on Sales and Leasebacks

Neither CRH plc nor any Issuer will enter into any sale and leaseback transaction involving a property

other than as allowed by the covenant relating to these under the relevant Indenture. A sale and leaseback

transaction is an arrangement between an Issuer or CRH plc and any person where the relevant Issuer or

CRH plc leases a property that the relevant Issuer or CRH plc has owned for more than 270 days and has

sold to that person or to any person to whom that person has advanced funds on the security of the

property.

This restriction on sales and leasebacks does not apply to any sale and leaseback transaction that is

between CRH plc and one of its subsidiaries, or between a subsidiary of CRH plc and any other

subsidiary of CRH plc. It also does not apply to any lease with a term, including renewals, of three years

or less. Further, the Indentures do not restrict the ability of any subsidiary of CRH plc (other than the

Issuers) to enter into sale and leaseback transactions.

The covenant allows an Issuer or CRH plc to enter into sale and leaseback transactions in two additional

situations. First, an Issuer or CRH plc may enter sale and leaseback transactions if they could grant a lien

on the property in an amount equal to the indebtedness attributable to the sale and leaseback transaction

without being required to grant an equivalent or higher-ranking lien to the holders of the Notes under the

restriction on liens described above.

Second, an Issuer or CRH plc may enter into sale and leaseback transactions if, within one year of the

transaction, such Issuer or CRH plc, as the case may be, invests an amount equal to at least the net

proceeds of the sale of the property that such Issuer or CRH plc, as the case may be, lease in the

transaction or the fair value of that property, whichever is greater. This amount must be invested in any of

such Issuer’s or CRH plc’s property or used to retire any indebtedness for money that such Issuer or CRH

plc borrowed, incurred or assumed. (Section 1009)

Restrictions on Mergers and Similar Events

Each Issuer and CRH plc are generally permitted to consolidate or merge, including under a scheme of

arrangement, with another entity.

Each Issuer and CRH plc are also permitted to sell or lease substantially all of their assets to another firm

or to buy or lease substantially all of the assets of another firm. However, neither CRH plc nor any Issuer

may take any of these actions unless all the following conditions are met:

1.Where CRH plc merges out of existence or sells or leases substantially all its assets, the other

firm must be duly organized and validly existing under the laws of the applicable jurisdiction. If

such other entity is organized under the laws of a jurisdiction other than the United States, any

State thereof, or the District of Columbia, or the Republic of Ireland, it must indemnify holders

against any tax, assessment or governmental charge or other cost or expense resulting from the

transaction.

2.Where an Issuer merges out of existence or sell or lease substantially all of its assets, the other

firm must be duly organized and validly existing under the laws of a U.S. State, or the District of

Columbia or under U.S. federal law or (in the case of SMW Finance only) under the laws of the

Republic of Ireland.

3.If an Issuer or CRH plc merges out of existence or sells or leases substantially all of its assets, the

surviving entity must execute a supplement to the relevant Indenture, known as a supplemental

indenture. In the supplemental indenture, the entity must promise to be bound by every obligation

in the Indenture applicable to the relevant Issuer or CRH plc, as the case may be, including CRH

plc’s and (if applicable) an Issuer’s obligation to pay additional amounts.

4.Neither the relevant Issuer nor CRH plc may be in default on the debt securities or guarantees

immediately prior to such action and such action must not cause a default. For purposes of this

no-default test, a default would include an event of default that has occurred and not been cured.

A default for this purpose would also include any event that would be an event of default if the

requirements for notice of default or existence of defaults for a specified period of time were

disregarded.

5.The relevant Issuer or CRH plc, as the case may be, must deliver certain certificates and other

documents to the Trustee with respect to the compliance of the consolidation or merger with the

Indenture.

6.Neither the relevant Issuer nor CRH plc’s assets or properties may become subject to any

impermissible lien unless the debt securities issued under the relevant Indenture are secured

equally and ratably with the indebtedness secured by the impermissible lien. (Section 801)

Payment of Additional Amounts

All payments by an Issuer of the principal or interest on a series of Notes and all payments by CRH plc

under the guarantees will be made free and clear of any withholding for taxes or any other governmental

charge, unless such withholding is required by the laws of any jurisdiction where CRH plc is incorporated

or (in respect of the 2029 Notes only) any jurisdiction where SMW Finance is incorporated or, in each

case, tax resident. In the event that CRH plc or SMW Finance is required to withhold such taxes or

governmental charges, CRH plc or SMW Finance, as applicable, will be required, subject to certain

exceptions, to pay holders of the relevant series of Notes an additional amount so that the net amount they

receive is the amount specified in the Notes to which they are entitled. No additional amounts will be

payable in respect of any withholding for taxes or governmental charges imposed by the United States

government or any political subdivision of the United States government.

CRH plc (or with respect to the 2029 Notes, CRH plc or SMW Finance) will not be required to make any

payment of additional amounts under any of the following circumstances:

•The United States government or any political subdivision of the United States government is the

entity that is imposing the tax or governmental charge.

•The tax or charge is imposed only because the holder, or a fiduciary, settlor, beneficiary or

member or shareholder of, or possessor of a power over, the holder, if the holder is an estate,

trust, partnership or corporation, was or is connected to the taxing jurisdiction. These connections

include, but are not limited to, where the holder or related party:

ois or has been a citizen or resident of the jurisdiction;

ois or has been engaged in trade or business in the jurisdiction; or

ohas or had a permanent establishment in the jurisdiction.

•The tax or charge is imposed due to the presentation of the Notes for payment on a date more

than 30 days after the Notes became due or after the payment was provided for.

•There is an estate, inheritance, gift, sale, transfer, personal property or similar tax, assessment or

other governmental charge.

•The tax, assessment or governmental charge is payable in a manner that does not involve

withholdings.

•The tax, assessment or governmental charge is imposed or withheld because the holder or

beneficial owner failed to comply with any of the relevant Issuer’s or CRH plc’s requests for the

following that the statutes, treaties, regulations or administrative practices or the taxing

jurisdiction require as a precondition to exemption from all or part of such withholding:

oto provide information about the nationality, residence or identity of the holder or

beneficial owner; or

oto make a declaration or satisfy any other information requirements.

•With respect to the 2033 Notes, the withholding or deduction is imposed pursuant to the EU

Directive on Taxation of Savings (2003/48/EC), or any law implementing such Directive.

•With respect to the 2029 Notes, the withholding or deduction is imposed or required pursuant to

Sections 1471 through 1474 of the U.S. Internal Revenue Code of 1986, as amended from time to

time, any current or future regulations or official interpretations thereof, any agreement entered

into pursuant to Section 1471(b) of the Code, or any fiscal or regulatory legislation, rules or

practices adopted pursuant to any intergovernmental agreement entered into in connection with

the implementation of such Sections of the Code (or any law implementing such an

intergovernmental agreement).

•The withholding or deduction is imposed on a holder or beneficial owner who could have avoided

such withholding or deduction by presenting the Notes to (i) another paying agent in a member

state of the European Union with respect to the 2033 Notes, or (ii) another paying agent with

respect to the 2029 Notes and the 2034 Notes.

•The holder is a fiduciary or partnership or an entity that is not the sole beneficial owner of the

payment of the principal of, or any interest on, the Notes, and the laws of the jurisdiction require

the payment to be included in the income of a beneficiary or settlor for tax purposes with respect

to such fiduciary or a member of such partnership or a beneficial owner who would not have been

entitled to such additional amounts had it been the holder of such security.

With respect to the 2033 Notes, these provisions will also apply to any taxes, assessments or

governmental charges imposed by any jurisdiction in which a successor to CRH plc is incorporated.

With respect to the 2029 Notes, these provisions will also apply to any taxes, assessments or

governmental charges imposed by any jurisdiction in which a successor to SMW Finance or CRH plc is

incorporated. (Section 1004)

Additional amounts may also be payable in the event of certain consolidations, mergers, sales of assets or

assumptions of obligations. Under the Indenture, CRH plc or any subsidiary of CRH plc may assume the

relevant Issuer’s obligations under the Notes. This may be a taxable event to U.S. holders. U.S. holders

may be treated as having exchanged their Notes for other debt securities issued by CRH plc or the

relevant Issuer and may have to recognize gain or loss for U.S. federal income tax purposes upon such

assumption. (Section 803)

Redemption and Repayment

Notice of Redemption

Notice of any redemption will be mailed (with respect to the 2033 Notes) at least 30 days or (with respect

to the 2029 notes and the 2034 Notes) at least 10 days but not more than 60 days before the redemption

date to each holder of the Notes to be redeemed. (Section 1104) On and after any redemption date, interest

will cease to accrue on the Notes or any portion thereof called for redemption. On or before any

redemption date, CRH plc or the relevant Issuer shall deposit with a paying agent (or the Trustee) money

sufficient to pay the redemption price of and accrued interest on the Notes to be redeemed on such date.

(Section 1105)

Notice by DTC to participating institutions and by these participants to street name holders of indirect

interests in the Notes will be made according to arrangements among them and may be subject to

statutory or regulatory requirements.

Optional Make-Whole Redemption

—2029 Notes

Prior to April 21, 2029 (the “2029 Par Call Date”), SMW Finance may redeem all or part of the 2029

Notes at its option in whole at any time or in part from time to time at a redemption price equal to the

greater of:

(1) 100% of the principal amount of the 2029 Notes to be redeemed and

(2) (a) the sum of the present values of the remaining scheduled payments of principal and

interest thereon discounted to the redemption date (assuming the 2029 Notes matured on the 2029

Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-

day months) at the Treasury Rate (as defined in the relevant prospectus supplement) plus 15 basis

points less (b) interest accrued to (but excluding) the date of redemption

plus, in each case, accrued and unpaid interest on the principal amount of the 2029 Notes to be

redeemed to (but excluding) the date of redemption.

On or after the 2029 Par Call Date, SMW Finance may redeem the 2029 Notes, in whole or in part, at any

time and from time to time, at a redemption price equal to 100% of the principal amount of the 2029

Notes being redeemed plus accrued and unpaid interest thereon to the redemption date.

—2033 Notes

CRH plc or CRH America may redeem the 2033 Notes at its option in whole at any time or in part from

time to time at a redemption price equal to the greater of

(1) 100% of the principal amount of the 2033 Notes to be redeemed and

(2) the sum of the present values of the Remaining Scheduled Payments (as defined in the CRH

America Indenture) discounted to the date of redemption on a semi-annual basis (assuming a 360-

day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the CRH

America Indenture) plus 25 basis points, together with, in each case, accrued interest on the

principal amount of the Notes to be redeemed to the date of redemption.

—2034 Notes

Prior to February 21, 2034 (the “2034 Par Call Date”), CRH America Finance may redeem all or part of

the 2034 Notes at its option in whole at any time or in part from time to time at a redemption price equal

to the greater of

(1) 100% of the principal amount of the 2034 Notes to be redeemed and

(2)(a) the sum of the present values of the remaining scheduled payments of principal and interest

thereon discounted to the redemption date (assuming the 2034 Notes matured on the 2034 Par

Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months)

at the Treasury Rate (as defined in the relevant prospectus supplement) plus 15 basis points less

(b) interest accrued to (but excluding) the date of redemption

plus, in each case, accrued and unpaid interest on the principal amount of the 2034 Notes to be

redeemed to (but excluding) the date of redemption.

On or after the 2034 Par Call Date, CRH America Finance may redeem the 2034 Notes, in whole or in

part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of

the 2034 Notes being redeemed plus accrued and unpaid interest thereon to the redemption date.

Partial Redemption

If less than all of the Notes are to be redeemed, the Notes to be redeemed shall be selected by the Trustee

by (with respect to the 2033 Notes) such method as the Trustee shall deem fair and appropriate and (with

respect to the 2029 Notes and the 2034 Notes) in the case where the Notes are held in certificated form,

by lot, and in the case where the Notes are held in global form, in accordance with the applicable

procedures of the applicable Depositary.

Optional Tax Redemption

The Notes may be redeemed in whole but not in part at the option of CRH plc or the relevant Issuer in the

three situations described below.

The redemption price for the Notes in such circumstances will be equal to the principal amount thereof

plus accrued interest to the date fixed for redemption.

The first situation is where, as a result of a change in, execution of or amendment to any laws or treaties

or the official application or interpretation of any laws or treaties, CRH plc determines that it (or in the

case of the 2029 Notes, it or SMW Finance) would be required to pay additional amounts as described

under “Payment of Additional Amounts”. This applies only in the case of changes, executions or

amendments that occur on or after the date of pricing of the Notes in the jurisdiction where CRH plc or

SMW Finance is incorporated. If CRH plc or SMW Finance has been succeeded by another entity, the

applicable jurisdiction will be the jurisdiction in which such successor entity is (i) with respect to the

2033 Notes, organized, or (ii) with respect to the 2029 Notes and 2034 Notes, organized and resident for

tax purposes, and the applicable date will be the date the entity became a successor.

The second situation is where, as a result of a change in, execution of or amendment to any laws or

treaties or the official application or interpretation of any laws or treaties, CRH plc or any of its

subsidiaries determines that it would have to deduct or withhold tax on any payment to the relevant Issuer

to enable it to make a payment of principal or interest on the Notes, including the payment of additional

amounts as described under “Payment of Additional Amounts”. This applies only in the case of changes,

executions or amendments that occur on or after the date of issuance of the Notes in the jurisdiction where

CRH plc is incorporated. If CRH plc has been succeeded by another entity, the applicable jurisdiction will

be the jurisdiction in which such successor entity is organized, and the applicable date will be the date the

entity became a successor. The relevant Issuer or CRH plc would not have the option to redeem in this

case if the relevant Issuer could have avoided the payment of additional amounts or the deduction or

withholding by using reasonable measures available.

In each case above, the relevant Issuer or CRH plc would not have the option to redeem if the relevant

Issuer, CRH plc or the applicable successor entity could have avoided the payment of additional amounts

or the deduction or withholding by using reasonable measures available.

The third situation is where, following a merger, consolidation or sale or lease of CRH plc’s assets to a

person that assumes or, if applicable, guarantees the relevant Issuer’s obligations on the Notes, that person

is required to pay additional amounts as described under “Payment of Additional Amounts”. The relevant

Notes could be redeemed at the option of the other person in this situation even if additional amounts

became payable immediately upon completion of the merger or sale transaction, including in connection

with an internal corporate reorganization. Neither the relevant Issuer nor that person have any obligation

under the relevant Indenture to seek to avoid the obligation to pay additional amounts in this situation.

The relevant Issuer, or that person, as applicable, shall deliver to the Trustee an officer’s certificate to the

effect that the circumstances required for redemption exist. (Section 1108)

Modification of an Indenture

Each Indenture contains provisions permitting the relevant Issuer, CRH plc and the Trustee to modify

such Indenture or the rights of the holders of debt securities issued pursuant thereto, including the relevant

Notes. There are three types of changes that such parties can make to an Indenture and a series of Notes.

Holders should consult with their banks or brokers for information on how approval may be granted or

denied if the relevant Issuer seeks to change the relevant Indenture or the Notes issued thereunder or

request a waiver.

Changes Requiring Approval of the Holders of the Notes. First, there are changes that cannot be made to a

series of Notes without the specific approval of each holder. The following is a list of those types of

changes:

•change the stated maturity of the principal, or any installment of principal, or interest on the

Notes;

•reduce any amounts and the rate of interest of the Notes or any premium due upon its redemption;

•change any obligation of CRH plc to pay additional amounts;

•reduce the amount of principal payable upon acceleration of the maturity of the Notes following a

default;

•change the place or currency of payment of the Notes;

•impair the holder’s right to sue for payment or conversion;

•reduce the percentage of holders of the Notes whose consent is needed to modify or amend the

indentures;

•reduce the percentage of holders of the Notes whose consent is needed to waive compliance with

various provisions of an Indenture or to waive various defaults;

•modify any other aspect of the provisions dealing with modification and waiver of an Indenture,

unless to provide that additional provisions of an Indenture cannot be modified or waived without

the holders’ consent; and

•modify or affect in any manner adverse to the holder the obligations of CRH plc that relate to

payment of principal, premium and interest, sinking fund payments and conversion rights.

(Section 902)

Changes Requiring a Majority Vote. The second type of change to an Indenture and a series of Notes is

the kind that requires a vote in favor by holders of the Notes owning a majority of the principal amount of

the Notes. Most changes fall into this category, except for clarifying changes, amendments, supplements

and other changes that would not adversely affect the holders in any material respect. (Sections 901 and

902) The same majority vote would be required for an Issuer to obtain a waiver of all or part of the

covenants herein below or a waiver of a past default. However, an Issuer cannot obtain a waiver of a

payment default or any other aspect of an Indenture or the Notes listed in the first category described

under “-Changes Requiring Approval of the Holders of the Notes” unless such Issuer obtains the holders’

individual consent to the waiver. (Section 513)

Changes Not Requiring Approval. The third type of change does not require any vote by holders of the

Notes. This type is limited to clarifications and other changes that would not adversely affect holders of

the Notes in any material respect. (Section 901)

Events of Default and Remedies

The holders of the Notes will have special rights if an event of default occurs and is not cured, as

described below.

What Is An Event of Default? The term event of default means any of the following:

•Neither the relevant Issuer nor CRH plc pays the principal or any premium on the relevant series

of Notes on the maturity date or, in the case of technical difficulties, within 1 day of its due date.

•Neither the relevant Issuer nor CRH plc pays interest or any additional amounts on the relevant

Notes within 30 days of its due date.

•An Issuer or CRH plc remain in breach of a covenant or any other term of the relevant Indenture

or Notes for 90 days after such Issuer or CRH plc, as the case may be, receive a notice of default

stating that such Issuer or CRH plc, as the case may be, are in breach. The notice must be sent by

either the Trustee or by the holders of 25% of such series of Notes.

•The relevant Issuer or CRH plc files for bankruptcy or certain other events or a judgment in

bankruptcy or a similar judgment, decree or order for relief is entered.

•Only with respect to the 2033 Notes, (i) CRH America’s or CRH plc’s other borrowings with an

outstanding principal amount of at least US$50,000,000 (or its equivalent in any other currency)

are accelerated by reason of a default and steps are taken to obtain repayment of these

borrowings; (ii) CRH America or CRH plc fail to make a payment of principal of at least

US$50,000,000 or fail to honor any guarantee or indemnity with respect to borrowings with an

outstanding principal amount of at least US$50,000,000 (or its equivalent in any other currency)

and steps are taken to enforce either of these obligations; or (iii) any mortgage, pledge or other

charge granted by CRH America or CRH plc in relation to any borrowing with an outstanding

principal amount at least US$50,000,000 (or its equivalent in any other currency) becomes

enforceable and steps are taken to enforce the mortgage, pledge or other charge, as the case may

be. (Section 501)

Remedies If an Event of Default Occurs. If an event of default, other than a bankruptcy or similar event of

default, has occurred and has not been cured, the Trustee or the holders of not less than 25% in principal

amount of the relevant series of Notes may declare, by a notice in writing to the relevant Issuer and CRH

plc (and to the Trustee if given by holders), the entire principal amount and any other amounts, including

accrued interest, to be due and immediately payable to the holders to the extent such amounts are

permitted by law to be paid. This is called a declaration of acceleration of maturity. The outstanding

principal amount of the relevant series Notes (or specified amount) and any interest accrued thereon shall

become immediately due and payable on the date the written declaration is received. In a bankruptcy or

similar event of default, the entire principal amount of the relevant series Notes will automatically

become due and immediately payable without any declaration or other action on the part of the Trustee or

any holder. A declaration of acceleration of maturity may be canceled by the holders of at least a majority

in principal amount of the relevant series of Notes if the relevant Issuer or CRH plc have paid the

outstanding amounts due because of the acceleration of maturity and the relevant Issuer or CRH plc have

satisfied certain other conditions. (Section 502)

Except in cases of default, where the Trustee has some special duties, the Trustee is not required to take

any action under an Indenture at the request of any holders unless the holders offer the Trustee reasonable

protection from expenses and liability. (Section 603) This protection is called an indemnity. If reasonable

indemnity is provided, the holders of a majority in principal amount of the outstanding Notes may direct

the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy

available to the Trustee. These majority holders may also direct the Trustee in performing any other

action under the Indenture. (Section 512)

Before the holders of the Notes bypass the Trustee and bring their own lawsuit or other formal legal

action or take other steps to enforce their rights or protect their interests relating to the Notes, the

following must occur:

•The holders must give the Trustee written notice that an event of default has occurred and

remains uncured;

•The holders of 25% in principal amount of the outstanding Notes must make a written request

that the Trustee take action because of the default, and must offer reasonable indemnity to the

Trustee against the cost and other liabilities of taking that action; and

•The Trustee must have not taken action for 60 days after receipt of the foregoing notice and offer

of indemnity and the Trustee has not received an inconsistent direction from the holders of a

majority in principal amount of all outstanding Notes during that period. (Section 507)

However, such limitations do not apply to a suit instituted by the holders of the Notes for the enforcement

of payment of the principal of or interest on the Notes on or after the respective due dates. (Section 508)

Holders should consult their banks or brokers as needed for information on how to give notice or

direction to or make a request of the Trustee and to make or cancel a declaration of acceleration.

Each Indenture requires the relevant Issuer and CRH plc to furnish to the Trustee every year a written

statement of certain of the such Issuer’s and CRH plc’s officers certifying that, to their knowledge, such

Issuer and CRH plc are in compliance with the relevant Indenture and the Notes, or else specifying any

default. (Section 1005)

Regarding the Trustee

As a result of the transfer of J.P. Morgan Chase Bank’s corporate trust business to The Bank of New York

Mellon effective October 1, 2006, The Bank of New York Mellon is currently the trustee under the CRH

America Indenture. The Trustee’s current address is The Bank of New York Mellon, 240 Greenwich

Street, Floor 7E, New York, NY 10286, United States of America. The Trustee is also the current trustee

under the AF Indenture and the SMW Indenture. In addition to acting as trustee, The Bank of New York

Mellon also maintains various banking and trust relationships with each Issuer and some of their

affiliates.

CRH plc and some of its affiliates maintain various banking and trust relationships with the Trustee in the

ordinary course of their business. If an event of default occurs, or an event occurs that would be an event

of default if the requirements for giving an Issuer default notice or an Issuer’s default having to exist for a

specific period of time were disregarded, the Trustee may be considered to have a conflicting interest with

respect to the Notes or the Indentures for purposes of the Trust Indenture Act of 1939. In that case, the

Trustee may be required to resign as trustee under the Indentures and the Issuers or CRH plc would be

required to appoint a successor trustee.

Exhibit 10.25 - Group Chief Executive Service Agreement (A. Manifold) 1

EXHIBIT 10.25

Dated  6 DECEMBER 2023

CRH Group Services Limited

and

Albert Manifold

_________________________________________________

GROUP CHIEF EXECUTIVE SERVICE AGREEMENT

_________________________________________________

2

This Agreement is made on December 6, 2023 between

(1)CRH Group Services Limited incorporated in the Ireland whose registered office is at 42

Fitzwilliam Square, Dublin 2 (the “Company”); and

(2)Albert Manifold of [*****] (the “Executive”).

This Agreement records the terms on which the Executive will serve the Group as its Group

Chief Executive.

1.Interpretation

In this Agreement (and any schedules to it):

“Board” means the board of directors of CRH plc from time to time or anyone/any

person or committee nominated by the board of directors as its representative for the

purposes of this Agreement;

“Chairman” means Chairman of the Board of CRH plc;

“Employment” means the employment governed by this Agreement;

“Group” means the Company, any Associated Company and any undertakings which

are subsidiary undertakings or holding undertakings of any Associated Company, and

each undertaking which is a member of the Group shall be a “Group Company”;

“Person” means any individual person, firm, company, partnership, unincorporated

association, joint venture or other legal entity; and

“Termination Date” means the date on which the Employment terminates.

2.Commencement of Employment as Group Chief Executive Officer

1.The Employment of the Executive under this Agreement commenced on I January

2014 (the “Commencement Date”). The Employment will continue thereafter,

unless and until it is terminated or terminates in accordance with the provisions of this

Agreement. It is acknowledged that the Executive has previously been continuously

employed in different roles by the Company since 7 September 1998.

3.Appointment and Duties of the Executive

1.The Executive will serve as Group Chief Executive Officer.

2.The Executive will:

3

(a)subject as provided for in clause 5.1, devote all of his working time, attention

and skill to the Employment;

(b)properly perform his duties and exercise his powers;

(c)accept any offices or directorships in/with Group Companies as reasonably

required by the Board;

(d)comply with all applicable rules and regulations issued by the Company:

(e)obey the reasonable and lawful directions of the Board; and

(f)use his best endeavours to promote the interests and reputation of every

Group Company.

3.The Executive accepts that the Company may require him to perform duties for any

other Group Company, for part of his working time. In performing those duties,

clause 3.2.(d) will apply as if references to the Company are to the appropriate Group

Company. The Company will remain responsible for the payments and benefits the

Executive is entitled to receive under this Agreement.

4.The Executive will keep the Board (and, where appropriate the board of directors of

any other Group Company) fully informed of his conduct of the business, finances or

affairs of the Company or any other Group Company in a prompt and timely manner.

The Executive will provide information to the Board in writing if requested.

5.The Executive will promptly disclose to the Board full details of any wrongdoing by

any employee of any Group Company where he is aware of that wrongdoing and

where it is material to that relevant company or to the interests or reputation of any

Group Company.

6.Each year during the Employment, the Executive will, at the expense of the

Company, undergo a medical examination by a medical practitioner. If the Executive

becomes aware of any health issue which may impact on his ability to perform his

duties as Chief Executive, he will immediately notify the Chairman thereof.

7.The Board shall be entitled to appoint an interim Chief Executive and to vest in that

person the duties of Chief Executive in any case where the Executive is incapacitated

or unable to perform his duties.

4.Hours

1.The Executive will comply with the Company’s normal hours of work and will also

work any additional hours which may be reasonably necessary to perform his duties

to the satisfaction of the Board. The Executive will not receive any further

remuneration for any hours worked in addition to the normal working hours.

2.The Executive and the Company agree that, as the Executive is able to determine the

duration of his working time himself, Part 2 of the Organisation of Working Time Act

1997 shall not apply to his Employment under this Agreement.

5.Interests of the Executive

1.The Executive’s current interests (including all directorships and any shareholdings in

companies other than CRH plc) at the date of this Agreement are set out in Schedule

1. The Executive will be permitted to carry out any such disclosed interests during the

course of the Employment and to be paid and retain fees therefor, subject to the

limitations set out in clauses 3.2.(a) and 5.2. Any additional business involvements

that may arise or be offered to the Executive outside of the CRH Group will be

disclosed to, and be subject to, the agreement of the Chairman.  While the Executive

is a member of the CRH Board of Directors, if such additional business involvements

4

are agreed by the Chairman, the approval of the CRH Board will also be required

prior to acceptance of any external Board position.

2.Subject to the permitted investments set out in clause 5.3, during the Employment the

Executive will not be directly or indirectly engaged or concerned in the conduct of

any activity in any  country in which the Company or any Group Company has

significant presence, which is similar to or competes with any activity carried on by

any Group Company (except as a representative of the Company or with the written

consent of the Board),

3.The Executive may not hold or be interested in investments which amount to more

than five per cent of the issued securities of any class of any one company which are

listed or quoted on any recognised Stock Exchange.

4.The Executive will (and will endeavour to procure that his spouse and dependent

children) comply with all rules of law, and rules or policies applicable to CRH plc

from time to time in relation to the holding or trading of securities in CRH plc.

6.Location

1.The Executive will work at the principal office of the Company where he will be

expected to be based. He will also be required to travel and work outside Ireland.

7.Salary and Benefits

1.The Company will pay the Executive a basic salary of € 1,709,442 per annum (less

any deductions which the Company is required by law to make). Salary will be paid

monthly in arrears and will accrue from day to day. The Executive’s basic salary will

be reviewed annually by the Board Remuneration Committee, such review not to

result in a basic salary lower than the salary in the previous year unless otherwise

agreed with the Executive.

2.The basic salary referred to in clause 7.1 includes director’s fees from Group

Companies and any other companies in which the Executive is required to accept a

directorship under the terms of this Employment. To achieve this:

(a)the Executive will repay any fees he receives to the Company; or

(b)his salary will be reduced by the amount of those fees; or

(c)a combination of the methods set out in clauses 7.2(a) and 7.2(b) will be

applied.

3.The Executive is entitled to 28 days’ paid holiday each calendar year of the Company

(in addition to other public holidays), to be taken at times to be agreed in advance

with the Chairman. Holiday entitlement will accrue on a pro-rated basis. For part

calendar years, the Executive’s holiday entitlement for the year will be pro-rated to

the length of his service in that year. The Company may require the Executive to take

any accrued holiday during any notice period. If, on the Termination Date, the

Executive has exceeded his accrued holiday entitlement, the excess may be deducted

from any sums due to him.

4.If the Executive is absent from work due to sickness or injury which is caused by the

fault of another person, and as a consequence recovers from that person or another

person any sum representing compensation for loss of salary under this Agreement,

the Executive will repay to the Company any money it has paid to him as salary in

respect of the same period of absence.

5.The Executive will be eligible to receive an annual bonus of up to 225% of basic

annual salary, with a target of 112.5%, which will be tied to performance targets set

from time to time and to the achievement of agreed personal objectives. The bonus is

subject to a share deferral annually as may be determined by the Board Remuneration

Committee. Any bonus will be paid to the Executive in accordance with any bonus

5

plan rules from time to time in force less any deductions which the Company is

required by law to make and may be refundable in circumstances determined by the

company.

6.The Executive will be eligible to participate in the CRH 2014 Performance Share

Plan (or any successor or replacement plan approved by shareholders) up to 365% of

basic annual salary in accordance with the rules of that plan.

7.The Company will provide the Executive with a suitable motor car the cost of which

shall be subject to the approval of the Chairman (together with the right to use such

car for business or private purposes on such terms as to private use as the Board of

Directors of the Company may from time to time direct) and will discharge the road

tax and insurance premiums payable thereon together with all running expenses

incurred in connection with travelling in Ireland with the exception of costs

associated with traffic violations which will be the responsibility of the driver. While

the car shall remain the property of the Company the Executive shall ensure that at all

times when it is driven it is in the state and condition required by law. The Executive

shall ensure that the car is properly maintained and shall on the termination of this

Contract, return the car in a roadworthy condition to the Company without delay.

8.The Executive will be covered by the Group’s Directors and Officers liability

insurance on the same basis as other members of the Board.

9.The Executive will be provided with cover under a medical scheme for his benefit

and for the benefit of his wife and dependent children, subject to the terms of the

relevant health insurance scheme from time to time. The Executive understands that

any claim he may have in respect of the Scheme will be against the insurer, not the

Group.

10.The Executive will be covered for a Death-in-Service Lump Sum Benefit of three

times gross basic annual salary subject to the terms of the insurance policy in place

from time to time.

11.The Executive is eligible to receive long term disability cover of 2/3rd of gross annual

basic salary less the state disability pension (the “Disability Cover”). The Disability

Cover is subject to the terms and conditions of the insurer’s policy in place from time

to time.  The Executive is admitted to the Company’s insured scheme as at the date of

execution of this agreement.  If the maximum benefit payable is lower than the

Disability Cover then the Company shall pay the Executive the difference between

the amount received and the Disability Cover for the duration of the insured claim

provided always that the Executive is not receiving in excess of the Disability Cover

at any time. In the event that the Company does not have a Disability Cover policy in

place with an insurance provider, the Company shall operate a Disability Cover

Scheme pursuant to which the Executive will be eligible to receive Disability Cover,

subject to the relevant terms and conditions of the Company’s scheme.

12.In the case of incapacity to attend work due to illness or injury, the Executive will be

paid sick pay consisting of full remuneration (other than in respect of bonus and other

incentive arrangements, for which the discretion of the Board Remuneration

Committee will remain) up to six months, less statutory sick pay and any other social

welfare benefits in any 12 month rolling period. As a condition of payment a medical

doctor must certify absence from work in excess of two days. Medical certificates

must be submitted to the Company on the third day of absence and weekly thereafter.

The Company reserves the right to refer the Executive for a medical examination, to

determine the state of his health, and/or physical or mental capability to carry out his

duties, at any time during his employment, and to receive a report thereon.

13.The Company will reimburse the Executive’s annual subscription fee to a

professional institution relevant to his role in the Company (the Company to

determine at its sole discretion whether membership of a professional institution is

relevant). Full membership details and receipt will be required.

6

8.Shareholding Requirements

1. In accordance with the remuneration policies applied by the Board Remuneration

Committee from time to time, the Executive shall be required to maintain certain

shareholding requirements, which may include a required ownership percentage for

the duration of his employment and a minimum post-employment required ownership

percentage of common stock in CRH Plc. The terms of these shareholding

requirements shall be determined from time to time by the Board Remuneration

Committee and communicated to the Executive accordingly.

2.The Board Remuneration Committee of CRH plc shall be responsible for the

administration of the requirements contained in this clause 8 and shall determine the

appropriate means of enforcing its provisions which may include the withholding of

shares by CRH plc or considering the Executive in breach of his obligations under

this agreement. Should the Executive breach this requirements of this Agreement as a

result of an unexpected and precipitous decrease in the CRH share price, the

Executive shall remedy the breach as soon as reasonably possible. The Board

Remuneration Committee shall have the discretion to determine, in consultation with

the Executive, a reasonable time period in which the Executive must remedy the said

breach.

9.Expenses

1.The Company will refund to the Executive all reasonable expenses properly incurred

by him in performing his duties under this Agreement, provided that these are

incurred in accordance with Company expenses policy from time to time. The

Company will require the Executive to produce receipts or other supporting

documents as proof that he has incurred any expenses he claims.

2.If the Executive is provided with a credit or charge card by the Company, this must

only be used for expenses which he incurs in performing the duties of the

Employment.

10.Confidentiality

1.Without prejudice to the common law duties which he owes to the Group, the

Executive agrees that he will not, except in the proper performance of his duties,

copy, use or disclose to any person any of the Group’s trade secrets, or confidential

information. This restriction will continue to apply after the termination of the

Employment without limit in time but will not apply to trade secrets or confidential

information which become public other than through unauthorised disclosure by the

Executive. The Executive will use his best endeavours to prevent the unauthorised

copying use or disclosure of such information.  Notwithstanding anything to the

contrary in this Agreement or otherwise, nothing shall limit the Executive’s rights

under applicable law to provide truthful information to any governmental entity or to

file a charge with or participate in an investigation conducted by any governmental

entity. Nothing in this Agreement shall be read as requiring the Executive to waive

any right the Executive may have to receive an award for information provided to any

governmental entity.

2.For the purposes of this Agreement, trade secrets and confidential information include

but will not be limited to technical information, intellectual property, business and

marketing plans, strategies, customer information, software, other information

concerning the products, promotions, development, financing, expansion plans,

business policies and practices of the Group and other forms of information

considered by the Group to be confidential and in the nature of trade secrets

(including, without limitation, ideas, research and development, know-how, formulas,

technical data, designs, drawings, specifications, customer and supplier lists, pricing

and cost information and business and marketing plans and proposals) and any other

information in whatever form (written, oral, visual and electronic) concerning the

confidential affairs of the Group. In the course of the Employment the Executive is

likely to obtain trade secrets and confidential information belonging or relating to

other Group Companies and other persons. He will treat such information as if it falls

7

within the terms of clause 10.1 and clause 10.2 will apply with any necessary

amendments to such information. If requested to do so by the Group, the Executive

will enter into an agreement with other Group Companies and any other persons in

the same terms as clause 10.1 with any amendments necessary to give effect to this

provision.

11.Intellectual Property Rights

1.For the purposes of this clause, “Intellectual Property” means patents, trade marks,

service marks, registered designs (including applications for and rights to apply for

any of them), inventions, unregistered design rights, logos, trade or business names,

copyrights, database rights, confidential information, knowhow and any similar rights

in any country.

2.The Executive acknowledges that (i) it is part of his normal duties to develop the

products and services of the Group; and (ii) because of the nature of his position he

has a special obligation to further the interests of the Group. All Intellectual Property

which the Executive develops or produces in the course of his Employment duties, or

outside such duties but relating to the business of the Group, will be owned by the

Company to the fullest extent permitted by law. The Executive agrees, at the

Company’s expense, to sign all documents and carry out all such acts as will be

necessary to vest such Intellectual Property in the Company, and to obtain protection

and enforce the Company’s rights anywhere in the world. The Executive also hereby

waives all moral rights in all Intellectual Property which is owned by the Company,

or will be owned by the Company, further to this clause. The Executive will not copy,

disclose or make use of any Intellectual Property belonging to the Company (whether

or not subject to this clause) except to the extent necessary for the proper performance

of his duties. Rights and obligations under this clause will continue after the

termination of this Agreement in respect of all Intellectual Property arising during the

Employment.

12.Termination and Suspension

1.The Employment will continue until terminated by either party giving written notice

at any time as set out in clause 12.2.

2.Each of the Company and the Executive may terminate the Employment by giving to

the other not less than twelve months’ written notice.

3. In the event that written notice is served by either party in accordance with Clause

12.2 at any time following the date of execution of this contract, the Executive’s

employment will be deemed to have terminated by reason of retirement.

4.The Company may at its sole and absolute discretion pay a sum equal to the

Executive’s full remuneration (other than in respect of bonus, performance share plan

and other incentive arrangements, for which the discretion of the Board Remuneration

Committee will remain) in lieu of any unexpired period of notice (less any deductions

the Company is required by law to make).

5.Notwithstanding the other provisions of the Agreement, the Company may terminate

the Employment by giving written notice to take immediate effect if the Executive

does not perform the duties of the Employment for a period of 120 consecutive days

or 180 days (whether or not consecutive) in any period of 365 days because of

sickness, injury or other incapacity. Notice can be given whilst the Executive

continues not to perform his duties or on expiry of the 120 or 180 day period. In this

clause, ‘days’ includes Saturdays, Sundays and public holidays. The Employment

will not be terminated under this clause 12.5 if to do so would operate to deprive the

Executive of benefits in payment under any permanent health insurance policy

provided by the Company.

8

6.Notwithstanding the other provisions of the Agreement, the Company may terminate

the Employment by giving written notice to take immediate effect if the Executive:

(a)commits any serious or persistent breach of his material obligations under

this Agreement: or

(b)is guilty of any gross misconduct which is materially injurious or causes

financial or reputational harm to any Group Company; or

(c)is guilty of dishonesty or is convicted of an offence (other than a motoring

offence which does not result in imprisonment) whether in connection with

the Employment or otherwise; or

(d)commits (or is reasonably believed by the Board to have committed) a

material breach of any relevant legislation in force which may affect or relate

to the business of any Group Company; or

(e)becomes of unsound mind, is bankrupted or has a receiving order made

against him or makes any general composition with his creditors or takes

advantage of any statute affording relief for insolvent debtors; or

(f)becomes disqualified from being a director of a company or if the

Executive’s directorship of the Company terminates without the consent or

concurrence of the Company.

7.Where the Company terminates the Employment by giving written notice to take

immediate effect in accordance with clause 12.6, for the avoidance of doubt there is

no obligation to give notice as set out in clause 12.2 or any other period of notice or

to make any payment in lieu of notice.

8.When the Employment terminates, the Company may deduct from any money due to

the Executive (including remuneration) any amount which he owes to any Group

Company.

9.The Board may suspend the Executive from the Employment on full remuneration

(other than in respect of bonus, performance share plan and other incentive

arrangements for which the discretion of the Remuneration Committee will remain) at

any time and for any reason to investigate any matter in which the Executive appears

to be involved (whether directly or indirectly) and to conduct any related disciplinary

proceedings.

13.Garden Leave

1.At any time after notice to terminate the Employment is given by either party under

clause 12 above, or if the Executive resigns without giving due notice and the

Company does not accept his resignation, the Company may, at its absolute

discretion, require the Executive to take a period of absence, called garden leave, for

some or all of the remaining period of notice pursuant to clause 12, which for the

avoidance of doubt could be for a maximum period of 12 months (pursuant to clause

12.2) (the “Garden Leave Period”). The provisions of this clause shall apply to any

Garden Leave Period. During the Garden Leave Period, the Executive will be entitled

to receive full remuneration (other than in respect of bonus, performance share plan

and other incentive arrangements for which the discretion of the Board Remuneration

Committee will remain) in accordance with the terms of this Agreement, any unused

holiday accrued at the commencement of the Garden Leave Period and any holiday

accrued during any such period will be deemed to be taken by the Executive during

the Garden Leave Period. At the end of the Garden Leave Period, the Company may,

at its sole and absolute discretion, pay the Executive full remuneration (other than in

respect of bonus and other incentive arrangements for which the discretion of the

Board Remuneration Committee will remain) in lieu of the balance of any period of

notice given by the Company or the Executive (less any deductions the Company is

required by law to make),

9

2.The Company may require that the Executive will not, without prior written consent

of the Board or as otherwise permitted pursuant to clause 5 above, be employed or

otherwise engaged in the conduct of any activity, whether or not of a business nature,

during the Garden Leave Period and further, if so requested by the Company, the

Executive will not:

(a)enter or attend the premises of the Company or any other Group Company; or

(b)contact or have any communication with any customer or client of the

Company or any other Group Company in relation to the business of the

Company or any other Group Company (other than purely social contact); or

(c)contact or have any communication with any employee, officer, director,

agent or consultant of the Company or any other Group Company in relation

to the business of the Company or any other Group Company (other than

purely social contact); or

(d)remain or become involved in any aspect of the business of the Company or

any other Group Company except as required by such companies.

3.During the Garden Leave Period, the Company may require the Executive:

(a)to comply with the provisions of clause 16; and

(b)to immediately resign from any directorship, trusteeships or other offices

which he holds in the Company, any other Group Company or any other

company where such directorship or other office is held as a consequence or

requirement of the Employment, unless he is required to perform duties to

which any such directorship, trusteeship or other office relates in which case

he may retain such directorships, trusteeship or other offices while those

duties are ongoing. The Executive hereby irrevocably appoints the Company

to be his attorney to execute any instrument and do anything in his name and

on his behalf to effect his resignation if he fails to do so in accordance with

this clause 13.3.(b).

4.During the Garden Leave Period:

(a)the Executive shall provide such assistance as the Company or any Group

Company may require to effect an orderly handover of his responsibilities to

any individual or individuals appointed by the Company or any Group

Company to take over his role or responsibilities;

(b)the Executive shall make himself available to deal with requests for

information, provide assistance, be available for meetings and to advise on

matters relating to work (unless the Company has agreed that the Executive

may be unavailable for a period); and

(c)the Company may appoint another person to carry out his duties in

substitution for the Executive.

5.All duties of the Employment (whether express or implied), including without

limitation the Executive’s duties of fidelity, good faith and exclusive service, shall

continue throughout the Garden Leave Period save as expressly varied by this clause

13. The Executive agrees that the exercise by the Company of its rights pursuant to

this clause 13 shall not entitle the Executive to claim that he has been constructively

dismissed provided that the Company complies with its obligations under this

Agreement.

14.Restrictions after Termination of Employment

1.In this clause:

10

“Capacity” means as agent, consultant, director, employee, owner, partner,

shareholder or in any other capacity

“Prohibited Area” means any country in which the Company or any Group

Company has a significant presence at the Relevant Date;

“Restricted Business” those parts of the business of any Group Company with which

the Executive (and/or persons reporting to the Executive) were involved to a material

extent in the twelve months prior the date of commencement of Garden Leave or the

Termination Date whichever is the earlier;

“Restricted Customer” any firm, company or person who, during the twelve months

immediately  prior to the date of commencement of Garden Leave or the Termination

Date whichever is the earlier date, was a customer of or in the habit of dealing with

any Group Company or with whom any Group Company was in the process of

negotiating in relation to the business of any such Group Company and in each case

with whom you (and/or persons reporting to you) had contact or about whom you

became aware or informed in the course of your employment;

“Restricted Person” anyone employed or engaged by any Group Company who

could materially damage the interests of the relevant Group Company if that person

were to be involved in any Capacity in any business concern which competes with

any Restricted Business, and with whom the Executive (and/or persons reporting to

the Executive) dealt in the twelve months immediately prior to the date of

commencement of Garden Leave or the Termination Date whichever is the earlier;

“Relevant Date” means the Termination Date or, if earlier, the date on which the

Executive commences any Garden Leave Period; and

“Restricted Period” means the period of

(a)nine months for the purpose of clause 14.2 (c); and

(b)twelve months for any other purpose;

in either case less any Garden Leave Period, commencing on the Relevant Date, save

that in the event the Restricted Period less any Garden Leave Period would result in

no period of time or a negative period of time, then for the purposes of this clause 14

there will be deemed to be no further Restricted Period.

2.The Executive is likely to obtain trade secrets and confidential information and

personal knowledge of and influence over customers and employees of the Group

during the course of the Employment. To protect these interests, the Executive

covenants with the Company (for itself and as a trustee and agent for each Group

Company) that the Executive will not, without the prior written consent of the Chair,

during the Restricted Period:

(a)in the course of any business concern which is in competition with any

Restricted Business, offer to employ or engage or otherwise endeavour to

entice away from any Group Company any Restricted Person; and or

(b)for the Restricted Period, be involved with the provision of goods or services

to (or otherwise have any business dealings with) any Restricted Customer in

the course of any business concern which is in competition with any

Restricted Business; and/or

11

(c)in any Capacity within any  country in which the Group operates, carry on or

be engaged, concerned or interested in or provide advice to any business

concern which is (or intends to be) in competition with any Restricted

Business.

3.Each of the paragraphs contained in clause 14.2 constitutes an entirely separate and

independent covenant. If any covenant is found to be invalid this will not affect the

validity or enforceability of any of the other covenants.

4.Following the Termination Date, the Executive will not represent himself as being in

any way connected with the businesses of the Company or of any other Group

Company (except to the extent agreed by such a company) and neither shall the

Executive disparage the Company or its directors, officers, employees or agents.

5.Any benefit given or deemed to be given by the Executive to any Group Company

under the terms of clause 14 is received and held on trust by the Company for the

relevant Group Company. The Executive will enter into appropriate restrictive

covenants directly with other Group Companies if asked to do so by the Company.

6.The Executive agrees that if in the course of his employment or thereafter during the

continuance in force of the restrictions set out in this clause 14, the Executive

receives an offer of employment from any Person, the Executive will immediately

provide that person with a complete and accurate copy of this Agreement.

15.(a) Offers on Liquidation

The Executive will have no claim against the Company or any Group Company if the

Employment is terminated by reason of liquidation in order to reconstruct or

amalgamate the Company or by reason of any reorganisation of the Company and the

Executive is offered employment with the company succeeding to the Company upon

such liquidation or reorganization and the new terms of employment offered to the

Executive are no less favourable to him than the terms of this agreement.

(b) Change of Control

The Executive shall be entitled to terminate his employment by giving to the

Company not less than thirty days prior notice at any time within six months after a

change in control of CRH plc, if the Executive has reasonable grounds to contend that

such change of control has resulted or will result in a diminution of his powers, duties

or functions in relation to CRH plc. Upon such termination the Company shall make

to the Executive in extinction of all and any claims which the Executive may have in

respect of the termination of his employment a payment which (subject to the

deduction of tax and other statutory payments as required by law and any other sums

owed by the Executive to the Company or any Group company) is equal to one years’

remuneration, provided that the Executive accepts such payment in full and final

discharge and satisfaction of such (if any) equitable, statutory, contractual and other

common law rights, claims and demands as the Executive may have against the

Company and any Group company. For the purpose of this clause, the Executive’s

remuneration will be calculated as inclusive of his then current base salary, any

Vested Awards due under the incentive scheme and the cost to the employer of

providing all other current contractual benefits which will otherwise be ongoing in

nature. The treatment of any annual bonus or Unvested Awards will remain at the

discretion of the Board Remuneration Committee in accordance with the provisions

of the bonus plan and the rules of the relevant scheme. For the purposes of this Clause

a change in control of CRH plc shall be deemed to have occurred if a person or

persons acting in concert acquires, directly or indirectly, shares in CRH plc which,

when aggregated with any existing holding by such person or persons, carries more

12

than fifty percent (50%) of the voting rights of CRH plc; and in this sub-clause

“person” includes a partnership, company, statutory corporation or other body

corporate.

In the event of a dispute between the parties as to whether a change in control of CRH

plc has occurred or has resulted or will result in a diminution of the Executive’s

powers, duties or functions in relation to CRH plc, the parties hereto shall, at the

request of the Executive and in advance of the termination of his employment refer

such dispute to a third party for decision. Any such dispute between the parties

concerning or relating to the provisions of this Clause shall be referred to such a third

party as the parties hereto may mutually agree in writing or, in the default of

agreement, to such independent third party as shall be nominated by the President for

the time-being of the Institute of Chartered Accountants in Ireland (hereinafter called

the “third party”). Once the third party has been agreed or appointed as aforesaid,

each of the parties hereto shall, within 10 days of the date thereof, furnish written

submissions to the third party setting out their respective positions in relation to the

matters in dispute. The third party may, if he or she deems it appropriate to do so,

convene a meeting with the parties after receipt of such written submissions. After the

third party has heard the parties and/or considered their written submissions, he or she

shall make a determination of all matters in dispute. In making such determination,

the third party’ shall act as an expert and not as an arbitrator. The decision of the third

party shall be final and binding on both parties save in the case of manifest error. The

costs incurred by the third party shall be discharged by the Company.

16.Return of Company Property

1.Any time during the Employment (at the request of the Company) and in any event

when the Employment terminates, the Executive will immediately return to the

Company:

(a)all documents and other materials (whether originals or copies) made or

compiled by or delivered to the Executive during the Employment and

concerning all the Group Companies. The Executive will not retain any

copies of any materials or other information; and

(b)all other property belonging or relating to any of the Group Companies.

2.If the Executive commences Garden Leave in accordance with clause 13, he may be

required to comply with the provisions of clause 16.1.

17.Directorships

1.The Executive’s office as a director of the Company or any other Group Company is

subject to the Constitution of the relevant company (as amended from time to time),

If the provisions of this Agreement conflict with the provisions of the Constitution

then the Constitution will prevail.

2.The Executive must resign from any office held in any Group Company if he is asked

to do so by the Company on the termination of the Employment.

3.If the Executive does not resign as an officer of a Group Company, having been

requested to do so in accordance with clause 17.2, the Company will be appointed as

his attorney to effect the resignation. By entering into this Agreement, the Executive

irrevocably appoints the Company as his attorney to act on his behalf to execute any

document or do anything in his name necessary to effect his resignation in accordance

with clause 17.2. If there is any doubt as to whether such a document (or other thing)

has been carried out within the authority conferred by this clause 17.3, a certificate in

writing (signed by any director or the secretary of the Company) will be sufficient to

prove that the act of thing falls within that authority.

13

4.During the Employment, the Executive will not do anything which could cause him to

be disqualified from continuing to act as a director of any Group Company.

18.Notices

1.Any notices given under this Agreement must be given by letter or email. Notice to

the Company must be addressed to the Chairman at the Company’s registered office

at the time the notice is given. Notice to the Executive must be given to him

personally or sent to his last known address.

2.Except for notices given by hand, notices given by post will be deemed to have been

given on the next working day after the day of posting and notices given by email will

be deemed to have been given in the ordinary course of transmission.

19.Data Protection

1.The Company holds personal information about you which is subject to the General

Data Protection Regulation (GDPR) and the Data Protection Acts 1988-2018. By

signing this Agreement you accept that the Company will process personal

information about you where it is necessary to do so in the normal course of the

employer/employee relationship and/or in the course of the legitimate business

interests pursued by the Company. In doing so, the Company may from time to time

require that the personal information is transferred within the Group both inside and

outside the European Union and also to third party service providers as necessary to

administer your employment (e.g. benefit providers) and as necessary for the

Company’s legitimate business interests (e.g. its professional advisers).

2.Your data will be retained for the duration of your employment plus an additional

period (typically 7 years but possibly longer) to address the relevant retention and

limitation periods determined by law. The Company will process your personal

information in accordance with data protection laws and you can consult the

Company’s Data Protection Policy (as may be amended from time to time) for details

about how to exercise rights in respect of data. The Company’s Data Protection

Policy provides detailed information on the processing of personal data.  The

Company will ensure that your information is accurate, kept up to date and not kept

for longer than is necessary and you agree to let the Company know of any material

change in such personal data (e.g. next of kin for emergency contact purposes).  The

Company will also take measures to safeguard your data against unauthorised or

unlawful processing and accidental loss or destruction or damage to the data and the

Company relies on you as an employee to comply with all applicable workplace

policies governing the use of Company facilities and the use and disclosure of data.

3.The Company reserves the right to monitor your use of Group facilities in exceptional

cases where the Company believes it is necessary to ensure compliance with

acceptable usage and other applicable policies therefore you should not assume that

workplace email communications are private. You are advised that where appropriate

and available, evidence such as CCTV footage, web-logs, etc. will be used by the

Company in the context of internal investigations and/or disciplinary proceedings.

20.Miscellaneous

1.This Agreement may be entered into in any number of counterparts, all of which

taken together shall constitute one and the same instrument. Any party may enter into

this Agreement by executing any such counterpart.

2.This Agreement may only be modified by the written agreement of the parties.

3.The Executive cannot assign this Agreement to anyone else.

4.References in this Agreement to rules, regulations, policies, handbooks or other

similar documents which supplement it or are referred to in it are references to the

14

versions or forms of the relevant documents as amended or updated from time to

time.

5.This Agreement supersedes any previous written or oral agreement between the

parties in relation to the matters dealt within it. It contains the whole agreement

between the parties relating to the Employment at the date the agreement was entered

into (except for those terms implied by law which cannot be excluded by the

agreement of the parties). The Executive acknowledges that he has not been induced

to enter into this Agreement by any representation, warranty or undertaking not

expressly incorporated into it. The Executive agrees and acknowledges that his only

rights and remedies in relation to any representation, warranty or undertaking made or

given in connection with this Agreement (unless such representation, warranty or

undertaking was made fraudulently) will be for breach of the terms of this

Agreement, to the exclusion of all other rights and remedies. By signing the

Agreement, the Executive acknowledges that he does so with full understanding of its

meaning and effect and with the benefit of independent legal advice.

6.Neither party’s rights or powers under this agreement will be affected if:

(a)one party delays in enforcing any provision of this Agreement; or

(b)one party grants time to the other party.

7.References to any statutory provisions include any modifications or re-enactments of

those provisions.

8.Headings will be ignored in construing this Agreement.

9.If either party agrees to waive his rights under a provision of this Agreement, that

waiver will only be effective if it is in writing and it is signed by him. A party’s

agreement to waive any breach of any term or condition of this Agreement will not be

regarded as a waiver of any subsequent breach of the same term or condition or a

different term or condition.

10.The Executive will at all times comply with the Rules of any Exchange in which

CRH plc is listed and any corporate governance rules and standards affecting CRH

plc.

11.The Executive acknowledges and agrees that any compensation payable pursuant to

or contemplated by this Agreement shall be subject to reduction, cancellation,

forfeiture or recoupment in accordance with the terms of any Company Clawback

policy approved by the CRH Board or any delegated Committee in effect from time

to time or applicable law.

12.This Agreement is governed by and will be interpreted in accordance with the laws of

Ireland. Each of the parties submits to the jurisdiction of the courts of Ireland as

regards any claim or matter arising under this agreement.

15

PRESENT when the Common Seal of

CRH Group Services Limited was affixed hereto

/s/ Richie Boucher

Authorised Signatory/ Director

/s/ Neil Colgan

Company Secretary/ Director

SIGNED by Albert Manifold

in the presence of:

/s/ Albert Manifold

Albert Manifold

Witness’s signature:[*****]

Name  Address:[*****]

Occupation:[*****]

16

Schedule 1

INTERESTS OF EXECUTIVE

[Intentionally Omitted]

Exhibit 10.27 - Group Chief Financial Officer Service Agreement (J. Mintern) 1

EXHIBIT 10.27

Dated  6 DECEMBER  2023

CRH Group Services Limited

and

Denis James Mintern

_____________________________________________________

CHIEF FINANCIAL OFFICER SERVICE AGREEMENT

_____________________________________________________

2

This Agreement is made on December 6, 2023 between

(1)CRH Group Services Limited incorporated in the Ireland whose registered office is at 42

Fitzwilliam Square, Dublin 2 (the “Company”); and

(2)Denis James Mintern of [*****] (the “Executive”).

This Agreement records the terms on which the Executive will serve the Group as its Chief

Financial Officer.

1.Interpretation

In this Agreement (and any schedules to it):

“Board” means the board of directors of CRH plc from time to time or anyone/any

person or committee nominated by the board of directors as its representative for the

purposes of this Agreement;

“Chief Executive” means Chief Executive of CRH plc for the time being;

“Employment” means the employment governed by this Agreement;

“Group” means the Company, any Associated Company and any undertakings which

are subsidiary undertakings or holding undertakings of any Associated Company, and

each undertaking which is a member of the Group shall be a “Group Company”;

“Person” means any individual person, firm, company, partnership, unincorporated

association, joint venture or other legal entity; and

“Termination Date” means the date on which the Employment terminates.

2.Commencement of Employment as Chief Financial Officer

1.The Employment of the Executive under this Agreement commenced on 1 June 2021

(the ‘Commencement Date”). The Employment will continue thereafter, unless and

until it is terminated or terminates in accordance with the provisions of this

Agreement. It is acknowledged that the Executive has previously been continuously

employed in different roles by the Group since April 2002.

3.Appointment and Duties of the Executive

1.The Executive will serve as Chief Financial Officer.

2.The Executive will:

(a)subject as provided for in clause 5.1, devote all of his working time, attention

and skill to the Employment;

3

(b)carry out the duties customarily carried out by a Chief Financial Officer and

such duties as may be assigned to him by the Chief Executive or the Board;

(c)properly perform his duties and exercise his powers;

(d)accept any offices or directorships in/with Group Companies as reasonably

required by the Board;

(e)comply with all applicable rules and regulations issued by the Company from

time to time;

(f)obey the reasonable and lawful directions of the Chief Executive and the

Board; and

(g)use his best endeavours to promote the interests and reputation of every

Group Company.

3.The Executive accepts that the Company may require him to perform duties for any

other Group Company, for part of his working time. In performing those duties,

clause 3.2. (e) will apply as if references to the Company are to the appropriate Group

Company. The Company will remain responsible for the payments and benefits the

Executive is entitled to receive under this Agreement.

4.The Executive will keep the Chief Executive fully informed of the discharge of his

duties in a prompt and timely manner. The Executive will provide information to the

Chief Executive in writing if requested.

5.The Executive will promptly disclose to the Chief Executive full details of any

wrongdoing by any employee of any Group Company where he is aware of that

wrongdoing and where it is material to that relevant company or to the interests or

reputation of any Group Company.

6.Each year during the Employment, the Executive will, at the expense of the

Company, undergo a medical examination by a medical practitioner. If the Executive

becomes aware of any health issue which may impact on his ability to perform his

duties, he will immediately notify the Chief Executive thereof.

7.The Company shall be entitled to appoint an interim Chief Financial Officer and to

vest in that person the duties of Chief Financial Officer in any case where the

Executive is incapacitated or unable to perform his duties.

8.The Executive shall serve the Company as Chief Financial Officer or in any other

executive capacity as the Executive and the Company may agree from time to time.

4.Hours

1.The Executive will comply with the Company’s normal hours of work and will also

work any additional hours which may be reasonably necessary to perform his duties

to the satisfaction of the Chief Executive. The Executive will not receive any further

remuneration for any hours worked in addition to the normal working hours.

2.The Executive and the Company agree that, as the Executive is able to determine the

duration of his working time himself, Part 2 of the Organisation of Working Time Act

1997 shall not apply to his Employment under this Agreement.

4

5.Interests of the Executive

1.The Executive’s current interests (including all directorships and any shareholdings in

companies other than CRH plc) at the date of this Agreement are set out in Schedule

1. The Executive will be permitted to carry out any such disclosed interests during the

course of the Employment and to be paid and retain fees therefor, subject to the

limitations set out in clauses 3.2.(a) and 5.2. Any additional business involvements

that may arise or be offered to the Executive outside of the CRH Group will be

disclosed to, and be subject to, the agreement of the Chief Executive. While the

Executive is a member of the CRH Board of Directors, if additional business

involvements are agreed by the Chief Executive, the approval of the CRH Board will

also be required prior to acceptance of any external Board positions.

2.Subject to the permitted investments set out in clause 5.3, during the Employment the

Executive will not be directly or indirectly engaged or concerned in the conduct of

any activity in any country in which the Company or any Group Company has

significant presence, which is similar to or competes with any activity carried on by

any Group Company (except as a representative of the Company or with the written

consent of the Board).

3.The Executive may not hold or be interested in investments which amount to more

than five per cent of the issued securities of any class of any one company which are

listed or quoted on any recognised Stock Exchange.

4.The Executive will (and will endeavour to procure that his spouse and dependent

children) comply with all rules of law, and rules or policies applicable to CRH plc

from time to time in relation to the holding or trading of securities in CRH plc.

6.Location

1.The Executive will work at the principal office of the Company (currently

Stonemasons Way, Rathfarnham, Dublin 16) where he will be expected to be based.

He will also be required to travel and work outside Ireland. The Company reserves

the right to transfer the Executive to another location within Ireland in accordance

with business requirements. In the event of such a transfer there will be no relocation

package offered, however depending upon the distance of the move, assistance may

be provided under the Relocation Policy in operation at the time.

7.Salary and Benefits

1.The Company will pay the Executive a basic salary of €891,182 per annum (less any

deductions which the Company is required by law to make). Salary will be paid

monthly in arrears and will accrue from day to day.

Salaries are reviewed annually by the CEO and Board Remuneration Committee;

such review not to result in a basic salary lower than the salary in the previous year

unless otherwise agreed with the Executive.

2.The basic salary referred to in clause 7.1 includes director’s fees from Group

Companies and

any other companies in which the Executive is required to accept a directorship under

the terms of this Employment. To achieve this:

(a)the Executive will repay any fees he receives to the Company; or

(b)his salary will be reduced by the amount of those fees; or

(c)a combination of the methods set out in clauses 7.2(a) and 7.2.(b) will be

applied.

5

3.The Executive is entitled to 28 days’ paid holiday each calendar year of the Company

(in addition to other public holidays), to be taken at times to be agreed in advance

with the Chief Executive. Holiday entitlement will accrue on a pro-rated basis

(including two days on which the Company is closed (Good Friday and Christmas

Eve) where Christmas Eve falls between Monday and Friday). For part calendar

years, the Executive’s holiday entitlement for the year will be pro-rated to the length

of his service in that year. The Company may require the Executive to take any

accrued holiday during any notice period. If, on the Termination Date, the Executive

has exceeded his accrued holiday entitlement, the excess may be deducted from any

sums due to him.

4.If the Executive is absent from work due to sickness or injury which is caused by the

fault of another person, and as a consequence recovers from that person or another

person any sum representing compensation for loss of salary under this Agreement,

the Executive will repay to the Company any money it has paid to him as salary in

respect of the same period of absence.

5.The Executive will be eligible to receive an annual bonus of up to 200% of basic

annual salary, with a target of 100%, which will be tied to performance targets set

from time to time and to the achievement of agreed personal objectives. The bonus is

subject to a share deferral annually as may be determined by the Board Remuneration

Committee. Any bonus will be paid to the Executive less any deductions which the

Company is required by law to make and may be refundable in circumstances

determined by the company.

6.The Executive will be eligible to participate in the CRH 2014 Performance Share

Plan (or any successor or replacement plan approved by shareholders) up to 250% of

basic annual salary in accordance with the rules of that plan.

7.The Executive will receive a basic Car Allowance of €20,000 gross per annum (less

any deductions which the Company is required by law to make) payable monthly

together with the Executive’s normal salary payment.

8.Having already reached the Irish pension cap, the Executive will receive a taxable

pension cash adjustment calculated as 10% of annual base salary. This will be paid

monthly together with the Executive’s normal salary payment.

9.The Executive will be covered for a Death-in-Service Lump Sum Benefit of three

times gross basic annual salary subject to the terms of the insurance policy in place

from time to time.

10.The Executive will be covered by the Group’s Directors and Officers liability

insurance on the same basis as other members of the Board.

11.The Executive will be provided with cover under a medical scheme for his benefit

and for the benefit of his wife and dependent children, subject to the terms of the

relevant health insurance scheme from time to time. The Executive understands that

any claim he may have in respect of the Scheme will be against the insurer, not the

Group.

12.In the case of incapacity to attend work due to illness or injury, the Executive will be

paid sick pay consisting of full remuneration (other than in respect of bonus and other

incentive arrangements, for which the discretion of the Board Remuneration

Committee will remain) up to six months, less statutory sick pay and any other social

welfare benefits in any 12 month rolling period. As a condition of payment a medical

doctor must certify absence from work in excess of two days. Medical certificates

must be submitted to the Company on the third day of absence and weekly thereafter.

The Company reserves the right to refer the Executive for a medical examination, to

determine the state of his health, and/or physical or mental capability to carry out his

duties, at any time during his employment, and to receive a report thereon.

13.The Executive is eligible to receive long term disability cover of 2/3rd of gross annual

basic salary less the state disability pension (the “Disability Cover”). The Disability

6

Cover is subject to the terms and conditions of the insurer’s policy in place from time

to time.  The Executive is admitted to the Company’s insured scheme as at the date of

execution of this agreement.  If the maximum benefit payable is lower than the

Disability Cover then the Company shall pay the Executive the difference between

the amount received and the Disability Cover for the duration of the insured claim

provided always that the Executive is not receiving in excess of the Disability Cover

at any time. In the event that the Company does not have a Disability Cover policy in

place with an insurance provider, the Company shall operate a Disability Cover

Scheme pursuant to which the Executive will be eligible to receive Disability Cover,

subject to the relevant terms and conditions of the Company’s scheme.

14.The Company will reimburse the Executive’s annual subscription fee to a

professional institution relevant to his role in the Company (the Company to

determine at its sole discretion whether membership of a professional institution is

relevant). Full membership details and receipt will be required.

8.Shareholding Requirements

1.In accordance with the remuneration policies applied by the Board Remuneration

Committee from time to time, the Executive shall be required to maintain certain

shareholding requirements, which may include a required ownership percentage for

the duration of his employment and a minimum post-employment required ownership

percentage of common stock in CRH Plc. The terms of these shareholding

requirements shall be determined from time to time by the Board Remuneration

Committee and communicated to the Executive accordingly.

2.The Board Remuneration Committee of CRH plc shall be responsible for the

administration of the requirements contained in this clause 8 and shall determine the

appropriate means of enforcing its provisions which may include the withholding of

shares by CRH plc or considering the Executive in breach of his obligations under

this agreement. Should the Executive breach this requirements of this Agreement as a

result of an unexpected and precipitous decrease in the CRH share price, the

Executive shall remedy the breach as soon as reasonably possible. The Board

Remuneration Committee shall have the discretion to determine, in consultation with

the Executive, a reasonable time period in which the Executive must remedy the said

breach.

9.Expenses

1.The Company will refund to the Executive all reasonable expenses properly incurred

by him in performing his duties under this Agreement, provided that these are

incurred in accordance with Company expenses policy from time to time. The

Company will require the Executive to produce receipts or other supporting

documents as proof that he has incurred any expenses he claims.

2.If the Executive is provided with a credit or charge card by the Company, this must

only be used for expenses which he incurs in performing the duties of the

Employment.

10.Confidentiality

1.Without prejudice to the common law duties which he owes to the Group, the

Executive agrees that he will not, except in the proper performance of his duties,

copy, use or disclose to any person any of the Group’s trade secrets, or confidential

information. This restriction will continue to apply after the termination of the

Employment without limit in time but will not apply to trade secrets or confidential

information which become public other than through unauthorised disclosure by the

Executive. The Executive will use his best endeavours to prevent the unauthorised

copying use or disclosure of such information.  Notwithstanding anything to the

contrary in this Agreement or otherwise, nothing shall limit the Executive’s rights

under applicable law to provide truthful information to any governmental entity or to

file a charge with or participate in an investigation conducted by any governmental

entity. Nothing in this Agreement shall be read as requiring the Executive to waive

7

any right the Executive may have to receive an award for information provided to any

governmental entity.

2.For the purposes of this Agreement, trade secrets and confidential information include

but will not be limited to technical information, intellectual property, business and

marketing plans, strategies, customer information, software, other information

concerning the products, promotions, development, financing, expansion plans,

business policies and practices of the Group and other forms of information

considered by the Group to be confidential and in the nature of trade secrets

(including, without limitation, ideas, research and development, know-how, formulas,

technical data, designs, drawings, specifications, customer and supplier lists, pricing

and cost information and business and marketing plans and proposals) and any other

information in whatever form (written, oral, visual and electronic) concerning the

confidential affairs of the Group. In the course of the Employment the Executive is

likely to obtain trade secrets and confidential information belonging or relating to

other Group Companies and other persons. He will treat such information as if it falls

within the terms of clause 10.1 and clause 10.1 will apply with any necessary

amendments to such information. If requested to do so by the Group, the Executive

will enter into an agreement with other Group Companies and any other persons in

the same terms as clause 10.1 with any amendments necessary to give effect to this

provision.

11.Intellectual Property Rights

1.For the purposes of this clause, “Intellectual Property” means patents, trade marks,

service marks, registered designs (including applications for and rights to apply for

any of them), inventions, unregistered design rights, logos, trade or business names,

copyrights, database rights, confidential information, knowhow and any similar rights

in any country.

2.The Executive acknowledges that (i) it is part of his normal duties to develop the

products and services of the Group; and (ii) because of the nature of his position he

has a special obligation to further the interests of the Group. All Intellectual Property

which the Executive develops or produces in the course of his Employment duties, or

outside such duties but relating to the business of the Group, will be owned by the

Company to the fullest extent permitted by law. The Executive agrees, at the

Company’s expense, to sign all documents and carry out all such acts as will be

necessary to vest such Intellectual Property in the Company, and to obtain protection

and enforce the Company’s rights anywhere in the world. The Executive also hereby

waives all moral rights in all Intellectual Property which is owned by the Company,

or will be owned by the Company, further to this clause. The Executive will not copy,

disclose or make use of any Intellectual Property belonging to the Company (whether

or not subject to this clause) except to the extent necessary for the proper performance

of his duties. Rights and obligations under this clause will continue after the

termination of this Agreement in respect of all Intellectual Property arising during the

Employment.

12.Termination and Suspension

1.The Employment will continue until terminated by either party giving written notice

at any time as set out in clause 12.2.

2.Each of the Company and the Executive may terminate the Employment by giving to

the other not less than twelve months’ written notice.

3.Notwithstanding the other provisions of this Agreement and in particular clause 12.2,

and unless otherwise agreed between the parties, the Employment will automatically

terminate on the Executive’s 65th birthday.

4.The Company may at its sole and absolute discretion pay a sum equal to the

Executive’s full remuneration (other than in respect of bonus, performance share plan

and other incentive arrangements, for which the discretion of the Board Remuneration

8

Committee will remain) in lieu of any unexpired period of notice (less any deductions

the Company is required by law to make).

5.Notwithstanding the other provisions of the Agreement, the Company may terminate

the Employment by giving written notice to take immediate effect if the Executive

does not perform the duties of the Employment for a period of 120 consecutive days

or 180 days (whether or not consecutive) in any period of 365 days because of

sickness, injury or other incapacity. Notice can be given whilst the Executive

continues not to perform his duties or on expiry of the 120 or 180 day period. In this

clause, ‘days’ includes Saturdays, Sundays and public holidays. The Employment

will not be terminated under this clause 12.5 if to do so would operate to deprive the

Executive of benefits in payment under any permanent health insurance policy

provided by the Company.

6.Notwithstanding the other provisions of the Agreement, the Company may terminate

the Employment by giving written notice to take immediate effect if the Executive:

(a)commits any serious or persistent breach of his material obligations under

this Agreement; or

(b)is guilty of any gross misconduct which is materially injurious or causes

financial or reputational harm to any Group Company; or

(c)is guilty of dishonesty or is convicted of an offence (other than a motoring

offence which does not result in imprisonment) whether in connection with

the Employment or otherwise; or

(d)commits (or is reasonably believed by the Board to have committed) a

material breach of any relevant legislation in force which may affect or relate

to the business of any Group Company; or

(e)becomes of unsound mind, is bankrupted or has a receiving order made

against him or makes any general composition with his creditors or takes

advantage of any statute affording relief for insolvent debtors; or

(f)becomes disqualified from being a director of a company or if the

Executive’s directorship of the Company terminates without the consent or

concurrence of the Company.

7.Where the Company terminates the Employment by giving written notice to take

immediate effect in accordance with clause 12.6, for the avoidance of doubt there is

no obligation to give notice as set out in clause 12.2 or any other period of notice or

to make any payment in lieu of notice.

8.When the Employment terminates, the Company may deduct from any money due to

the Executive (including remuneration) any amount which he owes to any Group

Company.

9.The Board may suspend the Executive from the Employment on full remuneration

(other than in respect of bonus, performance share plan and other incentive

arrangements for which the discretion of the Remuneration Committee will remain) at

any time and for any reason to investigate any matter in which the Executive appears

to be involved (whether directly or indirectly) and to conduct any related disciplinary

proceedings.

13.Garden Leave

1.At any time after notice to terminate the Employment is given by either party under

clause 12 above, or if the Executive resigns without giving due notice and the

Company does not accept his resignation, the Company may, at its absolute

discretion, require the Executive to take a period of absence, called garden leave, for

some or all of the remaining period of notice pursuant to clause 12, which for the

avoidance of doubt could be for a maximum period of 12 months (pursuant to clause

9

12.2) (the “Garden Leave Period”). The provisions of this clause shall apply to any

Garden Leave Period. During the Garden Leave Period, the Executive will be entitled

to receive full remuneration (other than in respect of bonus and other incentive

arrangements for which the discretion of the Board Remuneration Committee will

remain) in accordance with the terms of this Agreement, any unused holiday accrued

at the commencement of the Garden Leave Period and any holiday accrued during

any such period will be deemed to be taken by the Executive during the Garden

Leave Period. At the end of the Garden Leave Period, the Company may, at its sole

and absolute discretion, pay the Executive full remuneration (other than in respect of

bonus, performance share plan and other incentive arrangements for which the

discretion of the Board Remuneration Committee will remain) in lieu of the balance

of any period of notice given by the Company or the Executive (less any deductions

the Company is required by law to make).

2.The Company may require that the Executive will not, without prior written consent

of the Board or as otherwise permitted pursuant to clause 5 above, be employed or

otherwise engaged in the conduct of any activity, whether or not of a business nature,

during the Garden Leave Period and further, if so requested by the Company, the

Executive will not:

(a)enter or attend the premises of the Company or any other Group Company; or

(b)contact or have any communication with any customer or client of the

Company or any other Group Company in relation to the business of the

Company or any other Group Company (other than purely social contact); or

(c)contact or have any communication with any employee, officer, director,

agent or consultant of the Company or any other Group Company in relation

to the business of the Company or any other Group Company (other than

purely social contact); or

(d)remain or become involved in any aspect of the business of the Company or

any other Group Company except as required by such companies.

3.During the Garden Leave Period, the Company may require the Executive:

(a)to comply with the provisions of clause 16; and

(b)to immediately resign from any directorship, trusteeships or other offices

which he holds in the Company, any other Group Company or any other

company where such directorship or other office is held as a consequence or

requirement of the Employment, unless he is required to perform duties to

which any such directorship, trusteeship or other office relates in which case

he may retain such directorships, trusteeship or other offices while those

duties are ongoing. The Executive hereby irrevocably appoints the Company

to be his attorney to execute any instrument and do anything in his name and

on his behalf to effect his resignation if he fails to do so in accordance with

this clause 13.3.(b).

4.During the Garden Leave Period:

(a)the Executive shall provide such assistance as the Company or any Group

Company may require to effect an orderly handover of his responsibilities to

any individual or individuals appointed by the Company or any Group

Company to take over his role or responsibilities;

(b)the Executive shall make himself available to deal with requests for

information, provide assistance, be available for meetings and to advise on

matters relating to work (unless the Company has agreed that the Executive

may be unavailable for a period); and

(c)the Company may appoint another person to carry out his duties in

substitution for the Executive.

10

5.All duties of the Employment (whether express or implied), including without

limitation the Executive’s duties of fidelity, good faith and exclusive service, shall

continue throughout the Garden Leave Period save as expressly varied by this clause

13. The Executive agrees that the exercise by the Company of its rights pursuant to

this clause 13 shall not entitle the Executive to claim that he has been constructively

dismissed provided that the Company complies with its obligations under this

Agreement.

14.Restrictions after Termination of Employment

1.In this clause:

“Capacity” means as agent, consultant, director, employee, owner, partner,

shareholder or in any other capacity

“Prohibited Area” means any country in which the Company or any Group

Company has a significant presence at the Relevant Date;

“Restricted Business” means those parts of the business of any Group Company with

which the Executive (and/or persons reporting to the Executive) were involved to a

material extent in the twelve months prior the date of commencement of Garden

Leave or the Termination Date whichever is the earlier;

“Restricted Customer” means any firm, company or person who, during the twelve

months immediately  prior to the date of commencement of Garden Leave or the

Termination Date whichever is the earlier date, was a customer of or in the habit of

dealing with any Group Company or with whom any Group Company was in the

process of negotiating in relation to the business of any such Group Company and in

each case with whom you (and/or persons reporting to you) had contact or about

whom you became aware or informed in the course of your employment;

“Restricted Person” means anyone employed or engaged by any Group Company

who could materially damage the interests of the relevant Group Company if that

person were to be involved in any Capacity in any business concern which competes

with any Restricted Business, and with whom the Executive (and/or persons reporting

to the Excutive) dealt in the twelve months immediately prior to the date of

commencement of Garden Leave or the Termination Date whichever is the earlier;

“Relevant Date” means the Termination Date or, if earlier, the date on which the

Executive commences any Garden Leave Period; and

“Restricted Period” means the period of

(a)nine months for the purpose of clause 14.2(a)and

(b)twelve months for any other purpose;

in either case less any Garden Leave Period, commencing on the Relevant Date, save

that in the event the Restricted Period less any Garden Leave Period would result in

no period of time or a negative period of time, then for the purposes of this clause 14

there will be deemed to be no further Restricted Period.

2.The Executive is likely to obtain trade secrets and confidential information and

personal knowledge of and influence over customers and employees of the Group

during the course of the Employment. To protect these interests, the Executive

covenants with the Company (for itself and as a trustee and agent for each Group

11

Company) that the Executive will not, without the prior written consent of the Chair,

during the Restricted Period:

(a)in the course of any business concern which is in competition with any

Restricted Business, offer to employ or engage or otherwise endeavour to

entice away from any Group Company any Restricted Person; and/or

(b)be involved with the provision of goods or services to (or otherwise have any

business dealings with) any Restricted Customer in the course of any

business concern which is in competition with any Restricted Business; and/

or

(c)in any Capacity within any country in which the Group operates, carry on or

be engaged, concerned or interested in or provide advice to any business

concern which is (or intends to be) in competition with any Restricted

Business.

3.Each of the paragraphs contained in clause 14.2 constitutes an entirely separate and

independent covenant. If any covenant is found to be invalid this will not affect the

validity or enforceability of any of the other covenants.

4.Following the Termination Date, the Executive will not represent himself as being in

any way connected with the businesses of the Company or of any other Group

Company (except to the extent agreed by such a company) and neither shall the

Executive disparage the Company or its directors, officers, employees or agents.

5.Any benefit given or deemed to be given by the Executive to any Group Company

under the terms of clause 14 is received and held on trust by the Company for the

relevant Group Company. The Executive will enter into appropriate restrictive

covenants directly with other Group Companies if asked to do so by the Company.

6.The Executive agrees that that if in the course of his employment or thereafter during

the continuance in force of the restrictions set out in this clause 9, the Executive

receives an offer of employment from any Person, the Executive will immediately

provide that person with a complete and accurate copy of this Agreement.

15.Return of Company Property

1.Any time during the Employment (at the request of the Company) and in any event

when the Employment terminates, the Executive will immediately return to the

Company:

(a)all documents and other materials (whether originals or copies) made or

compiled by or delivered to the Executive during the Employment and

concerning all the Group Companies. The Executive will not retain any

copies of any materials or other information; and

(b)all other property belonging or relating to any of the Group Companies.

2.If the Executive commences Garden Leave in accordance with clause 13, he may be

required to comply with the provisions of clause 15.1.

16.Directorships

1.The Executive’s office as a director of the Company or any other Group Company is

subject to the Constitution of the relevant company (as amended from time to time),

If the provisions of this Agreement conflict with the provisions of the Constitution

then the Constitution will prevail.

2.The Executive must resign from any office held in any Group Company if he is asked

to do so by the Company on the termination of the Employment.

12

3.If the Executive does not resign as an officer of a Group Company, having been

requested to do so in accordance with clause 16.2, the Company will be appointed as

his attorney to effect the resignation. By entering into this Agreement, the Executive

irrevocably appoints the Company as his attorney to act on his behalf to execute any

document or do anything in his name necessary to effect his resignation in accordance

with clause 16.2. If there is any doubt as to whether such a document (or other thing)

has been carried out within the authority conferred by this clause 16.3, a certificate in

writing (signed by any director or the secretary of the Company) will be sufficient to

prove that the act of thing falls within that authority.

4.During the Employment, the Executive will not do anything which could cause him to

be disqualified from continuing to act as a director of any Group Company.

17.Notices

1.Any notices given under this Agreement must be given by letter or email. Notice to

the Company must be addressed to the Chairman at the Company’s registered office

at the time the notice is given. Notice to the Executive must be given to him

personally or sent to his last known address.

2.Except for notices given by hand, notices given by post will be deemed to have been

given on the next working day after the day of posting and notices given by email will

be deemed to have been given in the ordinary course of transmission.

18.Data Protection

1.The Company holds personal information about you which is subject to the General

Data Protection Regulation (GDPR) and the Data Protection Acts 1988-2018. By

signing this Agreement you accept that the Company will process personal

information about you where it is necessary to do so in the normal course of the

employer/employee relationship and/or in the course of the legitimate business

interests pursued by the Company. In doing so, the Company may from time to time

require that the personal information is transferred within the Group both inside and

outside the European Union and also to third party service providers as necessary to

administer your employment (e.g. benefit providers) and as necessary for the

Company’s legitimate business interests (e.g. its professional advisers).

2.Your data will be retained for the duration of your employment plus an additional

period (typically 7 years but possibly longer) to address the relevant retention and

limitation periods determined by law. The Company will process your personal

information in accordance with data protection laws and you can consult the

Company’s Data Protection Policy (as may be amended from time to time) for details

about how to exercise rights in respect of data. The Company’s Data Protection

Policy provides detailed information on the processing of personal data.  The

Company will ensure that your information is accurate, kept up to date and not kept

for longer than is necessary and you agree to let the Company know of any material

change in such personal data (e.g. next of kin for emergency contact purposes).  The

Company will also take measures to safeguard your data against unauthorised or

unlawful processing and accidental loss or destruction or damage to the data and the

Company relies on you as an employee to comply with all applicable workplace

policies governing the use of Company facilities and the use and disclosure of data.

3.The Company reserves the right to monitor your use of Group facilities in exceptional

cases where the Company believes it is necessary to ensure compliance with

acceptable usage and other applicable policies therefore you should not assume that

workplace email communications are private. You are advised that where appropriate

and available, evidence such as CCTV footage, web-logs, etc. will be used by the

Company in the context of internal investigations and/or disciplinary proceedings.

19.Miscellaneous

13

1.This Agreement may be entered into in any number of counterparts, all of which

taken together shall constitute one and the same instrument. Any party may enter into

this Agreement by executing any such counterpart.

2.This Agreement may only be modified by the written agreement of the parties.

3.The Executive cannot assign this Agreement to anyone else.

4.References in this Agreement to rules, regulations, policies, handbooks or other

similar documents which supplement it or are referred to in it are references to the

versions or forms of the relevant documents as amended or updated from time to

time.

5.This Agreement supersedes any previous written or oral agreement between the

parties in relation to the matters dealt within it. It contains the whole agreement

between the parties relating to the Employment at the date the agreement was entered

into (except for those terms implied by law which cannot be excluded by the

agreement of the parties). The Executive acknowledges that he has not been induced

to enter into this Agreement by any representation, warranty or undertaking not

expressly incorporated into it. The Executive agrees and acknowledges that his only

rights and remedies in relation to any representation, warranty or undertaking made or

given in connection with this Agreement (unless such representation, warranty or

undertaking was made fraudulently) will be for breach of the terms of this

Agreement, to the exclusion of all other rights and remedies. By signing the

Agreement, the Executive acknowledges that he does so with full understanding of its

meaning and effect and with the benefit of independent legal advice.

6.Neither party’s rights or powers under this agreement will be affected if:

(a)one party delays in enforcing any provision of this Agreement; or

(b)one party grants time to the other party.

7.References to any statutory provisions include any modifications or re-enactments of

those provisions.

8.Headings will be ignored in construing this Agreement.

9.If either party agrees to waive his rights under a provision of this Agreement, that

waiver will only be effective if it is in writing and it is signed by him. A party’s

agreement to waive any breach of any term or condition of this Agreement will not be

regarded as a waiver of any subsequent breach of the same term or condition or a

different term or condition.

10.The Executive acknowledges and agrees that any compensation payable pursuant to

or contemplated by this Agreement shall be subject to reduction, cancellation,

forfeiture or recoupment in accordance with the terms of any Company Clawback

policy approved by the CRH Board or any delegated Committee in effect from time

to time or applicable law.

11.The Executive will at all times comply with the Rules of any Exchange in which

CRH pic is listed and any corporate governance rules and standards affecting CRH

plc.

12.This Agreement is governed by and will be interpreted in accordance with the laws of

Ireland.  Each of the parties submits to the jurisdiction of the courts of Ireland as

regards any claim or matter arising under this agreement.

14

PRESENT when the Common Seal of

CRH Group Services Limited was affixed hereto

/s/ Albert Manifold

Albert Manifold, Chief Executive Officer

/s/ Richie Boucher

Richie Boucher, Chairman

SIGNED by

/s/ Denis James Mintern

Denis James Mintern

WITNESSED by

Witness’s signature[*****]

Name Address[*****]

Occupation [*****]

Date[*****]

15

Schedule 1

INTERESTS OF EXECUTIVE

[Intentionally Omitted]

Exhibit 10.28 - Group Chief Executive Services Agreement (J. Mintern) 1

EXHIBIT 10.28

Dated  20 DECEMBER 2024

CRH Group Management Limited

and

Denis James Mintern

_________________________________________________

GROUP CHIEF EXECUTIVE SERVICE AGREEMENT

_________________________________________________

2

This Agreement is made on December 20, 2024 between

(1)CRH Group Management Limited incorporated in the Ireland whose registered office is at 42

Fitzwilliam Square, Dublin 2 (the “Company”); and

(2)Denis James Mintern (the “Executive”).

This Agreement records the terms on which the Executive will serve the Group as its Group

Chief Executive.

1.Interpretation

In this Agreement (and any schedules to it):

“Associated Company” means a subsidiary undertaking or holding undertaking of

the Company, within the meaning of section 275 of the Companies Act 2014, or any

subsidiary undertaking of such a holding undertaking, and any undertaking that the

Board may determine for the purposes of this Agreement from time to time;

“Board” means the board of directors of CRH plc from time to time or anyone/any

person or committee nominated by the board of directors as its representative for the

purposes of this Agreement;

“Chairman” means Chairman of the Board of CRH plc;

“Employment” means the employment governed by this Agreement;

“Group” means the Company, any Associated Company and any undertakings which

are subsidiary undertakings or holding undertakings of any Associated Company, and

each undertaking which is a member of the Group shall be a “Group Company”;

“Holding Undertaking”, “Undertaking” and “Subsidiary Undertaking” shall

have the meanings respectively given to them Section 275 of the Companies Act

2014, and “Associated Undertaking” shall mean any undertaking that is a Holding

Undertaking or a Subsidiary Undertaking of such Holding Undertaking or Subsidiary

Undertaking of the Company; and

“Person” means any individual person, firm, company, partnership, unincorporated

association, joint venture or other legal entity;

“Compensation Committee” means the committee appointed by the Board to

determine policy for the remuneration of directors and senior management; and

“Termination Date” means the date on which the Employment terminates

howsoever arising.

Words such as “hereunder”, “hereto”, “hereof” and “herein” and other words

commencing with “here” will unless the context clearly indicates to the contrary refer

to the whole of this Agreement and not to any particular clause thereof.

Save as otherwise provided herein, any reference to a clause will be a reference to a

clause of this Agreement.

3

Words denoting the masculine gender will include the feminine and neuter genders

and words denoting the singular will include the plural and vice versa.

2.Commencement of Employment as Group Chief Executive Officer

1.The Employment of the Executive under this Agreement will commence on 1 January

2025 (the “Commencement Date”). The Employment will continue thereafter,

unless and until it is terminated or terminates in accordance with the provisions of this

Agreement. It is acknowledged that the Executive has previously been continuously

employed in different roles by the Company since April 2002.

3.Appointment and Duties of the Executive

1.The Executive will serve as Group Chief Executive Officer.

2.The Executive will:

(a)subject as provided for in clause 5.1, devote all of his working time, attention

and skill to the Employment;

(b)faithfully and diligently perform such duties and exercise such powers in

relation to the Group, as the Board shall from time to time assign to or vest in

him;

(c)properly perform his duties and exercise his powers;

(d)in pursuance of his duties hereunder, perform such services for such Group

Companies (including, if so required by the Board, acting as a director or

consultant of such Group Company) without any further remuneration and

accept such offices in such Group Companies as the Board may from time to

time reasonably require. The Company reserves the right on giving the

Executive written notice to terminate any office or directorship immediately

at any time and upon receipt of that notice, he will immediately resign from

that office or directorship.;

(e)abide by the constitution of the Company (and any Group Company, as

appropriate), as amended from to time and any statutory, fiduciary or

common law duties to any Group Company of which he is a director;

(f)in the discharge of such duties and in the exercise of such powers observe and

comply with all reasonable and lawful resolutions, regulations and directions

from time to time made or given by the Board;;

(g)use his best endeavours to promote, protect, develop and extend the interests

and reputation of every Group Company;

(h)not do anything that would cause him to be disqualified from acting as a

director;

(i)report his own wrongdoing and any wrongdoing or potential wrongdoing of

any other employee or director of any Group Company to the Board

immediately upon becoming aware of it;

(j)comply with any instructions, advices or codes of practice issued by the

Company or applicable to the Company relating to transactions in securities

and all codes of practice, requirements, recommendations, rules and

regulations (as amended from time to time) of any stock exchange on which

the Company’s securities may be traded and any other authority or body

authorised to regulate transactions in securities relevant to any Group

Company (including for the avoidance of doubt complying with requirements

under both legislation and regulation as to the disclosure of inside

information)

4

(k)use his best endeavours to promote, protect, develop and extend the interests

and reputation of every Group Company; and

(l)exercise his duties having regard to relevant obligations under prevailing law

and regulation including but not limited to the Companies Act 2014.

3.The Executive accepts that the Company may require him to perform duties for any

other Group Company, for part of his working time. In performing those duties,

clause 3.2. will apply as if references to the Company are to the appropriate Group

Company. The Company will remain responsible for the payments and benefits the

Executive is entitled to receive under this Agreement.

4.The Executive will keep the Board (and, where appropriate the board of directors of

any other Group Company) fully informed of his conduct of the business, finances or

affairs of the Company or any other Group Company in a prompt and timely manner.

The Executive will provide information to the Board in writing if requested.

5.The Executive will promptly disclose to the Board full details of any wrongdoing by

any employee of any Group Company where he is aware of that wrongdoing and

where it is material to that relevant company or to the interests or reputation of any

Group Company.

6.Each year during the Employment, the Executive will, at the expense of the

Company, undergo a medical examination by a medical practitioner. If the Executive

becomes aware of any health issue which may impact on his ability to perform his

duties as Chief Executive, he will immediately notify the Chairman thereof.

7.The Board shall be entitled to appoint an interim Chief Executive and to vest in that

person the duties of Chief Executive in any case where the Executive is incapacitated

or unable to perform his duties.

4.Hours

1.The Executive will comply with the Company’s normal hours of work and will also

work any additional hours which may be reasonably necessary to perform his duties

to the satisfaction of the Board. The Executive will not receive any further

compensation for any hours worked in addition to the normal working hours.

2.The Executive and the Company agree that, as the Executive is able to determine the

duration of his working time himself therefore, Part 2 of the Organisation of Working

Time Act 1997 shall not apply to his Employment under this Agreement.

5.Interests of the Executive

1.The Executive’s current interests (including all directorships and any shareholdings in

companies other than CRH plc) at the date of this Agreement are set out in Schedule

1. The Executive will be permitted to carry out any such disclosed interests during the

course of the Employment and to be paid and retain fees therefor, subject to the

limitations set out in clauses 3.2(a) and 5.2. Any additional business involvements

that may arise or be offered to the Executive outside of the CRH Group will be

disclosed to, and be subject to, the agreement of the Chairman.  While the Executive

is a member of the CRH Board of Directors, if such additional business involvements

are agreed by the Chairman, the approval of the CRH Board will also be required

prior to acceptance of any external Board position.

2.Subject to the permitted investments set out in clause 5.3, during the Employment the

Executive will not be directly or indirectly engaged or concerned in the conduct of

any activity in any  country in which the Company or any Group Company has

significant presence, which is similar to or competes with any activity carried on by

any Group Company (except as a representative of the Company or with the written

consent of the Board),

5

3.The Executive may not hold or be interested in investments which amount to more

than five per cent of the issued securities of any class of any one company which are

listed or quoted on any recognised Stock Exchange.

4.The Executive will (and will endeavour to procure that his spouse and dependent

children) comply with all rules of law, and rules or policies applicable to CRH plc

from time to time in relation to the holding or trading of securities in CRH plc.

6.Location

1.The Executive will travel and work in such locations as the Board may reasonably

require for the proper performance and exercise of his duties.

7.Salary and Benefits

1.The Company will pay the Executive a basic salary of $1,750,000.00 per annum (pro

rata for any lesser period and less any deductions which the Company is required by

law to make). Salary will be paid monthly in arrears (subject to all statutory and

agreed deductions) by credit transfer to the Executive’s nominated bank account, and

such payment arrangements will remain in force until otherwise mutually agreed.

Salary will accrue from day to day. The Executive’s basic salary will be reviewed

annually by the Board Compensation Committee, save where notice of termination of

this Agreement has been given by either party and such review not to result in a basic

salary lower than the salary in the previous year unless otherwise agreed with the

Executive.

2.The basic salary referred to in clause 7.1 includes director’s fees from Group

Companies and any other companies in which the Executive is required to accept a

directorship under the terms of this Employment. To achieve this:

(a)the Executive will repay any fees he receives to the Company; or

(b)his salary will be reduced by the amount of those fees; or

(c)a combination of the methods set out in clauses 7.2(a) and 7.2(b) will be

applied.

3.The Executive’s basic salary takes into account the possibility that he may be

required to work on a Sunday.  For the avoidance of doubt, he will not be entitled to

any additional remuneration for working on a Sunday.

4.The Company reserves the right to make deductions from payments due to the

Executive so as to reimburse sums due by him to the Company and by executing this

Agreement, the Executive consents to the deduction of such sums.

5.The Executive is entitled to 28 days’ paid holiday each calendar year of the Company

(in addition to other public holidays), to be taken at times to be agreed in advance

with the Chairman. Holiday entitlement will accrue on a pro-rated basis. For part

calendar years, the Executive’s holiday entitlement for the year will be pro-rated to

the length of his service in that year. The Company may require the Executive to take

any accrued holiday during any notice period and any period of Garden Leave. If, on

the Termination Date, the Executive has exceeded his accrued holiday entitlement,

the excess may be deducted from any sums due to him.

6.The Company’s annual leave year runs from 1 January to 31 December.

7.Annual leave entitlement untaken at the end of the annual leave year may not be

carried forward to the next annual leave year except with the prior consent of the

Board.

8.The Executive will be entitled to the benefit of all statutory public holidays in

accordance with the provisions of the Organisation of Working Time Act, 1997.

6

9.If the Executive is absent from work due to sickness or injury which is caused by the

fault of another person, and as a consequence recovers from that person or another

person any sum representing compensation for loss of salary under this Agreement,

the Executive will repay to the Company any money it has paid to him as salary in

respect of the same period of absence.

10.Any benefits provided to the Executive are subject to such policies regarding same as

are in place from time to time and subject also to any limitations and/or conditions

and/or amendments imposed by the Company and/or imposed by the underwriters of

benefit plans or schemes.

11.The Company reserves the right to vary and/or discontinue any benefit plans or

schemes in which the Executive may be eligible to participate from time to time

without replacement.

12.The Executive is liable for any and all tax payable from time to time for benefits-in-

kind enjoyed by him arising from the provisions of this Agreement. In certain

circumstances, tax shall be operated at source in accordance with applicable

legislation.

13.If any insurance provider refuses for any reason to provide a benefit to the Executive,

the Company will not be liable to provide to him with any replacement benefit of the

same or similar kind or pay any compensation in lieu of such benefit.

14.The Executive will be eligible to receive a target annual bonus opportunity equal to

150% of basic annual salary, with a maximum opportunity of 300%, of basic annual

salary.  Any bonus will be paid to the Executive less any deductions which the

Company is required by law to make (“Deductions”). The Executive will also be

eligible to receive annual equity incentives with a total target grant date fair value of

585% of basic annual salary.  Such annual equity incentive awards will be split 60%

in the form of performance stock units (“PSUs”) and 40% in the form of restricted

share units (“RSUs”), provided that the Compensation Committee will be entitled at

its discretion, from time to time, to adjust the mix between PSUs and RSUs. The

Executive acknowledges that the Company reserves the right to sell sufficient shares

from any equity award vesting to satisfy any Deductions or to issue to the Executive

the net amount of shares due after such Deductions.

15.The Company will provide and maintain for the Executive’s use, for the duration of

the Employment, a mobile phone and laptop, which will at all times remain the

property of the Company. The Company will pay all expenses in connection with the

use of such mobile phone and laptop properly and reasonably incurred by the

Executive in connection with the business of the Company during his employment.

The Executive must return the mobile phone and laptop to the Company immediately

on the termination of the Employment.

16.Having already reached the Irish pension cap, the Executive will receive a taxable

pension cash adjustment calculated as 10% of annual base salary. This will be paid

monthly together with the Executive’s normal salary payment.

17.The Executive will be covered by the Group’s Directors and Officers liability

insurance on the same basis as other members of the Board.

18.The Executive will be provided with cover under a medical scheme for his benefit

and for the benefit of his wife and dependent children, (subject always to and

conditional upon the applicable rules, conditions, and limitations imposed from time

to time by the Group’s insurers). The Executive understands that any claim he may

have in respect of the Scheme will be against the insurer, not the Group.

19.The Executive will be covered for a Death-in-Service Lump Sum Benefit of three

times gross basic annual basic salary subject to the terms of the insurance policy in

place from time to time. Payment of this death in service benefit is subject to any

underwriting conditions of, and acceptance of the claim by, insurers.

7

20.The Executive is eligible to receive long term disability cover of 2/3rd of gross annual

basic salary less the state disability pension (the “Disability Cover”). The Disability

Cover is subject to the terms and conditions of the insurer’s policy in place from time

to time.  The Executive is admitted to the Company’s insured scheme as at the date of

execution of this Agreement.  If the maximum benefit payable is lower than the

Disability Cover then the Company shall pay the Executive the difference between

the amount received and the Disability Cover for the duration of the insured claim

provided always that the Executive is not receiving in excess of the Disability Cover

at any time. In the event that the Company does not have a Disability Cover policy in

place with an insurance provider, the Company shall operate a Disability Cover

Scheme pursuant to which the Executive will be eligible to receive Disability Cover,

subject to the relevant terms and conditions of the Company’s scheme.

21.If the Executive is in receipt of Disability Cover, he will resign, without any claim for

compensation, from any offices held by him in any Group Company if requested to

do so and if he fails to do so the Company is hereby irrevocably authorised and

empowered, as his agent, to appoint an officer of the Company to be his attorney in

his name and on his behalf to execute all documents and to do all things requisite to

give effect to such resignation provided always that such resignation shall be without

prejudice to any rights accrued to either party, and shall be subject to his right to be

re-appointed to such offices in the event of his return to work as Group Chief

Executive. Nothing in this clause 7.21 will preclude the Compensation Committee

from releasing equity incentive awards to the Executive on a recommendation of

“good leaver” status, should the Executive be in receipt of Disability Cover.

22.In the case of incapacity to attend work due to illness or injury, the Executive will be

paid sick pay consisting of full remuneration (other than in respect of bonus and other

incentive arrangements, for which the discretion of the Board Compensation

Committee will remain) up to six months, less statutory sick pay and any other social

welfare benefits in any 12 month rolling period. Thereafter, the Executive may be

eligible to receive “Disability Cover”. As a condition of payment a medical doctor

must certify absence from work in excess of two days. Medical certificates must be

submitted to the Company on the third day of absence and weekly thereafter. The

Company reserves the right to refer the Executive for a medical examination, to

determine the state of his health, and/or physical or mental capability to carry out his

duties, at any time during his employment, and to receive a report thereon. The

Executive authorises such medical practitioner or specialist to disclose the results of

their examinations and their report to the Company.

23.The Company will reimburse the Executive’s annual subscription fee to a

professional institution relevant to his role in the Company (the Company to

determine at its sole discretion whether membership of a professional institution is

relevant). Full membership details and receipt will be required.

24.Any benefits provided to the Executive are subject to such policies regarding the

same as are in place from time to time and subject also to any limitations and/or

conditions and/or amendments imposed by the Company and/or imposed by the

underwriters of benefit plans or schemes. The Company reserves the right to vary

and/or discontinue any benefit plans or schemes in which the Executive may be

eligible to participate from time to time without replacement.

25.The Executive is liable for any and all tax payable from time to time for benefits-in-

kind enjoyed by them arising from the provisions of this Agreement. In certain

circumstances, tax shall be operated at source in accordance with applicable

legislation.

26.If any insurance provider refuses for any reason to provide a benefit to the Executive,

the Company will not be liable to provide to the Executive any replacement benefit of

the same or similar kind or pay any compensation in lieu of such benefit.

8.Shareholding Requirements

8

1.In accordance with the remuneration policies applied by the Board Compensation

Committee from time to time, the Executive shall be required to maintain certain

shareholding requirements, which may include a required ownership percentage for

the duration of his employment and a minimum post-employment required ownership

percentage of common stock in CRH Plc. The terms of these shareholding

requirements shall be determined from time to time by the Board Compensation

Committee and communicated to the Executive accordingly, and as of the

Commencement Date shall be 6 times the Executive’s basic salary, to be achieved by

31 December 2029, or such other later date determined by the Committee at its sole

discretion.

2.The Board Compensation Committee of CRH plc shall be responsible for the

administration of the requirements contained in this clause 8 and shall determine the

appropriate means of enforcing its provisions which may include the withholding of

shares by CRH plc or considering the Executive in breach of his obligations under

this agreement. Should the Executive breach the requirements of this Agreement as a

result of an unexpected and precipitous decrease in the CRH share price, the

Executive shall remedy the breach as soon as reasonably possible. The Board

Compensation Committee shall have the discretion to determine, in consultation with

the Executive, a reasonable time period in which the Executive must remedy the said

breach.

9.Expenses

1.The Company will reimburse the Executive for all reasonable expenses properly and

necessarily incurred by him in performing his duties under this Agreement, provided

that these are incurred in accordance with Company expenses policy from time to

time. The Company will require the Executive to produce receipts or other supporting

documents as proof that he has incurred any expenses he claims.

2.If the Executive is provided with a credit or charge card by the Company, this must

only be used for expenses which he incurs in performing the duties of the

Employment and must return it to the Company immediately on the termination of

the Employment.

10.Confidentiality

1.The Employment will involve the Executive’s exposure to and/or development of

confidential, proprietary and trade secret information, whether in written, electronic

or any other format, relating to the business of the Company and the Group, including

but not limited to:

(a)supply chain processes and information, manufacturing processes and plant

information and technology, information about costs, profits, markets, sales,

contracts, suppliers, customers and distributors;

(b)business, marketing or strategic plans, programs and tactics;

(c)research and development information (including, without limitation,

information relating to the formulation, testing, registration, use, safety,

efficacy and/or effects of products and compounds under development);

(d)forecasts, budgets, and projections;

(e)all non-public information concerning the products, promotions,

development, financing, expansion plans, business policies and practices of

the Group;

(f)all other non-public proprietary technical, intellectual property, marketing,

operational, economic, business, management, organisational or financial

information, knowledge, data or software; and

9

(g)the same or similar information that the Company or Group has obtained

from any third party under an obligation to maintain such information as

confidential

collectively, (“Confidential Information”). It is also a condition of the Executive’s

employment that he do not bring to or use in the course of the Employment, any

Trade Secrets or Confidential Information belonging to his previous employers or to

any other third party, without prior written authorisation of such employers or third

parties.

2.The Executive agrees that all Confidential Information is of irreplaceable value to the

Group. He will not except as authorised or required by his obligations under this

Agreement or as required by law or a court of competent jurisdiction reveal to any

person, persons or company any of the trade secrets, or any Confidential Information

which may come to his knowledge during the Employment and use his best

endeavours to prevent the publication or disclosure of any Confidential Information

which has come, or may come to his knowledge during the Employment or

previously or otherwise. The Executive will keep with complete secrecy all

Confidential Information entrusted to him and will not use or attempt to use any such

information in any manner which may injure or cause loss either directly or indirectly

to the Group or their business or in any way be likely so to do.  It is agreed that this

restriction will continue to apply after the termination of this Agreement without limit

in point of time but will cease to apply to information or knowledge which may come

into the public domain through no fault on the Executive’s part. As used herein, a

“Trade Secrets” mean any information or material which qualifies as such under

applicable statutory or common law, including, without limitation, ideas, research and

development, know-how, formulas, technical data, designs, drawings, specifications,

customer and supplier lists, pricing and cost information and business and marketing

plans and proposals and any other information in whatever form (written, oral, visual

and electronic) concerning the confidential affairs of the Group. Notwithstanding

anything to the contrary in this Agreement or otherwise, nothing in this Agreement

shall limit the Executive’s rights under applicable law to report possible violations of

law or provide information to any governmental entity or in response to a subpoena or

other legal process or to file a charge with or participate in an investigation conducted

by any governmental entity , or prohibit the Executive from making statements or

engaging in any other activities or conduct protected by applicable law. Nothing in

this Agreement shall be read as requiring the Executive to waive any right the

Executive may have to receive an award for information provided to any

governmental entity.

3.In the course of the Employment the Executive is likely to obtain trade secrets and

confidential information belonging or relating to other Group Companies and other

persons. He will treat such information as if it falls within the terms of clause 10.1and

clause 10.2will apply with any necessary amendments to such information. If

requested to do so by the Group, the Executive will enter into an agreement with

other Group Companies and any other persons in the same terms as clause 10.1 and

clause 10.2 with any amendments necessary to give effect to this provision.

11.Intellectual Property Rights

1.For the purposes of this clause 11, “Intellectual Property” means patents, trade marks,

service marks, registered designs (including applications for and rights to apply for

any of them), inventions, unregistered design rights, logos, trade or business names,

copyrights, database rights, confidential information, knowhow and any similar rights

in any country.

2.The Executive acknowledges that (i) it is part of his normal duties to develop the

products and services of the Group; and (ii) because of the nature of his position he

has a special obligation to further the interests of the Group. All Intellectual Property

which the Executive develops or produces in the course of his Employment duties, or

outside such duties but relating to the business of the Group, will vest in and be the

absolute, sole and unencumbered property of the Company to the fullest extent

10

permitted by law and the Executive undertakes not to dispute the Company’s

ownership of such Intellectual Property. The Executive agrees to disclose full details

of all such Intellectual Property to the Company, and at the Company’s expense, to

sign all documents and carry out all such acts as will be reasonably necessary to vest

such Intellectual Property in the Company absolutely and unconditionally for its full

term throughout the world and to enable the Company to obtain and maintain the

benefit of all such Intellectual Property, and to obtain protection and enforce the

Company’s rights anywhere in the world. The Executive also hereby waives all moral

rights in all Intellectual Property which is owned by the Company, or will be owned

by the Company, further to this clause 11. The Executive will not copy, disclose or

make use of any Intellectual Property belonging to the Company (whether or not

subject to this clause 11) except to the extent necessary for the proper performance of

his duties. Rights and obligations under this clause 11 will continue after the

termination of this Agreement in respect of all Intellectual Property arising during the

Employment. The Executive warrants and represents that he is free to assign such

Intellectual Property to the Company without any third-party claims, liens, charges or

encumbrances of any kind.

3.To the extent that any such Intellectual Property cannot be assigned to the Company,

the Executive hereby:

(a)grants to the Company an exclusive, irrevocable, perpetual, fully paid up,

royalty-free, worldwide, transferable, sub-licensable licence to use and

commercialise such Intellectual Property without restriction; and

(b)to the extent that any such Intellectual Property cannot be licensed to the

Company, irrevocably and unconditionally waives, abandons and will not

assert, to the fullest extent permissible by applicable law, any such right, title

or interest in and to such Intellectual Property as against the Company, unless

otherwise instructed in writing by the Company or its successors in title.

4.The Executive also hereby unconditionally and irrevocably waives all moral rights

which he may have in all such Intellectual Property, and to obtain protection and

enforce the Company’s rights anywhere in the world. The Executive also hereby

waives all moral rights in all Intellectual Property which is owned by the Company,

or will be owned by the Company, further to this clause. The Executive will not copy,

disclose or make use of any Intellectual Property belonging to the Company (whether

or not subject to this clause) or use or exploit any such Intellectual Property except to

the extent necessary for the proper performance of his duties. The Executive agrees to

indemnify the Company against any and all liability, loss, damage, costs and

expenses which the Company may incur or suffer as a result of a breach by the

Employee of the warranties set out in this clause 11.

5.The Company will, in its sole discretion, be entitled to apply to register, in its own

name, any of the Intellectual Property in the Company.

6.The Executive irrevocably appoints the Company to be their attorney or agent in their

name and on their behalf to do all such acts and things and to sign all such deeds and

documents as may be necessary in order to give the Company the full benefit of the

provisions of this clause 11 and he agrees that a certificate in writing in favour of any

third party signed by any duly authorised officer of the Company that any act or thing

or deed, document or instrument falls within the authority hereby conferred will be

conclusive evidence that this is the case.

7.Rights and obligations under this clause 11 will continue after the termination of this

Agreement in respect of all Intellectual Property arising during the Employment.

12.Termination and Suspension

1.The Employment will continue until terminated by either party giving written notice

at any time as set out in clause 12.2.

11

2.Each of the Company and the Executive may terminate the Employment by giving to

the other not less than twelve months’ written notice.

3.Notwithstanding the other provisions of this Agreement and in particular clause 12.2,

and unless otherwise agreed between the parties, the Employment will automatically

terminate on the Executive’s 65th birthday.

4.The Company may at its sole and absolute discretion pay a sum equal to the

Executive’s basic salary (payment in respect of bonus, PSUs or RSUs and other

incentive arrangements will remain at the discretion of the Board Compensation

Committee) in lieu of any unexpired period of notice (less any deductions the

Company is required by law to make).

5.Notwithstanding the other provisions of the Agreement, the Company may terminate

the Employment by giving written notice to take immediate effect if the Executive

does not perform the duties of the Employment for a period of 120 consecutive days

or 180 days (whether or not consecutive) in any period of 365 days because of

sickness, injury or other incapacity. Notice can be given whilst the Executive

continues not to perform his duties or on expiry of the 120 or 180 day period. In this

clause 12, ‘days’ includes Saturdays, Sundays and public holidays.

6.Notwithstanding the other provisions of the Agreement, the Company may terminate

the Employment by giving written notice to take immediate effect if the Executive:

(a)commits any serious or persistent breach of any of his obligations or duties to

the Group (whether under this Agreement or otherwise) or fails to comply

with any code of professional conduct directly applicable to him: or

(b)commits fraud, serious misconduct, gross default or wilful neglect in the

discharge of his duties hereunder or in connection with or affecting the

business of the Group or any Group Company or which is materially

injurious or causes financial or reputational harm to any Group Company; or

(c)commits, or is charged with, or convicted of, dishonesty or any offence (save

summary Road Traffic Acts offences or any other offence that in the

reasonable opinion of the Board does not affect his position within the

Group)) whether in connection with the Employment or otherwise; or

(d)refuses or repeatedly neglects to comply with any lawful and reasonable

instructions or directions given to him in accordance with this Agreement; or

(e)commits (or is reasonably believed by the Board to have committed) a

material breach of any relevant legislation in force which may affect or relate

to the business of any Group Company; or

(f)becomes of unsound mind, is prevented by reason of permanent incapacity

from carrying out his duties, is bankrupted or has a receiving order made

against him or makes any general composition with his creditors or takes

advantage of any statute affording relief for insolvent debtors; or

(g)becomes disqualified from holding office in any other company in which he

is concerned or interested;

(h)becomes disqualified from holding office or being a director of a company or

if the Executive’s directorship of the Company or any Group Company

terminates without the consent or concurrence of the Board; or

(i)causes, by any act or omission, his own name or the name or reputation of the

Group or any Group Company to be brought into disrepute, or

(j)ceases to be eligible to work in any country where he is required to perform

his duties through his own fault.

12

7.Where the Company terminates the Employment by giving written notice to take

immediate effect in accordance with clause 12.6, for the avoidance of doubt there is

no obligation to give notice as set out in clause 12.2 or any other period of notice or

to make any payment in lieu of notice.

8.When the Employment terminates, the Company reserves the right to deduct from

any final salary payment due to the Executive, any monies due and owing by him to

the Company or any Group Company. By executing this Agreement, the Executive

agrees to such deductions being made for the purposes of the Payment of Wages Act

1991.

9.The Company’s disciplinary procedure is available from the Human Resources

Department. The spirit and principles of the procedure apply to the Executive suitably

adapted to reflect his seniority and status but the procedure is not incorporated by

reference in this Agreement and therefore does not form part of the Executive’s

contract of employment.

10.The Board may suspend the Executive from the Employment on full remuneration

(other than in respect of bonus, and other incentive arrangements for which the

discretion of the Compensation Committee will remain) at any time and for any

reason and for whatever period the Company reasonably considers necessary to

investigate any matter in which the Executive appears to be involved (whether

directly or indirectly) and to conduct any related disciplinary proceedings or if the

Executive’s dismissal is being considered. Suspension may be for whatever period the

Board reasonably considers necessary.

11.During any period of suspension, the Executive may be directed by the Company not

to communicate with suppliers, customers, other business connections and other

employees of the Company or any Group Company and may be relieved of some or

all of his powers and duties. The Executive will comply with any such direction. The

exercise of any or all of the Company’s right to suspend does not amount to or should

not be treated by the Executive as a repudiation of this Agreement or as the

termination of the Employment by the Company.

13.Garden Leave

1.At any time after notice to terminate the Employment is given by either party under

clause 12 above, if the Executive resigns without giving due notice and the Company

does not accept his resignation, if the Executive repudiates or purports to terminate

this Agreement in breach of contract, or, if the Company so decides, at any time

during this Agreement, the Company may, at its absolute discretion, by written notice

require the Executive not to perform any services (or to perform only specified and/or

limited services) for the Company or to take a period of absence, (hereinafter called

“Garden Leave”), for some or all of the remaining period of notice pursuant to

clause 12, which for the avoidance of doubt could be for a maximum period of 12

months (pursuant to clause 12.2) (the “Garden Leave Period”). The provisions of

this clause shall apply to any Garden Leave Period. During the Garden Leave Period,

the Executive will be entitled to receive full remuneration (other than in respect of

bonus and other incentive arrangements for which the discretion of the Board

Compensation Committee will remain) in accordance with the terms of this

Agreement, any unused holiday accrued at the commencement of the Garden Leave

Period and any holiday accrued during any such period will be deemed to be taken by

the Executive during the Garden Leave Period. The Executive will remain an

employee of the Company and bound by the terms of his Agreement during the

Garden Leave Period. At the end of the Garden Leave Period, the Company may, at

its sole and absolute discretion, pay the Executive basic salary (other than in respect

of bonus and other incentive arrangements for which the discretion of the Board

Compensation Committee will remain) in lieu of the balance of any period of notice

given by the Company or the Executive (less any deductions the Company is required

by law to make),

2.The Company may require that the Executive will not, without prior written consent

of the Board or as otherwise permitted pursuant to clause 5 above, be employed or

13

otherwise engaged in the conduct of any activity, whether or not of a business nature,

during the Garden Leave Period and further, if so requested by the Company, the

Executive will not:

(a)enter or attend the premises of the Company or any other Group Company; or

(b)contact or have any communication or dealings with (or attempt to contact or

have communications or dealings with) with any customer, client, supplier,

agent distributor, or other business contact of the Company or any other

Group Company in relation to the business of the Company or any other

Group Company (other than purely social contact); or

(c)contact or have any communication or dealings with (or attempt to contact or

have communications or dealings with) with any employee, officer, director,

agent, consultant, shareholder, advisor or other business contact of the

Company or any other Group Company in relation to the business of the

Company or any other Group Company (other than purely social contact); or

(d)remain or become involved in any aspect of the business of the Company or

any other Group Company except as required by such companies.

3.During the Garden Leave Period, the Company may require the Executive:

(a)to comply with the provisions of clause 16; and

(b)to immediately resign from any directorship, trusteeships or other offices

which he holds in the Company, any other Group Company or any other

company where such directorship or other office is held as a consequence or

requirement of the Employment, unless he is required to perform duties to

which any such directorship, trusteeship or other office relates in which case

he may retain such directorships, trusteeship or other offices while those

duties are ongoing. The Executive hereby irrevocably appoints the Company

to be his attorney to execute any instrument and do anything in his name and

on his behalf to effect his resignation if he fails to do so in accordance with

this clause 13.3(b)

4.During the Garden Leave Period:

(a)the Executive shall provide such assistance as the Company or any Group

Company may require to effect an orderly handover of his responsibilities to

any individual or individuals appointed by the Company or any Group

Company to take over his role or responsibilities;

(b)(except during any periods taken as holidays in the usual way) ensure that the

Board knows where the Executive will be and how he can be contacted

during each working day and shall comply with any written requests to

contact a specified employee of any Group Company at specified intervals;

(c)the Executive shall make himself available to deal with requests for

information, provide assistance, be available for meetings and to advise on

matters relating to work (unless the Company has agreed that the Executive

may be unavailable for a period); and

(d)the Company may appoint another person to carry out his duties in

substitution for the Executive.

5.All duties of the Employment (whether express or implied), including without

limitation the Executive’s duties of fidelity, good faith and exclusive service, shall

continue throughout the Garden Leave Period save as expressly varied by this clause

13. The Executive agrees that the exercise by the Company of its rights pursuant to

this clause 13 shall not entitle the Executive to claim that he has been constructively

dismissed provided that the Company complies with its obligations under this

Agreement.

14

6.Immediately upon termination of the Employment, the Executive will amend all of

his social media profiles such as LinkedIn in order to ensure that such profiles do not

wrongly represent him as being an employee of, or otherwise associated with, any

Group Company.

14.Restrictions after Termination of Employment

1.In this clause:

“Capacity” means as agent, consultant, director, employee, owner, partner,

shareholder or in any other capacity;

“Prohibited Area” means any country in which the Company or any Group

Company has a significant presence at the Relevant Date;

“Restricted Business” those parts of the business of any Group Company with which

the Executive (and/or persons reporting to the Executive) were involved to a material

extent in the twelve months prior the date of commencement of Garden Leave or the

Termination Date whichever is the earlier;

“Restricted Customer” any firm, company or person who, during the twelve months

immediately  prior to the date of commencement of Garden Leave or the Termination

Date whichever is the earlier date, was a customer of or in the habit of dealing with

any Group Company or with whom any Group Company was in the process of

negotiating in relation to the business of any such Group Company and in each case

with whom the Executive (and/or persons reporting to him) had contact or about

whom he became aware or informed in the course of his employment;

“Restricted Person” anyone employed or engaged by any Group Company who

could materially damage the interests of the relevant Group Company if that person

were to be involved in any Capacity in any business concern which competes with

any Restricted Business, and with whom the Executive (and/or persons reporting to

the Executive) dealt in the twelve months immediately prior to the date of

commencement of Garden Leave or the Termination Date whichever is the earlier;

“Relevant Date” means the Termination Date or, if earlier, the date on which the

Executive commences any Garden Leave Period; and

“Restricted Period” means the period of

(a)nine months for the purpose of clause 14.2(g); and

(b)twelve months for any other purpose;

in either case less any Garden Leave Period, commencing on the Relevant Date, save

that in the event the Restricted Period less any Garden Leave Period would result in

no period of time or a negative period of time, then for the purposes of this clause 14

there will be deemed to be no further Restricted Period.

2.The Executive is likely to obtain trade secrets, confidential information, business

connections and personal knowledge of and influence over customers and employees

of the Group during the course of the Employment. To protect these interests, the

Executive covenants with the Company (for itself and as a trustee and agent for each

Group Company) that the Executive will not, without the prior written consent of the

Chairman, during the Restricted Period:

15

(a)canvass or solicit the services of or entice away (or try to entice away) from

the Company, or the Group, or engage, whether on the Executive’s own

behalf or on behalf of others, a Restricted Person or any person who is or was

an executive director of, or employed at the level of a senior manager (or

above), by the Company or the Group at any time during the twelve month

period immediately preceding the Termination Date;

(b)employ or engage or otherwise facilitate the employment or engagement of

any Restricted Person, whether or not such person would be in breach of

contract as a result of such employment or engagement;

(c)canvass or solicit the custom of or entice away (or try to entice away) from

the Company, or the Group, whether on the Executive’s own behalf or on

behalf of others, the custom or business of any person who is or was a

customer or client of, or in the habit of dealing with, the Company or (as the

case may be) any other Group Company at any time during the twelve month

period immediately preceding the Termination Date and in respect of whom

the Executive had access to confidential information or with whose custom or

business he were personally concerned or employees reporting directly to him

were personally concerned;

(d)deal with or otherwise accept, in competition with the Company or the Group

the custom of, any person who was at any time during the twelve month

period immediately preceding the Termination Date a customer or client of,

or in the habit of dealing with, the Company or (as the case may be) the

Group and in respect of whom the Executive had access to Confidential

Information or with whose custom or business he was personally concerned

or employees reporting directly to him were personally concerned;

(e)canvass or solicit the custom of or entice away (or try to entice away) from

the Company, or the Group, whether on the Executive’s own behalf or on

behalf of others, the custom or business of any person who is or was a

supplier to the Company or (as the case may be) any other Group Company at

any time during the twelve month period immediately preceding the

Termination Date and in respect of whom he had access to Confidential

Information or with whose custom or business he was personally concerned

or employees reporting directly to him were personally concerned;

(f)deal with or otherwise accept, in competition with the Company or the Group

the custom of, any person who was at any time during the twelve month

period immediately preceding the Termination Date a supplier to the

Company or (as the case may be) the Group and in respect of whom the

Executive had access to Confidential Information or with whose custom or

business he was personally concerned or employees reporting directly to him

were personally concerned; or

(g)in a capacity similar to the Executive’s position within the Group, work for or

be engaged by or concerned or interested (except as the holder of any shares,

stock or debentures which in aggregate do not exceed 3% of the total shares,

stocks or debentures of a company quoted on any recognised stock exchange)

in any business which is similar or in competition with any business carried

out by the Company or any Group Company which operates from or carries

on business in:

(i)Ireland;

(ii)the United States of America;

(iii)the United Kingdom; and/or

(iv)any other country in which the Company or the Group has a material

presence at the Termination Date,

16

(h)in competition with the Company or any Group Company.

3.The Executive acknowledges that the restrictions in this clause 14 are separate and

severable and are fair and reasonable in all the circumstances. The Executive

acknowledges that while it is the intention of the parties to this Agreement that the

restrictions set out in this clause 14 are considered by the parties no greater than is

necessary for the protection of the interests of the Company and any Group Company,

nevertheless in the event that any of the said restrictions be adjudged to be invalid or

unenforceable by any Court of competent jurisdiction but would be adjudged fair and

reasonable if any part of the wording thereof were amended, modified, deleted or

reduced in scope then this clause 14 shall apply with such amendments,

modifications, deletions and reductions in scope as may be necessary to make them

valid and effective.

4.Following the Termination Date, the Executive will not represent himself as being in

any way connected with the businesses of the Company or of any other Group

Company (except as a former employee or to the extent agreed by such a company)

and neither shall the Executive disparage the Company or its directors, officers,

employees or agents.

5.None of the restrictions in this clause 14 shall prevent the Executive from:

(a)holding an investment by way of shares or other securities of not more than

3% of the total issued share capital of any company, whether or not it is listed

or dealt in on a recognised stock exchange; or

(b)being engaged or concerned in any business concern insofar as his duties or

work shall relate solely to geographical areas where the business concern is

not in competition with any Restricted Business; or

(c)being engaged or concerned in any business concern, provided that his duties

or work shall relate solely to services or activities of a kind with which he

was not concerned to a material extent in the twelve months prior to the

Termination Date.

The restrictions imposed on the Executive by this clause 14 apply to him acting:

(a)directly or indirectly; and

(b)on his own behalf or on behalf of, or in conjunction with, any firm, company

or person.

6.The Executive will not at any time after the termination of the Employment use in

connection with any business any name that includes the name of the Company or of

any Group Company or their respective publications or any colourable imitation of

such names.

7.Any benefit given or deemed to be given by the Executive to any Group Company

under the terms of clause 14 is received and held on trust by the Company for the

relevant Group Company. The Executive will, at the request and expense of the

Company, enter into a direct agreement or undertaking with any Group Company to

which he provides services whereby he will accept restrictions corresponding to the

restrictions in this clause 14 (or such of them as may be appropriate in the

circumstances) as the Company may reasonably require in the circumstances.

8.The Executive agrees that if in the course of his employment or thereafter during the

continuance in force of the restrictions set out in this clause 14, the Executive

receives an offer of employment from any Person, the Executive will immediately

provide that person with a complete and accurate copy of this Agreement and shall

tell the Board the identity of that person as soon as possible after accepting the offer.

17

9.The Executive acknowledges and agrees that any breach by him of this agreement

may cause great and irreparable injury, harm and damage to the Company and/or its

Group Companies, which cannot be adequately compensated for in damages.

Therefore, the Executive acknowledges and agrees that the Company (on its own

behalf or on behalf of any Group Company) may seek to enforce this agreement in

any court having appropriate jurisdiction and, in addition to any other rights or

remedies it may have at law or in equity or by statute, shall be entitled to obtain

injunctive or other equitable relief to prevent or curtail any actual, intended,

threatened or potential breach of this clause 14.  If the Company should initiate legal

proceedings to enforce its rights under this clause 14 and be substantially successful

in such proceedings, the Executive agrees to fully reimburse the Company for the

legal costs it may incur in connection with such legal proceedings.

10.The Executive confirms that he has entered into the restrictions in this clause 14

having been given the opportunity to take independent legal advice.

15.(a) Offers on Liquidation

The Executive will have no claim against the Company or any Group Company if the

Employment is terminated by reason of liquidation in order to reconstruct or

amalgamate the Company or by reason of any reorganisation of the Company and the

Executive is offered employment with the company succeeding to the Company upon

such liquidation or reorganization and the new terms of employment offered to the

Executive are no less favourable to him than the terms of this agreement.

(b) Change of Control

The Executive shall be entitled to terminate his employment by giving to the

Company not less than thirty days prior notice at any time within six months after a

change in control of CRH plc, if the Executive has reasonable grounds to contend that

such change of control has resulted or will result in a diminution of his powers, duties

or functions in relation to CRH plc. Upon such termination the Company shall make

to the Executive in extinction of all and any claims which the Executive may have in

respect of the termination of his employment a payment which (subject to the

deduction of tax and other statutory payments as required by law and any other sums

owed by the Executive to the Company or any Group company) is equal to one years’

remuneration, provided that the Executive accepts such payment in full and final

discharge and satisfaction of such (if any) equitable, statutory, contractual and other

common law rights, claims and demands as the Executive may have against the

Company and any Group company. For the purpose of this Clause 15(b), the

Executive’s remuneration will be calculated as inclusive of his then current base

salary, any Vested Awards due under the incentive scheme and the cost to the

employer of providing all other current contractual benefits which will otherwise be

ongoing in nature. The treatment of any annual bonus or Unvested Awards will

remain at the discretion of the Board Compensation Committee in accordance with

the provisions of the bonus plan and the rules of the relevant scheme. For the

purposes of this Clause 15(b) a change in control of CRH plc shall be deemed to have

occurred if a person or persons acting in concert acquires, directly or indirectly,

shares in CRH plc which, when aggregated with any existing holding by such person

or persons, carries more than fifty percent (50%) of the voting rights of CRH plc; and

in this Clause 15(b) “person” includes a partnership, company, statutory corporation

or other body corporate.

In the event of a dispute between the parties as to whether a change in control of CRH

plc has occurred or has resulted or will result in a diminution of the Executive’s

powers, duties or functions in relation to CRH plc, the parties hereto shall, at the

18

request of the Executive and in advance of the termination of his employment refer

such dispute to a third party for decision. Any such dispute between the parties

concerning or relating to the provisions of this Clause 15(b) shall be referred to such a

third party as the parties hereto may mutually agree in writing or, in the default of

agreement, to such independent third party as shall be nominated by the President for

the time-being of the Institute of Chartered Accountants in Ireland (hereinafter called

the “third party”). Once the third party has been agreed or appointed as aforesaid,

each of the parties hereto shall, within 10 days of the date thereof, furnish written

submissions to the third party setting out their respective positions in relation to the

matters in dispute. The third party may, if he or she deems it appropriate to do so,

convene a meeting with the parties after receipt of such written submissions. After the

third party has heard the parties and/or considered their written submissions, he or she

shall make a determination of all matters in dispute. In making such determination,

the third party’ shall act as an expert and not as an arbitrator. The decision of the third

party shall be final and binding on both parties save in the case of manifest error. The

costs incurred by the third party shall be discharged by the Company.

This Clause 15(b) may be modified by the Compensation Committee to align it with

any other policy on change of control approved by the Committee from time to time,

provided that the terms of such policy are not less favourable than the terms outlined

herein.  The Executive will be notified in writing of any such modifications.

16.Return of Company Property

1.Any time during the Employment (at the request of the Company) and in any event

when the Employment terminates, the Executive will immediately return to the

Company:

(a)all documents and other materials (whether originals or copies) made or

compiled by or delivered to the Executive during the Employment and

relating to or concerning all the Group Companies (such documents and

materials, for the avoidance of doubt, constitute the property of the

Company). The Executive will not retain any copies of any materials or other

information; and

(b)all other property belonging or relating to any of the Group Companies.

17.Directorships

1.The Executive’s office as a director of the Company or any other Group Company is

subject to the Constitution of the relevant company (as amended from time to time),

If the provisions of this Agreement conflict with the provisions of the Constitution

then the Constitution will prevail.

2.The Executive must resign from any office held in any Group Company if he is asked

to do so by the Company on the termination of the Employment.

3.If the Executive does not resign as an officer of a Group Company, having been

requested to do so in accordance with clause 17.2, the Company will be appointed as

his attorney to effect the resignation. By entering into this Agreement, the Executive

irrevocably appoints the Company as his attorney to act on his behalf to execute any

document or do anything in his name necessary to effect his resignation in accordance

with clause 17.2. If there is any doubt as to whether such a document (or other thing)

has been carried out within the authority conferred by this clause 17.3, a certificate in

writing (signed by any director or the secretary of the Company) will be sufficient to

prove that the act of thing falls within that authority.

4.During the Employment, the Executive will not do anything which could cause him to

be disqualified from continuing to act as a director of any Group Company.

19

18.Notices

1.Notices and other communications to any party to this Agreement required or

permitted hereunder or any proceedings relating hereto shall be in writing and will be

sufficiently served:

(a)if delivered by hand to the Executive at his last known address or to the

Chairman at the Company’s registered office for the time being or to such

other address as is from time to time designated by the parties, or

(b)if sent by email to the Executive at his last known email address or to the

Chairman at their last known email address for the time being or to such other

email address as is from time to time designated by the parties, or

(c)if sent by prepaid registered post to the Executive at his last known address or

to the Chairman at the Company’s registered office for the time being or to

such other address as is from time to time designated by the parties.

2.Any notice or communication required to be given pursuant to this Agreement shall

be deemed to have been served:

(a)if delivered by hand, at the time of delivery;

(b)if sent by email, at the time of sending, where no delivery failure or out of

office is received; and

(c)if sent by prepaid registered post, 48 hours after posting;

3.provided that any such delivery, transmission or postage outside the hours of 9.00

a.m. to 5.30 p.m. shall be deemed to have been served on the next business day i.e.

any day excluding Saturdays, Sundays, bank holidays and public holidays.

19.Data Protection

1.The Company holds personal information about the Executive which is subject to the

General Data Protection Regulation (GDPR) and the Data Protection Acts 1988-2018.

By signing this Agreement, the Executive accepts that the Company will process

personal information about him where it is necessary to do so in the normal course of

the employer/employee relationship and/or in the course of the legitimate business

interests pursued by the Company. In doing so, the Company may from time to time

require that the personal information is transferred within the Group both inside and

outside the European Union and also to third party service providers as necessary to

administer the Employment (e.g. benefit providers) and as necessary for the

Company’s legitimate business interests (e.g. its professional advisers).

2.The Executive’s data will be retained for the duration of his employment plus an

additional period (typically 7 years but possibly longer) to address the relevant

retention and limitation periods determined by law. The Company will process his

personal information in accordance with data protection laws and he can consult the

Company’s Data Protection Policy (as may be amended from time to time) for details

about how to exercise rights in respect of data. The Company’s Data Protection

Policy provides detailed information on the processing of personal data.  The

Company will ensure that the Executive’s information is accurate, kept up to date and

not kept for longer than is necessary and he agrees to let the Company know of any

material change in such personal data (e.g. next of kin for emergency contact

purposes).  The Company will also take measures to safeguard his data against

unauthorised or unlawful processing and accidental loss or destruction or damage to

the data and the Company relies on him as an employee to comply with all applicable

workplace policies governing the use of Company facilities and the use and

disclosure of data.

20

3.The Company reserves the right to monitor the Executive’s use of Group facilities in

exceptional cases where the Company believes it is necessary to ensure compliance

with acceptable usage and other applicable policies therefore he should not assume

that workplace email communications are private. The Executive is advised that

where appropriate and available, evidence such as CCTV footage, web-logs, etc. will

be used by the Company in the context of internal investigations and/or disciplinary

proceedings.

20.Miscellaneous

1.This Agreement may only be modified by the written agreement of the parties.

2.The Executive cannot assign this Agreement to anyone else.

3.References in this Agreement to rules, regulations, policies, handbooks or other

similar documents which supplement it or are referred to in it are references to the

versions or forms of the relevant documents as amended or updated from time to

time.

4.This Agreement supersedes any previous written or oral agreement between the

parties in relation to the matters dealt within it. It contains the whole agreement

between the parties relating to the Employment at the date the agreement was entered

into (except for those terms implied by law which cannot be excluded by the

agreement of the parties). The Executive acknowledges that he has not been induced

to enter into this Agreement by any representation, warranty or undertaking not

expressly incorporated into it. The Executive agrees and acknowledges that his only

rights and remedies in relation to any representation, warranty or undertaking made or

given in connection with this Agreement (unless such representation, warranty or

undertaking was made fraudulently) will be for breach of the terms of this

Agreement, to the exclusion of all other rights and remedies. By signing the

Agreement, the Executive acknowledges that he does so with full understanding of its

meaning and effect and with the benefit of independent legal advice.

5.If any provision or term of this Agreement or any part thereof shall become or be

declared illegal, invalid or unenforceable for any reason whatsoever including but

without limitation by reason of the provisions of any legislation or other provisions

having force of law or by reason of any decision of any court or other body or

authority having jurisdiction over the parties to this Agreement, such terms or

provisions shall be divisible from this Agreement and shall be deemed to be deleted

from this Agreement in the jurisdiction in question provided always that if any such

deletion substantially affects or alters the commercial basis of this Agreement the

parties shall negotiate in good faith to amend and modify the provisions and terms of

this Agreement as may be necessary or desirable in the circumstances.

6.Neither party’s rights or powers under this agreement will be affected if:

(a)one party delays in enforcing any provision of this Agreement; or

(b)one party grants time to the other party.

7.References to any statutory provisions include any modifications or re-enactments of

those provisions.

8.Headings will be ignored in construing this Agreement.

9.The Executive will at all times comply with the Rules of any Exchange in which

CRH plc is listed and any corporate governance rules and standards affecting CRH

plc.

10.The Executive acknowledges and agrees that any compensation payable pursuant to

or contemplated by this Agreement shall be subject to reduction, cancellation,

forfeiture or recoupment in accordance with the terms of any Company Clawback

21

policy approved by the CRH Board or any delegated Committee in effect from time

to time or applicable law.

11.The termination of this Agreement, howsoever arising, shall not affect such of the

provisions hereof as are expressed to operate thereafter and shall be without prejudice

to any right of action which has accrued to either party in respect of any breach of this

Agreement by the other party.

12.The expiration or determination of this Agreement, howsoever arising, will not affect

such of the provisions hereof as are expressed to operate or have effect thereafter and

will be without prejudice to any right of action already accrued to either party in

respect of any breach of this Agreement by the other party.

13.This Agreement shall ensure to the benefit of and be binding upon the parties to this

Agreement, their respective personal representatives and successors.

14.The Company shall be entitled to assign this Agreement and all its rights and

obligations hereunder to any Group Company.

15.A waiver by either party to this Agreement of any breach by the other party of any of

the terms of this Agreement or the acquiescence of such party in any act which but for

such acquiescence would be a breach as aforesaid, will not operate as a waiver of any

rights or the exercise thereof.

16.This Agreement is governed by and will be interpreted in accordance with the laws of

Ireland. Each of the parties submits to the jurisdiction of the courts of Ireland as

regards any claim or matter arising under this Agreement.

17.This Agreement may be executed in any number of counterparts, each of which,

when executed and delivered, shall constitute a duplicate original, but all the

counterparts shall together constitute the one agreement and may be executed

electronically. Provided that both Parties enter into this Agreement in this way, it has

the same effect as if the signatures on the counterparts were on a single copy of this

Agreement.

18.Save as otherwise provided herein, any reference to a clause will be a reference to a

clause of this Agreement.

19.Words denoting the masculine gender will include the feminine and neuter genders

and words denoting the singular will include the plural and vice versa.

22

Signed for and on behalf of

CRH Group Management Limited

/s/ Richie Boucher

Authorised Signatory/ Director

/s/ Neil Colgan

Authorised Signatory/ Director

SIGNED by Denis James Mintern:

/s/ Denis James Mintern

Denis James Mintern

23

Schedule 1

INTERESTS OF EXECUTIVE

[Intentionally Omitted]

Exhibit 10.29 - Employment Agreement (P. Buckley) Initials Employer: AM Initials Employee: PB

Exhibit 10.29

EMPLOYMENT AGREEMENT

The undersigned parties:

CRH Nederland B.V., a private company with limited liability (besloten vennootschap met

beperkte aansprakelijkheid), incorporated under the Dutch law, having its statutory seat (zetel)

in Rijswijk, the Netherlands, and its business address at De Klencke 10-12, 1083 HL

Amsterdam, the Netherlands and registered with the Chamber of Commerce under number

28068878 (“the Employer” or “the Company”)

and

Mr. P.J. Buckley, date of birth [*****], living at [*****], hereinafter “The Employee”

declare to have agreed as follows:

This Agreement records the terms on which the Employee will serve as President – CRH Europe.

Interpretation

In this Agreement (and any schedules to it):

“Manager” means the Chief Operating Officer of CRH plc for the time being;

“Employment” means the employment governed by this Agreement;

“Group Company” means any company affiliated to Employer (including subsidiaries) and

“Group Companies’ will be interpreted accordingly;

“Group” means the Company together with all other Group Companies;

“Termination Date” means the date on which the Employment terminates.

1.Date of Employment, Appointment of Duties, and Working hours of the Employee

1.1.The Employee shall enter into an employment agreement with the Employer in the position of

President – CRH Europe and is a member of the Group Leadership Team (GLT) effective as

of 1 January 2024.

1.2.Based on prior employment of the Employee for CRH Group and/or one or more of its

subsidiaries/affiliated companies, the start date of employment remains 25 March 2009.

a.This agreement supersedes all previous agreements between the Employee and the

Employer and between the Employee and any subsidiaries/affiliated companies. After

this agreement is signed, the Employee and the Employer can no longer derive any

rights from agreements which have been superseded herewith.

b.This agreement constitutes the entire employment agreement between the Employee

and the Employer. The Employee is not employed by any subsidiaries/affiliated

companies of the Employer.

Initials Employer: AM Initials Employee: PB

1.3.The Employee shall perform to the best of Employee’s abilities all duties in connection with

the business of the Employer and shall act in accordance with the instructions issued by or on

behalf of the Employer.

1.4.The agreed working hours are 40 per week.

1.5.The Employee will:

a.subject as provided for in clause 16.1, devote all of his working time, attention and

skill to the Employment;

b.carry out such duties as may be assigned to him by the Manager from time to time;

c.properly perform his duties and exercise his powers;

d.comply with all applicable rules, policies and regulations issued by the Company from

time to time;

e.obey the reasonable and lawful directions of the Manager; and

f.use his best endeavours to promote the interests and reputation of every Group

Company.

1.6.The Employee accepts that the Company may require him to perform duties for any other

Group Company, for part of his working time. In performing those duties, clause 1.5. (d) will

apply as if references to the Company are to the appropriate Group Company. The Company

will remain responsible for the payments and benefits the Employee is entitled to receive

under this Agreement.

1.7.The Employee will keep the Manager fully informed of the discharge of his duties in a prompt

and timely manner. The Employee will provide information to the Manager in writing if

requested.

2.Work Location

2.1.The work location of the Employee shall be the office of the Employer in Amsterdam, the

Netherlands.

2.2.The Employee accepts the right of the Employer to temporarily or permanently move the

workplace to another location. Unless the workplace moves to another country, the Employee

is obliged to follow suit. In case of a move abroad, the Employee will be offered the possibility

to move.

2.3.The Employee will be exclusively tax resident of the Netherlands for the duration of this

employment agreement, unless and until explicitly agreed with the Employer.

2.4.Where the Employee travels and works outside the Netherlands for more than 30 days in a

calendar year (or such other period as advised to him in writing by Manager) he shall keep a

travel calendar indicating the days travelled outside of the Netherlands and produce this to the

Company on request.

2.5.The Employer recognises that travel for the purposes of your employment can give rise to

additional tax and social security requirements for both you and the Employer. The Employer’s

goal is to make your cross-border experience as smooth as possible and to assist you with

any tax or social security related matters where needed. As an employee who travels at the

request of the Employer, all tax and social security compliance requirements will be met by

the Employer and you will not pay any more tax on your employment income than you would

have paid if you continued to work solely in your home country (Netherlands) of employment.

You are responsible for your own tax on salary, bonus and any home country benefits,

however, you are protected from cash-flow implications of dual payroll requirements and

excess tax liabilities over your stay at home position on employment income. In the event it is

determined that a tax liability in respect of employment income has arisen in a country where

you have been travelling to at the request of the Employer, the Employer will arrange to pay

Initials Employer: AM Initials Employee: PB

the tax liability due. You will then arrange to reimburse CRH the corresponding refund that will

be received through the filing of your home country tax return, as indicated by the CRH

authorised tax vendor. Any tax liability (including any penalties and interest thereon) which is

not related to your employment income shall remain your sole liability.

3.Duration of the Agreement and Trial Period

3.1.The employment agreement shall be entered into for an indefinite period.

3.2.There is no trial period applicable.

4.Suspensive Condition: work / residence permit

4.1.The Employee must be a EU citizen or have a valid Dutch work permit and/or residence

permit, before the employment commences, as well as during the full duration of the

employment. Where applicable the Employer shall apply for and sponsor the permit. The

Employee has the duty to inform the Employer of any relevant information that might impact

his/her legal residence/work permission/tax position. This information obligation is including,

but not limited to change in residence, change in work pattern, change in family situation, not

meeting legal thresholds, change in criminal record.

5.Salary and Benefits

5.1.Based on a fulltime employment the base salary of the Employee will amount to €810,000

gross per annum including 8% holiday allowance and will be paid in twelve monthly

instalments. Salary will be paid monthly in arrears and will accrue from day to day. The

Employee’s basic salary will be reviewed annually, such review not to result in a basic salary

lower than the salary in the previous year unless otherwise agreed with the Employee. Any

benefit in kind tax liability arising on benefits provided to the Employee under this agreement

shall be a matter for the Employee.

5.2.The basic salary referred to in clause 5.1 includes director’s fees from Group Companies and

any other companies in which the Employee is required to accept a directorship under the

terms of this Employment. To achieve this:

a.the Employee will repay any fees he receives to the Company; or

b.his salary will be reduced by the amount of those fees; or

c.combination of the methods set out in clauses 5.2(a) and 5.2(b) will be applied.

5.3.In addition to the base salary the Employee will be considered for a discretionary variable

bonus amounting to a maximum of 175% of the annual base salary, with a target of 87.5%,

which will be tied to performance targets set from time to time and to the achievement of

agreed personal objectives. As a GLT member 25% of your annual bonus will be delivered in

deferred shares which normally vest after 3 years from the date of grant subject to the terms

of the grant. Any bonus will be paid to the Employee less any deductions which the Company

is required by law to make and may be refundable in circumstances determined by the

company. A condition for pay-out is that the Employee is still employed by the Employer in the

month of the following calendar year in which the bonus is customary paid. No right can be

claimed to receive a bonus in the future.

5.4.The Employee will be provided with housing in Amsterdam at an acceptable standard. The

housing budget will be agreed under separate cover.

5.5.The Employee will be eligible to participate in the CRH 2014 Performance Share Plan (“the

Plan”) in accordance with the rules of that plan.

5.6.The Employee will be covered by the Group’s Directors and Officers liability insurance on the

same basis as other senior executives.

Initials Employer: AM Initials Employee: PB

5.7.The Company will refund to the Employee all reasonable expenses properly incurred by him

in performing his duties under this Agreement, provided that these are incurred in accordance

with Company expenses policy from time to time. The Company will require the Employee to

produce receipts or other supporting documents as proof that he has incurred any expenses

he claims. If the Employee is provided with a credit or charge card by the Company, this must

only be used for expenses which he incurs in performing the duties of the Employment.

6.Overtime

6.1.The Employee, on signing this employment agreement, is aware that the Employee will have

to sometimes perform work outside the working hours as referred to in article 1.4 without the

Employee being entitled to additional compensation in this regard.

7.Vacations

7.1.In case of a fulltime employment agreement the Employee shall be entitled to 30 days’ holiday

per calendar year. If the Employee works part time and/or enters or leaves the employ in the

course of a calendar year this entitlement will be calculated proportionally. The Employee shall

enjoy the holidays in consultation with and after approval of the Employer.

8.Car policy

8.1.For the performance of duties, the Employer will provide Employee with a Company Car/or

another mobility type in accordance with the latest car policy (“Autoregeling”).

8.2.The Employee will receive a basic car allowance of €20,000 gross per annum (less any

deductions which the Company is required by law to make), payable monthly together with the

Employee’s normal salary payment.

9.Sickness

9.1.In the event of sickness as defined in article 7:629 of the Dutch Civil code, the Employee shall

notify the Employer as soon as possible. The Employee shall observe the Employer’s policy

pertaining to sickness as determined and stated in the “Personeelshandboek CRH Nederland

BV”.

9.2.In the event of sickness, the Employer shall from the first day of sickness pay the Employee

100% of the base salary and holiday allowance as defined in article 5.1 up to a maximum of

52 weeks. The above applies, however, only if and to the extent that pursuant to the

requirements of article 7:629 of the Dutch Civil Code, the Employer is under the obligation to

pay salary. Should the sickness continue after this period of 52 weeks, the Employer shall

thereupon (to a maximum of – once again – 52 weeks) pay the Employee 70% of the base

salary and holiday allowance.

9.3.The Employee shall not be entitled to the salary payment referred to in paragraph 2 of this

article if, and to the extent that, in connection with the sickness, the Employee can validly

claim damages from a third party as a result of loss of salary and if and to the extent that the

payments by the Employer set forth in paragraph 2 of this article exceed the minimum

obligation referred to in article 7:629 sub 1 of the Dutch Civil Code. In the event, the Employer

shall satisfy payment solely by means of advanced payments on the compensation to be

received from the third party and upon assignment by the Employee of the right to damages

vis-à-vis the third party concerned up to the total amount of advanced payments made. The

advanced payments shall be set-off by the Employer if the compensation is paid or, as the

case may be, in proportion thereto.

Initials Employer: AM Initials Employee: PB

10.Pension

10.1.The Employee participates in the Employers company pension plan. The Pension fund

“Stichting CRH Pensioenfonds” is the pension plan administrator. The pension plan is

recorded in the Pension funds pension plan rules and is part of the employment agreement.

The company pension plan may be downloaded from the Pension funds website

www.crhpensioenfonds.nl. On request the pension plan will be sent to the Employee by mail.

10.2.In accordance to article 12 of the Dutch “Pensioenwet” and subsequent to the rules in the

pension plan, the Employer preserves the right to:

a.diminish or discontinue the Employer’s contribution to the pension plan in case of

a drastic change in circumstances (for example: a drastic change in circumstances

can be “suspension of payment” or “insolvency”).

b.unilaterally amend the pension plan.

10.3.At the Employer’s request, the pension plan can be legally altered by the board of the Pension

fund, defined in paragraph 1, after the Pension Council’s consent to the alteration.

10.4.Pension accrual commences at the age mentioned in article 2 of the pension plan rules. As of

this age the years of service are taken into account for determining the Employee’s pension

rights.

11.Documents

11.1.The Employee shall neither have nor keep in the Employee’s possession, any documents

and/or correspondence and/or data carriers and/or copies thereof in any manner whatsoever,

which belong to the Employer (and/or the companies that are linked economically or

organizationally to the Employer), and which have been made available to the Employee as a

result of the Employee’s employment, except insofar as and for as long as necessary for the

performance of the Employee’s work for the Employer. In any event, the Employee will be

obliged to immediately return to the Employer, without necessitating the need of any request

to be made, any and all such documents and/or correspondence and/or data carriers and/or

copies thereof at termination of the agreement or on suspension of the Employee from active

duty for whatever reason.

12.Additional Functions

12.1.During the term of employment, the Employee shall not fulfil any additional functions or carry

out any additional activities, whether or not for a fee, without the prior written approval of the

Employer, such at the discretion of the Employer.

12.2.At the express written and substantiated request of the Employee, the Employer may grant

general or specific approval to deviate from the stipulations of this present article. The

Employer may attach certain conditions to the approval.

13.Gifts

13.1.The Employee shall not, directly or indirectly, in connection with the performance of the

Employee’s duties accept or demand commission, contributions, gifts or reimbursement in any

form whatsoever from third parties. This does not apply to customary promotional gifts of little

value.

14.Other Applicable Rules

14.1.In addition to the provisions contained in the agreement, the conditions of employment as

determined by the Employer from time to time and laid down in the CRH Code of Conduct

shall apply to the Employee.

Initials Employer: AM Initials Employee: PB

15.Penalty Clause

15.1.Contrary to article 7:650 paragraphs 3 and 5 of the Dutch Civil Code, the Employee shall in

case of any violation of stipulations 11, 12, 13 and 22 forfeit an immediately payable penalty to

the benefit of the Employer of Euro 15.000,- in one payment, increased by an amount of Euro

6.000,- per day that the violation continues, without prejudice to the other rights of the

Employer by virtue of the law or this present contract, such as the right to fulfilment of a

violated stipulation or to demand an injunction or, instead of this penalty, compensation, as

well as to terminate this present employment agreement, if it still exists.

16.Interests of the Employee

16.1.The Employee will disclose promptly in writing to the Manager all his interests (for example all

directorships and any shareholdings in companies other than CRH plc) that may be material

to the Employment. The Employee will be permitted to carry out any such disclosed interests

during the course of the Employment and to be paid and retain fees therefor, subject to the

limitations set out in clauses 1.5.(a) and 16.2. Any additional business involvements that may

arise or be offered to the Employee outside of the CRH Group will be disclosed to, and be

subject to, the agreement of the Manager.

16.2.Subject to the permitted investments set out in clause 16.3, during the Employment the

Employee will not be directly or indirectly engaged or concerned in the conduct of any activity

in any country in which the Company or any Group Company has significant presence, which

is similar to or competes with any activity carried on by any Group Company (except as a

representative of the Company or with the written consent of the Board).

16.3.The Employee may not hold or be interested in investments which amount to more than five

per cent of the issued securities of any class of any one company which are listed or quoted

on any recognised Stock Exchange.

16.4.The Employee will (and will endeavour to procure that his spouse and dependent children)

comply with all rules of law, and rules or policies applicable to CRH plc from time to time in

relation to the holding or trading of securities in CRH plc.

17.Shareholding Requirements

17.1.The Employee, at any point during which he is a GLT member, shall be required within five (5)

years of the effective date of this Agreement and for the duration of the time during which the

Employee remains a GLT member, to own common stock in CRH plc which is valued at 100%

of the Employee's basic salary on the date of this agreement (the "Required Ownership

Percentage"). Furthermore, if the Employee's basic salary subsequently increases, the

Employee shall be required to own common stock in CRH plc equal to 100% of any such

increased amount within five (5) years of the effective date of the increase.

17.2. The stock which shall be counted in measuring achievement of this requirement shall include

the following:

a.shares owned outright or beneficially by the Employee (or his or her spouse and

other immediate family members who are dependents);

b.shares which the Employee does not hold but which (i) have vested and are being

beneficially held for the Employee under the Company's Performance Share Plan or

an annual bonus plan, or (ii) have not vested and are held in the Employee's name

under a Company annual bonus plan, or any other restricted share plan other than

the Performance Share Plan in existence from time to time; provided, however, in

Initials Employer: AM Initials Employee: PB

either case these shares shall be counted on a net-of-taxes basis, which is

determined in accordance with the Group's tax policies.

17.3.Annually, all shares held by the Employee or otherwise counted as being includable in

meeting the Required Ownership Percentage shall, each December 31, be reported by the

Employee and valued by the Company for the purpose of assessing progress and

achievement of the Required Ownership Percentage and the value shall be the higher of (i)

the prevailing share price on such December 31 or (ii) the prevailing share price on the date of

purchase or vesting, as the case may be.

17.4.The Board Compensation Committee of CRH plc shall be responsible for the administration of

the policy in this clause 17 and shall determine the appropriate means of enforcing its

provisions which may include the withholding of shares by CRH plc or considering the

Employee in breach of his obligations under this agreement. Should the Employee breach this

requirement of this agreement as a result of an unexpected and precipitous decrease in the

CRH share price, the Employee shall remedy the breach as soon as reasonably possible. The

Board Compensation Committee shall have the discretion to determine, in consultation with

the Employee, a reasonable time period in which the Employee must remedy the said breach.

18.Confidentiality

18.1.Without prejudice to the common law duties which he owes to the Group, the Employee

agrees that he will not, except in the proper performance of his duties, copy, use or disclose to

any person any of the Group’s trade secrets, or confidential information. This restriction will

continue to apply after the termination of the Employment without limit in time but will not

apply to trade secrets or confidential information which become public other than through

unauthorised disclosure by the Employee. The Employee will use his best endeavours to

prevent the unauthorised copying use or disclosure of such information.

18.2.For the purposes of this Agreement, trade secrets and confidential information include but will

not be limited to technical information, intellectual property, business and marketing plans,

strategies, customer information, software, other information concerning the products,

promotions, development, financing, expansion plans, business policies and practices of the

Group and other forms of information considered by the Group to be confidential and in the

nature of trade secrets (including, without limitation, ideas, research and development, know-

how, formulas, technical data, designs, drawings, specifications, customer and supplier lists,

pricing and cost information and business and marketing plans and proposals) and any other

information in whatever form (written, oral, visual and electronic) concerning the confidential

affairs of the Group. In the course of the Employment the Employee is likely to obtain trade

secrets and confidential information belonging or relating to other Group Companies and other

persons. He will treat such information as if it falls within the terms of clause 18.1 and clause

18.1 will apply with any necessary amendments to such information. If requested to do so by

the Group, the Employee will enter into an agreement with other Group Companies and any

other persons in the same terms as clause 18.1 with any amendments necessary to give

effect to this provision.

19.Intellectual Property Rights

19.1.For the purposes of this clause, “Intellectual Property” means patents, trade marks, service

marks, registered designs (including applications for and rights to apply for any of them),

inventions, unregistered design rights, logos, trade or business names, copyrights, database

rights, confidential information, knowhow and any similar rights in any country.

Initials Employer: AM Initials Employee: PB

19.2.The Employee acknowledges that (i) it is part of his normal duties to develop the products and

services of the Group; and (ii) because of the nature of his position he has a special obligation

to further the interests of the Group. All Intellectual Property which the Employee develops or

produces in the course of his employment duties, or outside such duties but relating to the

business of the Group, will be owned by the Company to the fullest extent permitted by law.

The Employee agrees, at the Company’s expense, to sign all documents and carry out all

such acts as will be necessary to vest such Intellectual Property in the Company, and to

obtain protection and enforce the Company’s rights anywhere in the world. The Employee

also hereby waives all moral rights in all Intellectual Property in the company, and to obtain

protection and enforce the Company’s rights anywhere in the world. The Employee also

hereby waives all moral rights in all Intellectual Property which is owned by the Company, or

will be owned by the Company, further to this clause. The Employee will not copy, disclose or

make use of any Intellectual Property belonging to the Company (whether or not subject to

this clause) except to the extent necessary for the proper performance of his duties. Rights

and obligations under this clause will continue after the termination of this Agreement in

respect of all intellectual property arising during the Employment.

20.Termination and Suspension

20.1.Each of the Company and the Employee may terminate the Employment by giving to the other

not less than:

a.in the case of the Employee, six months’ written notice; and

b.in the case of the Company, twelve months’ written notice.

20.2.Notwithstanding the other provisions of this Agreement and in particular clause 20.1 and

unless otherwise agreed between the parties, the Employment will automatically terminate,

without notice being required, on the date the Employee reaches the state pension age

(“AOW gerechtigde leeftijd”).

20.3.The Company may at its sole and absolute discretion pay a sum equal to the Employee’s full

remuneration (other than in respect of bonus and other incentive arrangements, for which the

discretion of the Compensation Committee will remain) in lieu of any unexpired period of

notice (less any deductions the Company is required by law to make).

20.4.Notwithstanding the other provisions of the Agreement, the Company may terminate the

Employment by giving written notice to take immediate effect if the Employee:

a.commits any serious or persistent breach of his material obligations under this

Agreement; or

b.is guilty of any gross misconduct which is materially injurious or causes financial or

reputational harm to any Group Company; or

c.is guilty of dishonesty or is convicted of an offence (other than a motoring offence

which does not result in imprisonment) whether in connection with the Employment or

otherwise; or

d.commits (or is reasonably believed by the Board to have committed) a material

breach of any relevant legislation in force which may affect or relate to the business

of any Group Company; or

e.becomes of unsound mind, is bankrupted or has a receiving order made against him

or makes any general composition with his creditors or takes advantage of any

statute affording relief for insolvent debtors; or

f.becomes disqualified from being a director of a company or if the Employee’s

directorship of the Company terminates without the consent or concurrence of the

Company.

Initials Employer: AM Initials Employee: PB

20.5.Where the Company terminates the Employment by giving written notice to take immediate

effect in accordance with clause 20.4, for the avoidance of doubt there is no obligation to give

notice as set out in clause 20.1 or any other period of notice or to make any payment in lieu of

notice.

20.6.When the Employment terminates, or as appropriate during the term of the contract, the

Company may deduct from any money due to the Employee (including remuneration) any

amount which he owes to any Group Company.

20.7.The Company may suspend the Employee from the Employment on full remuneration (other

than in respect of bonus and other incentive arrangements for which the discretion of the

Compensation Committee will remain) at any time and for any reason to investigate any

matter in which the Employee appears to be involved (whether directly or indirectly) and to

conduct any related disciplinary proceedings.

21.Garden Leave

21.1.At any time after notice to terminate the Employment is given by either party under clause 20

above, or if the Employee resigns without giving due notice and the Company does not accept

his resignation, the Company may, at its absolute discretion, require the Employee to take a

period of absence, called garden leave, for some or all of the remaining period of notice

pursuant to clause 20, which for the avoidance of doubt could be for a maximum period of 12

months (pursuant to clause 20.1) (the “Garden Leave Period”). The provisions of this clause

shall apply to any Garden Leave Period. During the Garden Leave Period, the Employee will

be entitled to receive full remuneration (other than in respect of bonus and other incentive

arrangements for which the discretion of the Compensation Committee will remain) in

accordance with the terms of this Agreement, any unused holiday accrued at the

commencement of the Garden Leave Period and any holiday accrued during any such period

will be deemed to be taken by the Employee during the Garden Leave Period. At the end of

the Garden Leave Period, the Company may, at its sole and absolute discretion, pay the

Employee full remuneration (as defined above) in lieu of the balance of any period of notice

given by the Company or the Employee (less any deductions the Company is required by law

to make).

21.2.The Company may require that the Employee will not, without prior written consent of the

Manager or as otherwise permitted pursuant to clause 16 above, be employed or otherwise

engaged in the conduct of any activity, whether or not of a business nature, during the Garden

Leave Period and further, if so requested by the Company, the Employee will not:

(a)enter or attend the premises of the Company or any other Group

Company; or

(b)contact or have any communication with any customer or client of the

Company or any other Group Company in relation to the business of the

Company or any other Group Company (other than purely social contact);

or

(c)contact or have any communication with any employee, officer, director,

agent or consultant of the Company or any other Group Company in

relation to the business of the Company or any other Group Company

(other than purely social contact); or

(d)remain or become involved in any aspect of the business of the Company

or any other Group Company except as required by such companies.

Initials Employer: AM Initials Employee: PB

21.3.During the Garden Leave Period, the Company may require the Employee:

a.to comply with the provisions of clause 22; and

b.to immediately resign from any directorship, trusteeships or other offices which he

holds in the Company, any other Group Company or any other company where such

directorship or other office is held as a consequence or requirement of the

Employment, unless he is required to perform duties to which any such directorship,

trusteeship or other office relates in which case he may retain such directorships,

trusteeship or other offices while those duties are ongoing. The Employee hereby

irrevocably appoints the Company to be his attorney to execute any instrument and

do anything in his name and on his behalf to effect his resignation if he fails to do so

in accordance with this clause 21.3(b).

21.4.During the Garden Leave Period:

a.the Employee shall provide such assistance as the Company or any Group Company

may require to effect an orderly handover of his responsibilities to any individual or

individuals appointed by the Company or any Group Company to take over his role or

responsibilities; and

b.the Employee shall make himself available to deal with requests for information,

provide assistance, be available for meetings and to advise on matters relating to

work (unless the Company has agreed that the Employee may be unavailable for a

period); and

c.the Company may appoint another person to carry out his duties in substitution for

the Employee.

21.5.All duties of the Employment (whether express or implied), including without limitation the

Employee’s duties of fidelity, good faith and exclusive service, shall continue throughout the

Garden Leave Period save as expressly varied by this clause 21. The Employee agrees that

the exercise by the Company of its rights pursuant to this clause 21 shall not entitle the

Employee to claim that he has been constructively dismissed provided that the Company

complies with its obligations under this Agreement.

22.Restrictions after Termination of Employment

22.1.In this clause:

“Prohibited Area” means the Netherlands and any country in which the Company or any

Group Company has a significant presence at the Relevant Date;

“Relevant Date” means the Termination Date or, if earlier, the date on which the Employee

commences any Garden Leave Period; and

‘‘Restricted Period” means the period of

a.nine months for the purpose of clause 22.2 (a); and

b.twelve months for any other purpose;

in either case less any Garden Leave Period, commencing on the Relevant Date, save that in

the event the Restricted Period less any Garden Leave Period would result in no period of

time or a negative period of time, then for the purposes of this clause 22 there will be deemed

to be no further Restricted Period.

22.2.The Employee is likely to obtain trade secrets and confidential information and personal

knowledge of and influence over customers and employees of the Group during the course of

the Employment. To protect these interests, the Employee agrees with the Company that he

will be bound by the following covenants (save where otherwise agreed in writing between the

Manager and the Employee):

Initials Employer: AM Initials Employee: PB

a.during any Restricted Period and within the Prohibited Area, he will not be employed

in, or carry on for his own account or for any other person, whether directly or

indirectly (or be a director of any company engaged in) any business which, by virtue

of its location or otherwise, is or is about to be in competition with any business of the

Company or any other Group Company being carried on by such company at the

Relevant Date provided he was concerned or involved with that business to a

material extent at any time during the 12 months prior to the Relevant Date;

b.during any Restricted Period he will not (either on his own behalf or for or with any

other person), whether directly or indirectly, canvass or solicit in competition with the

Company or any other Group Company the custom of any person who at any time

during the six months prior to the Relevant Date was a customer or client of, or in the

habit of dealing with, the Company or (as the case may be) any other Group

Company and in respect of whom the Employee had access to confidential

information or with whose custom or business the Employee was personally

concerned or employees reporting directly to him were personally concerned;

c.during any Restricted Period he will not (either on his own behalf or for or with any

other person), whether directly or indirectly, deal with or otherwise accept in

competition with the Company or any Group Company the custom of any person who

was at any time during the six months prior to the Relevant Date a customer or client

of, or in the habit of dealing with, the Company or (as the case may be) any Group

Company and in respect of whom the Employee had access to confidential

information or with whose custom or business the Employee was personally

concerned;

d.during any Restricted Period he will not (either on his own behalf or for or with any

other person, whether directly or indirectly) entice or try to entice away from the

Company, or any other Group Company any person who was employed as a director

or in a senior managerial position (which shall generally be considered to be an

individual appointed at job level 20 and above) of such a company at the Relevant

Date and with whom he had worked closely during the six months prior to the

Relevant Date.

22.3.Each of the paragraphs contained in clause 22.2 constitutes an entirely separate and

independent covenant. If any covenant is found to be invalid this will not affect the validity or

enforceability of any of the other covenants.

22.4.Following the Termination Date, the Employee will not represent himself as being in any way

connected with the businesses of the Company or of any other Group Company (except to the

extent agreed by such a company) and neither shall the Employee disparage the Company or

its directors, officers, employees or agents.

22.5.Any benefit given or deemed to be given by the Employee to any Group Company under the

terms of clause 22 is received and held on trust by the Company for the relevant Group

Company. The Employee will enter into appropriate restrictive covenants directly with other

Group Companies if asked to do so by the Company.

23.Return of Company Property

23.1.Any time during the Employment (at the request of the Company) and in any event latest on

the Termination Date, the Employee will immediately return to the Company:

a.all documents and other materials (whether originals or copies) made or compiled by

or delivered to the Employee during the Employment and concerning all the Group

Initials Employer: AM Initials Employee: PB

Companies. The Employee will not retain any copies of any materials or other

information; and

b.all other property belonging or relating to any of the Group Companies.

23.2.If the Employee commences Garden Leave in accordance with clause 21, he may be required

to comply with the provisions of clause 23.1.

24.Directorships

24.1.Should the Employee be appointed as a director of any Group Company, the Employee’s

office as a director of the Group Company will be subject to the Constitution of the relevant

company (as amended from time to time). If the provisions of this Agreement conflict with the

provisions of the Constitution, the Constitution will prevail.

24.2.The Employee shall resign from any office (including for the avoidance of doubt, any statutory

office as director) held in any Group Company if he is asked to do so by the Company on the

termination of the Employment.

24.3.If the Employee does not resign as an officer of a Group Company, having been requested to

do so in accordance with clause 24.2, the Company will be appointed as his attorney to effect

the resignation. By entering into this Agreement, the Employee irrevocably appoints the

Company as his attorney to act on his behalf to execute any document or do anything in his

name necessary to effect his resignation in accordance with clause 24.2. If there is any doubt

as to whether such a document (or other thing) has been carried out within the authority

conferred by this clause 24.3, a certificate in writing (signed by any director or the secretary of

the Company) will be sufficient to prove that the act or thing falls within that authority.

24.4.During the Employment, the Employee will not do anything which could cause him to be

disqualified from continuing to act as a director of any Group Company.

25.Notices

25.1.Any notices given under this Agreement must be given by letter or email. Notice to the

Company must be addressed to its registered office at the time the notice is given. Notice to

the Employee must be given to him personally or sent to his last known address.

25.2.Except for notices given by hand, notices given by post will be deemed to have been given on

the next working day after the day of posting and notices given by email will be deemed to

have been given in the ordinary course of transmission.

26.Data Protection

26.1.For the purposes of the data protection legislation in any applicable jurisdiction (including but

not limited to the Netherlands), the Employee acknowledges and accepts that the Company

may hold, process and disclose his personal data (including special categories of personal

data within the meaning of any such legislation) provided by the Employee to the Company or

any Group Company in the normal course of the employer/employee relationship and in the

course of the Company’s legitimate business interests. This includes where this is required for

all purposes relating to the performance of this agreement including, but not limited to

circumstances where it is necessary for:

a.administering and maintaining personnel records;

b.paying and reviewing salary and other remuneration and benefits;

c.providing and administering benefits (including if relevant, pension, life assurance,

permanent health insurance and medical insurance;

d.undertaking performance appraisals and reviews;

e.maintaining sickness and other absence records;

Initials Employer: AM Initials Employee: PB

f.taking decisions as to the Employee’s fitness for work, eligibility to receive certain

benefits or participate in a Company process (in such circumstances, the Company

reserves the right to require the Employee to be examined by a medical practitioner

and to receive a report)

g.providing references and information to future employers, and if necessary,

governmental and quasi-governmental bodies for social security and other purposes,

and any other relevant authorities;

h.providing information to future purchasers of the Company or any Group company or

of the business which the Employee works; and

i.(f)transferring information concerning the Employee to a country or territory

outside the EEA.

26.2.The Employee acknowledges that during his Employment he will have access to and process,

or authorise the processing of, personal data and special categories of personal data relating

to employees, customers and other individuals held and controlled by the Company and any

Group Company. The Employee agrees to comply with the terms of any applicable data

protection legislation in relation to such data and to abide by the Company’s data protection

policy issued from time to time.

27.Miscellaneous

27.1.This Agreement may be entered into in any number of counterparts, all of which taken

together shall constitute one and the same instrument. Any party may enter into this

Agreement by executing any such counterpart.

27.2.This Agreement may only be modified by the written agreement of the parties.

27.3.The Employee cannot assign this Agreement to anyone else.

27.4.References in this Agreement to rules, regulations, policies, handbooks or other similar

documents which supplement it or are referred to in it are references to the versions or forms

of the relevant documents as amended or updated from time to time.

27.5.This Agreement supersedes any previous written or oral agreement between the parties in

relation to the matters dealt within it. It contains the whole agreement between the parties

relating to the Employment at the date the agreement was entered into (except for those

terms implied by law which cannot be excluded by the agreement of the parties). The

Employee acknowledges that he has not been induced to enter into this Agreement by any

representation, warranty or undertaking not expressly incorporated into it. The Employee

agrees and acknowledges that his only rights and remedies in relation to any representation,

warranty or undertaking made or given in connection with this Agreement (unless such

representation, warranty or undertaking was made fraudulently) will be for breach of the terms

of this Agreement, to the exclusion of all other rights and remedies. By signing the Agreement,

the Employee acknowledges that he does so with full understanding of its meaning and effect

and with the benefit of independent legal advice.

27.6.Neither party’s rights or powers under this agreement will be affected if:

a.one party delays in enforcing any provision of this Agreement; or

b.one party grants time to the other party.

27.7.References to any statutory provisions include any modifications or re-enactments of those

provisions.

27.8.Headings will be ignored in construing this Agreement.

27.9.If either party agrees to waive their rights under a provision of this Agreement, that waiver will

only be effective if it is in writing and it is signed by them. A party’s agreement to waive any

Initials Employer: AM Initials Employee: PB

breach of any term or condition of this Agreement will not be regarded as a waiver of any

subsequent breach of the same term or condition or a different term or condition.

27.10.The Employee will at all times comply with the Rules of any Exchange in which CRH plc is

listed and any corporate governance rules and standards affecting CRH plc.

27.11.This Agreement is governed by and will be interpreted in accordance with the laws of the

Netherlands. Each of the parties submits to the jurisdiction of the courts of the Netherlands as

regards any claim or matter arising under this agreement

28.Privacy

28.1.The latest version of the Privacy Policy is applicable. Attached to this employment agreement

is an outline of the way the personal data of the Employee are processed and the rights and

obligations of the Employer and the Employee. By acknowledging the appendix the Employee

agrees thereto.

29.Personeelshandboek CRH Nederland B.V.

29.1.The latest version of the “Personeelshandboek CRH Nederland B.V.” is applicable.

30.Unilateral Amendment

30.1.The Employer reserves the right to unilaterally amend the conditions:

-in the employment agreement

-in the Personeelshandboek

-in the Code of Conduct

-in the Privacy Policy

-and in any other Regulation that governs the employment agreement as may come

into force.

31.Applicable Law

31.1.The employment agreement is governed by the laws of the Netherlands. Only the Dutch court

shall be authorised to take cognisance of any disputes between parties.

31.2.No Collective Labour Agreement (in Dutch: “CAO”) is applicable to the agreement.

Thus, agreed upon and executed in duplicate,

Signed on behalf of CRH Nederland B.V.

Amsterdam, on 20 February 2024

/s/ Albert Manifold/s/ Peter Buckley

Albert ManifoldThe Employee

Chief Executive

On signing this present contract, the employee has received a copy of:

•The CRH Code of Conduct

•Personeelshandboek CRH Nederland B.V.

•The Privacy policy

Initials Employer: AM Initials Employee: PB

ADDENDUM TO EMPLOYMENT AGREEMENT

The undersigned parties:

CRH Nederland B.V., a private company with limited liability (besloten vennootschap met

beperkte aansprakelijkheid), incorporated under the Dutch law, having its statutory seat (zetel)

in Rijswijk, the Netherlands, and its business address at De Klencke 10-12, 1083 HL

Amsterdam, the Netherlands and registered with the Chamber of Commerce under number

28068878 (“the Employer” or “the Company”)

and

Mr. P.J. Buckley, date of birth [*****], living at [*****], hereinafter “The Employee”

declare to have agreed as follows:

In deviation from clause 2.3 of the Agreement, the Employee can remain tax resident in the

United Kingdom until 31 December 2024, after which he must relocate to the Netherlands.

While the Employee resides in the UK he will continue to be eligible to receive a gross

Mobility Allowance of 10% of base salary per annum, plus the continuation of housing, for

the period 1 January 2024 to 31 December 2024 at the latest.

The cash pension allowance that was previously in place will cease effective 31 December

2023.

Thus, agreed upon and executed in duplicate,

Signed on behalf of CRH Nederland B.V.

Amsterdam, on 20 February 2024

/s/ Albert Manifold/s/ Peter Buckley

Albert ManifoldThe Employee

Chief Executive

Exhibit 10.30 - Employment Agreement (N. Creech) EXHIBIT 10.30

THIS EMPLOYMENT AGREEMENT (“Employment Agreement”) is entered into,

effective as of January 1, 2021 (“Effective Date”), by and between CRH AMERICAS, INC. (the

“Company”) and NATHAN CREECH (the “Executive”). NOW, THEREFORE, in consideration of

material advancement and the mutual agreements set forth below, the adequacy of which are hereby

acknowledged, the parties agree as follows:

1.Employment. The Executive commenced his employment with the Company on May 16,

2011. The Company hereby agrees to continue to employ the Executive, and the Executive

hereby accepts to continue his employment with the Company, upon the terms and conditions

set forth herein. The Executive’s employment shall continue to be “at-will,” except as

otherwise provided in Section 4 below. The Executive shall be employed by the Company as

President Building Products. This is a full-time exempt position. The Executive may also

serve as one of the Company’s board members or as an officer or director of any affiliate of

the Company. The Executive’s normal places of work and duties shall be at the Company’s

subsidiary’s offices located in Texas. In addition, the Executive may be required to travel

both within the United States and abroad.

2.Duties. The services performed by the Executive shall be subject to the terms and conditions

set forth in this Agreement, and the Company’s policies, rules and practices generally

applicable to its employees at the executive level, as established from time to time by the

Company. Such duties shall be performed to the reasonable satisfaction of the Company and

shall be rendered at such places as the interests, needs, business, and opportunities of the

Company require or make advisable, with the exception that any permanent relocation of

Executive from the normal place of work and duties stated in Section 1 shall require

Executive’s prior written consent. The Executive acknowledges that the employment

described herein is full-time employment, and the Executive agrees that he shall diligently

and conscientiously devote his exclusive service, attention, energies, talents, and best efforts

in discharging his duties. The Executive shall devote all time necessary to meet or exceed the

Company’s business goals and objectives. The Executive will disclose promptly in writing to

the Chief Executive of CRH, plc all directorships, partnerships, and any shareholdings in

companies other than a company from the Group, as defined below, in excess of one percent

(1%) of the outstanding shares of capital stock of any company which is traded on a

nationally recognized stock exchange. The Executive will be permitted to carry out any such

disclosed interests during the course of the employment and to be paid and retain fees

therefor, subject to the limitations set out in Section 8(e).

3.Compensation.

(a)Base Salary. The Company shall pay to the Executive a fixed annual salary (the

“Base Salary”) of USD$900,000, less applicable taxes, withholdings and authorized

deductions. The Base Salary shall be due and payable in equal semi-monthly

installments or in such other installments as may be necessary to comport with the

Company’s normal pay periods (“Installments”). The Base Salary will be reviewed

annually, such review not to result in a basic salary lower than the salary in the

previous year unless otherwise agreed with the Executive.

(b)Performance Bonus. The Executive will be eligible to receive an annual discretionary

bonus with a target of 87.5% of the Base Salary (the “Target Bonus”), a minimum of

0% of Base Salary and up to a maximum of 175% of the Base Salary. Said bonus will

be tied to performance targets set from time to time for both the Company and its

affiliates and for the Executive. Any bonus will be paid to the Executive less any

deductions required by law or Company practice. Except in the case of a Termination

for Cause under Section 4(c), the Executive’s eligibility under this clause to receive

an annual discretionary performance bonus in respect of a particular calendar year

shall not be adversely impacted (whether as to payment or calculation) if the

Executive ceases employment with the Company between the beginning of the

following calendar year and the usual payout date in respect of any such bonus.

In addition to the foregoing, as to any such bonus received by the Executive during the time

the Executive is a GLT member, 25% of such bonus will be delivered in restricted shares of common

stock of CRH, plc which will vest three (3) years after the date of grant of such shares. Such grant

shall be subject to the terms of any plan sponsored by the Company, or by any Company parent or

affiliate, which governs restricted stock grants, as well as any applicable grant agreement, including

but not limited to the CRH plc 2014 Deferred Share Bonus Plan, which may be modified from time

to time.

(c)Benefits. The Executive shall continue to be entitled to participate in the standard

Company benefit package, which may be modified by the Company from time to

time, subject to plan requirements and contribution by the Executive toward the cost

of such insurance coverage as similarly required from other employees. During the

Executive’s employment, the Executive will be entitled to such vacation allotment as

has been dictated by past practice for similarly situated employees, subject to the

terms of the Company’s normal vacation policy. The Executive will continue to

receive an auto allowance in the same amount as may be allocated to similarly

situated employees on the same terms that apply to the receipt of this benefit as of the

date of execution of this Agreement. The Executive will be entitled to participate in

the following Plans/Programs:

(i)CRH Performance Share Plan 2014,

(ii)CRH Americas Supplemental Executive Retirement Plan (SERP),

(iii)Executive Life Insurance Program,

(iv)CRH Americas 401k Plan,

(v)CRH Americas Medical Plan,

(vi)Executive Long and Short Term Disability Plans, and

(vii)any other plans or programs outlined in the Corporate Group Handbook

applicable to the Executive. Participation in any plan is at all times subject to

the rules and requirements of that Plan. The Company and its affiliates reserve

the right to amend or modify in their entirety any of the above-mentioned

benefit programs.

(d)Expenses. The Executive shall be entitled to reimbursement for reasonable and

necessary out-of-pocket business, entertainment, and travel expenses incurred by the

Executive in connection with the performance of the Executive’s duties, in

accordance with the reimbursement policies adopted by the Company from time-to-

time.

(e)Withholding Taxes. Taxes, applicable withholding and authorized or required

deductions will be deducted from all payments to Executive.

(f)Shareholding Requirements.

The Executive, at any point during which he is a GLT member, shall be required, within

five (5) years of the date Executive initially becomes a GLT member, or the Effective Date of this

Agreement, whichever is later, and for the duration of the time which Executive remains a GLT

member, to own common stock in CRH plc which is valued at 150% of the Executive’s Base Salary

on the Effective Date of this Agreement (the “Required Ownership Percentage”). Furthermore, if the

Executive’s Base Salary subsequently increases, the Executive shall be required to own common

stock in CRH plc equal to 150% of any such increased amount within five (5) years of the effective

date of the increase. The stock which shall be counted in measuring achievement of this requirement

shall include the following:

(i)shares owned outright or beneficially by the Executive (or his or her spouse

and other immediate family members who are dependents);

(i)shares which the Executive does not hold but which (a) have vested and are

being beneficially held for Executive under the Company’s Performance

Share Plan or an annual bonus plan, or (b) have not vested and are held in the

Executive’s name under a Company annual bonus plan, or any other restricted

share plan other than the Performance Share Plan in existence from time to

time; provided, however, in either case these shares shall be counted on a net-

of-taxes basis, which is determined in accordance with the Group’s tax

policies.

Annually, all shares held by the Executive or otherwise counted as being includable in

meeting the Required Ownership Percentage, shall, each December 31, be reported by the Executive

and valued by the Company for the purpose of assessing progress and achievement of the Required

Ownership Percentage, and the value shall be the higher of (i) the prevailing US Dollar equivalent of

the share price on the London Stock Exchange on such December 31 or (ii) the prevailing US Dollar

equivalent of the share price on the London Stock Exchange on the date of purchase or vesting, as

the case may be.

The Remuneration Committee of CRH plc shall be responsible for the administration of this

policy and shall determine the appropriate means of enforcing its provisions which may include the

withholding of shares by CRH plc or considering the Executive in breach of his obligations under

this Employment Agreement. Should the Executive breach this requirement of the Employment

Agreement as a result of an unexpected and precipitous decrease in CRH share price, the Executive

shall remedy the breach as soon as reasonably possible. The Remuneration Committee shall have the

discretion to determine, in consultation with the Executive, a reasonable time period in which the

Executive must remedy said breach.

4.Termination and Notice. This Employment Agreement and the Executive’s employment

may be terminated as follows:

(a)Resignation by the Executive.

(i)Notice: The Executive shall provide the Company with six months of prior

notice (“Executive Prior Notice Period”) before ending his employment with

the Company. During this notice period, the Company may place Executive

on Garden Leave, as defined in Section 5 below. The Company may, at its

sole discretion and at any time during the Executive Prior Notice period,

waive the remainder of the unexpired notice period (and any period of Garden

Leave that may be remaining if applicable), and, in that case, the Company

may, at its sole discretion, pay Executive an amount equal to his Base Salary

for the remainder of the applicable Executive Prior Notice Period (a

“Company Notice Buyout”) in exchange for Executive signing and not

revoking a Separation Agreement, as defined below. Whether or not

Executive remains employed for the full Executive Prior Notice Period,

Executive shall be entitled to receive the following upon termination of

employment:

1.Payout of any accrued but unused vacation time, and

2.Reimbursement for unreimbursed business expenses properly accrued

by the Executive, which shall be subject to and paid in accordance

with the Company’s expense reimbursement policy.

(ii)Bonus Payment: Whether or not Executive remains employed for the full

Executive Prior Notice Period, Executive shall receive a pro-rated Target

Bonus, as determined by the Company, which payment shall be made in a

lump sum at the time performance bonuses are regularly paid to similarly

situated employees of the Company. Such pro-rated Target Bonus shall be

determined as a percentage of the calendar year that the Executive was

employed by Company or would have been employed by Company if he had

been employed until the end of the Executive Prior Notice Period. For the

avoidance of doubt, regardless of the date of notice, in no case shall the

Executive receive both a pro-rated Target Bonus under this Section and a

discretionary performance bonus under 2(b) for the same overlapping time

period.

(iii)Severance Payment: If Executive resigns in compliance with this Section 4(a),

upon termination of employment the Company shall provide Executive a

Severance Payment as defined and under the terms and conditions below:

1.Fifty-two (52) weeks of pay at Executive’s Base Salary in effect as of

the date of termination, less the number of weeks Executive was

placed on Garden Leave and/or less the amount of weeks Executive

was paid as a Company Notice Buyout, plus

2.A pro-rated Target Bonus determined by the number of weeks of

severance pay received by the Executive as a percentage of the

applicable calendar bonus year, plus

3.A lump sum amount equal to the cost of Executive’s Consolidated

Omnibus Budget Reconciliation Act (“COBRA”) health insurance

premium for the same number of weeks as described in 4(a)(iii)(A)

(the “COBRA Payment”). The COBRA Payment shall be grossed up

to account for taxes.

4.The payments in (iii)(A), (iii)(B) and (iii)(C) shall collectively be

referred to herein as the “Severance Payment”.

5.For the avoidance of doubt, in no case shall the total amount received

during Garden Leave, as a Company Notice Buyout, and/or as

Severance Payment ever in the aggregate equate to greater than fifty-

two weeks of pay at the Executive’s Base Salary in effect as of the

date of termination, plus his Target Bonus for the applicable period,

plus the COBRA Payment.

6.Any payment to Executive under this section 4, including but not

limited to the Company Notice Buyout, the Severance Payment and/or

the pro-rated Target Bonus, is conditioned upon Executive signing and

not revoking a Separation Agreement, in the form typically used by the

Company, releasing all claims against the Company and agreeing not

to contest the continuing effect and enforceability of the Restrictive

Covenants (the “Separation Agreement”). The Separation Agreement

shall be substantially in the form of the template attached hereto as

Exhibit B, with appropriate modifications and updates as determined

by the Company.

7.Subject to all other terms of this Agreement, the Severance Payment

and, where applicable, the Company Notice Buyout payment shall be

paid in substantially equal monthly installments, the first of which

would occur within 15 days after the effective execution date of the

Separation Agreement and the last of which would occur no later than

365 days after the effective execution date of the Separation

Agreement.

8.At the time of his resignation, should the Executive be the subject of

an ongoing internal or external investigation into any conduct by

Executive which would constitute Cause (as defined below), then these

Sections 4(a)(ii) and 4(a)(iii) shall be temporarily null and void,

Company may postpone a final decision on Executive’s resignation

under this Section until conclusion of the investigation, and Executive

shall be entitled to no Bonus Payment or Severance Payment of any

kind until the investigation is resolved, which conclusion shall be

made with reasonable timeliness. At conclusion of the investigation,

should Company find Cause to terminate Executive, Executive’s

resignation shall be treated as a Termination for Cause as described

below. Should the investigation fail to conclude that there was Cause

to terminate the Executive, Executive shall be entitled to payout of the

benefits described in this Section 4(a).

(b)Without Cause by Company. The Company may terminate the Executive’s

employment without Cause (as defined below) subject to the following requirements:

(i)Notice: The Company shall provide the Executive with six months of prior

notice (“Company Prior Notice Period”). The Company may, at its sole

discretion, and at any time during the Company Prior Notice Period, place the

Executive on Garden Leave, and/or, in lieu of placing the Executive on

Garden Leave, pay the Executive an amount equal to his Base Salary for the

remainder of the Company Prior Notice Period (provide a “Company Notice

Buyout”). Whether or not Executive remains employed for the full Company

Prior Notice Period, Executive shall be entitled to receive the following upon

termination of employment:

1.Payout of any accrued but unused vacation time, and

2.Reimbursement for unreimbursed business expenses properly accrued

by the Executive, which shall be subject to and paid in accordance

with the Company’s expense reimbursement policy.

(ii)Bonus Payment: Whether or not Executive remains employed for the full

Company Prior Notice Period, Executive shall receive a pro-rated Target

Bonus, as determined by the Company, which payment shall be made in a

lump sum at the time performance bonuses are regularly paid to similarly

situated employees of the Company. Such pro-rated Target Bonus shall be

determined as a percentage of the calendar year that the Executive was

employed by the Company or would have been employed by the Company if

he had been employed until the end of the Company Prior Notice Period. For

the avoidance of doubt, regardless of the date of notice, in no case shall the

Executive receive both a pro-rated Target Bonus under this Section and a

discretionary performance bonus under 2(b) for the same overlapping time

period.

(iii)Severance Payment: The Company shall provide Executive a Severance

Payment as defined and subject to the terms and conditions in Section

4(a)(iii).

(c)Cause. The Company may terminate the Executive’s employment hereunder for

Cause. For the purpose of this Employment Agreement, the Company shall have

“Cause” to terminate the Executive’s employment if the Executive has engaged in

any of the following: (i) the Executive has breached a material policy, procedure or

rule of the Company, including but not limited to the CRH Americas Code of

Conduct, which may be altered or amended from time to time, and other obligations

under this Employment Agreement, which breach, if deemed curable by the

Company, remains uncured to the reasonable satisfaction of the Company for thirty

(30) calendar days after the Executive receives written notice of the breach from the

Company; (ii) the Executive has committed gross negligence or willful failure to

perform substantially and satisfactorily his duties under this Employment Agreement;

(iii) the Executive has engaged in an act of fraud, dishonesty or fraudulent activity,

misappropriation, embezzlement, theft, bribery, forgery or similar conduct; (iv) the

Executive is indicted for, convicted of or pleads guilty or nolo contendere to a crime

that constitutes a felony (or state law equivalent) or a crime that constitutes a

misdemeanor involving moral turpitude; or (v) the Executive has engaged in any

other act or omission which, if it were known to the public, in the Company’s

reasonable judgment could have a significant adverse impact on the Company or the

Group, and their business or reputation. If the Executive’s employment shall be

terminated by the Company for Cause, such termination shall be effective

immediately, and the Executive shall receive only Base Salary up to and including the

termination date. “Cause” shall not be construed as including conduct described in

Section 9 (b) herein.

(d)Death. The Executive’s employment shall terminate upon his death. If the Executive’s

employment shall be terminated by reason of his death, Executive shall continue to

receive Base Salary through the end of the pay period in which the date of his death

occurred.

(e)Disability. If, as a result of the Executive’s incapacity due to physical or mental

illness, the Executive shall have been absent from his duties hereunder on a full-time

basis for ninety (90) consecutive calendar days, and within thirty (30) days after

written notice of termination is given (which may occur no earlier than thirty (30)

days before, but at any time after, the end of such ninety (90) day period), the

Executive shall not have returned to the performance of his duties hereunder on a full-time basis,

the Company may terminate this Employment Agreement. This Section 4(e) is subject to the

requirements of the Family and Medical Leave Act, the Americans with Disabilities Act, and all

other applicable law. Therefore, if required by law, the Executive may remain employed by the

Company on an at-will basis even if the Employment Agreement is terminated pursuant to this

Section 4(e).

(f)No Further Obligations after Payment. After all payments, if any, have been made to

the Executive pursuant to any of paragraphs (a) through (e) of this Section 4, the

Company shall have no further obligations to the Executive under this Employment

Agreement other than the provision of any of the Executive benefits required to be

continued under applicable law.

(g)Resignation of All Other Positions. Upon termination of the Executive’s employment

hereunder for any reason, the Executive shall be deemed to have resigned, effective

on the termination date, from all positions that the Executive holds as an officer or

member of the Board (or a committee thereof) of the Company or its affiliates, or any

of their subsidiaries, except as otherwise agreed to by the Parties in writing.

5.Garden Leave. For the purpose of this Employment Agreement, “Garden Leave” refers to

that portion of any notice period during which Executive is relieved from Executive’s usual

employment duties but remains an employee of the Company in a consulting role. During

Garden Leave, the Executive shall not attend work, enter the Company’s premises, use

Company’s property, or have business-related contact with the Company’s customers,

suppliers, contractors, or employees of the Company, except as directed by the Company. If

requested by the Company, the Executive shall provide advice and information related to

prior work performed for the Company, report to work during Garden Leave at such time and

place as the Company may require, and cooperate fully with the Company in helping it

transition the Executive’s duties to others and retain valuable business relationships. During

Garden Leave, the Executive will: remain a loyal employee of the Company; avoid conflicts

of interest such as, but not limited to engaging in competition with the Company, assisting a

competitor, or actively pursuing the creation or development of a competitive business

enterprise; remain bound to all Company’s policies and the terms of this Employment

Agreement; and, continue to receive his Base Salary, benefits and other regular compensation

through the termination date, to the extent permitted by the plans and/or applicable law.

6.Section 409A. This Employment Agreement will be construed and administered to preserve

the exemption from Section 409A of the Internal Revenue Code of 1986, as amended (the

“Code”) of payments that qualify as short-term deferrals pursuant to Treas. Reg.

§1.409A-1(b)(4) or that qualify for the two-times compensation separation pay exemption of

Treas. Reg. §1.409A-1(b)(9)(iii). With respect to other amounts that are subject to Code

Section 409A, it is intended, and this Agreement will be so construed, that any such amounts

payable under this Agreement and the Company’s and the Executive’s exercise of authority

or discretion hereunder shall comply with the provisions of Section 409A of the Code and the

regulations and other guidance promulgated thereunder (“Section 409A”) so as not to subject

Executive to the payment of interest and additional tax that may be imposed under Section

409A. As a result, in the event the Executive is a “specified employee” on the date of the

Executive’s termination of employment, any payment that is subject to Section 409A and that

is payable to the Executive in connection with Executive’s separation from service shall not

be paid until the first business day following the expiration of six months after the

Executive’s separation from service (if the Executive dies after the Executive’s separation

from service but before any payment has been made, such remaining payments that were or

could have been delayed will be paid to the Executive’s estate without regard to such six-

month delay). Solely as necessary to comply with Section 409A, “termination of

employment” or “employment termination” or similar terms shall have the same meaning as

“separation from service” under Section 409A(a)(2)(A)(i) of the Code. Each payment under

this Employment Agreement is a separate payment within the meaning of the final

regulations under Section 409A. Notwithstanding the above, the Executive agrees that the

Company has made no representation as to the tax treatment of the compensation provided

pursuant to this Employment Agreement and that the Executive is solely responsible for all

taxes due with respect to such compensation.

7.Duties Upon Termination. Upon the termination of the Executive’s employment for any

reason whatsoever, the Executive shall promptly return to the Company any Confidential

Information, Trade Secrets, and, whether or not constituting Confidential Information, any

technical data, performance information and reports, sales or marketing plans, documents, or

other records, rolodexes, and any manuals, drawings, tape recordings, computer programs,

disks, and any other physical or electronic representations of any other information relating

to the Company, any of its subsidiaries or affiliates. The Executive hereby acknowledges that

any and all of such documents, items, physical or electronic representations, and information

are, and shall remain, at all times the exclusive property of the Company.

8.Restrictive Covenants.

(a)Protectable Interests / Ancillary Agreement: The restrictions provided for in the other

Sections of this Agreement are not sufficient, standing alone, to protect the legitimate

business interests of the Company. In reliance upon Executive’s covenants in this

Agreement, and particularly those contained in this Section 8 (the “Restrictive

Covenants”), Company will employ Executive in a position of special trust and

confidence where Executive will be provided one or more of the following: (a)

Confidential Information related to Executive’s position, (b) special access to

suppliers, customers and other valuable business relationships of the Company, and/

or (c) specialized training. The Executive agrees that the foregoing will give

Executive an unfair competitive advantage if Executive’s activities are not restricted

as provided for in the Restrictive Covenants below. The Executive acknowledges the

Company would not enter into this Employment Agreement without the execution of

the Restrictive Covenants contained herein. The Executive acknowledges that his

employment with the Company, material advancement, receipt of access to

Confidential Information, and other consideration provided hereunder are sufficient

and valuable consideration for the execution of the restrictive covenants contained

herein.

(b)Definitions:

(i)“Business of the Company” means any line of business that the Company or

the Group is engaged in or preparing to engage in, relating to services and/or

products for the construction industry. Executive stipulates that the scope of

activity covered by this definition of Business of the Company is understood

by him, and that the Executive will be informed of changes in the Business of

the Company as they occur as a natural consequence of Executive’s position.

(ii)“Competitive Business(es)” means any business enterprise (firm, partnership,

joint venture, corporation and/or any other entity and/or person) that competes

with any part of the Business of the Company that the Executive has

involvement with or access to Confidential Information about in the Look

Back Period. It will be presumed that any business enterprise that develops,

manufactures, markets, distributes, provides and/or sells a Conflicting Product

in markets where the Company or the Group do business is a Competitive

Business.

(iii)“Confidential Information” means an item of information or compilation of

information, in any form (tangible or intangible), related to Company’s

business and of value to the Company that Executive first acquires or gains

access to during employment with the Company, that Company has not

authorized public disclosure of, and that is not readily available through

lawful and proper means to the public or persons outside Company who are

under no obligation to keep the information confidential. Confidential

Information includes, but it is not limited to: (1) finances and business plans;

(2) financial projections; (3) sales information relating to the Company’s

product roll-outs, including price, discounts, commissions, margins, targets,

and other related information; (4) customized software, marketing tools, and/

or supplies that the Executive has access to and/or will create; (5) the identity

of the Company’s Customers, and/or Customer Prospects; (6) any list(s) of the

Company’s Customers and/or Customer Prospects; (7) the account terms and

pricing of sales contracts between the Company and its Customers; (8) the

proposed account terms and pricing of sales contracts between the Company

and its Customer Prospects; (9) the techniques, methods, and strategies by

which the Company develops, manufactures, markets, distributes, and/or sells

any of its products; and (10) Trade Secrets. An item of Confidential

Information need not be marked “confidential” or otherwise labeled in a

particular way to qualify as Confidential Information; instead, the definition

provided above will control at all times. Due to its special value and utility as

a compilation, a confidential compilation of information by the Company will

remain protected as Confidential Information even if individual pieces of

information in it are public. Private disclosure of Confidential Information to

parties the Company is doing business with for business purposes shall not

cause the information to lose its protected status under this Agreement.

Confidential Information shall not include any data or information which has

been voluntarily disclosed to the public by the Company (except where such

public disclosure has been made by the Executive without authorization from

the Company) or that has been independently developed and disclosed by

others, or that has otherwise entered the public domain through lawful means.

“Trade Secrets” means Confidential Information which meets the additional

requirements of applicable law.

(iv)“Conflicting Product” means a product or service of another business

enterprise (not the Company or the Group) that is of the type conducted,

authorized, offered, or provided by the Company or the Group in the Look

Back Period and with respect to which Executive had involvement or access

to Confidential Information.

(v)“Covered Customers” means any customer (firm, partnership, corporation

and/or any other entity and/or person) that purchases or seeks to purchase

products or services from the Company or the Group with which Executive

has Material Contact. It will be presumed that Covered Customers includes

active prospective customers as of the date Executive’s employment ends with

whom Executive has Material Contact.

(vi)“Covered Vendors and Suppliers” means any supplier, distributor, broker, or

vendor that the Company or the Group relies upon in the ordinary course of

business and with which Executive has Material Contact.

(vii)“Group” means the Company and its parent companies, subsidiaries and

affiliates in the United States, Ireland or any other country as may be the case

from time to time, with respect to which Executive has some involvement or

access to Confidential Information.

(viii)“Look Back Period” refers to the last two (2) years of the Executive’s

employment with the Company or the Group, or any lesser period of such

employment if not employed for two years, inclusive of employment with a

predecessor entity of the Company or Group; or, if not enforceable, then such

lesser period as would be enforceable.

(ix)“Material Contact” means personal contact or material interaction with a

person or entity, or the supervision of contact or material interaction with a

person or entity, in the Look Back Period. Material interaction is presumed

present if Executive participated in or supervised communications with the

individual or entity, or received commissions, bonuses, or other beneficial

credit or attribution for business done with the person or entity, or was

provided Confidential Information about business done or proposed with the

person or entity, in the Look Back Period.

(x)“Material Individual” means any person who was employed by the Company

or the Group as a director or in a senior managerial position (which shall

generally be considered to be an individual appointed at job level 20 and

above), or any contractor or consultant of the Group of equivalent seniority.

(xi)“Territory” means the geographic territory where Executive is working at the

time of employment termination, which shall be understood to mean the state

Executive resides in and each additional state (and state equivalent) in the

United States and other countries where the Company or the Group market

their products or services or otherwise do business that Executive has some

involvement with or access to Confidential Information about in the Look

Back Period. Executive stipulates that the nature of the Company’s business is

national within the United States and also international in nature. Given the

nature of the Executive’s position with the Company, it will be presumed that

Executive’s involvement and Confidential Information access covers the

entire United States and each additional country where the Company and the

Group do business during the Look Back Period, and continue to do business

as of the date of enforcement. The Executive acknowledges and agrees that

due to the nature of his executive duties and the Confidential Information and/

or Trade Secrets involved in his role, the geographic area covered by the

Territory definition is reasonable.

(c)The Executive agrees his work for the Company brings him into close contact with

many Covered Customers, Covered Vendors and Suppliers, Trade Secrets, and

Confidential Information. The Executive further agrees the covenants in this Section

8 are reasonable as to the time and the scope of activity to be restrained and necessary

to protect the Company’s and the Group’s legitimate business interests and

relationships, Trade Secrets, and Confidential Information.

(d)The Executive further agrees that the harm caused by a violation of the Restrictive

Covenants would not only cause recoverable monetary damages but would also cause

irreparable harm to the Company and/or the Group which cannot be effectively

remedied through monetary damages, and can only be effectively addressed through

injunctive relief and special remedies as provided for in Section 10 below.

(e)Non-Competition. The Executive covenants and agrees that during employment and

for twelve (12) months after the Executive’s employment with the Company ends for

any reason, the Executive will not (as an employee, consultant, director, owner,

partner, or otherwise), directly or indirectly, anywhere in the Territory, on behalf of or

for the benefit of a Competitive Business: (i) perform duties or services that are the

same as, or similar in function or purpose to those Executive performed for the

Company in the Look Back Period, (ii) assist a Competitive Business in producing,

developing or improving a Conflicting Product, or (iii) accept competing business

from a Company customer, or otherwise knowingly interfere with the relationship

between the Company and one of its customers, vendors, or suppliers. If the

Executive is placed on Garden Leave, as provided in Section 5, the months he spends

on Garden Leave shall be offset against this 12-month restriction. Nothing in this

Employment Agreement shall be construed to prevent the Executive from having an

interest of less than one percent (1%) of the outstanding shares of capital stock of any

company which is traded on a nationally recognized stock exchange. The Executive

agrees and acknowledges that: (i) the provisions of this Section 8(e) are reasonable

and necessary for the protection of the Company and the Group; (ii) such provisions

contain reasonable limitations as to the time and the scope of activity to be restrained;

(iii) the consideration provided in this Employment Agreement is sufficient to

compensate the Executive for the restrictions contained in this Section 8(e),

regardless of how his employment is terminated and (iv) the provisions of this Section

8(e) will not unduly limit the Executive in finding or obtaining employment in a

capacity or at a level of compensation similar to that which the Executive has under

this Employment Agreement.

(f)Non-Solicitation of Employees. The Executive covenants and agrees that for twelve

(12) months after Executive’s employment with the Company ends for any reason he

will not, directly or indirectly, on behalf of (or for the benefit of) a Competitive

Business: (i) recruit, solicit, or induce, or attempt to recruit, solicit, or induce, any

Material Individual, to terminate their relationship with the Company or the Group, or

(ii) assist in hiring a Material Individual. If the Executive is placed on Garden Leave,

the months he spends on Garden Leave shall be offset against this 12-month

restriction.

(g)Non-Solicitation of Customers or Customer Prospects. The Executive covenants and

agrees that for twelve (12) months after the Executive’s employment with the

Company ends for any reason he will not, directly or indirectly, on behalf of (or for

the benefit of) a Competitive Business: (i) solicit or induce, or attempt to solicit or

induce, any Covered Customer for any business purpose that involves providing

products or services that are competitive with those provided by the Company or the

Group, or (ii) solicit a Covered Customer to terminate an existing or prospective

business relationship with the Company or the Group, or otherwise change such a

relationship to the detriment of the Company or the Group. If the Executive is placed

on Garden Leave, the months he spends on Garden Leave shall be offset against this

12-month restriction.

(h)Non-Solicitation of Vendors or Suppliers. The Executive covenants and agrees that

for twelve (12) months after the Executive’s employment with the Company ends for

any reason he will not, directly or indirectly, knowingly solicit or induce, or attempt

to solicit or induce, any Covered Vendor or Supplier to terminate their relationship

with the Company or the Group or change such relationship to the detriment of the

Company or the Group. If the Executive is placed on Garden Leave, the months he

spends on Garden Leave shall be offset against this 12-month restriction.

(i)Solicitation Understandings and Effect of Presumptions. For purposes of the non-

solicitation restrictions (Sections 8(f), (g), and (h)), it shall be presumed that “to

solicit” means to knowingly interact with a person or entity with the intent, purpose or

foreseeable result being to cause a particular responsive action, irrespective of which

party first initiates contact. The non-solicitation restrictions are understood to be

reasonably limited by geography to those locations and/or places of business where

the Material Individual, Covered Customer, and Covered Vendors and Suppliers are

located and available for solicitation. However, if any of the non-solicitation

restrictions require a different form of geographic limitation under applicable law to

be enforceable then such restriction shall be deemed limited to the Territory. The non-

solicitation restrictions are not intended to cover or prohibit general advertising that is

not targeted at the customers or employees of Company such as advertisements

directed to the general public or “help wanted” ads. A presumption provided for in

this Agreement may only be overcome through clear and convincing evidence, and

will not be applicable where it would make a provision of this Agreement to which it

applies unenforceable.

(j)Intellectual Property Rights.

For the purposes of this clause, “Intellectual Property” means patents, trademarks,

service marks, registered designs (including applications for and rights to apply for any of them),

inventions, innovations, improvements, developments, methods, ideas, concepts, unregistered design

rights, logos, trade or business names, copyrights, database rights, confidential information, know

how and any similar rights.

The Executive acknowledges that (i) it has been part of his normal duties to develop the

products and services of the Group; and (ii) because of the nature of his position he has a special

obligation to further the interests of the Group. All Intellectual Property which the Employee

develops or produces, alone or with others, in the course of his employment duties or outside such

duties but relating to the business of the Group in any manner whatsoever, either prior or after he

signs this Agreement, will be considered a "work made for hire" and shall be the sole and exclusive

property of the Company. If for any reason the results and proceeds of Executive’s services to the

Company are determined at any time not to be a "work made for hire," Executive hereby irrevocably

assigns, transfers and sets over, all of his right, title and interest in such Intellectual Property to the

Company, and the Company shall be entitled to obtain and hold in its own name all patents,

copyrights or other intellectual property rights with respect to such Intellectual Property. The

Executive appoints the Company, or its designee, as the Executive’s attorney- in-fact for purposes of

obtaining patents and copyrights which result from my work during his employment with the

Company and to perfect ownership in the Company or its assigns and successors in interest. The

Company will consider each disclosure submitted by the Executive. The election of whether or not

to file a patent application or a copyright registration application on such disclosure and the manner

of preparation and prosecution of any patent or copyright application or applications filed in the

United States of America or in foreign countries shall be wholly within the discretion of the

Company, and at its expense. The Executive shall disclose in writing to Company (or persons

designated by it) the existence and nature of any Intellectual Property and shall, during and after the

period of employment with the Company, and without further consideration from the Company, (i)

execute all documents requested by the Company for vesting in the Company and the entire right,

title and interest in and to the same, (ii) cooperate with the Company and execute all documents

requested by the Company for the filing of such applications for and the procuring of such patents,

trademarks, service marks or copyrights as the Company, in its sole discretion, may desire to

prosecute, and (iii) give the Company all assistance and cooperation it may reasonably require in

order to obtain, maintain, defend, enforce, and protect the Company's right therein and thereto

anywhere in the world. The Employee also hereby waives all moral rights in all Intellectual Property

of the Company or the Group, and to obtain protection and enforce the Company’s rights anywhere

in the world. The Executive also hereby waives all moral rights in all Intellectual Property which is

owned by the Company, or will be owned by the Company, further to this clause. The Executive will

not copy, disclose, or make use of any Intellectual Property belonging to the Company (whether or

not subject to this clause) except to the extent necessary for the proper performance of his duties.

Rights and obligations under this clause will continue after the termination of this Agreement in

respect of all intellectual Property arising during the employment. Any and all such Intellectual

Property, reduced to written, graphic, or other tangible form and any and all copies and

reproductions thereof shall be furnished to the Company upon request, and in any case, shall be

returned to the Company upon termination of the Executive’s employment with the Company.

Executive may not sell, reproduce, distribute, modify, display, publicly perform, or prepare

derivative works based on any content used by or created for the Company, by the Executive or any

other third party, in any way for public or commercial purposes without the Company’s prior written

consent.

The Executive warrants and agrees that all inventions, innovations, improvements,

developments, methods, designs, analyses, ideas, concepts, reports, software, and all similar or

related information which he made, invented, or conceived prior to entering the employ of the

Company, to which the Executive now claims title, and which are to be specifically excluded from

this Agreement, are completely described in Exhibit A attached.

9.Protection of Confidential Information

(a)No Unauthorized Use or Disclosure. The Executive agrees not to engage in any use,

disclosure, copying or transfer of Confidential Information that is not authorized as

part of the Executive’s employment duties and undertaken in careful compliance with

all Company policies and directives for the handling of such information. The

Executive understands and accepts the duty to use reasonable care in maintaining the

confidentiality of Confidential Information, and agrees to report to the Company any

unauthorized use or disclosure that the Executive becomes aware of and to cooperate

with the Company in taking all reasonable and necessary steps to recover any

misappropriated Confidential Information. When the Executive’s employment ends,

Executive will return all records of Confidential Information to the Company without

retaining any copies thereof that he is not expressly authorized to retain in writing.

The Executive will not use his knowledge of Confidential Information to recreate

records of Confidential Information or otherwise reproduce Confidential Information

entrusted to him in confidence after his employment ends without Company

authorization. The foregoing obligations regarding Confidential Information will

apply to the Executive while employed with the Company or the Group and for as

long thereafter as the information at issue continues to qualify as Confidential

Information under the definition applied in this Agreement; provided, however, that if

a post-employment time limit on the use of Confidential Information is required in

order for this restriction to be enforceable, and only in such event, the restrictions on

use of Confidential Information that does not qualify as a Trade Secret shall expire

three (3) years after the Executive’s employment ends and all records of Confidential

Information in Executive’s possession and control have been returned to the

Company. No such time limitation will apply to Trade Secrets. A permitted disclosure

of Confidential Information under Section 9(b) below will not be considered an

unauthorized use or disclosure of Confidential Information for purposes of the

foregoing restrictions or any other section of this Agreement.

(b)Permitted Disclosure. Nothing herein shall be construed to prevent disclosure of

Confidential Information, Trade Secrets or Intellectual Property as may be required or

permitted by applicable law or regulation, or pursuant to the valid order of a court of

competent jurisdiction or an authorized government agency, provided that the

disclosure does not exceed the extent of disclosure required by such law, regulation or

order. The provisions in this Employment Agreement do not prohibit the Executive

from communicating with any governmental authority or making a report in good

faith and with a reasonable belief of any violations of law or regulation to a

governmental authority, or disclosing Confidential Information, including providing

documents, which the Executive has acquired through lawful means in the course of

employment to such governmental authority in connection with such communications

or report, or from filing, testifying or participating in a legal proceeding relating to

such violations, including making other disclosures protected or required by any

whistleblower law or regulation to the Securities and Exchange Commission, the

Department of Labor, or any other appropriate government authority; provided

expressly that to the extent that the Executive discloses any Confidential Information,

the Employee will honor the other confidentiality obligations in this Employment

Agreement and will only share such Confidential Information in accordance with this

section. The Executive is hereby notified that under the Defend Trade Secrets Act

(DTSA), (1) no individual will be held criminally or civilly liable under Federal or

State trade secret law for disclosure of a trade secret (as defined in the Economic

Espionage Act) that is: (A) made in confidence to a Federal, State, or local

government official, either directly or indirectly, or to an attorney, and made solely

for the purpose of reporting or investigating a suspected violation of law; or, (B)

made in a complaint or other document filed in a lawsuit or other proceeding, if such

filing is made under seal so that it is not made public; and, (2) an individual who

pursues a lawsuit for retaliation by an employer for reporting a suspected violation of

the law may disclose the trade secret to the attorney of the individual and use the

trade secret information in the court proceeding, if the individual files any document

containing the trade secret under seal, and does not disclose the trade secret, except as

permitted by court order.

10.Reliefs and Survival.

(a)Injunctive Relief. The Executive acknowledges that his breach of any covenant

contained in Sections 8 and 9 will result in irreparable injury to the Company and that

the remedy at law of such parties for such a breach will be inadequate. Accordingly,

the Executive agrees and consents that the Company, in addition to all other remedies

available to it at law and in equity, shall be entitled to seek and receive both

preliminary and permanent injunctions to prevent and/or halt a breach or threatened

breach by the Executive of any provision contained in Sections 8 and 9 with One

Thousand Dollars ($1,000.00) being the agreed-upon amount of bond (if any) that

need be posted to secure such relief. The Company shall be deemed the prevailing

party if it recovers any relief requested in a legal action to enforce this Agreement

irrespective of whether some of the relief requested is also denied or the contract must

be reformed to be enforced. In the event Executive violates the Material Individual

non-solicitation obligation (Section 8(f)) which causes (in whole or in part) the

Company or the Group to lose the services of a Material Individual before injunctive

relief to prevent such loss can be secured, Executive shall owe Company a sum equal

to one third of the Material Individual’s annual total compensation at his or her last

rate of pay with Company or the Group as liquidated damages. This sum shall be in

addition to, and not in lieu of injunctive relief to prevent further violations with

respect to other Material Individuals.

(b)Severability and Judicial Modification. Except where otherwise expressly provided,

the terms of this Agreement are severable. The covenants contained in Sections 8 and

9 shall be presumed to be reasonable and enforceable, and any reading causing

unenforceability shall yield to a construction permitting enforcement. In the event an

arbitrator or court of competent jurisdiction should determine not to enforce a

covenant as written due to overbreadth, the parties specifically agree that said

covenant shall be modified and enforced to the extent reasonable, whether said

modifications are in time, territory, or scope of prohibited activities. If any single

covenant or clause in this Employment Agreement shall be found unenforceable and

not subject to modification to allow enforceability, it shall be severed and the

remaining covenants and clauses enforced in accordance with the tenor of the

Employment Agreement.

(c)Survival. The covenants and agreements made by the Executive in Sections 8 and 9

will survive the termination of the Executive’s employment and the termination of

this Employment Agreement, a change in Executive’s position or terms and

conditions of employment, and any claim asserted by Executive against the Company

arising from this Agreement or otherwise.

11.Indemnification and Insurance. The Company agrees that during the course of Executive’s

employment, it will maintain Directors and Officers insurance or appropriate self-insurance

covering Executive for decisions made and actions taken by Executive that are consistent

with Company policy and taken in the course of Executive’s employment. The Company

shall provide to Executive such coverage and limits as are generally provided by FTSE 100

companies of similar size and geographic presence to their non-Board of Director executives.

12.Entire Agreement; Modification; Waiver. This Employment Agreement constitutes the

entire agreement between the parties pertaining to the subject matter contained in it and

supersedes all prior and contemporaneous agreements, representations, and understandings of

the parties concerning its subject matter. No supplement, modification, or amendment of this

Employment Agreement shall be binding unless executed in writing by all parties hereto. No

waiver of any of the provisions of this Employment Agreement will be deemed, or will

constitute, a waiver of any other provision, whether or not similar, nor will any waiver

constitute a continuing waiver. No waiver will be binding unless executed in writing by the

party making the waiver.

13.Successors and Assigns; Assignment. This Employment Agreement shall be binding on, and

inure to the benefit of, the parties hereto and their respective heirs, executors, legal

representatives, successors, and assigns; provided, however, that this Employment Agreement is

intended to be personal to the Executive and the rights and obligations of the Executive

hereunder may not be assigned or transferred by him/her. It is expressly understood that CRH,

plc shall be a beneficiary of this Agreement, and entitled to enforce it as needed to protect the

interests of itself and its subsidiaries and affiliates. Executive understands and agrees that this

Agreement may be assigned by the Company, and that the assignee shall be entitled to enforce it

against Executive. Should the Company assign this Employment Agreement to any affiliate or

other entity associated with the Company, this Employment Agreement shall be binding on such

assignee and any references in this Employment Agreement to the “Company” shall be

deemed to be a reference to such assignee.

14.Notice. Any notice or other communication required or permitted under this Employment

Agreement by either party hereto to the other shall be in writing, and shall be deemed

effective upon (a) personal delivery, if delivered by hand, (b) three days after the date of

deposit in the mails, postage prepaid, if mailed by certified or registered mail, or (c) the next

business day, if sent by a prepaid overnight courier service, and in each case addressed as

follows:

If to the Executive:          Nathan Creech

[*****]

[*****]

If to the Company:        CRH Americas, Inc.

ATTN: General Counsel

[*****]

[*****]

[*****]

Either party may change the address or addresses to which notices are to be sent by giving notice of

such change of address in the manner provided by this section.

15.Counterparts. This Employment Agreement may be executed in multiple counterparts, each

of which shall be deemed an original, but all of which together shall constitute one and the

same document. This Employment Agreement may be executed by facsimile signature and a

facsimile signature shall constitute an original signature for all purposes. Each undersigned

further agrees that electronic signatures, whether digital or encrypted, of the parties hereto are

intended to have the same force and effect as manual signatures. As used in the previous

sentence, the term “electronic signatures” means any electronic sound, symbol or process

attached to or logically associated with this Agreement and executed and adopted by a party

with the intent to sign such Agreement, including, but not limited to, e- mail electronic

signatures executed through DocuSign®.

16.Severability of Provisions. The invalidity or unenforceability of any particular provision of

this Employment Agreement shall not affect the other provisions hereof, and this

Employment Agreement shall be construed in all respects as if such invalid or unenforceable

provisions were omitted.

17.Governing Law and Jurisdiction. This Employment Agreement is executed and delivered

in, and shall be governed by, enforced and interpreted in accordance with the laws of the

State of Texas, without regard to its conflict of laws principles. Any dispute, claim or cause

of action arising out of, or related to, this Agreement shall be commenced only in a federal or

state court in the State of Georgia, County of Dekalb, and the parties hereby submit to the

exclusive jurisdiction of such courts and waive any claim of an inconvenient forum.

18.Waiver of Jury Trial. The Parties agree to waive any right to a trial by jury regarding any

dispute, claim or cause of action arising out of, concerning, or related to, the Executive’s

employment, his separation from employment, or this Employment Agreement.

19.Construction.              In construing this Employment Agreement, whenever appropriate, the

singular tense shall also be deemed to mean the plural, and vice versa, and the captions

contained in this Employment Agreement shall be ignored.

20.Legally Binding Obligation; Legal Counsel. The Executive acknowledges that he has had

an opportunity to read this Employment Agreement, raise questions about its terms, and seek

advice of legal counsel if desired. The Executive understands that this Employment

Agreement is a legally binding contractual obligation, which includes restrictive covenants,

and enters into it willingly, knowingly and voluntarily.

IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement

effective as of the Effective Date stated above.

CRH AMERICAS, INC.                                                              NATHAN CREECH

By:/s/ Albert Manifold                                                          /s/ Nathan Creech

EXHIBIT A

LIST OF PRIOR INVENTIONS

AND ORIGINAL WORKS OF AUTHORSHIP

[Intentionally Omitted]

EXHIBIT B

SEPARATION AGREEMENT, RELEASE AND WAIVER

[Intentionally Omitted]

Exhibit 10.31 - Employment Agreement (R. Lake) Exhibit 10.31

THIS EMPLOYMENT AGREEMENT (“Employment Agreement”) is entered into, effective as

of January 1, 2021 (“Effective Date”), by and between CRH AMERICAS, INC. (the “Company”) and

RANDALL LAKE (the “Executive”). NOW, THEREFORE, in consideration of material advancement

and the mutual agreements set forth below, the adequacy of which are hereby acknowledged, the parties

agree as follows:

1.Employment. The Executive commenced his employment with the Company on

November 15, 1996. The Company hereby agrees to continue to employ the Executive, and the Executive

hereby accepts to continue his employment with the Company, upon the terms and conditions set forth

herein. The Executive’s employment shall continue to be “at-will,” except as otherwise provided in

Section 4 below. The Executive shall be employed by the Company as Group Executive Strategic

Operations. This is a full-time exempt position. The Executive may also serve as one of the Company’s

board members or as an officer or director of any affiliate of the Company. The Executive’s normal places

of work and duties shall be at the Company’s offices located in Atlanta, GA. In addition, the Executive

may be required to travel both within the United States and abroad.

2.Duties. The services performed by the Executive shall be subject to the terms and

conditions set forth in this Agreement, and the Company’s policies, rules and practices generally

applicable to its employees at the executive level, as established from time to time by the Company. Such

duties shall be performed to the reasonable satisfaction of the Company and shall be rendered at such

places as the interests, needs, business, and opportunities of the Company require or make advisable, with

the exception that any permanent relocation of Executive from the normal place of work and duties stated

in Section 1 shall require Executive’s prior written consent. The Executive acknowledges that the

employment described herein is full-time employment, and the Executive agrees that he shall diligently

and conscientiously devote his exclusive service, attention, energies, talents, and best efforts in

discharging his duties. The Executive shall devote all time necessary to meet or exceed the Company’s

business goals and objectives. The Executive will disclose promptly in writing to the Chief Executive of

CRH, plc all directorships, partnerships, and any shareholdings in companies other than a company from

the Group, as defined below, in excess of one percent (1%) of the outstanding shares of capital stock of

any company which is traded on a nationally recognized stock exchange. The Executive will be permitted

to carry out any such disclosed interests during the course of the employment and to be paid and retain

fees therefor, subject to the limitations set out in Section 8(e).

3.Compensation.

(a)Base Salary. The Company shall pay to the Executive a fixed annual salary (the “Base

Salary”) of USD$1,250,000, less applicable taxes, withholdings and authorized deductions. The Base

Salary shall be due and payable in equal semi-monthly installments or in such other installments as may

be necessary to comport with the Company’s normal pay periods (“Installments”). The Base Salary will be

reviewed annually, such review not to result in a basic salary lower than the salary in the previous year

unless otherwise agreed with the Executive.

(b)Performance Bonus. The Executive will be eligible to receive an annual discretionary

bonus with a target of 100% of the Base Salary (the “Target Bonus”), a minimum of 0% of Base Salary

and up to a maximum of 200% of the Base Salary. Said bonus will be tied to performance targets set from

time to time for both the Company and its affiliates and for the Executive. Any bonus will be paid to the

Executive less any deductions required by law or Company practice. Except in the case of a Termination

for Cause under Section 4(c), the Executive’s eligibility under this clause to receive an annual discretionary

performance bonus in respect of a particular calendar year shall not be adversely impacted (whether as to

payment or calculation) if the Executive ceases employment with the Company between the beginning of

the following calendar year and the usual payout date in respect of any such bonus.

In addition to the foregoing, as to any such bonus received by the Executive during the time the

Executive is a GLT member, 25% of such bonus will be delivered in restricted shares of common stock of

CRH, plc which will vest three (3) years after the date of grant of such shares. Such grant shall be subject

to the terms of any plan sponsored by the Company, or by any Company parent or affiliate, which governs

restricted stock grants, as well as any applicable grant agreement, including but not limited to the CRH plc

2014 Deferred Share Bonus Plan, which may be modified from time to time.

(c)Benefits. The Executive shall continue to be entitled to participate in the standard

Company benefit package, which may be modified by the Company from time to time, subject to plan

requirements and contribution by the Executive toward the cost of such insurance coverage as similarly

required from other employees. During the Executive’s employment, the Executive will be entitled to

such vacation allotment as has been dictated by past practice for similarly situated employees, subject to

the terms of the Company’s normal vacation policy. The Executive will continue to receive an auto

allowance in the same amount as may be allocated to similarly situated employees on the same terms that

apply to the receipt of this benefit as of the date of execution of this Agreement. The Executive will be

entitled to participate in the following Plans/Programs:

(i)CRH Performance Share Plan 2014,

(ii)CRH Americas Supplemental Executive Retirement Plan (SERP),

(iii)Executive Life Insurance Program,

(iv)CRH Americas 401k Plan,

(v)CRH Americas Medical Plan,

(vi)Executive Long and Short Term Disability Plans, and

(vii)any other plans or programs outlined in the Corporate Group Handbook

applicable to the Executive. Participation in any plan is at all times subject to the

rules and requirements of that Plan. The Company and its affiliates reserve the

right to amend or modify in their entirety any of the above-mentioned benefit

programs.

(d)Expenses. The Executive shall be entitled to reimbursement for reasonable and necessary

out-of-pocket business, entertainment, and travel expenses incurred by the Executive in connection with

the performance of the Executive’s duties, in accordance with the reimbursement policies adopted by the

Company from time-to-time.

(e)Withholding Taxes. Taxes, applicable withholding and authorized or required deductions

will be deducted from all payments to Executive.

(f)Shareholding Requirements.

The Executive, at any point during which he is a GLT member, shall be required, within five (5)

years of the date Executive initially becomes a GLT member, or the Effective Date of this Agreement,

whichever is later, and for the duration of the time which Executive remains a GLT member, to own

common stock in CRH plc which is valued at 150% of the Executive’s Base Salary on the Effective Date

of this Agreement (the “Required Ownership Percentage”). Furthermore, if the Executive’s Base Salary

subsequently increases, the Executive shall be required to own common stock in CRH plc equal to 150%

of any such increased amount within five (5) years of the effective date of the increase. The stock which

shall be counted in measuring achievement of this requirement shall include the following:

(i)shares owned outright or beneficially by the Executive (or his or her spouse and

other immediate family members who are dependents);

(ii)shares which the Executive does not hold but which (a) have vested and are being

beneficially held for Executive under the Company’s Performance Share Plan or an annual

bonus plan, or (b) have not vested and are held in the Executive’s name under a Company

annual bonus plan, or any other restricted share plan other than the Performance Share Plan in

existence from time to time; provided, however, in either case these shares shall be counted

on a net-of-taxes basis, which is determined in accordance with the Group’s tax policies.

Annually, all shares held by the Executive or otherwise counted as being includable in meeting

the Required Ownership Percentage, shall, each December 31, be reported by the Executive and valued

by the Company for the purpose of assessing progress and achievement of the Required Ownership

Percentage, and the value shall be the higher of (i) the prevailing US Dollar equivalent of the share price

on the London Stock Exchange on such December 31 or (ii) the prevailing US Dollar equivalent of the

share price on the London Stock Exchange on the date of purchase or vesting, as the case may be.

The Remuneration Committee of CRH plc shall be responsible for the administration of this policy

and shall determine the appropriate means of enforcing its provisions which may include the withholding

of shares by CRH plc or considering the Executive in breach of his obligations under this Employment

Agreement. Should the Executive breach this requirement of the Employment Agreement as a result of an

unexpected and precipitous decrease in CRH share price, the Executive shall remedy the breach as soon

as reasonably possible. The Remuneration Committee shall have the discretion to determine, in

consultation with the Executive, a reasonable time period in which the Executive must remedy said

breach.

4.Termination and Notice. This Employment Agreement and the Executive’s employment

may be terminated as follows:

(a)Resignation by the Executive.

(i)Notice: The Executive shall provide the Company with six months of prior notice

(“Executive Prior Notice Period”) before ending his employment with the Company. During this notice

period, the Company may place Executive on Garden Leave, as defined in Section 5 below. The

Company may, at its sole discretion and at any time during the Executive Prior Notice period, waive

the remainder of the unexpired notice period (and any period of Garden Leave that may be remaining if

applicable), and, in that case, the Company may, at its sole discretion, pay Executive an amount equal

to his Base Salary for the remainder of the applicable Executive Prior Notice Period (a “Company

Notice Buyout”) in exchange for Executive signing and not revoking a Separation Agreement, as

defined below. Whether or not Executive remains employed for the full Executive Prior Notice Period,

Executive shall be entitled to receive the following upon termination of employment:

A.Payout of any accrued but unused vacation time, and

B.Reimbursement for unreimbursed business expenses properly accrued by the Executive,

which shall be subject to and paid in accordance with the Company’s expense

reimbursement policy.

(ii)Bonus Payment: Whether or not Executive remains employed for the full Executive Prior

Notice Period, Executive shall receive a pro-rated Target Bonus, as determined by the Company, which

payment shall be made in a lump sum at the time performance bonuses are regularly paid to similarly

situated employees of the Company. Such pro-rated Target Bonus shall be determined as a

percentage of the calendar year that the Executive was employed by Company or would have been

employed by Company if he had been employed until the end of the Executive Prior Notice Period.

For the avoidance of doubt, regardless of the date of notice, in no case shall the Executive receive

both a pro-rated Target Bonus under this Section and a discretionary performance bonus under 2(b)

for the same overlapping time period.

(iii)Severance Payment: If Executive resigns in compliance with this Section 4(a), upon

termination of employment the Company shall provide Executive a Severance Payment as defined

and under the terms and conditions below:

A.Fifty-two (52) weeks of pay at Executive’s Base Salary in effect as of the date of

termination, less the number of weeks Executive was placed on Garden Leave and/or less

the amount of weeks Executive was paid as a Company Notice Buyout, plus

B.A pro-rated Target Bonus determined by the number of weeks of severance pay received

by the Executive as a percentage of the applicable calendar bonus year, plus

C.A lump sum amount equal to the cost of Executive’s Consolidated Omnibus Budget

Reconciliation Act (“COBRA”) health insurance premium for the same number of weeks

as described in 4(a)(iii)(A) (the “COBRA Payment”). The COBRA Payment shall be

grossed up to account for taxes.

D.The payments in (iii)(A), (iii)(B) and (iii)(C) shall collectively be referred to herein as the

“Severance Payment”.

E.For the avoidance of doubt, in no case shall the total amount received during Garden

Leave, as a Company Notice Buyout, and/or as Severance Payment ever in the aggregate

equate to greater than fifty-two weeks of pay at the Executive’s Base Salary in effect as

of the date of termination, plus his Target Bonus for the applicable period, plus the COBRA

Payment.

F.Any payment to Executive under this section 4, including but not limited to the Company

Notice Buyout, the Severance Payment and/or the pro-rated Target Bonus, is conditioned

upon Executive signing and not revoking a Separation Agreement, in the form typically

used by the Company, releasing all claims against the Company and agreeing not to

contest the continuing effect and enforceability of the Restrictive Covenants (the

“Separation Agreement”). The Separation Agreement shall be substantially in the form

of the template attached hereto as Exhibit B, with appropriate modifications and updates as

determined by the Company.

G.Subject to all other terms of this Agreement, the Severance Payment and, where

applicable, the Company Notice Buyout payment shall be paid in substantially equal

monthly installments, the first of which would occur within 15 days after the effective

execution date of the Separation Agreement and the last of which would occur no later

than 365 days after the effective execution date of the Separation Agreement.

H.At the time of his resignation, should the Executive be the subject of an ongoing internal

or external investigation into any conduct by Executive which would constitute Cause (as

defined below), then these Sections 4(a)(ii) and 4(a)(iii) shall be temporarily null and void,

Company may postpone a final decision on Executive’s resignation under this Section until

conclusion of the investigation, and Executive shall be entitled to no Bonus Payment or

Severance Payment of any kind until the investigation is resolved, which conclusion shall

be made with reasonable timeliness. At conclusion of the investigation, should Company

find Cause to terminate Executive, Executive’s resignation shall be treated as a

Termination for Cause as described below. Should the investigation fail to conclude that

there was Cause to terminate the Executive, Executive shall be entitled to payout of the

benefits described in this Section 4(a).

(b)Without Cause by Company. The Company may terminate the Executive’s employment

without Cause (as defined below) subject to the following requirements:

(i)Notice: The Company shall provide the Executive with six months of prior notice

(“Company Prior Notice Period”). The Company may, at its sole discretion, and at any time during the

Company Prior Notice Period, place the Executive on Garden Leave, and/or, in lieu of placing the

Executive on Garden Leave, pay the Executive an amount equal to his Base Salary for the remainder

of the Company Prior Notice Period (provide a “Company Notice Buyout”). Whether or not Executive

remains employed for the full Company Prior Notice Period, Executive shall be entitled to receive the

following upon termination of employment:

A.Payout of any accrued but unused vacation time, and

B.Reimbursement for unreimbursed business expenses properly accrued by the Executive,

which shall be subject to and paid in accordance with the Company’s expense

reimbursement policy.

(ii)Bonus Payment: Whether or not Executive remains employed for the full Company Prior

Notice Period, Executive shall receive a pro-rated Target Bonus, as determined by the Company, which

payment shall be made in a lump sum at the time performance bonuses are regularly paid to similarly

situated employees of the Company. Such pro-rated Target Bonus shall be determined as a

percentage of the calendar year that the Executive was employed by the Company or would have been

employed by the Company if he had been employed until the end of the Company Prior Notice

Period. For the avoidance of doubt, regardless of the date of notice, in no case shall the Executive

receive both a pro-rated Target Bonus under this Section and a discretionary performance bonus

under 2(b) for the same overlapping time period.

(iii)Severance Payment: The Company shall provide Executive a Severance Payment as

defined and subject to the terms and conditions in Section 4(a)(iii).

(c)Cause. The Company may terminate the Executive’s employment hereunder for Cause.

For the purpose of this Employment Agreement, the Company shall have “Cause” to terminate the

Executive’s employment if the Executive has engaged in any of the following: (i) the Executive has

breached a material policy, procedure or rule of the Company, including but not limited to the CRH

Americas Code of Conduct, which may be altered or amended from time to time, and other obligations

under this Employment Agreement, which breach, if deemed curable by the Company, remains uncured

to the reasonable satisfaction of the Company for thirty (30) calendar days after the Executive receives

written notice of the breach from the Company; (ii) the Executive has committed gross negligence or

willful failure to perform substantially and satisfactorily his duties under this Employment Agreement;

(iii) the Executive has engaged in an act of fraud, dishonesty or fraudulent activity, misappropriation,

embezzlement, theft, bribery, forgery or similar conduct; (iv) the Executive is indicted for, convicted of or

pleads guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent) or a crime

that constitutes a misdemeanor involving moral turpitude; or (v) the Executive has engaged in any other

act or omission which, if it were known to the public, in the Company’s reasonable judgment could have

a significant adverse impact on the Company or the Group, and their business or reputation. If the

Executive’s employment shall be terminated by the Company for Cause, such termination shall be

effective immediately, and the Executive shall receive only Base Salary up to and including the

termination date. “Cause” shall not be construed as including conduct described in Section 9 (b) herein.

(d)Death. The Executive’s employment shall terminate upon his death. If the Executive’s

employment shall be terminated by reason of his death, Executive shall continue to receive Base Salary

through the end of the pay period in which the date of his death occurred.

(e)Disability. If, as a result of the Executive’s incapacity due to physical or mental illness, the

Executive shall have been absent from his duties hereunder on a full-time basis for ninety (90) consecutive

calendar days, and within thirty (30) days after written notice of termination is given (which may occur no

earlier than thirty (30) days before, but at any time after, the end of such ninety (90) day period), the

Executive shall not have returned to the performance of his duties hereunder on a full-time basis, the

Company may terminate this Employment Agreement. This Section 4(e) is subject to the requirements of

the Family and Medical Leave Act, the Americans with Disabilities Act, and all other applicable law.

Therefore, if required by law, the Executive may remain employed by the Company on an at-will basis

even if the Employment Agreement is terminated pursuant to this Section 4(e).

(f)No Further Obligations after Payment. After all payments, if any, have been made to the

Executive pursuant to any of paragraphs (a) through (e) of this Section 4, the Company shall have no

further obligations to the Executive under this Employment Agreement other than the provision of any of

the Executive benefits required to be continued under applicable law.

(g)Resignation of All Other Positions. Upon termination of the Executive’s employment

hereunder for any reason, the Executive shall be deemed to have resigned, effective on the termination

date, from all positions that the Executive holds as an officer or member of the Board (or a committee

thereof) of the Company or its affiliates, or any of their subsidiaries, except as otherwise agreed to by the

Parties in writing.

5.Garden Leave. For the purpose of this Employment Agreement, “Garden Leave” refers

to that portion of any notice period during which Executive is relieved from Executive’s usual employment

duties but remains an employee of the Company in a consulting role. During Garden Leave, the Executive

shall not attend work, enter the Company’s premises, use Company’s property, or have business-related

contact with the Company’s customers, suppliers, contractors, or employees of the Company, except as

directed by the Company. If requested by the Company, the Executive shall provide advice and

information related to prior work performed for the Company, report to work during Garden Leave at

such time and place as the Company may require, and cooperate fully with the Company in helping it

transition the Executive’s duties to others and retain valuable business relationships. During Garden

Leave, the Executive will: remain a loyal employee of the Company; avoid conflicts of interest such as, but

not limited to engaging in competition with the Company, assisting a competitor, or actively pursuing the

creation or development of a competitive business enterprise; remain bound to all Company’s policies and

the terms of this Employment Agreement; and, continue to receive his Base Salary, benefits and other

regular compensation through the termination date, to the extent permitted by the plans and/or applicable

law.

6.Section 409A. This Employment Agreement will be construed and administered to

preserve the exemption from Section 409A of the Internal Revenue Code of 1986, as amended (the

“Code”) of payments that qualify as short-term deferrals pursuant to Treas. Reg. §1.409A-1(b)(4) or that

qualify for the two-times compensation separation pay exemption of Treas. Reg. §1.409A-1(b)(9)(iii).

With respect to other amounts that are subject to Code Section 409A, it is intended, and this Agreement

will be so construed, that any such amounts payable under this Agreement and the Company’s and the

Executive’s exercise of authority or discretion hereunder shall comply with the provisions of Section 409A

of the Code and the regulations and other guidance promulgated thereunder (“Section 409A”) so as not to

subject Executive to the payment of interest and additional tax that may be imposed under Section 409A.

As a result, in the event the Executive is a “specified employee” on the date of the Executive’s

termination of employment, any payment that is subject to Section 409A and that is payable to the

Executive in connection with Executive’s separation from service shall not be paid until the first business

day following the expiration of six months after the Executive’s separation from service (if the Executive

dies after the Executive’s separation from service but before any payment has been made, such remaining

payments that were or could have been delayed will be paid to the Executive’s estate without regard to

such six-month delay). Solely as necessary to comply with Section 409A, “termination of employment” or

“employment termination” or similar terms shall have the same meaning as “separation from service”

under Section 409A(a)(2)(A)(i) of the Code. Each payment under this Employment Agreement is a separate

payment within the meaning of the final regulations under Section 409A. Notwithstanding the above, the

Executive agrees that the Company has made no representation as to the tax treatment of the

compensation provided pursuant to this Employment Agreement and that the Executive is solely

responsible for all taxes due with respect to such compensation.

7.Duties Upon Termination. Upon the termination of the Executive’s employment for any

reason whatsoever, the Executive shall promptly return to the Company any Confidential Information,

Trade Secrets, and, whether or not constituting Confidential Information, any technical data,

performance information and reports, sales or marketing plans, documents, or other records, rolodexes,

and any manuals, drawings, tape recordings, computer programs, disks, and any other physical or

electronic representations of any other information relating to the Company, any of its subsidiaries or

affiliates. The Executive hereby acknowledges that any and all of such documents, items, physical or

electronic representations, and information are, and shall remain, at all times the exclusive property of

the Company.

8.Restrictive Covenants.

(a)Protectable Interests / Ancillary Agreement: The restrictions provided for in the other

Sections of this Agreement are not sufficient, standing alone, to protect the legitimate business interests of

the Company. In reliance upon Executive’s covenants in this Agreement, and particularly those contained

in this Section 8 (the “Restrictive Covenants”), Company will employ Executive in a position of special

trust and confidence where Executive will be provided one or more of the following: (a) Confidential

Information related to Executive’s position, (b) special access to suppliers, customers and other valuable

business relationships of the Company, and/or (c) specialized training. The Executive agrees that the

foregoing will give Executive an unfair competitive advantage if Executive’s activities are not restricted

as provided for in the Restrictive Covenants below. The Executive acknowledges the Company would

not enter into this Employment Agreement without the execution of the Restrictive Covenants contained

herein. The Executive acknowledges that his employment with the Company, material advancement,

receipt of access to Confidential Information, and other consideration provided hereunder are sufficient

and valuable consideration for the execution of the restrictive covenants contained herein.

(b)Definitions:

(i)“Business of the Company” means any line of business that the Company or the Group is

engaged in or preparing to engage in, relating to services and/or products for the construction industry.

Executive stipulates that the scope of activity covered by this definition of Business of the Company is

understood by him, and that the Executive will be informed of changes in the Business of the Company as

they occur as a natural consequence of Executive’s position.

(ii)“Competitive Business(es)” means any business enterprise (firm, partnership, joint

venture, corporation and/or any other entity and/or person) that competes with any part of the Business of

the Company that the Executive has involvement with or access to Confidential Information about in the

Look Back Period. It will be presumed that any business enterprise that develops, manufactures, markets,

distributes, provides and/or sells a Conflicting Product in markets where the Company or the Group do

business is a Competitive Business.

(iii)“Confidential Information” means an item of information or compilation of

information, in any form (tangible or intangible), related to Company’s business and of value to the

Company that Executive first acquires or gains access to during employment with the Company, that

Company has not authorized public disclosure of, and that is not readily available through lawful and

proper means to the public or persons outside Company who are under no obligation to keep the

information confidential. Confidential Information includes, but it is not limited to: (1) finances and

business plans; (2) financial projections; (3) sales information relating to the Company’s product roll-outs,

including price, discounts, commissions, margins, targets, and other related information; (4) customized

software, marketing tools, and/or supplies that the Executive has access to and/or will create; (5) the

identity of the Company’s Customers, and/or Customer Prospects; (6) any list(s) of the Company’s

Customers and/or Customer Prospects; (7) the account terms and pricing of sales contracts between the

Company and its Customers; (8) the proposed account terms and pricing of sales contracts between the

Company and its Customer Prospects; (9) the techniques, methods, and strategies by which the Company

develops, manufactures, markets, distributes, and/or sells any of its products; and (10) Trade Secrets. An

item of Confidential Information need not be marked “confidential” or otherwise labeled in a particular

way to qualify as Confidential Information; instead, the definition provided above will control at all times.

Due to its special value and utility as a compilation, a confidential compilation of information by the

Company will remain protected as Confidential Information even if individual pieces of information in it

are public. Private disclosure of Confidential Information to parties the Company is doing business with

for business purposes shall not cause the information to lose its protected status under this Agreement.

Confidential Information shall not include any data or information which has been voluntarily disclosed to

the public by the Company (except where such public disclosure has been made by the Executive without

authorization from the Company) or that has been independently developed and disclosed by others, or

that has otherwise entered the public domain through lawful means. “Trade Secrets” means Confidential

Information which meets the additional requirements of applicable law.

(iv)“Conflicting Product” means a product or service of another business enterprise

(not the Company or the Group) that is of the type conducted, authorized, offered, or provided by the

Company or the Group in the Look Back Period and with respect to which Executive had involvement or

access to Confidential Information.

(v)“Covered Customers” means any customer (firm, partnership, corporation and/or

any other entity and/or person) that purchases or seeks to purchase products or services from the

Company or the Group with which Executive has Material Contact. It will be presumed that Covered

Customers includes active prospective customers as of the date Executive’s employment ends with whom

Executive has Material Contact.

(vi)“Covered Vendors and Suppliers” means any supplier, distributor, broker, or

vendor that the Company or the Group relies upon in the ordinary course of business and with which

Executive has Material Contact.

(vii)“Group” means the Company and its parent companies, subsidiaries and affiliates in

the United States, Ireland or any other country as may be the case from time to time, with respect to

which Executive has some involvement or access to Confidential Information.

(viii)“Look Back Period” refers to the last two (2) years of the Executive’s employment

with the Company or the Group, or any lesser period of such employment if not employed for two years,

inclusive of employment with a predecessor entity of the Company or Group; or, if not enforceable, then

such lesser period as would be enforceable.

(ix)“Material Contact” means personal contact or material interaction with a person or

entity, or the supervision of contact or material interaction with a person or entity, in the Look Back

Period. Material interaction is presumed present if Executive participated in or supervised

communications with the individual or entity, or received commissions, bonuses, or other beneficial credit

or attribution for business done with the person or entity, or was provided Confidential Information about

business done or proposed with the person or entity, in the Look Back Period.

(x)“Material Individual” means any person who was employed by the Company or

the Group as a director or in a senior managerial position (which shall generally be considered to be an

individual appointed at job level 20 and above), or any contractor or consultant of the Group of equivalent

seniority.

(xi)“Territory” means the geographic territory where Executive is working at the time

of employment termination, which shall be understood to mean the state Executive resides in and each

additional state (and state equivalent) in the United States and other countries where the Company or the

Group market their products or services or otherwise do business that Executive has some involvement

with or access to Confidential Information about in the Look Back Period. Executive stipulates that the

nature of the Company’s business is national within the United States and also international in nature.

Given the nature of the Executive’s position with the Company, it will be presumed that Executive’s

involvement and Confidential Information access covers the entire United States and each additional

country where the Company and the Group do business during the Look Back Period, and continue to do

business as of the date of enforcement. The Executive acknowledges and agrees that due to the nature of

his executive duties and the Confidential Information and/or Trade Secrets involved in his role, the

geographic area covered by the Territory definition is reasonable.

(c)The Executive agrees his work for the Company brings him into close contact with many

Covered Customers, Covered Vendors and Suppliers, Trade Secrets, and Confidential Information. The

Executive further agrees the covenants in this Section 8 are reasonable as to the time and the scope of

activity to be restrained and necessary to protect the Company’s and the Group’s legitimate business

interests and relationships, Trade Secrets, and Confidential Information.

(d)The Executive further agrees that the harm caused by a violation of the Restrictive

Covenants would not only cause recoverable monetary damages but would also cause irreparable harm to

the Company and/or the Group which cannot be effectively remedied through monetary damages, and

can only be effectively addressed through injunctive relief and special remedies as provided for in Section

10 below.

(e)Non-Competition. The Executive covenants and agrees that during employment and for

twelve (12) months after the Executive’s employment with the Company ends for any reason, the

Executive will not (as an employee, consultant, director, owner, partner, or otherwise), directly or

indirectly, anywhere in the Territory, on behalf of or for the benefit of a Competitive Business: (i) perform

duties or services that are the same as, or similar in function or purpose to those Executive performed for

the Company in the Look Back Period, (ii) assist a Competitive Business in producing, developing or

improving a Conflicting Product, or (iii) accept competing business from a Company customer, or

otherwise knowingly interfere with the relationship between the Company and one of its customers,

vendors, or suppliers. If the Executive is placed on Garden Leave, as provided in Section 5, the months he

spends on Garden Leave shall be offset against this 12-month restriction. Nothing in this Employment

Agreement shall be construed to prevent the Executive from having an interest of less than one percent

(1%) of the outstanding shares of capital stock of any company which is traded on a nationally recognized

stock exchange. The Executive agrees and acknowledges that: (i) the provisions of this Section 8(e) are

reasonable and necessary for the protection of the Company and the Group; (ii) such provisions contain

reasonable limitations as to the time and the scope of activity to be restrained; (iii) the consideration

provided in this Employment Agreement is sufficient to compensate the Executive for the restrictions

contained in this Section 8(e), regardless of how his employment is terminated and (iv) the provisions of

this Section 8(e) will not unduly limit the Executive in finding or obtaining employment in a capacity or at

a level of compensation similar to that which the Executive has under this Employment Agreement.

(f)Non-Solicitation of Employees. The Executive covenants and agrees that for twelve (12)

months after Executive’s employment with the Company ends for any reason he will not, directly or

indirectly, on behalf of (or for the benefit of) a Competitive Business: (i) recruit, solicit, or induce, or

attempt to recruit, solicit, or induce, any Material Individual, to terminate their relationship with the

Company or the Group, or (ii) assist in hiring a Material Individual. If the Executive is placed on Garden

Leave, the months he spends on Garden Leave shall be offset against this 12-month restriction.

(g)Non-Solicitation of Customers or Customer Prospects. The Executive covenants and

agrees that for twelve (12) months after the Executive’s employment with the Company ends for any

reason he will not, directly or indirectly, on behalf of (or for the benefit of) a Competitive Business: (i)

solicit or induce, or attempt to solicit or induce, any Covered Customer for any business purpose that

involves providing products or services that are competitive with those provided by the Company or the

Group, or (ii) solicit a Covered Customer to terminate an existing or prospective business relationship with

the Company or the Group, or otherwise change such a relationship to the detriment of the Company or

the Group. If the Executive is placed on Garden Leave, the months he spends on Garden Leave shall be

offset against this 12-month restriction.

(h)Non-Solicitation of Vendors or Suppliers. The Executive covenants and agrees that for

twelve (12) months after the Executive’s employment with the Company ends for any reason he will not,

directly or indirectly, knowingly solicit or induce, or attempt to solicit or induce, any Covered Vendor or

Supplier to terminate their relationship with the Company or the Group or change such relationship to the

detriment of the Company or the Group. If the Executive is placed on Garden Leave, the months he

spends on Garden Leave shall be offset against this 12-month restriction.

(i)Solicitation Understandings and Effect of Presumptions. For purposes of the non-

solicitation restrictions (Sections 8(f), (g), and (h)), it shall be presumed that “to solicit” means to

knowingly interact with a person or entity with the intent, purpose or foreseeable result being to cause a

particular responsive action, irrespective of which party first initiates contact. The non-solicitation

restrictions are understood to be reasonably limited by geography to those locations and/or places of

business where the Material Individual, Covered Customer, and Covered Vendors and Suppliers are

located and available for solicitation. However, if any of the non-solicitation restrictions require a

different form of geographic limitation under applicable law to be enforceable then such restriction shall

be deemed limited to the Territory. The non-solicitation restrictions are not intended to cover or prohibit

general advertising that is not targeted at the customers or employees of Company such as advertisements

directed to the general public or “help wanted” ads. A presumption provided for in this Agreement may

only be overcome through clear and convincing evidence, and will not be applicable where it would make

a provision of this Agreement to which it applies unenforceable.

(j)Intellectual Property Rights.

For the purposes of this clause, “Intellectual Property” means patents, trademarks, service

marks, registered designs (including applications for and rights to apply for any of them), inventions,

innovations, improvements, developments, methods, ideas, concepts, unregistered design rights, logos,

trade or business names, copyrights, database rights, confidential information, knowhow and any similar

rights.

The Executive acknowledges that (i) it has been part of his normal duties to develop the

products and services of the Group; and (ii) because of the nature of his position he has a special obligation

to further the interests of the Group. All Intellectual Property which the Employee develops or produces,

alone or with others, in the course of his employment duties or outside such duties but relating to the

business of the Group in any manner whatsoever, either prior or after he signs this Agreement, will be

considered a "work made for hire" and shall be the sole and exclusive property of the Company. If for any

reason the results and proceeds of Executive’s services to the Company are determined at any time not to

be a "work made for hire," Executive hereby irrevocably assigns, transfers and sets over, all of his right,

title and interest in such Intellectual Property to the Company, and the Company shall be entitled to obtain

and hold in its own name all patents, copyrights or other intellectual property rights with respect to such

Intellectual Property. The Executive appoints the Company, or its designee, as the Executive’s attorney-

in-fact for purposes of obtaining patents and copyrights which result from my work during his

employment with the Company and to perfect ownership in the Company or its assigns and successors in

interest. The Company will consider each disclosure submitted by the Executive. The election of whether

or not to file a patent application or a copyright registration application on such disclosure and the manner of

preparation and prosecution of any patent or copyright application or applications filed in the United

States of America or in foreign countries shall be wholly within the discretion of the Company, and at its

expense. The Executive shall disclose in writing to Company (or persons designated by it) the existence

and nature of any Intellectual Property and shall, during and after the period of employment with the

Company, and without further consideration from the Company, (i) execute all documents requested by

the Company for vesting in the Company and the entire right, title and interest in and to the same, (ii)

cooperate with the Company and execute all documents requested by the Company for the filing of such

applications for and the procuring of such patents, trademarks, service marks or copyrights as the

Company, in its sole discretion, may desire to prosecute, and (iii) give the Company all assistance and

cooperation it may reasonably require in order to obtain, maintain, defend, enforce, and protect the

Company's right therein and thereto anywhere in the world. The Employee also hereby waives all moral

rights in all Intellectual Property of the Company or the Group, and to obtain protection and enforce the

Company’s rights anywhere in the world. The Executive also hereby waives all moral rights in all

Intellectual Property which is owned by the Company, or will be owned by the Company, further to this

clause. The Executive will not copy, disclose, or make use of any Intellectual Property belonging to the

Company (whether or not subject to this clause) except to the extent necessary for the proper performance

of his duties. Rights and obligations under this clause will continue after the termination of this

Agreement in respect of all intellectual Property arising during the employment. Any and all such

Intellectual Property, reduced to written, graphic, or other tangible form and any and all copies and

reproductions thereof shall be furnished to the Company upon request, and in any case, shall be returned to

the Company upon termination of the Executive’s employment with the Company. Executive may not

sell, reproduce, distribute, modify, display, publicly perform, or prepare derivative works based on any

content used by or created for the Company, by the Executive or any other third party, in any way for

public or commercial purposes without the Company’s prior written consent.

The Executive warrants and agrees that all inventions, innovations, improvements,

developments, methods, designs, analyses, ideas, concepts, reports, software, and all similar or related

information which he made, invented, or conceived prior to entering the employ of the Company, to

which the Executive now claims title, and which are to be specifically excluded from this Agreement, are

completely described in Exhibit A attached.

9.Protection of Confidential Information

(a)No Unauthorized Use or Disclosure. The Executive agrees not to engage in any use,

disclosure, copying or transfer of Confidential Information that is not authorized as part of the Executive’s

employment duties and undertaken in careful compliance with all Company policies and directives for the

handling of such information. The Executive understands and accepts the duty to use reasonable care in

maintaining the confidentiality of Confidential Information, and agrees to report to the Company any

unauthorized use or disclosure that the Executive becomes aware of and to cooperate with the Company in

taking all reasonable and necessary steps to recover any misappropriated Confidential Information. When

the Executive’s employment ends, Executive will return all records of Confidential Information to the

Company without retaining any copies thereof that he is not expressly authorized to retain in writing. The

Executive will not use his knowledge of Confidential Information to recreate records of Confidential

Information or otherwise reproduce Confidential Information entrusted to him in confidence after his

employment ends without Company authorization. The foregoing obligations regarding Confidential

Information will apply to the Executive while employed with the Company or the Group and for as long

thereafter as the information at issue continues to qualify as Confidential Information under the definition

applied in this Agreement; provided, however, that if a post-employment time limit on the use of

Confidential Information is required in order for this restriction to be enforceable, and only in such event,

the restrictions on use of Confidential Information that does not qualify as a Trade Secret shall expire

three (3) years after the Executive’s employment ends and all records of Confidential Information in

Executive’s possession and control have been returned to the Company. No such time limitation will apply

to Trade Secrets. A permitted disclosure of Confidential Information under Section 9(b) below will not be

considered an unauthorized use or disclosure of Confidential Information for purposes of the foregoing

restrictions or any other section of this Agreement.

(b)Permitted Disclosure. Nothing herein shall be construed to prevent disclosure of

Confidential Information, Trade Secrets or Intellectual Property as may be required or permitted by

applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an

authorized government agency, provided that the disclosure does not exceed the extent of disclosure

required by such law, regulation or order. The provisions in this Employment Agreement do not prohibit

the Executive from communicating with any governmental authority or making a report in good faith and

with a reasonable belief of any violations of law or regulation to a governmental authority, or disclosing

Confidential Information, including providing documents, which the Executive has acquired through

lawful means in the course of employment to such governmental authority in connection with such

communications or report, or from filing, testifying or participating in a legal proceeding relating to such

violations, including making other disclosures protected or required by any whistleblower law or

regulation to the Securities and Exchange Commission, the Department of Labor, or any other appropriate

government authority; provided expressly that to the extent that the Executive discloses any Confidential

Information, the Employee will honor the other confidentiality obligations in this Employment Agreement

and will only share such Confidential Information in accordance with this section. The Executive is hereby

notified that under the Defend Trade Secrets Act (DTSA), (1) no individual will be held criminally or

civilly liable under Federal or State trade secret law for disclosure of a trade secret (as defined in the

Economic Espionage Act) that is: (A) made in confidence to a Federal, State, or local government official,

either directly or indirectly, or to an attorney, and made solely for the purpose of reporting or

investigating a suspected violation of law; or, (B) made in a complaint or other document filed in a

lawsuit or other proceeding, if such filing is made under seal so that it is not made public; and, (2) an

individual who pursues a lawsuit for retaliation by an employer for reporting a suspected violation of the

law may disclose the trade secret to the attorney of the individual and use the trade secret information in

the court proceeding, if the individual files any document containing the trade secret under seal, and does

not disclose the trade secret, except as permitted by court order.

10.Reliefs and Survival.

(a)Injunctive Relief. The Executive acknowledges that his breach of any covenant contained

in Sections 8 and 9 will result in irreparable injury to the Company and that the remedy at law of such

parties for such a breach will be inadequate. Accordingly, the Executive agrees and consents that the

Company, in addition to all other remedies available to it at law and in equity, shall be entitled to seek and

receive both preliminary and permanent injunctions to prevent and/or halt a breach or threatened breach

by the Executive of any provision contained in Sections 8 and 9 with One Thousand Dollars ($1,000.00)

being the agreed-upon amount of bond (if any) that need be posted to secure such relief. The Company

shall be deemed the prevailing party if it recovers any relief requested in a legal action to enforce this

Agreement irrespective of whether some of the relief requested is also denied or the contract must be

reformed to be enforced. In the event Executive violates the Material Individual non-solicitation

obligation (Section 8(f)) which causes (in whole or in part) the Company or the Group to lose the services

of a Material Individual before injunctive relief to prevent such loss can be secured, Executive shall owe

Company a sum equal to one third of the Material Individual’s annual total compensation at his or her last

rate of pay with Company or the Group as liquidated damages. This sum shall be in addition to, and not

in lieu of injunctive relief to prevent further violations with respect to other Material Individuals.

(b)Severability and Judicial Modification. Except where otherwise expressly provided, the

terms of this Agreement are severable. The covenants contained in Sections 8 and 9 shall be presumed

to be reasonable and enforceable, and any reading causing unenforceability shall yield to a construction

permitting enforcement. In the event an arbitrator or court of competent jurisdiction should determine not

to enforce a covenant as written due to overbreadth, the parties specifically agree that said covenant shall

be modified and enforced to the extent reasonable, whether said modifications are in time, territory, or

scope of prohibited activities. If any single covenant or clause in this Employment Agreement shall be

found unenforceable and not subject to modification to allow enforceability, it shall be severed and the

remaining covenants and clauses enforced in accordance with the tenor of the Employment Agreement.

(c)Survival. The covenants and agreements made by the Executive in Sections 8 and 9 will

survive the termination of the Executive’s employment and the termination of this Employment

Agreement, a change in Executive’s position or terms and conditions of employment, and any claim

asserted by Executive against the Company arising from this Agreement or otherwise.

11.Indemnification and Insurance. The Company agrees that during the course of

Executive’s employment, it will maintain Directors and Officers insurance or appropriate self-insurance

covering Executive for decisions made and actions taken by Executive that are consistent with Company

policy and taken in the course of Executive’s employment. The Company shall provide to Executive such

coverage and limits as are generally provided by FTSE 100 companies of similar size and geographic

presence to their non-Board of Director executives.

12.Entire Agreement; Modification; Waiver. This Employment Agreement constitutes the

entire agreement between the parties pertaining to the subject matter contained in it and supersedes all

prior and contemporaneous agreements, representations, and understandings of the parties concerning its

subject matter. No supplement, modification, or amendment of this Employment Agreement shall be

binding unless executed in writing by all parties hereto. No waiver of any of the provisions of this

Employment Agreement will be deemed, or will constitute, a waiver of any other provision, whether or

not similar, nor will any waiver constitute a continuing waiver. No waiver will be binding unless executed

in writing by the party making the waiver.

13.Successors and Assigns; Assignment. This Employment Agreement shall be

binding on, and inure to the benefit of, the parties hereto and their respective heirs, executors, legal

representatives, successors, and assigns; provided, however, that this Employment Agreement is

intended to be personal to the Executive and the rights and obligations of the Executive hereunder

may not be assigned or transferred by him/her. It is expressly understood that CRH, plc shall be a

beneficiary of this Agreement, and entitled to enforce it as needed to protect the interests of itself and

its subsidiaries and affiliates. Executive understands and agrees that this Agreement may be assigned

by the Company, and that the assignee shall be entitled to enforce it against Executive. Should the

Company assign this Employment Agreement to any affiliate or other entity associated with the

Company, this Employment Agreement shall be binding on such assignee and any references in this

Employment Agreement to the “Company” shall be deemed to be a reference to such assignee.

14.Notice. Any notice or other communication required or permitted under this Employment

Agreement by either party hereto to the other shall be in writing, and shall be deemed effective upon (a)

personal delivery, if delivered by hand, (b) three days after the date of deposit in the mails, postage

prepaid, if mailed by certified or registered mail, or (c) the next business day, if sent by a prepaid

overnight courier service, and in each case addressed as follows:

If to the Executive:Randall Lake

[*****]

[*****]

If to the Company:CRH Americas, Inc.

ATTN: General Counsel

[*****]

[*****]

[*****]

Either party may change the address or addresses to which notices are to be sent by giving notice of such

change of address in the manner provided by this section.

15.Counterparts. This Employment Agreement may be executed in multiple counterparts,

each of which shall be deemed an original, but all of which together shall constitute one and the same

document. This Employment Agreement may be executed by facsimile signature and a facsimile signature

shall constitute an original signature for all purposes. Each undersigned further agrees that electronic

signatures, whether digital or encrypted, of the parties hereto are intended to have the same force and

effect as manual signatures. As used in the previous sentence, the term “electronic signatures” means any

electronic sound, symbol or process attached to or logically associated with this Agreement and executed

and adopted by a party with the intent to sign such Agreement, including, but not limited to, e- mail

electronic signatures executed through DocuSign®.

16.Severability of Provisions. The invalidity or unenforceability of any particular provision of

this Employment Agreement shall not affect the other provisions hereof, and this Employment Agreement

shall be construed in all respects as if such invalid or unenforceable provisions were omitted.

17.Governing Law and Jurisdiction. This Employment Agreement is executed and

delivered in, and shall be governed by, enforced and interpreted in accordance with the laws of the State of

Georgia, without regard to its conflict of laws principles. Any dispute, claim or cause of action arising out

of, or related to, this Agreement shall be commenced only in a federal or state court in the State of

Georgia, County of Dekalb, and the parties hereby submit to the exclusive jurisdiction of such courts and

waive any claim of an inconvenient forum.

18.Construction. In construing this Employment Agreement, whenever appropriate, the

singular tense shall also be deemed to mean the plural, and vice versa, and the captions contained in this

Employment Agreement shall be ignored.

19.Legally Binding Obligation; Legal Counsel. The Executive acknowledges that he has

had an opportunity to read this Employment Agreement, raise questions about its terms, and seek advice

of legal counsel if desired. The Executive understands that this Employment Agreement is a legally

binding contractual obligation, which includes restrictive covenants, and enters into it willingly,

knowingly and voluntarily.

IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement

effective as of the Effective Date stated above.

CRH AMERICAS, INC.RANDY LAKE

By:/s/ Albert Manifold/s/ Randy Lake

EXHIBIT A

LIST OF PRIOR INVENTIONS

AND ORIGINAL WORKS OF AUTHORSHIP

[Intentionally Omitted]

EXHIBIT B

SEPARATION AGREEMENT, RELEASE AND WAIVER

[Intentionally Omitted]

Exhibit 19.1 - Insider Trading Policy - Plain Text Version EXHIBIT 19.1

CRH plc

Insider Trading Policy

I.Policy Overview

CRH plc (together with its subsidiaries, “CRH”) has adopted this Insider Trading Policy (this “Policy”) to cover the purchase, sale or

transfer by CRH employees, directors and certain other individuals of CRH securities and securities of publicly traded companies with

whom CRH has or may have a business relationship.

U.S. federal and state securities laws restrict trading by certain individuals who learn of “material, non-public information” (“MNPI”)

regarding a company. See Appendix for a description of MNPI. If you have MNPI, you may not (i) buy, sell or transfer securities on

the basis of such information, or (ii) “tip” others about such information. Similar laws and regulations in the European Union, the

United Kingdom and other jurisdictions (including the Market Abuse Regulations) that apply to CRH also restrict trading in securities

by persons in possession of non-public inside information. Violations of these restrictions can carry both criminal and civil penalties.

CRH has adopted this policy to prevent both insider trading and allegations of insider trading, to ensure the proper handling of MNPI

and non-public inside information, and to ensure that we do the right things in the right way and comply with the law.

It is the responsibility of individuals subject to this Policy to read, understand and comply with it, which supplements your

responsibilities under CRH’s Code of Business Conduct. Every individual subject to this Policy should remember that he or she is

ultimately responsible for adhering to this Policy and avoiding improper trading. This Policy applies even if the activities prohibited

by this policy are not illegal in the country where any particular individual or entity is located. Violations of this policy can lead to

disciplinary action, up to and including termination, regardless of whether such actions violated the law.

Questions about this Policy can be directed to CRH’s Office of the Company Secretary and/or Group General Counsel. This Policy

may be amended or modified in any respect at any time.

II.Who is Subject to This Policy?

Directors and employees of CRH plc and its<br><br>subsidiaries (“CRH Persons”)	•Please note certain CRH Persons are subject to additional restrictions and<br><br>procedures – such additional restrictions and procedures are addressed in<br><br>detail in Section IV of this Policy.
Each CRH Person’s spouse or domestic<br><br>partner, minor children and step-children,<br><br>family members residing in the same<br><br>household, and financially dependent relatives<br><br>(“Related Persons”)	•Each CRH Person is responsible for ensuring his or her own compliance<br><br>and the compliance of individuals who qualify as Related Persons because<br><br>of their relationship.<br><br>•You should ensure that such Related Persons are aware of the restrictions<br><br>of this Policy and the need to consult with you before transacting in<br><br>securities covered by this Policy.
Entities, including any corporations,<br><br>partnerships or trusts, that a CRH Person<br><br>influences or controls (“Controlled Entities”)	•Transactions by Controlled Entities are treated for the purposes of this<br><br>Policy as if they were for the account of the CRH Person influencing or<br><br>controlling such entity.

The persons and entities listed above are referenced in this Policy as “Covered Persons” and are subject to the terms of this Policy.

In addition, consistent with applicable law, CRH is prohibited from trading in CRH securities on the basis of MNPI.

This Policy continues to apply to purchases, sales or transfers (including gifts) initiated after a Covered Person has ceased employment

or affiliation with CRH. If a Covered Person is aware of MNPI when the employment or relationship with CRH terminates, such

Covered Person may not trade CRH securities or any other securities about which the Covered Person has MNPI until that information

has become public or is no longer material.

III.What Rules Apply to Covered Persons?

No Trading on MNPI	Covered Persons may not, directly or indirectly:<br><br>•transact in CRH securities, directly or through other persons or entities, or<br><br>recommend that others transact in CRH securities, when aware of MNPI<br><br>relating to CRH,<br><br>•transact in any other company’s securities, directly or through other<br><br>persons or entities, or recommend that others transact in such securities<br><br>when aware of MNPI relating to CRH or the other company obtained<br><br>during the Covered Person’s employment or relationship with CRH, or
No Tipping	•If a Covered Person learns of MNPI during his or her relationship with<br><br>CRH, he or she may not give that MNPI to others or recommend to others<br><br>that they buy or sell any securities while aware of such information.<br><br>•This is known as “tipping” and can result in the same civil and criminal<br><br>penalties that apply to insider trading, even though the Covered Person did<br><br>not trade and did not gain directly any benefit from another’s trading.
Additional Covered Transactions	CRH prohibits Covered Persons from engaging in certain speculative<br><br>transactions in CRH securities or in other types of transactions that may lead to<br><br>inadvertent violations of the insider trading laws.<br><br>Accordingly, a Covered Person’s trading in CRH securities is subject to the<br><br>following additional guidance:<br><br>•Short Sales.  Covered Persons may not engage in short sales of CRH<br><br>securities.<br><br>•Gifts.  Gifts of CRH securities are subject to the restrictions of this Policy.<br><br>Covered Persons may not gift CRH securities to others while in possession<br><br>of MNPI.<br><br>•Hedging and Pledging of CRH Securities.  CRH has separately adopted its<br><br>Policy on Pledging or Hedging Securities. Covered Persons should<br><br>familiarize themselves with the requirements of this policy.<br><br>•Standing Orders.  A Standing Order is an order to buy or sell securities that<br><br>remains active until it is filled or cancelled (for example, to buy or sell<br><br>securities at a certain price for a certain period of time). Standing Orders<br><br>should be used only (i) within 2 business days of the granting of pre-<br><br>clearance in the case of Additional Restricted Persons, as defined below, or<br><br>(ii) for a maximum of 2 business days in the case of other Covered<br><br>Persons.
---	---
No Exception for Hardship.	The existence of a personal financial emergency does not excuse a Covered<br><br>Person from compliance with this Policy and the laws prohibiting insider<br><br>trading.

For the purposes of this Policy:

•a “security” includes the ordinary, common or preferred shares or any other shares, and any put, call, option contract, hedge or

other derivative securities relating to any such shares, or any debt instruments, of a publicly traded company.

•“transacting” or “trading” in a security includes buying and selling securities in the open market, as well as gifting securities,

executing a “cashless” option exercise, selling or purchasing a put or call option, entering into any “short sale,” or the

execution of any of such actions pursuant to prearranged instructions (such as standing orders), regardless of when such

instruction was given.

IV.Are There Exemptions To Rules Applicable to Covered Persons?

Benefit & Retirement Plans	•This Policy shall not apply to the receipt of awards, or the vesting of such<br><br>awards, pursuant to any CRH benefit plans or any share plan / scheme that<br><br>may be put in place from time to time for the benefit of CRH employees<br><br>(each, a “Benefit Plan”), including CRH’s Performance Share Plan,<br><br>Restricted Share Plan, Deferred Share Bonus Plan, or Savings-related<br><br>Share Option Scheme.<br><br>•Covered Persons may make ongoing investments in any CRH retirement<br><br>saving plan or any similar investment plan (each, a “Retirement Plan”)<br><br>pursuant to earlier elections made at a time when the Covered Person was<br><br>unaware of MNPI.
Vested Option Exercises	•Covered Persons may exercise vested options to purchase CRH securities<br><br>by paying the full exercise price in cash<br><br>•Sales of the CRH securities received upon such exercise may only be sold<br><br>in accordance with this Policy and while the Covered Person is not aware<br><br>of MNPI.
All Employee Share Plans	•This Policy’s trading restrictions do not apply to the purchases of securities<br><br>in any CRH share participation plans & schemes that may be in effect from<br><br>time to time (any such plan, an “SPPS”) that result from periodic payroll<br><br>contributions under an election a Covered Person made at the time of<br><br>enrollment when the Covered Person was unaware of MNPI.
Mutual & Exchange-Traded Funds	•Covered Persons may buy or sell investments in publicly traded mutual<br><br>funds or exchange-traded funds.
---	---
Approved “10b5-1 Plans”	•Covered Persons may transact in CRH securities pursuant to an approved<br><br>“10b5-1 plan”. 10b5-1 plans are written trading plans which, subject to<br><br>meeting certain requirements, allow for the sale or purchase of a<br><br>predetermined number of securities at a specific time and price.<br><br>•Covered Persons can enter into, amend or terminate a 10b5-1 plan only<br><br>when not aware of MNPI.<br><br>•Once a Covered Person signs the plan, he or she must not exercise any<br><br>influence over the amount of securities to be traded, the price at which they<br><br>are to be traded, or the date of the trade.<br><br>•Rule 10b5-1 includes restrictions as to when and how often 10b5-1 plans<br><br>may be entered into and are subject to a cooling off period before they are<br><br>active.<br><br>•Advice must be taken from personal counsel prior to entering into a 10b5-1<br><br>plan.<br><br>•All 10b5-1 plans, including any amendment, deviation, termination or<br><br>cancellation of a scheduled transaction, must be approved in writing in<br><br>advance by the Office of the Company Secretary or Group General<br><br>Counsel and must comply with all of the requirements set forth in Rule<br><br>10b5-1(c) of the Securities Exchange Act of 1934, as amended.

V.Blackout Windows and Pre-Clearance Policy

In addition to the above, CRH may notify individuals (the “Additional Restricted Persons”) from time to time that they are subject to

the following additional trading restrictions: Blackout Windows and Pre-Clearance Requirements. Please see below for further

discussion of each:

Blackout Windows

•During the below listed blackout periods, Additional Restricted Persons<br><br>may not transact in CRH securities or adopt, amend or terminate a 10b5-1<br><br>plan.<br><br>•If an Additional Restricted Person ceases their employment with CRH or<br><br>otherwise ceases to qualify as an Additional Restricted Person during a<br><br>blackout period, he or she will remain subject to the restrictions of such<br><br>blackout period until it has ended.<br><br>•CRH’s blackout periods are:<br><br>othe period beginning 14 calendar days prior to the end of each fiscal<br><br>quarter and ending one full U.S. trading day (being NYSE trading<br><br>hours beginning at 9:30 a.m. and ending at 4:00 p.m., times shown<br><br>U.S. Eastern) following the public release of CRH’s earnings for<br><br>such fiscal quarter, unless otherwise notified by the Office of the<br><br>Company Secretary or the Group General Counsel, and<br><br>oany event-specific blackout periods determined at the discretion of<br><br>the Disclosure Committee, the Office of the Company Secretary or<br><br>the Group General Counsel.

Pre-Clearance Requirement

•The following pre-clearance arrangements will apply prior to:<br><br>a)the completion of any transaction in CRH securities (including gifts<br><br>of CRH securities); or

CRH plc

Insider Trading Policy – Appendix

What is Material Non-Public Information (MNPI)?

The restrictions in this Policy apply to information that is both “material” and “non-public.”

Material Information. Information is “material” if there is a reasonable likelihood the information would be considered important to

an investor in making an investment decision about whether to buy, hold or sell a security. Both favorable and unfavorable

information can be material. However, there is no precise definition of “materiality,” and the question of whether information is

material is subjective and often judged in hindsight. Accordingly, Covered Persons are advised to take a cautious view when

evaluating whether information is “material” and, in case of questions about the materiality of certain information, consult with the

Office of the Company Secretary or the Group General Counsel before transacting.

Some examples of “material information” may include, depending on the particular circumstances:

•Projections of future earnings or losses or other earnings guidance.

•Preliminary financial results or key operating metrics.

•A major pending or proposed acquisition of or merger with another business, or a purchase or sale of significant assets or

businesses.

•New major contracts, orders, suppliers, customers or finance sources, or the loss thereof.

•A change in the Global Leadership Team or CRH plc’s board of directors.

•Significant cybersecurity incidents.

•Actual or threatened major litigation or governmental proceedings or investigations, or the actual or potential settlement of

such litigation, proceedings or investigations.

•Changes in dividend levels or dividend policy.

•Changes in anticipated share repurchases.

•Other information that could result in substantial revenue gains or losses.

This list is intended to be illustrative only and is not exhaustive. Many other types of information may be material at any particular

time depending upon the circumstances.

Non-Public Information. Non-public information is information that is not generally known or available to the public. Information is

“non-public” (1) if it has not yet been either the subject of an official announcement (such as through a press release or a publicly

available regulatory filing) or otherwise sufficiently publicized and widely reported in the media and (2) until investors have had a

reasonable period of time to absorb and react to the information. The length of time that is required to allow investors to react to

information varies depending on the circumstances and the information in question. As a general rule, information is considered non-

public until after the first full trading day after the information is released.

Information does not cease to be “non-public” as a result of being the subject of rumors or other unofficial statements, and information

can still be “non-public” even if a Covered Person obtained it from a source outside of the firm.

Document

Exhibit 21.1

Principal Subsidiary Undertakings

as at December 31, 2024

Americas Materials Solutions

Incorporated and operating in				% held		Products and services
Canada		CRH Canada Group Inc.		100		Aggregates, asphalt, cement and readymixed concrete and provider of construction services
United States		Ash Grove Cement Company		100		Aggregates and cement
	Callanan Industries, Inc.		100		Aggregates, asphalt, readymixed concrete and related construction activities
	CPM Development Corporation		100		Aggregates, asphalt, readymixed concrete, prestressed concrete and related construction activities
	Dolomite Products Company, Inc.		100		Aggregates, asphalt, readymixed concrete and related construction activities
	Michigan Paving and Materials Company		100		Aggregates, asphalt and related construction activities
	Mountain Enterprises, Inc.		100		Aggregates, asphalt and related construction activities
	Mulzer Crushed Stone		100		Aggregates, asphalt, readymixed concrete, aggregates distribution and related construction activities
	CRH Americas Materials, Inc. and subsidiaries		100		Holding company
	Oldcastle SW Group, Inc.		100		Aggregates, asphalt, readymixed concrete and related construction activities
	OMG Midwest, Inc.		100		Aggregates, asphalt, readymixed concrete and related construction activities
	Pennsy Supply, Inc.		100		Aggregates, asphalt, readymixed concrete and related construction activities
	Pike Industries, Inc.		100		Aggregates, asphalt, readymixed concrete and related construction activities
	P.J. Keating Company		100		Aggregates, asphalt and related construction activities
	Preferred Materials, Inc.		100		Aggregates, asphalt, readymixed concrete, aggregates distribution and related construction activities
	Staker & Parson Companies		100		Aggregates, asphalt, readymixed concrete and related construction activities
	Suwannee American Cement Company, LLC (trading as Ash Grove South)		80		Cement
	Tilcon Connecticut Inc.		100		Aggregates, asphalt, readymixed concrete and related construction activities
	Tilcon New York Inc.		100		Aggregates, asphalt and related construction activities
	The Shelly Company		100		Aggregates, asphalt, readymixed concrete and related construction activities
	Trap Rock Industries, LLC*		60		Aggregates, asphalt and related construction activities
	West Virginia Paving, Inc.		100		Aggregates, asphalt and related construction activities
	BoDean Company Inc.		100		Readymix
	Northgate Ready-Mix LLC.		100		Readymix

Americas Building Solutions

Incorporated and operating in				% held		Products and services
Canada		Oldcastle Building Products Canada, Inc. (trading as Groupe Permacon, Expocrete Concrete Products, Techniseal, Oldcastle Enclosure Solutions), C.R. Laurence of Canada		100		Specialty masonry, hardscape and patio products, utility boxes and trench systems
United States		APG Mid-Atlantic, Inc		100		Specialty masonry, hardscape and patio products
	Barrette Outdoor Living (Trading as Boyle Transportation Services, LLC and Barrette Logistics, Inc.)		100		Vinyl and aluminum fencing and railing and transportation
	CRH America Finance, Inc.		100		Holding company
	CRH America, Inc.		100		Holding company
	CRH Americas, Inc.		100		Holding company
	CRH Americas Products, Inc.		100		Holding company
	MoistureShield, Inc.		100		Composite building products
	National Pipe & Plastics, Inc.		100		Pipe Products
	Oldcastle APG Northeast, Inc. (trading principally as Anchor Concrete Products)		100		Specialty masonry, hardscape and patio products
	Oldcastle APG South, Inc. (trading principally as Adams Products, Georgia Masonry Supply, Northfield Block Company, and Oldcastle Coastal)		100		Specialty masonry, hardscape and patio products
	Oldcastle APG West, Inc. (trading principally as Amcor Masonry Products, Central Pre-Mix Concrete Products, Jewell Concrete, Sierra Building Products, US Mix, Superlite Block and Calstone)		100		Specialty masonry and stone products, hardscape and patio products
	Oldcastle APG, Inc. (trading principally as EP Henry, Pebble Technology International, and Anchor Wall Systems)		100		Specialty masonry and stone products, hardscape, patio products, aggregate pool finishes and freestanding and retaining wall systems
	Oldcastle Building Products, Inc.		100		Holding company
	Oldcastle Infrastructure, Inc.		100		Precast concrete products, concrete pipe, prestressed plank and structural elements
	Oldcastle Lawn & Garden, Inc.		100		Patio products, bagged stone, mulch and stone
	Hydro International Americas, Inc		100		Stormwater and waste water products
	Turner International Topco Limited (Hydro International)		100		Stormwater and waste water products
		Nordic Fiberglass Inc.		100		Fiberglass products

International Solutions

Incorporated and operating in				% held		Products and services
Australia		Infrastructure Products Australia Pty Ltd		100		Supplier of access chambers and ducting products
	Leviat Pty Limited		100		Construction accessories
	Tri-Underground Pty Ltd		100		Supplier of access chambers and ducting products
	CTC Precast Pty Ltd		100		Precast concrete
	Adbri Pty Ltd		57		Cement, lime, readymixed concrete, aggregates & masonry
Belgium		Ergon N.V.		100		Precast concrete and structural elements
	Prefaco N.V.		100		Precast concrete structural elements
	Schelfhout N.V.		100		Precast concrete wall elements
	VVM N.V.*		100		Clinker grinding and cement production
	Plakabeton N.V.		100		Construction accessories
	Marlux N.V.		100		Concrete paving and landscaping products
Britain & Northern Ireland		Northstone (NI) Limited		100		Building & civil engineering
	Northstone Materials Limited		100		Aggregates, readymixed concrete, mortar, coated macadam, rooftiles, building and civil engineering contracting
	Cubis Systems Limited		100		Chamber & covers
	Materials Testing Limited		100		Testing
	Premier Cement Limited		100		Marketing and distribution of cement
	Southern Cement Limited		100		Sale and distribution of cement
	Tarmac Aggregates Limited		100		Aggregates, asphalt, readymixed concrete and contracting
	Tarmac Building Products Limited		100		Building products
	Tarmac Cement Limited		100		Cement
	Tarmac Trading Limited		100		Aggregates, asphalt, cement, readymixed concrete and contracting
	Leviat Limited		100		Construction accessories
	MCL Industrial Enclosures Limited		100		Supplier of ducting products
	MCL Group Holdings Limited		100
	Filoform UK Ltd		100		Supplier of access chambers and ducting products
	NAL Limited		100		Supplier of access chambers and ducting products
Denmark		Betongruppen RBR A/S		100		Concrete paving manufacturer
	RC Beton A/S		100		Manufacturer of concrete paving, concrete blocks and underground products
	CRH Concrete A/S		100		Structural concrete products
Estonia		Rudus AS		100		Aggregates and readymixed concrete
Finland		Finnsementti Oy		100		Cement
	Rudus Oy		100		Aggregates, readymixed concrete and concrete products
France		Eqiom*		99.99		Aggregates, cement and readymixed concrete
	L’industrielle du Béton S.A.		100		Structural concrete products
	Stradal		100		Utility and infrastructural concrete products
	Leviat S.A.S (Name change, formerly Plaka Group SAS)		100		Construction accessories
	Cubis SARL		100		Supplier of access chambers and ducting products
Germany		Opterra GmbH*		100		Cement
	EHL AG		100		Concrete paving and landscape walling products
	Leviat GmbH		100		Construction accessories
	Filoform GmbH		100		Supplier of ducting products
Hungary		Danucem Magyarország Kft.		100		Cement, aggregates and readymixed concrete
	Ferrobeton Dunaújvárosi Beton- és Vasbetonelem-gyártó Zrt*		100		Precast concrete structural elements
Ireland		Irish Cement Limited		100		Cement
	Roadstone Limited		100		Aggregates, readymixed concrete, mortar, coated macadam, concrete blocks and pipes, asphalt, agricultural and chemical limestone and contract surfacing
	Cubis Systems Limited		100		Supplier of access chambers and ducting products
	NAL Products Limited		100		Supplier of access chambers and ducting products
Netherlands		Calduran B.V.		100		Sand-lime bricks and building elements
---	---	---	---	---	---	---
	Cementbouw B.V.		100		Cement transport and trading, readymixed concrete and aggregates
	Heembeton B.V.		100		Precast concrete structural elements
	Dycore B.V.		100		Concrete flooring elements
	Struyk Verwo Groep B.V.		100		Concrete paving products
	Leviat B.V.		100		Construction accessories
Poland		Przedsiebiorstwo Produkcji Mas Betonowych Bosta Beton Sp. z o.o.		90.3		Readymixed concrete
	Drogomex Sp. z o.o.*		100		Asphalt and contract surfacing
	Cement Ożarów S.A.		100		Cement
	Masfalt Sp. z o.o.*		100		Asphalt and contract surfacing
	Trzuskawica S.A.		100		Production of lime and lime products
	Polbruk S.A.		100		Concrete paving products
Romania		ROMCIM S.A.		98.61		Cement, aggregates and readymixed concrete
	Elpreco S.A.		100		Architectural concrete products
	TehnoWorld SRL		100		Water infrastructure solutions
	Ferrobeton Romania SRL*		100		Structural concrete products
	Bauelemente		100		Structural concrete products
Serbia		Moravacem d.o.o. Popovac		100		Cement
Slovakia		Danucem Slovensko a.s.		99.8		Cement, readymixed concrete and aggregates
	Premac, spol. s.r.o.*		100		Concrete paving and floor elements
Spain		Beton Catalan S.A.		100		Readymixed concrete
	Cementos Lemona S.A.		98.75		Cement
Sweden		Ulricehamns Betong AB		100		Structural concrete products
Switzerland		JURA-Holding AG		100		Cement, aggregates and readymixed concrete
	Leviat AG*		100		Construction accessories
Ukraine		LLC Cement		100		Cement
	PJSC Mykolaivcement		100		Cement
	VIPCEM PJSC		100		Cement
	Podilsky Cement PJSC*		100		Cement
United States		Meadow Burke, LLC		100		Concrete accessories
Philippines (i)		Republic Cement & Building Materials, Inc.		40		Cement
	Republic Cement Land & Resources Inc.		40		Cement and Building Materials
(i) 55% economic interest in the combined Philippines business.

1

* Audited by firms other than Deloitte. 1

Principal Equity Method Investments

as at December 31, 2024

Americas Materials Solutions

Incorporated and operating in				% held		Products and services
Canada		Airlinx Transit Partners Inc.*		50		Special-purpose entity on Ontario infrastructure construction
	Blackbird Infrastructure 407 General Partnership*		50		Special-purpose entity on highway infrastructure construction
	Blackbird Maintenance 407 General Partnership*		50		Construction
	Blackbird Constructors 407 General Partnership*		50		Construction
	Blackbird Infrastructure 407 CRH GP Inc.*		50		Special-purpose entity on highway infrastructure construction
	DAD (Finch West LRT Inc.)*		33		Special-purpose entity on Ontario infrastructure construction
	Kiewit-Dufferin Midtown Partnership*		35		Construction
	Mosaic Transit Partners General Partnership*		33		Special-purpose entity on infrastructure construction
	Mosaic Transit Constructors General Partnership*		33		Construction
United States		Buckeye Ready Mix, LLC*		45		Readymixed concrete
	Cadillac Asphalt, LLC*		50		Asphalt
	Piedmont Asphalt, LLC*		50		Asphalt
	Southside Materials, LLC*		50		Aggregates
	Camden Materials, LLC*		50		Asphalt
	Carrollton River Terminal, LLC*		50		Liquid asphalt storage
	Nally & Gibson Georgetown, LLC*		50		Aggregates, asphalt and construction
	S&Y Terminal, LLC*		20		Liquid asphalt terminal
	Great Lakes Slag US, LLC*		50		Slag

International Solutions

Incorporated and operating in				% held		Products and services
		2
Australia		E.B. Mawson & Sons Pty Ltd & Controlled Entities		50		Aggregates & readymixed concrete
	Independent Cement & Lime Pty Ltd		50		Cement
China		Yatai Building Materials Group Company Limited*		26		Cement
Ireland		Kemek Limited*		50		Commercial explosives

* Audited by firms other than Deloitte.2

Exhibit 22.1 - List of Guarantors and Subsidiary Issuers of Guaranteed Securities 2024 Exhibit 22.1

List of Subsidiary Issuers of Guaranteed Securities

As of December 31, 2024:

CRH SMW Finance Designated Activity Company, an indirect wholly owned finance subsidiary

of CRH public limited company that is incorporated under the laws of Ireland, is the issuer of the

following securities, which are fully and unconditionally guaranteed by CRH public limited

company:

•5.200% Guaranteed Notes due 2029

CRH America, Inc., a wholly owned consolidated subsidiary of CRH public limited company that

is incorporated under the laws of the State of Delaware, is the issuer of the following securities,

which are fully and unconditionally guaranteed by CRH public limited company:

•6.400% Notes due 2033

CRH America Finance, Inc., an indirect wholly owned finance subsidiary of CRH public limited

company that is incorporated under the laws of the State of Delaware, is the issuer of the

following securities, which are fully and unconditionally guaranteed by CRH public limited

company:

•5.400% Guaranteed Notes due 2034

Exhibit 23.1 - Consent of Independent Registered Public Accounting Firm - Deloitte Ireland LLP (2024) Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in (i) Registration Statement No. 333-279349 on Form S-3

of CRH plc, CRH America Finance, Inc. and CRH SMW Finance Designated Activity Company, (ii)

Registration Statement No. 333-273244 on Form F-3 of CRH plc, CRH America, Inc. and CRH America

Finance, Inc., and (iii) Registration Statements Nos. 333-90808, 333-165870, 333-173246, 333-202772,

and 333-274148 on Form S-8 of CRH plc, of our reports dated February 26, 2025, relating to the financial

statements of CRH plc and the effectiveness of CRH plc’s internal control over financial reporting

appearing in this Annual Report on Form 10-K for the year ended December 31, 2024.

/s/ Deloitte Ireland LLP

Dublin, Ireland

February 26, 2025

Exhibit 31.1 - Section 302 Certification (CEO) 2024 EXHIBIT 31.1

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, J. Mintern, certify that:

(1) I have reviewed this annual report on Form 10-K of CRH public limited company;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such statements were

made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly

present in all material respects the financial condition, results of operations and cash flows of the registrant as of,

and for, the periods presented in this report;

(4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls

and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial

reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to

be designed under our supervision, to ensure that material information relating to the registrant, including

its consolidated subsidiaries, is made known to us by others within those entities, particularly during the

period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial

reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of

financial reporting and the preparation of financial statements for external purposes in accordance with

generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this

report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the

period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that

occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case

of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s

internal control over financial reporting; and

(5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal

control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of

directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over

financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,

summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a

significant role in the registrant’s internal control over financial reporting.

Date: February 26, 2025
Signature:	/s/ J. Mintern
	J. Mintern
Title:	Director and Chief Executive Officer

Exhibit 31.2 - Section 302 Certification (CFO) 2024 EXHIBIT 31.2

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, A. Connolly, certify that:

(1) I have reviewed this annual report on Form 10-K of CRH public limited company;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a

material fact necessary to make the statements made, in light of the circumstances under which such statements were

made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly

present in all material respects the financial condition, results of operations and cash flows of the registrant as of,

and for, the periods presented in this report;

(4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls

and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial

reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to

be designed under our supervision, to ensure that material information relating to the registrant, including

its consolidated subsidiaries, is made known to us by others within those entities, particularly during the

period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial

reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of

financial reporting and the preparation of financial statements for external purposes in accordance with

generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this

report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the

period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that

occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case

of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s

internal control over financial reporting; and

(5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal

control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of

directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over

financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process,

summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a

significant role in the registrant’s internal control over financial reporting.

Date: February 26, 2025
Signature:	/s/ A. Connolly
	A. Connolly
Title:	Interim Chief Financial Officer

Exhibit 32.1 - Section 906 Certification (CEO) 2024 EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of CRH public limited company (the “Company”) on Form 10-K for the year

ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”),

I, J. Mintern, Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of

2002, that:

1	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of<br><br>1934; and
2	The information contained in the Report fairly presents, in all material respects, the financial condition and<br><br>results of operations of the Company.
---	---
Signature:	/s/ J. Mintern
---	---
	J. Mintern
	Director and Chief Executive Officer<br><br>February 26, 2025

Exhibit 32.2 - Section 906 Certification (CFO) 2024 EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of CRH public limited company (the “Company”) on Form 10-K for the year

ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”),

I, A. Connolly, Interim Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-

Oxley Act of 2002, that:

1	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of<br><br>1934; and
2	The information contained in the Report fairly presents, in all material respects, the financial condition and<br><br>results of operations of the Company.
---	---
Signature:	/s/ A. Connolly
---	---
	A. Connolly
	Interim Chief Financial Officer<br><br>February 26, 2025

Exhibit 95.1 - Disclosure of MSHA Safety Data 2024 Exhibit 95.1

Disclosure of Mine Safety and Health Administration (“MSHA”) Safety Data

CRH is committed to the health and safety of its employees and to providing an incident free workplace. The Company maintains a comprehensive health and safety

program that includes extensive training for all employees and contractors, site inspections, emergency response preparedness, crisis communications training,

incident investigation, regulatory compliance training and process auditing.

CRH’s US aggregate quarry and mine operations are subject to Mine Safety and Health Administration (MSHA) regulation under the Federal Mine Safety and

Health Act of 1977 (the “Mine Act”). MSHA inspects our mines on a regular basis and issues various citations and orders when it believes a violation has occurred

under the Mine Act. Whenever MSHA issues a citation or order, it also generally proposes a civil penalty, or fine, related to the alleged violation.

During the year ended December 31, 2024, two of our mining operations received orders under section 104(b); one of our mining operations received an order

under section 107(a); none of our mining operations received written notice from MSHA of a flagrant violation under section 110(b)(2), notice of pattern of

violations under section 104(e) or potential to have pattern under section 104(e) of the Mine Act. For the year ended December 31, 2024, we experienced one

fatality at our East Quarry mine (Mine ID 3400050).

The information in the table below reflects citations and orders MSHA issued to CRH during the year ended December 31, 2024, as reflected in our records. The

data in our system may not match or reconcile with the data MSHA maintains on its public website. In evaluating this information, consideration should also be

given to factors such as: (i) the number of citations and orders may vary depending on the size and operation of the mine; (ii) the number of citations issued may

vary from inspector to inspector and mine to mine; and (iii) citations and orders may be contested and appealed, and in that process, may be reduced in severity and

amount, and may be dismissed.

Mine ID (1)	Mine Name or Operating Name (2)	Section 104(a)<br><br>Significant and<br><br>Substantial<br><br>Citations (3)	Section<br><br>104(b)<br><br>Orders<br><br>(4)	Section<br><br>104(d)<br><br>Citations<br><br>and Orders<br><br>(5)	Section<br><br>107(a)<br><br>Orders<br><br>(6)	Received<br><br>Notice of<br><br>Pattern of<br><br>Violations<br><br>Under Section<br><br>104(e) yes/no<br><br>(7)	Received Notice<br><br>of Potential to<br><br>Have Pattern of<br><br>Violation Under<br><br>Section 104(e)<br><br>yes/no (8)	Proposed<br><br>MSHA<br><br>Assessments<br><br>(Dollar value in<br><br>thousands) (9)	Pending<br><br>Legal<br><br>Actions<br><br>(10)	Legal<br><br>Actions<br><br>Initiated<br><br>During<br><br>Period	Legal<br><br>Actions<br><br>Resolved<br><br>During<br><br>Period
102140	Alexander City	0	0	0	0	no	no	0.147	0	0	0
102727	Tarrant Quarry	0	0	0	0	no	no	0	0	0	0
102822	P & R Mining	0	0	0	0	no	no	0	0	0	0
102959	Sand Plant #131	0	0	0	0	no	no	0	0	0	0
103083	Opelika Quarry	0	0	0	0	no	no	0	0	0	0
103138	Plant 73201	0	0	0	0	no	no	0	0	0	0
103264	Wedowee Quarry	0	0	0	0	no	no	0	0	0	0
103380	Calera	0	0	0	0	no	no	0.441	0	0	0
200181	Darling Mine	0	0	0	0	no	no	0	0	0	0
202450	Young Block 1	0	0	0	0	no	no	0	0	0	0
300005	Alma Quarry & Plant Or Alma Quarry<br><br>& Mil	0	0	0	0	no	no	0	0	0	0
300039	WEST FORK QUARRY & PLANT	0	0	0	0	no	no	0	0	0	0
300040	Valley Springs Quarry	0	0	0	0	no	no	0.167	0	0	0
300256	Foreman Quarry & Plant	37	0	0	0	no	no	150.142	4	3	1
---	---	---	---	---	---	---	---	---	---	---	---
300379	Arkhola Dredge & Plant	0	0	0	0	no	no	0.882	0	0	0
300409	Pyatt Sand Plant	0	0	0	0	no	no	0	0	0	0
300429	Jenny Lind Quarry	0	0	0	0	no	no	0	0	0	0
300437	Avoca Quarry & Plant	0	0	0	0	no	no	0.294	0	0	0
301462	Preston Quarry	0	0	0	0	no	no	0.147	0	0	0
301576	FORT SMITH SAND PLT	0	0	0	0	no	no	0	0	0	0
301583	Sharps Quarry & Plant	1	0	0	0	no	no	0.492	0	0	0
301653	EVERTON SAND QUARRY	0	0	0	0	no	no	0	0	0	0
301695	Berryville Plant	0	0	0	0	no	no	0	0	0	0
301711	Portable Crusher	0	0	0	0	no	no	0	0	0	0
301714	Mountain Home Materials Sand Plant	2	0	0	0	no	no	1.821	0	0	0
301807	Hindsville Quarry & Plant	0	0	0	0	no	no	0.356	0	0	0
301808	APAC (BIRDEYE LOCATION)	0	0	0	0	no	no	0	0	0	0
301895	North Harrison Quarry	0	0	0	0	no	no	0.147	0	0	0
301899	Portable #1 Plant 1313	0	0	0	0	no	no	0	0	0	0
301908	Mountain Home Materials Quarry	0	0	0	0	no	no	0.588	0	0	0
301921	Portable #2 Plant 1400	0	0	0	0	no	no	0	0	0	0
301930	North Custer Quarry	0	0	0	0	no	no	0	0	0	0
301948	White Oaks Sand & Gravel	0	0	0	0	no	no	0	0	0	0
301974	Midland Quarry	0	0	0	0	no	no	0.294	0	0	0
302012	Gravette Quarry	0	0	0	0	no	no	0	0	0	0
302014	Bonanza Quarry	0	0	0	0	no	no	0	0	0	0
302018	Hard Rock Quarry	1	0	0	0	no	no	0.147	0	0	0
302061	1316	0	0	0	0	no	no	0	0	0	0
400021	San Rafael Rock Quarry	0	0	0	0	no	no	0	0	0	0
400276	Blue Rock Quarry	0	0	0	0	no	no	0	0	0	0
400600	Mark West Quarry	0	0	0	0	no	no	0	0	0	0
500967	SP1	0	0	0	0	no	no	0	0	0	0
500977	Mackenzie Pit	0	0	0	0	no	no	0	0	0	0
501050	WP1	0	0	0	0	no	no	0	0	0	0
502140	CALHOUN-EATON PIT	0	0	0	0	no	no	0	0	0	0
503007	Ralston Quarry	0	0	0	0	no	no	0.294	0	0	0
503178	CO Crusher	0	0	0	0	no	no	0	0	0	0
503422	Specialty Crusher	0	0	0	0	no	no	0	0	0	0
503510	Portable Wash Plant (WP #4)	0	0	0	0	no	no	0	0	0	0
503808	Portable Crusher #2	0	0	0	0	no	no	1.368	0	0	0
503850	CR2	0	0	0	0	no	no	0	0	0	0
503888	Hidden Valley Plant	0	0	0	0	no	no	0	0	0	0
504037	CURSHER UNIT #2	0	0	0	0	no	no	0	0	0	0
504119	FCM Rental Crusher	0	0	0	0	no	no	0	0	0	0
504131	150-3 TRIMBLE/TAULLI	0	0	0	0	no	no	0	0	0	0
504231	CR3	0	0	0	0	no	no	0	0	0	0
504356	FCM Crusher 4 (CSP#4)	0	0	0	0	no	no	0	0	0	0
504432	MONTGOMERY PIT	0	0	0	0	no	no	0	0	0	0
504484	Scott Pit	0	0	0	0	no	no	0	0	0	0
504549	WP 3	0	0	0	0	no	no	0.164	0	0	0
504552	Portable Screen Plant #1	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
504571	PORTABLE PLANT #1	0	0	0	0	no	no	0	0	0	0
504585	WP2	0	0	0	0	no	no	1.229	0	0	0
504624	SP 2	0	0	0	0	no	no	0	0	0	0
504641	Milner Pit	0	0	0	0	no	no	0	0	0	0
504656	CR4	0	0	0	0	no	no	0.164	0	0	0
504706	Portable Crusher #3	0	0	0	0	no	no	0	0	0	0
504739	CR5	0	0	0	0	no	no	0.164	0	0	0
504740	CR6	0	0	0	0	no	no	0.164	0	0	0
504741	SP3	0	0	0	0	no	no	0	0	0	0
504794	WP4	0	0	0	0	no	no	0	0	0	0
504832	Wash Plant #5	0	0	0	0	no	no	0.328	0	0	0
504834	SP4	0	0	0	0	no	no	0.328	0	0	0
504835	CR7	0	0	0	0	no	no	0.328	0	0	0
504836	CR8	0	0	0	0	no	no	0.312	0	0	0
504854	Portable Crusher #1	0	0	0	0	no	no	0	0	0	0
504858	Hidden Valley Plant	0	0	0	0	no	no	0	0	0	0
504875	Portable Crusher #4	0	0	0	0	no	no	0	0	0	0
504887	CR10	0	0	0	0	no	no	0	0	0	0
504888	CR9	0	0	0	0	no	no	0.164	0	0	0
504937	Portable Deck Screen	0	0	0	0	no	no	0	0	0	0
504999	Wash Plant 2	0	0	0	0	no	no	0	0	0	0
505040	Portable Crusher #6	0	0	0	0	no	no	0	0	0	0
505041	Portable Crusher # 5	0	0	0	0	no	no	0	0	0	0
505116	Kattenberg	0	0	0	0	no	no	0	0	0	0
505117	Portable Crusher #7	0	0	0	0	no	no	0	0	0	0
505121	Portable Wash Plant #3	0	0	0	0	no	no	0	0	0	0
505125	Coaldale	0	0	0	0	no	no	0	0	0	0
505163	Portable Crusher #9	0	0	0	0	no	no	0	0	0	0
600003	Tilcon Newington Quarry	0	0	0	0	no	no	0	0	0	0
600012	North Branford Quarry	0	0	0	0	no	no	0	0	0	0
600013	Wallingford Quarry	1	0	0	0	no	no	0	0	0	0
600015	Wauregan Quarry	0	0	0	0	no	no	0	0	0	0
600022	New Britain Quarry	0	0	0	0	no	no	0	0	0	0
600224	Tilcon Manchester Quarry	0	0	0	0	no	no	0	0	0	0
600251	Granby Notch Pit	0	0	0	0	no	no	0	0	0	0
600345	Southington Pit & Plant	0	0	0	0	no	no	0	0	0	0
600654	Griswold Sand & Gravel	0	0	0	0	no	no	0	0	0	0
600677	Montville Plant	0	0	0	0	no	no	0	0	0	0
600680	Groton Plant	0	0	0	0	no	no	0	0	0	0
600715	Fab Tec	0	0	0	0	no	no	0	0	0	0
600723	Power Screen Warrior	0	0	0	0	no	no	0	0	0	0
600810	Powerscreen Warrior 43.566616	0	0	0	0	no	no	0	0	0	0
600812	Powerscreen Chieftain 88.574023	0	0	0	0	no	no	0	0	0	0
700059	Bay Road Plant #7	0	0	0	0	no	no	0.147	0	0	0
700093	Tarburton Pit	0	0	0	0	no	no	0	0	0	0
700103	PLANT NO. 701	0	0	0	0	no	no	0	0	0	0
800526	Golden Gate Quarry	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
800995	Suwannee American Cement	0	0	0	0	no	no	0	0	0	0
801243	Laurel Shell Pit	0	0	0	0	no	no	0	0	0	0
801318	Suwannee American Cement	0	0	0	0	no	no	7.26	0	0	0
801340	CYD Cabbage Grove	1	1	0	0	no	no	1.978	0	0	0
801355	Sumterville Mine	0	0	0	0	no	no	0	0	0	0
801370	Sumterville Cement Plant	1	0	0	0	no	no	0.441	0	0	0
801408	Conrad Mine	0	0	0	0	no	no	0	0	0	0
900022	Galite #1	0	0	0	0	no	no	0	0	0	0
900305	Rossville Quarry	0	0	0	0	no	no	0	0	0	0
901024	Cartersville	0	0	0	0	no	no	0	0	0	0
901035	Forsyth Quarry	0	0	0	0	no	no	0	0	0	0
901039	Ringgold Quarry	0	0	0	0	no	no	0	0	0	0
901046	Harrison Chester White Quarry	0	0	0	0	no	no	0	0	0	0
901152	Mulberry Quarry	0	0	0	0	no	no	0.189	0	0	0
901169	Lithonia Quarry	0	0	0	0	no	no	0	0	0	0
901204	Warren County Quarry	0	0	0	0	no	no	0.68	0	0	0
1000006	Inkom Plant	0	0	0	0	no	no	0	0	0	0
1000099	Fan Claim	0	0	0	0	no	no	0	0	0	0
1000310	COEUR D'ALENE-PRE MIX #4	0	0	0	0	no	no	0	0	0	0
1000313	TV Portable Wash Plant #1	0	0	0	0	no	no	0.343	0	0	0
1000326	Mt Home Portable	0	0	0	0	no	no	0	0	0	0
1000343	Kathleen Facility	0	0	0	0	no	no	0	0	0	0
1000373	Pocatello Wash Plant	0	0	0	0	no	no	0.164	0	0	0
1000604	Federal Way Aggregates	0	0	0	0	no	no	0	0	0	0
1000727	Hayden Lake Pit	0	0	0	0	no	no	0	0	0	0
1000740	Eagle Pit	0	0	0	0	no	no	0	0	0	0
1000791	Newport	0	0	0	0	no	no	0	0	0	0
1000876	St Clair Pit	0	0	0	0	no	no	0	0	0	0
1000884	Oldcastle Infrastructure Idaho Falls	0	0	0	0	no	no	0	0	0	0
1001014	Coeur D Alene Pit	0	0	0	0	no	no	0	0	0	0
1001022	Moen Pit	0	0	0	0	no	no	0	0	0	0
1001253	Wilford Pit	0	0	0	0	no	no	0	0	0	0
1001304	Fr 52-S Pit	0	0	0	0	no	no	0	0	0	0
1001326	133 Portable Crusher	0	0	0	0	no	no	0.492	0	0	0
1001327	State Pit Bg-68-S	0	0	0	0	no	no	0	0	0	0
1001363	Cottonwood Pit	0	0	0	0	no	no	0	0	0	0
1001637	Pearl Pit	0	0	0	0	no	no	0	0	0	0
1001673	Dingle Pit	0	0	0	0	no	no	0	0	0	0
1001704	Treasure Valley Portable #1	0	0	0	0	no	no	0	0	0	0
1001709	Rental Portable Screen Plant	0	0	0	0	no	no	0	0	0	0
1001728	Portable #1	0	0	0	0	no	no	0	0	0	0
1001729	PORTABLE PLANT #2	0	0	0	0	no	no	0	0	0	0
1001742	Treasure Valley Portable #2	0	0	0	0	no	no	0	0	0	0
1001750	Amcor Albino Claim	0	0	0	0	no	no	0	0	0	0
1001818	TV Plant #001295	0	0	0	0	no	no	0	0	0	0
1001828	Portable #2	0	0	0	0	no	no	0	0	0	0
1001884	ICA Portable Crusher	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
1001892	134 Crusher H-K Portable Plant	0	0	0	0	no	no	0.164	0	0	0
1001912	Wyoming Facility	0	0	0	0	no	no	0	0	0	0
1001949	TV Portable Wash Plant #2	0	0	0	0	no	no	0	0	0	0
1001976	Greenleaf	0	0	0	0	no	no	0	0	0	0
1001994	TV Plant #001286	0	0	0	0	no	no	0	0	0	0
1002018	Post Falls Quarry	0	0	0	0	no	no	0	0	0	0
1002035	Summit Stone Portable	0	0	0	0	no	no	0	0	0	0
1002055	Richfield Pit	0	0	0	0	no	no	0	0	0	0
1002107	132 Portable Crusher	0	0	0	0	no	no	0.343	0	0	0
1002142	Portable Wash Plant  #1	0	0	0	0	no	no	0	0	0	0
1002191	Pep Screen / Spray bars	0	0	0	0	no	no	0	0	0	0
1002213	Portable Plant 130	0	0	0	0	no	no	0	0	0	0
1002222	1700 Trac Screening Plant	0	0	0	0	no	no	0	0	0	0
1002322	IMC Pocatello Portable Screening<br><br>Plant	0	0	0	0	no	no	0	0	0	0
1100176	J-Plant	0	0	0	0	no	no	0	0	0	0
1102750	Dallas City Quarry	0	0	0	0	no	no	0	0	0	0
1200058	Bryant Quarry	0	0	0	0	no	no	0	0	0	0
1200083	Eckerty Quarry	0	0	0	0	no	no	0	0	0	0
1200084	Cape Sandy #1	21	1	2	1	no	no	119.913	1	2	1
1200085	Derby Quarry	0	0	0	0	no	no	0	0	0	0
1200654	Evansville Mill	0	0	0	0	no	no	0	0	0	0
1200839	Temple Quarry	0	0	0	0	no	no	0.147	0	0	0
1200890	Griffin Plant	0	0	0	0	no	no	0.588	0	0	0
1200914	Stoneco Angola Pit	0	0	0	0	no	no	0.147	0	0	0
1201389	Rockport #15 Dredge	0	0	0	0	no	no	0	0	0	0
1201397	Derby Underground Mine	0	0	0	0	no	no	0	0	0	0
1201423	Derby Slope Mine	0	0	0	0	no	no	0	0	0	0
1201438	Tower Quarry	0	0	0	0	no	no	0.147	1	1	0
1201713	Eckerty Underground Mine	0	0	0	0	no	no	0	0	0	0
1201720	Charlestown Quarry	0	0	0	0	no	no	0	0	0	0
1201784	Cape Sandy #2	0	0	0	0	no	no	0	0	0	0
1201917	Temple Underground	0	0	0	0	no	no	0	0	0	0
1202100	Mill Creek Quarry	0	0	0	0	no	no	0	0	0	0
1202119	Mount Vernon Pit	0	0	0	0	no	no	0	0	0	0
1202129	I-69 Sand Pit	0	0	0	0	no	no	0	0	0	0
1202192	Abydel Quarry	0	0	0	0	no	no	0	0	0	0
1202236	New Amsterdam Quarry	0	0	0	0	no	no	0.441	1	1	0
1202332	London Aggregates Portable #1	0	0	0	0	no	no	0	0	0	0
1202379	Cape Sandy Underground	0	0	0	0	no	no	0	0	0	0
1202380	Newburgh Yard	0	0	0	0	no	no	0	0	0	0
1300181	Nelson Quarry	0	0	0	0	no	no	0	0	0	0
1300183	Heinold Quarry	0	0	0	0	no	no	0	0	0	0
1300185	Sullivan Slough	0	0	0	0	no	no	0	0	0	0
1300186	Geode Shop	0	0	0	0	no	no	0	0	0	0
1300187	Argyle Quarry	0	0	0	0	no	no	0	0	0	0
1300221	Camanche Quarry	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
1300395	Cedar Creek Quarry	0	0	0	0	no	no	0	0	0	0
1300620	Emmetsburg Pit	0	0	0	0	no	no	0	0	0	0
1300645	PWP #3	0	0	0	0	no	no	0.147	0	0	0
1300653	Commerce Pit	0	0	0	0	no	no	0	0	0	0
1300766	Spring Sand Plant	0	0	0	0	no	no	0	0	0	0
1300919	PWP #6	0	0	0	0	no	no	0	0	0	0
1300921	Vandalia Rd Plant	0	0	0	0	no	no	0	0	0	0
1300999	Portable  #3	0	0	0	0	no	no	0	0	0	0
1301000	Lake View Shop	0	0	0	0	no	no	0	0	0	0
1301019	Ames Plant	0	0	0	0	no	no	0	0	0	0
1301050	PCP #5	0	0	0	0	no	no	0	0	0	0
1301053	PWP #2	0	0	0	0	no	no	0	0	0	0
1301202	North Des Moines Plant	0	0	0	0	no	no	0	0	0	0
1301429	Le Grand/Quarry	0	0	0	0	no	no	0	0	0	0
1301502	Vincennes Sand Pit	0	0	0	0	no	no	0	0	0	0
1301514	J-Plant (Portable)	0	0	0	0	no	no	0	0	0	0
1301706	Booneville Plant	0	0	0	0	no	no	0	0	0	0
1301732	Donnellson Quarry	0	0	0	0	no	no	0	0	0	0
1301825	Stripping  #1	0	0	0	0	no	no	0	0	0	0
1301880	CHEROKEE NORTH	0	0	0	0	no	no	0	0	0	0
1302045	PCP #6	0	0	0	0	no	no	0	0	0	0
1302050	Fast Trax	0	0	0	0	no	no	0	0	0	0
1302056	Plant No 3	0	0	0	0	no	no	0	0	0	0
1302079	PCP #9	0	0	0	0	no	no	0	0	0	0
1302145	PWP #1	0	0	0	0	no	no	0	0	0	0
1302149	Fostoria Plant	0	0	0	0	no	no	0	0	0	0
1302151	Geode Wash Plant	0	0	0	0	no	no	0	0	0	0
1302176	PWP #4	0	0	0	0	no	no	0	0	0	0
1302177	Port. Plant #7 & #2 Stripping Crew	0	0	0	0	no	no	0	0	0	0
1302189	Stripping #2	0	0	0	0	no	no	0	0	0	0
1302190	PRP #5	0	0	0	0	no	no	0.319	0	0	0
1302210	PORTABLE WASH PLANT #2	0	0	0	0	no	no	0	0	0	0
1302218	PCP #7	0	0	0	0	no	no	0	0	0	0
1302240	PCP #2	0	0	0	0	no	no	0	0	0	0
1302248	Stripping Crew #3	0	0	0	0	no	no	0	0	0	0
1302293	Portable Screen #1	0	0	0	0	no	no	0	0	0	0
1302294	Portable Screen Plant #2	0	0	0	0	no	no	0	0	0	0
1302300	PCP #4	0	0	0	0	no	no	0	0	0	0
1302306	Pleasant Hill	0	0	0	0	no	no	0	0	0	0
1302311	PSP #3	0	0	0	0	no	no	0	0	0	0
1302313	PSP #4	0	0	0	0	no	no	0	0	0	0
1302321	PSP #5	0	0	0	0	no	no	0	0	0	0
1302322	PSP #6	0	0	0	0	no	no	0	0	0	0
1302323	Portable Stripping # 2	0	0	0	0	no	no	0	0	0	0
1302324	PSP #8	0	0	0	0	no	no	0	0	0	0
1302327	Van Meter Pit	0	0	0	0	no	no	0	0	0	0
1302328	Stripping Crew #3	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
1302329	Portable Wash Plant #7	0	0	0	0	no	no	0	0	0	0
1302331	PSP #8	0	0	0	0	no	no	0	0	0	0
1302336	PWP #8	0	0	0	0	no	no	0	0	0	0
1302342	OMG Midwest Shop	0	0	0	0	no	no	0	0	0	0
1302360	Burlington Shop	0	0	0	0	no	no	0	0	0	0
1302366	Old Johnston Pit	0	0	0	0	no	no	0	0	0	0
1302370	A-Plant	0	0	0	0	no	no	0.494	0	0	0
1302389	Hawkeye Quarry Shop	0	0	0	0	no	no	0	0	0	0
1302394	Lake View  Boyer	0	0	0	0	no	no	0	0	0	0
1302397	Portable Stripping	0	0	0	0	no	no	0	0	0	0
1302503	Booneville West Plant	0	0	0	0	no	no	0.147	0	0	0
1400034	CHANUTE QUARRY	9	0	1	0	no	no	61.863	1	2	4
1400068	Johnson County Aggregates	0	0	0	0	no	no	0	0	0	0
1400149	Stanley Quarry	0	0	0	0	no	no	0	0	0	0
1400492	Edwardsville Shop & Plant #4	0	0	0	0	no	no	0	0	0	0
1400494	Shawnee-Plant #2	0	0	0	0	no	no	0	0	0	0
1400501	HUTCHINSON SAND PLANT	0	0	0	0	no	no	0.672	0	0	0
1400660	HAYS PIT NO A-2	0	0	0	0	no	no	0	0	0	0
1400699	QUARTZITE QUARRY	0	0	0	0	no	no	2.241	0	0	0
1401180	LA CYGNE PLANT	0	0	0	0	no	no	0	0	0	0
1401207	Fulton Pit	0	0	0	0	no	no	0	0	0	0
1401255	Hays Pit No A-1	0	0	0	0	no	no	0	0	0	0
1401276	HAYS PIT NO A-3	0	0	0	0	no	no	0	0	0	0
1401326	Cedarapids 1 Portable Plant	0	0	0	0	no	no	0	0	0	0
1401334	HARTFORD QUARRY	0	0	0	0	no	no	0	0	0	1
1401346	KRAUS PIT	0	0	0	0	no	no	0	0	0	0
1401377	WICHITA SAND PLANT	0	0	0	0	no	no	0	0	0	0
1401425	Bieker Pit	0	0	0	0	no	no	0	0	0	0
1401441	Dodge City Sand Plant	0	0	0	0	no	no	0	0	0	0
1401460	CULLOR PORTABLE	0	0	0	0	no	no	0	0	0	0
1401468	FALL RIVER QUARRY	0	0	0	0	no	no	0	0	0	0
1401484	Bonner Springs-Plant #7	0	0	0	0	no	no	0	0	0	0
1401486	HAYS PORTABLE PLANT #1	0	0	0	0	no	no	0	0	0	0
1401524	Shawnee Quarry	0	0	0	0	no	no	0	0	0	0
1401564	Universal Portable Plant	0	0	0	0	no	no	0	0	0	0
1401578	Bonner Springs Quarry	0	0	0	0	no	no	0.497	0	0	0
1401591	CEDAR CREEK PORTABLE	0	0	0	0	no	no	0	0	0	0
1401636	Gardner	0	0	0	0	no	no	0	0	0	0
1401638	HAYS BRANCH PORTABLE 2	0	0	0	0	no	no	0	0	0	0
1401639	Moore Pit	0	0	0	0	no	no	0	0	0	0
1401640	Rental Plant	0	0	0	0	no	no	0	0	0	0
1401643	Pleasanton	0	0	0	0	no	no	0	0	0	0
1401646	HSS Q Portable Plant 1	0	0	0	0	no	no	0.147	0	0	0
1401649	Hays Portable Plant #3	0	0	0	0	no	no	0	0	0	0
1401669	Leiker Pit	0	0	0	0	no	no	0	0	0	0
1401680	Batesco Portable	0	0	0	0	no	no	0	0	0	0
1401684	Dodge City Portable	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
1401823	HSS Q Portable Plant 4	0	0	0	0	no	no	0	0	0	0
1500001	Valley Stone	2	0	0	0	no	no	1.981	0	0	0
1500004	Bassett Stone Company	0	0	0	0	no	no	0	0	0	0
1500012	Casey Stone Company	0	0	0	0	no	no	0	0	0	0
1500019	Tipton Ridge Quarry	0	0	0	0	no	no	0	0	0	0
1500048	Yellow Rock Quarry	0	0	0	0	no	no	0	0	0	0
1500056	Pine Mountain Stone	2	0	0	0	no	no	2.409	0	0	0
1500075	Natural Bridge Stone	3	0	0	0	no	no	2.246	0	0	0
1500081	Riverside Stone	0	0	0	0	no	no	0	0	0	0
1500094	Somerset Stone Company	0	0	0	0	no	no	0.294	0	0	0
1500098	Carter City	0	0	0	0	no	no	0	0	0	0
1500099	Lake Cumberland Stone	0	0	0	0	no	no	0	0	0	0
1500213	Elkhorn  Stone	0	0	0	0	no	no	0.294	0	0	0
1504261	Glass Sand & Gravel	0	0	0	0	no	no	0	0	0	0
1504272	DON C. RUSHING	0	0	0	0	no	no	0	0	0	0
1504600	Chintown Quarry	0	0	0	0	no	no	0	0	0	0
1507194	Cave Run Stone	0	0	0	0	no	no	0	0	0	0
1512148	Ogden Branch Stone	0	0	0	0	no	no	0	0	0	0
1516662	Pineville Quarry	0	0	0	0	no	no	0	0	0	0
1517102	Casey Stone Company	0	0	0	0	no	no	0	0	0	0
1517312	Grassy Stone	0	0	0	0	no	no	0	0	0	0
1517345	Barren East Stone	0	0	0	0	no	no	0	0	0	0
1517601	Tipton Ridge Quarry	0	0	0	0	no	no	0	0	0	0
1518079	PULASKI STONE COMPANY	0	0	0	0	no	no	0	0	0	0
1518251	HAMILTON STONE	0	0	0	0	no	no	0	0	0	0
1518415	Bourbon Limestone Company	0	0	0	0	no	no	0.809	0	0	0
1518549	Riverside Stone	0	0	0	0	no	no	0.588	0	0	0
1518712	Glasgow Quarry Pit #2	0	0	0	0	no	no	0	0	0	0
1519092	PULASKI STONE COMPANY	0	0	0	0	no	no	0	0	0	0
1519543	Brushy Creek Stone	0	0	0	0	no	no	0	0	0	0
1601177	Franklinton Crusher Plant	0	0	0	0	no	no	0	0	0	0
1601463	Frazier Gravel Pit	0	0	0	0	no	no	0	0	0	0
1601484	GRAVEL PIT PONDER	0	0	0	0	no	no	0	0	0	0
1601530	NSA Wet Plant	0	0	0	0	no	no	0.147	0	0	0
1601592	Barriere West	0	0	0	0	no	no	0.413	0	0	0
1700001	Westbrook Quarry & Mill	0	0	0	0	no	no	0	0	0	0
1700002	C636-Sidney Crushing Facility	1	0	0	0	no	no	0.351	0	0	0
1700114	Leeds Sand & Gravel C640	0	0	0	0	no	no	0	0	0	0
1700123	Cumberland Sand & Gravel C626	0	0	0	0	no	no	0	0	0	0
1700154	Wash Plant C611	0	0	0	0	no	no	0	0	0	0
1700218	Wells Quarry C624	3	0	0	0	no	no	2.323	0	0	0
1700310	NORTH WATERFORD PIT & MILL	0	0	0	0	no	no	0	0	0	0
1700443	Portable Crusher C621	0	0	0	0	no	no	0	0	0	0
1700582	Poland Crushed Stone C610	0	0	0	0	no	no	0	0	0	0
1700583	Crusher C608 (Portable)	0	0	0	0	no	no	0	0	0	0
1700603	C637-Dover-Foxcroft	0	0	0	0	no	no	0	0	0	0
1700605	Keller Pit C625	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
1700608	Pike Industries Incorporated X718	0	0	0	0	no	no	0	0	0	0
1700621	PORTABLE SANDSCREEN C657	0	0	0	0	no	no	0	0	0	0
1700625	PIKE INDUSTRIES, INC. C614	0	0	0	0	no	no	0	0	0	0
1700626	PORTABLE SANDSCREEN C655	0	0	0	0	no	no	0	0	0	0
1700666	Pike Industries	0	0	0	0	no	no	0	0	0	0
1700681	Manzer Pit	0	0	0	0	no	no	0	0	0	0
1700722	Portable Sand Screen 001692	0	0	0	0	no	no	0	0	0	0
1700757	C637 PORTABLE SAND SCREEN	0	0	0	0	no	no	0	0	0	0
1700758	C641 PORTABLE CRUSHER	0	0	0	0	no	no	0	0	0	0
1700783	PEP #8 Portable Sand Screen	0	0	0	0	no	no	0	0	0	0
1700794	Spring St Quarry C606	0	0	0	0	no	no	0	0	0	0
1700839	Newry Pit	0	0	0	0	no	no	0	0	0	0
1700866	Prospect Quarry-C646	0	0	0	0	no	no	0	0	0	0
1700877	New Vineyard	1	0	0	0	no	no	0	0	0	0
1700910	Windsor, ME Pit	0	0	0	0	no	no	0	0	0	0
1700925	Pike Washington	0	0	0	0	no	no	0	0	0	0
1700946	Pike Industries Inc-C647	0	0	0	0	no	no	0	0	0	0
1700959	Varney Mill C641	0	0	0	0	no	no	0	0	0	0
1701036	Crusher C664	0	0	0	0	no	no	0	0	0	0
1900007	Dracut Plant	0	0	0	0	no	no	0	0	0	0
1900018	Oldcastle Lawn and Garden Northeast	4	0	0	0	no	no	5.549	0	0	0
1900046	Acushnet Quarry	0	0	0	0	no	no	0	0	0	0
1900075	Keating Quarry and Mill	0	0	0	0	no	no	7.714	1	1	0
1900308	Bushika Sand & Gravel Inc	0	0	0	0	no	no	0	0	0	0
1900338	Monson Sand & Gravel	0	0	0	0	no	no	0	0	0	0
1900469	Pittsfield Sand and Gravel Inc	0	0	0	0	no	no	0	0	0	0
1900578	FOSTER/SOUTHEASTERN	0	0	0	0	no	no	0	0	0	0
1901045	Southwick Sand & Gravel	0	0	0	0	no	no	0	0	0	0
2000041	Ottawa Lake Quarry	0	0	0	0	no	no	0	0	0	0
2000042	Maybee Quarry	0	0	0	0	no	no	0.147	0	0	0
2001751	Coldwater	0	0	0	0	no	no	0	0	0	0
2002035	WOODWORTH PIT	0	0	0	0	no	no	0	0	0	0
2002524	Stoneco Burmeister	0	0	0	0	no	no	0	0	0	0
2002595	100th Street	0	0	0	0	no	no	0	0	0	0
2002812	Stoneco Zeeb West	0	0	0	0	no	no	0.294	0	0	0
2002835	London Aggregates-Milan	0	0	0	0	no	no	0	0	0	0
2002890	Stoneco Southwest Gravel	0	0	0	0	no	no	0	0	0	0
2002902	Newport	0	0	0	0	no	no	0.147	0	0	0
2002927	Stoneco Portable #1	0	0	0	0	no	no	0	0	0	0
2002934	Denniston Quarry	0	0	0	0	no	no	0.441	0	0	0
2002949	Zeeb Road	0	0	0	0	no	no	0	0	0	0
2002995	Patterson Road	0	0	0	0	no	no	0	0	0	0
2003001	T.M. DEVELOPMENT "87"	0	0	0	0	no	no	0	0	0	0
2003004	T.M. DEVELOPMENT	0	0	0	0	no	no	0	0	0	0
2003008	Stoneco Sturgis Wash Plant	0	0	0	0	no	no	0	0	0	0
2003051	Stoneco Portable Plant	0	0	0	0	no	no	0.294	0	0	0
2003085	Stoneco Portable #2	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
2003090	Moscow	0	0	0	0	no	no	0.147	0	0	0
2003538	Stoneco Portable #3	0	0	0	0	no	no	0	0	0	0
2003587	Stoneco Finlay Plant	0	0	0	0	no	no	0	0	0	0
2100056	#4093 Eljay Crusher Jefferson	0	0	0	0	no	no	0	0	0	0
2100521	#0521 Guaranteed Wash Plant	0	0	0	0	no	no	0	0	0	0
2100579	Medford Wash Plant	0	0	0	0	no	no	0	0	0	0
2100608	Rosemount Pit	0	0	0	0	no	no	0	0	0	0
2100789	00801	1	0	0	0	no	no	0.453	0	0	0
2100876	#0876 Dundas Wash Plant	0	0	0	0	no	no	0	0	0	0
2101578	Portable Cedar Rapids	0	0	0	0	no	no	0	0	0	0
2102956	#2956 Hewitt Robins Crusher	0	0	0	0	no	no	0	0	0	0
2102957	#401 Cedarapids Jaw Crusher-<br><br>Portable	0	0	0	0	no	no	0	0	0	0
2102958	#403 Pioneer Roll Crusher-Portable	0	0	0	0	no	no	0	0	0	0
2102959	972	0	0	0	0	no	no	0.466	0	0	0
2102961	974	0	0	0	0	no	no	0	0	0	0
2102977	Waite Park Pit	0	0	0	0	no	no	0	0	0	0
2103037	1825	0	0	0	0	no	no	0	0	0	0
2103060	#3060 Hewitt Robins Crusher (Kasota)	0	0	0	0	no	no	0	0	0	0
2103061	#408 Superior Wash Plant Hope	0	0	0	0	no	no	0	0	0	0
2103153	Crusher No CR-52	0	0	0	0	no	no	0	0	0	0
2103266	1963	0	0	0	0	no	no	0	0	0	0
2103268	WASH PLANT	0	0	0	0	no	no	0	0	0	0
2103343	PSG Screen	0	0	0	0	no	no	0	0	0	0
2103374	1963	0	0	0	0	no	no	0	0	0	0
2103375	Spokane Crusher	0	0	0	0	no	no	0	0	0	0
2103376	Kolberg Screening Plant	0	0	0	0	no	no	0	0	0	0
2103377	#3377 El Jay Wash Plant	0	0	0	0	no	no	0	0	0	0
2103385	1971	0	0	0	0	no	no	0	0	0	0
2103409	1962	0	0	0	0	no	no	0	0	0	0
2103411	#3411 Kohlman Screen Plant	0	0	0	0	no	no	0	0	0	0
2103413	#3413 Finley Screener	0	0	0	0	no	no	0	0	0	0
2103427	#4098 Lippman Jaw	0	0	0	0	no	no	0	0	0	0
2103432	#99-249 Cedar Rapids Jaw	0	0	0	0	no	no	0	0	0	0
2103483	#3483 Cedar Rapids VSI	0	0	0	0	no	no	0	0	0	0
2103488	1981	0	0	0	0	no	no	0	0	0	0
2103496	#3496 El Jay Cone	0	0	0	0	no	no	0	0	0	0
2103503	01971 C	0	0	0	0	no	no	0	0	0	0
2103504	977	0	0	0	0	no	no	0	0	0	0
2103530	#3530 Hydro Grid Screener	0	0	0	0	no	no	0	0	0	0
2103606	1978	0	0	0	0	no	no	0	0	0	0
2103609	Stripping Crew	0	0	0	0	no	no	0	0	0	0
2103628	1964	0	0	0	0	no	no	0	0	0	0
2103691	El Jay 45 Portable Cone Crusher	0	0	0	0	no	no	0	0	0	0
2103695	Pioneer 2500 Impactor	0	0	0	0	no	no	0	0	0	0
2103714	El Jay Portable 6 x 20 Screener	0	0	0	0	no	no	0	0	0	0
2103741	1976	0	0	0	0	no	no	0.356	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
2103742	01976 W	0	0	0	0	no	no	0	0	0	0
2103864	Stripping crew 2	0	0	0	0	no	no	0	0	0	0
2200103	MOON PLANT	0	0	0	0	no	no	0	0	0	0
2200122	Bowlin Pit	0	0	0	0	no	no	0	0	0	0
2200123	101 Pit	0	0	0	0	no	no	0	0	0	0
2200211	102 Pit	0	0	0	0	no	no	0	0	0	0
2200219	Blackhawk Pit and Plant	0	0	0	0	no	no	0.748	0	0	0
2200348	SPRING COTTAGE	0	0	0	0	no	no	0	0	0	0
2200371	Meeks Pit	0	0	0	0	no	no	0	0	0	0
2200455	Pit No 109	0	0	0	0	no	no	0	0	0	0
2200470	Buckley Pit	0	0	0	0	no	no	0	0	0	0
2200473	Buckley Pit	0	0	0	0	no	no	0	0	0	0
2200493	Vossburg Pit	0	0	0	0	no	no	0.147	0	0	0
2200513	Harris Pit	0	0	0	0	no	no	0	0	0	0
2200526	Harris Pit	0	0	0	0	no	no	0	0	0	0
2200544	Jones Pit	0	0	0	0	no	no	0	0	0	0
2200546	CEDAR GROVE	0	0	0	0	no	no	0	0	0	0
2200554	GREENVILLE CRUSHER	0	0	0	0	no	no	0	0	0	0
2200555	Yazoo Crusher	0	0	0	0	no	no	0	0	0	0
2200556	Tremont Crusher	0	0	0	0	no	no	0	0	0	0
2200559	Mathis Pit	0	0	0	0	no	no	0	0	0	0
2200572	Evans Pit	0	0	0	0	no	no	0	0	0	0
2200604	Corinth Crusher	0	0	0	0	no	no	0	0	0	0
2200606	Vicksburg Crusher	0	0	0	0	no	no	0	0	0	0
2200631	180 Pit	0	0	0	0	no	no	0	0	0	0
2200666	LOTT PIT	0	0	0	0	no	no	0	0	0	0
2200672	Robinson Pit	0	0	0	0	no	no	0	0	0	0
2200674	Sanders Plant	0	0	0	0	no	no	0	0	0	0
2200682	CLOVERHILL	4	0	0	0	no	no	6.471	0	0	0
2200688	Weyerhaeuser/Air Base Plant	0	0	0	0	no	no	0.147	0	0	0
2200696	POLK	0	0	0	0	no	no	0	0	0	0
2200706	BAILEY	0	0	0	0	no	no	0.441	0	0	0
2200717	Scribner Pit	0	0	0	0	no	no	0	0	0	0
2200719	Fuller Pit	0	0	0	0	no	no	0	0	0	0
2200721	THAMES	0	0	0	0	no	no	0	0	0	0
2200740	Coxburg Sand & Gravel	0	0	0	0	no	no	0	0	0	0
2200750	Ford Pit	0	0	0	0	no	no	0	0	0	0
2200764	Sidon Pit	0	0	0	0	no	no	0	0	0	0
2200784	Tremont Pit	0	0	0	0	no	no	0	0	0	0
2200826	Benton Plant	0	0	0	0	no	no	0.221	0	0	0
2200829	Sardis Plant	0	0	0	0	no	no	0.147	0	0	0
2200832	Scooter Mine	0	0	0	0	no	no	0	0	0	0
2200841	Hazlehurst Sand & Gravel	0	0	0	0	no	no	0	0	0	0
2300007	LICAUSI SERVICE CO	0	0	0	0	no	no	0	0	0	0
2300008	SPRINGFIELD SURFACE	0	0	0	0	no	no	0	0	0	0
2300035	Conco Willard Quarries	0	0	0	0	no	no	0.147	0	0	0
2300233	Montrose Quarry	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
2300536	Warsaw Quarry	0	0	0	0	no	no	0	0	0	0
2300695	Randolph Plant #9	1	0	0	0	no	no	0.741	0	0	0
2300696	St Joseph Plant #8	0	0	0	0	no	no	0	0	0	0
2300924	Northwest Mine & Mill	0	0	0	0	no	no	0	0	0	0
2300977	Sand And Gravel Plant	0	0	0	0	no	no	0	0	0	0
2301007	SPRINGFIELD UNDERGROUND	0	0	0	0	no	no	0	0	0	0
2301141	Quarles Quarry	0	0	0	0	no	no	0	0	0	0
2301142	Urich Quarry	0	0	0	0	no	no	0	0	0	0
2301145	Snyder Quarry	0	0	0	0	no	no	0	0	0	0
2301148	Harrisonville Quarry	1	0	0	0	no	no	0.716	0	0	0
2301170	Eagle #2, Portable Plant	0	0	0	0	no	no	0	0	0	0
2301277	K C METRO	0	0	0	0	no	no	0	0	0	0
2301420	D Y L Quarry	0	0	0	0	no	no	0	0	0	0
2301689	D R Crushing	0	0	0	0	no	no	0	0	0	0
2301695	PLANT #4	0	0	0	0	no	no	0	0	0	0
2301778	SHAMROCK AGGREGATES INC	0	0	0	0	no	no	0	0	0	0
2301782	Tightwad Quarry	0	0	0	0	no	no	0	0	0	0
2301871	QUARRY #12	0	0	0	0	no	no	0	0	0	0
2301911	PRESTAGE QY & MAT INC	0	0	0	0	no	no	0	0	0	0
2301915	Portable Plant #1	0	0	0	0	no	no	0	0	0	0
2301918	HSS Q Portable Plant 2	0	0	0	0	no	no	0	0	0	0
2301924	RENTAL PLANT PORTABLE	0	0	0	0	no	no	0	0	0	0
2301928	Conco Quarries-Marshfield	1	0	0	0	no	no	4.67	0	0	0
2301941	River Quarry	0	0	0	0	no	no	0	0	0	0
2301961	Eagle #I Portable Plant	0	0	0	0	no	no	0	0	0	0
2302035	Riverside Plant #11	0	0	0	0	no	no	0	0	0	0
2302042	Sand Plant	0	0	0	0	no	no	0	0	0	0
2302072	Gallatin Quarry	0	0	0	0	no	no	0	0	0	0
2302117	Conco Quarries- Fair Play	1	0	0	0	no	no	0.87	0	0	0
2302127	UNIVERSAL PORTABLE PLANT	0	0	0	0	no	no	0	0	0	0
2302138	Branson Quarry	0	0	0	0	no	no	0	0	0	0
2302157	Brickeys Quarry	0	0	0	0	no	no	0.239	0	0	0
2302173	Bates City Quarry	0	0	0	0	no	no	0	0	0	0
2302183	BELLA VISTA QUARRY & PLANT	0	0	0	0	no	no	0	0	0	0
2302204	Anderson Quarry	0	0	0	0	no	no	0	0	0	0
2302205	Nordberg NW 1213-YF16	0	0	0	0	no	no	0	0	0	0
2302206	Nordberg Nw1213-CC	0	0	0	0	no	no	0	0	0	0
2302244	Conco Quarries - Galloway	1	0	0	0	no	no	1.229	0	0	0
2302259	Nordberg 1213 LT	0	0	0	0	no	no	0	0	0	0
2302297	Nordberg LT 1213-71768	0	0	0	0	no	no	0	0	0	0
2302304	Miami Quarry	0	0	0	0	no	no	0	0	0	0
2302310	Cedar Heights Quarry	0	0	0	0	no	no	0	0	0	0
2302315	Anderson Quarry	0	0	0	0	no	no	0	0	0	0
2302320	Lanagan Quarry	0	0	0	0	no	no	0	0	0	0
2302337	Cullor Portable	0	0	0	0	no	no	0	0	0	0
2302342	Wash Plant	0	0	0	0	no	no	0	0	0	0
2302365	Rip Rap Plant	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
2302381	Portable Plant #4	0	0	0	0	no	no	0	0	0	0
2302404	Pettis Plant 1	0	0	0	0	no	no	0	0	0	0
2302508	Randolph Dredge	0	0	0	0	no	no	0	0	0	0
2302509	Riverside Dredge	0	0	0	0	no	no	0	0	0	0
2302547	HHS Q Portable Plant 3	0	0	0	0	no	no	0.294	0	0	0
2302576	ElDorado Springs Quarry	0	0	0	0	no	no	0	0	0	0
2302586	HHS Q Portable Plant 5	0	0	0	0	no	no	0	0	0	0
2400015	MONTANA CITY PLANT	0	0	0	0	no	no	0.882	0	0	0
2400489	Mill Creek	0	0	0	0	no	no	0	0	0	0
2400497	Helena Sand & Gravel-Portable Wash<br><br>Plant	0	0	0	0	no	no	0	0	0	0
2400785	HSG Portable Screen Plant #2	0	0	0	0	no	no	0	0	0	0
2401412	Helena Sand & Gravel Portable<br><br>Crusher	4	0	0	0	no	no	0	0	0	0
2401765	LS Jensen-Portable Crusher	0	0	0	0	no	no	0	0	0	0
2401820	LS Jensen Wash Plant	0	0	0	0	no	no	0	0	0	0
2401910	Blahnik Portable	0	0	0	0	no	no	0	0	0	0
2402140	Screen Plant	0	0	0	0	no	no	0	0	0	0
2402185	LS Jensen Screen Plant	0	0	0	0	no	no	0	0	0	0
2402254	Portable Crushing Plant #2	0	0	0	0	no	no	0	0	0	0
2402267	Portable Colberg Screen	0	0	0	0	no	no	0	0	0	0
2500002	Louisville Plant Quarry & Mill	16	0	0	0	no	no	128.114	1	3	3
2500223	Reese Pit #86	0	0	0	0	no	no	0	0	0	0
2500245	Pit #40 Waterloo	0	0	0	0	no	no	0.441	0	0	0
2500250	Portable #6 (Dredge)	0	0	0	0	no	no	0	0	0	0
2500279	PORTABLE #7	0	0	0	0	no	no	0	0	0	0
2500280	PIT #5 CULLOM	0	0	0	0	no	no	0	0	0	0
2500281	Plant #23 Bridgeport	0	0	0	0	no	no	0	0	0	0
2500282	PIT #11, VALLEY	0	0	0	0	no	no	0	0	0	0
2500283	Plant #87	0	0	0	0	no	no	0	0	0	0
2500506	Pit #71 Columbus	1	0	0	0	no	no	0.294	0	0	0
2500507	Pit #89  St Paul	0	0	0	0	no	no	0	0	0	0
2500508	Pit #73 - Bellwood	0	0	0	0	no	no	0.147	0	0	0
2500510	Pit #76 Norfolk	0	0	0	0	no	no	0	0	0	0
2500511	Pit #75 Genoa	0	0	0	0	no	no	0	0	0	0
2500556	Plant #10 Waterloo	0	0	0	0	no	no	0	0	0	0
2500686	Pit #77 Grand Island	0	0	0	0	no	no	0	0	0	0
2500735	Pit #8 Oreapolis	0	0	0	0	no	no	0	0	0	0
2500818	Plant #14 Waterloo	0	0	0	0	no	no	0	0	0	0
2501014	PIT #81, FULLERTON	0	0	0	0	no	no	0	0	0	0
2501047	PIT #49 GRETNA	0	0	0	0	no	no	0	0	0	0
2501092	Crusher #11 Portable	0	0	0	0	no	no	0	0	0	1
2501109	Crusher #4 Portable	0	0	0	0	no	no	0	0	0	0
2501110	Crusher #1 Portable	0	0	0	0	no	no	0	0	0	0
2501111	PORTABLE II 8	0	0	0	0	no	no	0	0	0	0
2501112	Portable #5 Dredge	0	0	0	0	no	no	0	0	0	0
2501114	PIT #47, FREMONT	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
2501125	PORTABLE #9 (SCREENING)	0	0	0	0	no	no	0	0	0	0
2501133	Pit #83, Ashland	0	0	0	0	no	no	0	0	0	0
2501137	Pit #90, Cedar Rapids	0	0	0	0	no	no	0	0	0	0
2501146	Pit #50	0	0	0	0	no	no	0	0	0	0
2501148	Crusher #3 Portable	0	0	0	0	no	no	0	0	0	0
2501207	Pit #92, Norfolk	0	0	0	0	no	no	0	0	0	0
2501212	Portable Crusher #2	0	0	0	0	no	no	0	0	0	0
2501219	Portable #10 Screening	0	0	0	0	no	no	0	0	0	0
2501235	Ehlers Sand Pit #7	0	0	0	0	no	no	0	0	0	0
2501236	Pit #97 Grand Island	0	0	0	0	no	no	0	0	0	0
2501238	Pit #7 Valley	0	0	0	0	no	no	0	0	0	0
2501245	Pit #4 East Oreapolis	0	0	0	0	no	no	0	0	0	0
2501249	Portable #23 Screening	0	0	0	0	no	no	0	0	0	0
2501254	Pit #3 West Cullom	0	0	0	0	no	no	0	0	0	0
2501259	Pit #95, North Genoa	0	0	0	0	no	no	0	0	0	0
2501275	Portable #26 Blending	0	0	0	0	no	no	0	0	0	0
2501287	Pit #51	0	0	0	0	no	no	0	0	0	0
2501290	Pit #45 Fremont North Pit	0	0	0	0	no	no	0.147	0	0	0
2501299	Pit #52 Gretna Bottoms	0	0	0	0	no	no	0	1	0	0
2600429	Boehler Pit	0	0	0	0	no	no	0	0	0	0
2601975	033 Crusher H K Portable Plant	0	0	0	0	no	no	0	0	0	0
2602394	Portable Wash Plant #1	0	0	0	0	no	no	0	0	0	0
2700003	Lebanon Crushed Stone C623	0	0	0	0	no	no	0	0	0	0
2700052	Campton Sand & Gravel C616	0	0	0	0	no	no	0	0	0	0
2700061	Gorham Sand & Gravel C619	0	0	0	0	no	no	0	0	0	0
2700069	TILTON SAND & GRAVEL (C613)	0	0	0	0	no	no	0	0	0	0
2700073	Farmington Pit & Mill C618	0	0	0	0	no	no	0	0	0	0
2700107	CONWAY SAND & GRAVEL C622	0	0	0	0	no	no	0	0	0	0
2700128	Madbury Pit C629	0	0	0	0	no	no	0.164	0	0	0
2700132	Pike Industries Inc C628	0	0	0	0	no	no	0	0	0	0
2700158	Twin Mountain Sand & Gravel (C609)	0	0	0	0	no	no	0	0	0	0
2700192	Hooksett Crushed Stone C607	0	0	0	0	no	no	0.147	0	0	0
2700221	Henniker Aggregates	0	0	0	0	no	no	0	0	0	0
2700247	Pike Industries Incorporated (Mac)	0	0	0	0	no	no	0	0	0	0
2700253	PORTABLE SANDSCREEN C654	0	0	0	0	no	no	0	0	0	0
2700260	Portable Sandscreen C652	0	0	0	0	no	no	0	0	0	0
2700273	Portable Sand Screen X714	0	0	0	0	no	no	0	0	0	0
2700275	Portable Sand Screen X712	0	0	0	0	no	no	0	0	0	0
2700276	Portable Sand Screen C659	0	0	0	0	no	no	0	0	0	0
2700289	LA Drew-Portable Plant	0	0	0	0	no	no	0	0	0	0
2700292	Portable Crusher C610	0	0	0	0	no	no	0	0	0	0
2700305	Portable Sandscreen C650	0	0	0	0	no	no	0	0	0	0
2700313	Belmont Sand & Gravel (C627)	0	0	0	0	no	no	0	0	0	0
2700338	Columbia Sand & Gravel-Wash Plant	0	0	0	0	no	no	0	0	0	0
2700350	PORTABLE SAND SCREEN (C-606)	0	0	0	0	no	no	0	0	0	0
2700374	Nordberg Portable Crusher C-653	0	0	0	0	no	no	0	0	0	0
2700379	VIPER-Portable Screen	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
2700477	Portable Read Screen	0	0	0	0	no	no	0	0	0	0
2700560	Pike Industries Inc C1664	0	0	0	0	no	no	0	0	0	0
2800001	Riverdale Quarry	0	0	0	0	no	no	0	0	0	0
2800014	Millington Quarry & Mill	0	0	0	0	no	no	0	0	0	0
2800024	Pompton Lakes Quarry	0	0	0	0	no	no	0.147	0	0	0
2800026	Mount Hope Quarry	0	0	0	0	no	no	0.458	0	0	0
2800030	Prospect Park Quarry & Mill	0	0	0	0	no	no	0	0	0	0
2800031	Lambertville Quarry	0	0	0	0	no	no	0	0	0	0
2800032	Pennington Quarry	0	0	0	0	no	no	0	0	0	0
2800033	Kingston Quarry	1	0	0	0	no	no	0.28	0	0	1
2800035	Clifton Quarry	0	0	0	0	no	no	0	0	0	0
2800490	CERTIFIED QUARRY	0	0	0	0	no	no	0	0	0	0
2800541	Oxford Quarry & Mill	0	0	0	0	no	no	0	0	0	0
2800670	Byram Aggregates	0	0	0	0	no	no	0	0	0	0
2800757	Ringwood Quarry	0	0	0	0	no	no	0	0	0	0
2800874	Moore's Station Quarry	0	0	0	0	no	no	0	0	0	0
2800994	Landing Quarry	0	0	0	0	no	no	0	0	0	0
2801011	Lafayette Plant Oldcastle Stone<br><br>Products	0	0	0	0	no	no	0	0	0	0
2900186	Crego Mine	0	0	0	0	no	no	0	0	0	0
2900450	FCM Portable Crusher	0	0	0	0	no	no	0	0	0	0
2901073	NM Wash Plant	0	0	0	0	no	no	0	0	0	0
2901258	NM Crusher #1 (portable)	0	0	0	0	no	no	0.328	0	0	0
2902149	Sandia  Pit	0	0	0	0	no	no	0	0	0	0
2902262	FCM Crusher 2	0	0	0	0	no	no	0	0	0	0
2902306	FCM Washplant #2	0	0	0	0	no	no	0	0	0	0
3000013	South Bethlehem	0	0	0	0	no	no	0.147	0	0	0
3000014	Kingston Plant #3	0	0	0	0	no	no	0	0	0	0
3000022	BROCKPORT PLANT	0	0	0	0	no	no	0	0	0	0
3000025	Pattersonville Plant #61	0	0	0	0	no	no	0.902	0	0	0
3000032	Leroy Plant	1	0	0	0	no	no	1.011	0	1	1
3000033	PENFIELD PLANT	0	0	0	0	no	no	0	0	0	0
3000034	Gates Plant	0	0	0	0	no	no	0	0	0	0
3000035	Walworth Plant	1	0	0	0	no	no	0.662	0	0	0
3000038	Goshen Quarry	1	0	0	0	no	no	2.126	0	0	0
3000074	Tomkins Cove Quarry	0	0	0	0	no	no	0	0	0	0
3000075	Haverstraw Quarry & Mill	2	0	0	0	no	no	3.408	0	0	0
3000082	Clinton Point Quarry & Mill	3	0	0	0	no	no	21.816	0	0	0
3000083	West Nyack Quarry	2	0	0	0	no	no	3.893	0	0	0
3000100	Bridgeville Plant  #70	0	0	0	0	no	no	0.588	0	0	0
3000101	Fosterdale Plant #73	0	0	0	0	no	no	0	0	0	0
3000110	Oxbow Pit 41	0	0	0	0	no	no	0	0	0	0
3000214	Bath Plant	1	0	0	0	no	no	0	1	1	0
3000806	South Amenia	0	0	0	0	no	no	0	0	0	0
3000857	REDMAN PLANT	0	0	0	0	no	no	0	0	0	0
3000985	Valente Sand & Gravel	0	0	0	0	no	no	0	0	0	0
3001130	Newark Plant	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
3001141	Ogden Plant	0	0	0	0	no	no	0	0	0	0
3001254	MANCHESTER PLANT	0	0	0	0	no	no	1.098	0	0	0
3001372	Cedarcliff Quarry And Mill	0	0	0	0	no	no	0	0	0	0
3001692	EMPIRE SAND & GRAVEL	0	0	0	0	no	no	0	0	0	0
3002253	MAYBROOK MATERIALS PLANT #80	0	0	0	0	no	no	0	0	0	0
3002654	Dyer Pit	0	0	0	0	no	no	0	0	0	0
3002684	Tilleys Pit	0	0	0	0	no	no	0	0	0	0
3002697	Schroon Lake Operation	0	0	0	0	no	no	0	0	0	0
3002754	Howard Plant	0	0	0	0	no	no	0.147	0	0	0
3002800	LEROY - CIRCULAR HILL	0	0	0	0	no	no	0	0	0	0
3002954	Cropseyville Plant 8	0	0	0	0	no	no	0	0	0	0
3002983	Schodack Pit - Plant 58	0	0	0	0	no	no	0	0	0	0
3003029	Ravena Plant  #2	0	0	0	0	no	no	0	0	0	0
3003452	EAST KINGSTON	1	0	0	0	no	no	2.916	0	0	0
3003840	Palmyra Plant	1	0	0	0	no	no	0.483	0	0	0
3100014	Oldcastle Industrial Minerals Inc	0	0	0	0	no	no	0	0	0	0
3100015	Tubbmill Quarry	0	0	0	0	no	no	0	0	0	1
3100400	Waynesville Quarry	0	0	0	0	no	no	0	0	0	0
3100557	Dillsboro Quarry	0	0	0	0	no	no	0.147	0	0	0
3101354	Candor Sand Pit	0	0	0	0	no	no	0.408	1	0	0
3101575	Murphy Quarry	0	0	0	0	no	no	0	0	0	0
3101849	Allen Pit	0	0	0	0	no	no	0	0	0	0
3102039	Mission Quarry	0	0	0	0	no	no	0	0	0	0
3102061	Hayesville Quarry	0	0	0	0	no	no	0.147	0	0	0
3102138	Cherokee Co Quarry	0	0	0	0	no	no	0.147	0	0	0
3102164	Massey Branch Quarry	0	0	0	0	no	no	0	0	0	0
3102173	Grady Pit	0	0	0	0	no	no	0	0	0	0
3300042	Fultonham Plant	4	0	0	0	no	no	3.735	0	0	0
3300049	East Liberty Quarry	0	0	0	0	no	no	0	0	0	0
3300079	Hardin Quarry	0	0	0	0	no	no	0	0	0	0
3300087	Celina Quarry	0	0	0	0	no	no	0	0	0	0
3300091	White Rock Quarry	0	0	0	0	no	no	0	0	0	0
3300096	Shawnee Quarry	0	0	0	0	no	no	0	0	0	0
3300097	Marble Cliff Quarry	2	0	0	0	no	no	0	0	0	0
3300102	Maumee Quarry	4	0	0	0	no	no	4.496	0	0	0
3300103	Auglaize Plant	0	0	0	0	no	no	0	0	0	0
3300104	Lime City Quarry	0	0	0	0	no	no	0	0	0	0
3300105	Portage Quarry	0	0	0	0	no	no	0	0	0	0
3300129	Belle Center Plant	0	0	0	0	no	no	0	0	0	0
3300149	Shelly Materials Inc York Center	0	0	0	0	no	no	0	0	0	0
3300167	Tri County Limestone Company	0	0	0	0	no	no	0	0	0	0
3300168	Shelly Material Inc.  Ostrander	0	0	0	0	no	no	0	0	0	0
3300169	Scott Quarry	0	0	0	0	no	no	0	0	0	0
3300181	Stoneco, Inc.	0	0	0	0	no	no	0.294	0	0	0
3301408	Coshocton Plant	1	0	0	0	no	no	0	0	0	0
3301419	Canton Aggregates C1	0	0	0	0	no	no	0	0	0	0
3301438	SHELLY MATERIALS INC DRESDEN<br><br>PL	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
3301471	St Louisville Plant	0	0	0	0	no	no	0	0	0	0
3301480	Lockbourne Plant	0	0	0	0	no	no	0	0	0	0
3301526	Jefferson Materials Co	0	0	0	0	no	no	0.147	0	0	0
3301627	Shelly Materials Inc Racine Plant	0	0	0	0	no	no	0	0	0	0
3301659	Shelly Materials Inc Springfield	0	0	0	0	no	no	0	0	0	0
3301661	Shalersville North Plant	0	0	0	0	no	no	0	0	0	0
3301662	Haver Hill Plant	0	0	0	0	no	no	0	0	0	0
3301675	North Montpelier Plant	0	0	0	0	no	no	0	0	0	0
3301688	Shelly Materials Plant #1402	0	0	0	0	no	no	0	0	0	0
3301706	Montpelier Sand & Gravel	0	0	0	0	no	no	0	0	0	0
3302696	Rocky Ridge Quarry	0	0	0	0	no	no	0	0	0	0
3302784	Columbus Limestone Quarry	0	0	0	0	no	no	0	0	0	0
3302913	Allied Corporation Inc	0	0	0	0	no	no	0.294	0	0	0
3303935	Shelly Materials Inc Lancaster	0	0	0	0	no	no	0	0	0	0
3304195	Petersburg	0	0	0	0	no	no	0	0	0	0
3304233	Shelly Materials Inc Chillicoth	0	0	0	0	no	no	0	0	0	0
3304334	Alexandria Plant	0	0	0	0	no	no	0	0	0	0
3304425	London Aggregates	0	0	0	0	no	no	0	0	0	0
3304444	Willow Island Plant	0	0	0	0	no	no	0	0	0	0
3304493	Forest Quarry	0	0	0	0	no	no	0	0	0	0
3304499	Stoneco Inc (Portable)	0	0	0	0	no	no	0	0	0	0
3304504	Chillicothe Plant #1404	0	0	0	0	no	no	0	0	0	0
3304581	Portland Plant	0	0	0	0	no	no	0	0	0	0
3304643	Black 17	0	0	0	0	no	no	0	0	0	0
3304657	Columbus Limestone	3	0	0	0	no	no	0	0	0	0
3304703	Reno Plant Site	0	0	0	0	no	no	0	0	0	0
3304737	Ostrander Tunnels	0	0	0	0	no	no	0	0	0	0
3304739	Canton Aggregates C2	0	0	0	0	no	no	0	0	0	0
3304741	Portable Plant	0	0	0	0	no	no	0	0	0	0
3304801	Southern Portable 1	0	0	0	0	no	no	0	0	0	0
3304806	Portable Washscreen	0	0	0	0	no	no	0	0	0	0
3400003	Arkhola No 1 Mine	0	0	0	0	no	no	0	0	0	0
3400025	Portable #3 4300 Plant	0	0	0	0	no	no	0	0	0	0
3400040	Pawhuska Quarry	1	0	0	0	no	no	1.746	0	0	0
3400050	East Quarry	4	0	0	0	no	no	2.876	0	0	0
3400394	Muskogee Dredge	0	0	0	0	no	no	0.147	0	0	0
3400407	Dewey Quarry	0	0	0	0	no	no	0	0	0	0
3400410	Claremore Quarry	0	0	0	0	no	no	0	0	0	0
3400445	Haskell Plant #20	0	0	0	0	no	no	0	0	0	0
3400554	Garnett Plant #15	0	0	0	0	no	no	0	0	0	0
3400788	Ft Gibson Mill	0	0	0	0	no	no	0	0	0	0
3400892	Coweta Plant #10	0	0	0	0	no	no	0.525	0	0	0
3400893	Vinita Quarry	0	0	0	0	no	no	0.441	0	0	0
3401036	Oologah Quarry	0	0	0	0	no	no	0.147	0	0	0
3401130	Roberts Quarry	0	0	0	0	no	no	0	0	0	0
3401369	Standard Quarry	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
3401761	Okay Quarry	0	0	0	0	no	no	0	0	0	0
3401805	Plant #17 Indian Road	0	0	0	0	no	no	0.322	0	0	0
3401847	Coweta West #19	0	0	0	0	no	no	0	0	0	0
3401876	129th St. Plant #14	0	0	0	0	no	no	0.525	0	0	0
3401940	Spiro Quarry	0	0	0	0	no	no	0	0	0	0
3402023	Leonard Plant #16	0	0	0	0	no	no	0	0	0	0
3402065	Afton Quarry	0	0	0	0	no	no	0	0	0	0
3402091	Mingo Plant #12	0	0	0	0	no	no	0	0	0	0
3500320	Rivergate Plant	0	0	0	0	no	no	0.147	0	0	0
3500484	RiverBend Materials North Pit	0	0	0	0	no	no	0	0	0	0
3500498	Cascade Locks Pit And Plant	0	0	0	0	no	no	0	0	0	0
3500556	Valley Concrete & Gravel Prtbl<br><br>Crusher	0	0	0	0	no	no	0	0	0	0
3500631	RiverBend Materials Dalton	0	0	0	0	no	no	0.147	0	0	0
3501002	RiverBend Materials Turner South	0	0	0	0	no	no	0.441	0	0	0
3501064	RiverBend Materials Coburg	0	0	0	0	no	no	0.294	0	0	0
3502478	RiverBend Turner Gravel	0	0	0	0	no	no	0	0	0	0
3502705	RiverBend Materials Corvallis	0	0	0	0	no	no	0.204	0	0	0
3502970	Durkee Cement Plant	0	0	0	0	no	no	0.882	0	0	1
3502986	Mission Pit	1	0	0	0	no	no	7.784	1	1	0
3503044	RiverBend Materials Bethel	0	0	0	0	no	no	0	0	0	0
3503311	Portable Screening Plant	0	0	0	0	no	no	0	0	0	0
3503367	Valley Concrete & Gravel Prtbl Wash<br><br>Plnt	0	0	0	0	no	no	0	0	0	0
3503370	KP Portable Crusher	0	0	0	0	no	no	0	0	0	0
3503425	Windsor Rock Products	0	0	0	0	no	no	0.239	0	0	0
3503426	ARP Westgate Quarry	0	0	0	0	no	no	0	0	0	0
3503437	Ontario Pit	0	0	0	0	no	no	0	0	0	0
3503451	BAKER PIT	0	0	0	0	no	no	0	0	0	0
3503596	RiverBend Materials RiverBend West	0	0	0	0	no	no	0	0	0	0
3503633	KP Portable Screen	0	0	0	0	no	no	0	0	0	0
3503807	Kenstone Quarry	0	0	0	0	no	no	0	0	0	0
3503953	RiverBend Materials Hilroy	0	0	0	0	no	no	0	0	0	0
3503968	Grubbs Quarry	0	0	0	0	no	no	0	0	0	0
3600023	East Petersburg Quarry	1	0	0	0	no	no	1.323	0	0	0
3600032	Newport Quarry	0	0	0	0	no	no	0	0	0	0
3600039	PRESCOTT QUARRY	1	0	0	0	no	no	0.916	0	0	0
3600048	Pittston Quarry	3	0	0	0	no	no	2.78	0	0	0
3600074	Landisville Quarry	0	0	0	0	no	no	0.441	0	0	0
3600212	Silver Springs Quarry	0	0	0	0	no	no	0.441	0	0	0
3600246	Summit Station Quarry	0	0	0	0	no	no	0	0	0	0
3600251	Thomasville Plant	0	0	0	0	no	no	0	1	0	0
3600513	Fontana Quarry	0	0	0	0	no	no	0	0	0	0
3603215	Mt Holly Quarry	2	0	0	0	no	no	3.508	0	0	0
3603432	Thomasville Mine	6	0	0	0	no	no	8.443	0	0	0
3604291	Hummelstown Quarry	0	0	0	0	no	no	0	0	0	0
3607946	Paradise Plant	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
3608033	SMALL MOUNTAIN QUARRY INC	8	0	0	0	no	no	9.044	0	0	0
3608076	Montrose Quarry	0	0	0	0	no	no	0	0	0	0
3608187	FIDDLERS NORTH QUARRY	0	0	0	0	no	no	0.147	0	0	0
3608573	Small Mountain Quarry Inc-Salem<br><br>Sand	0	0	0	0	no	no	0	0	0	0
3608736	Lawton Quarry	0	0	0	0	no	no	0	0	0	0
3609058	Millard Quarry	2	0	0	0	no	no	4.177	0	0	0
3609272	Penn Township Quarry	0	0	0	0	no	no	0	0	0	0
3609418	Hummelstown Fine Grind Plant	0	0	0	0	no	no	0	0	0	0
3609981	Auburn Quarry	0	0	0	0	no	no	0	0	0	0
3700002	Cranston Quarry	1	0	0	0	no	no	1.516	0	0	0
3800681	MARLBORO MINE	0	0	0	0	no	no	0	0	0	0
3901223	PQ 1764	0	0	0	0	no	no	0	0	0	0
3901408	PQ 2508	0	0	0	0	no	no	0	0	0	0
4000057	JELLICO STONE COMPANY	0	0	0	0	no	no	0.147	0	0	0
4000060	Lookout Valley Quarry	0	0	0	0	no	no	0.147	0	0	0
4001946	Harrison Sand Company	0	0	0	0	no	no	0	0	0	0
4003099	Crump Gravel Pit	0	0	0	0	no	no	0	0	0	0
4003127	APAC TENNESSEE, INC.	0	0	0	0	no	no	0	0	0	0
4003168	Sand Products of Monterey	0	0	0	0	no	no	0.294	0	0	0
4100026	Ash Grove Cement Company	14	0	0	0	no	no	9.427	3	4	1
4102820	Hunter Cement Plant	1	0	0	0	no	no	7.481	1	1	0
4104082	PEARLAND PLANT	0	0	0	0	no	no	0	0	0	0
4104096	DALLAS SAND PLANT	0	0	0	0	no	no	0	0	0	0
4104124	Austin Aggregates 973 Plant	0	0	0	0	no	no	0	0	0	0
4104235	BLUE BIRD SAND PLANT	0	0	0	0	no	no	0	0	0	0
4104441	Texas Materials Hergotz Plant	0	0	0	0	no	no	0.441	0	0	0
4104468	Naruna Quarry	0	0	0	0	no	no	0	0	0	0
4104489	Marble Falls Quarry	0	0	0	0	no	no	0.602	0	0	0
4104669	Finlay Screening Plant	0	0	0	0	no	no	0	0	0	0
4104693	Lampasas Quarry	0	0	0	0	no	no	0	0	0	0
4104879	Divot Quarry	1	0	0	0	no	no	0.441	0	0	0
4104963	Texas Materials Garfield Plant	0	0	0	0	no	no	1.623	0	0	0
4105252	Halo Pit	3	0	0	0	no	no	0	0	0	0
4105295	Portable Plant 01	0	0	0	0	no	no	0	0	0	0
4200021	Keigley Quarry	1	0	0	0	no	no	5.054	0	0	0
4200364	Heber Binggeli Quarry	0	0	0	0	no	no	0.826	0	0	0
4200370	PARSON COVE PITS	0	0	0	0	no	no	0	0	0	0
4200377	Brigham City South Pit	0	0	0	0	no	no	0	0	0	0
4200388	McGuire	0	0	0	0	no	no	0.454	0	0	0
4200398	Brigham City Pit	2	0	0	0	no	no	4.826	0	0	0
4200406	South Weber Pit	0	0	0	0	no	no	0.656	0	0	0
4200410	Beck Street South	0	0	0	0	no	no	0	0	0	0
4200415	Portable Crushing Unit #2	0	0	0	0	no	no	0	0	0	0
4200884	Bauer Pit	0	0	0	0	no	no	0	0	0	0
4201089	Centerfield Wash Plant	0	0	0	0	no	no	0	0	0	0
4201122	WR Portable Wash Plant # 1	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
4201452	Beck Street	3	0	0	0	no	no	1.51	0	0	1
4201572	Portable Crusher #1	0	0	0	0	no	no	0	0	0	0
4201665	Leamington Cement Plant	0	0	0	0	no	no	2.442	0	0	0
4201717	PORTABLE #5	0	0	0	0	no	no	0	0	0	0
4201816	Little Mac	0	0	0	0	no	no	0	0	0	0
4201857	Gomex	0	0	0	0	no	no	0	0	0	0
4201874	Falcon Ridge	0	0	0	0	no	no	0	0	0	0
4201964	H-K Portable Plant 033 Crusher	0	0	0	0	no	no	0	0	0	0
4201978	Lehi Peck	1	0	0	0	no	no	1.024	0	0	0
4202006	Erda	0	0	0	0	no	no	0	0	0	0
4202007	Burdick Portable #1	2	0	0	0	no	no	0.794	0	0	0
4202009	SPC Portable	0	0	0	0	no	no	0	0	0	0
4202043	Point West Lehi	0	0	0	0	no	no	0	0	0	0
4202082	Big Mac	0	0	0	0	no	no	0	0	0	0
4202090	PORTABLE #2	0	0	0	0	no	no	0	0	0	0
4202092	44035	0	0	0	0	no	no	0	0	0	0
4202099	Western Rock Fast Pack	0	0	0	0	no	no	0	0	0	0
4202103	44011	0	0	0	0	no	no	0	0	0	0
4202128	Crusher #2	0	0	0	0	no	no	0	0	0	0
4202130	Lehi Point East	1	0	0	0	no	no	0.328	2	1	0
4202150	Panguitch Pit	0	0	0	0	no	no	0	0	0	0
4202151	Crusher #3	0	0	0	0	no	no	0	0	0	0
4202154	Bauer	0	0	0	0	no	no	0	0	0	0
4202158	Crusher #4 Track Impactor	0	0	0	0	no	no	0.328	0	0	0
4202192	West Jordan Pit	0	0	0	0	no	no	0	0	0	0
4202201	Portable #3	0	0	0	0	no	no	0	0	0	0
4202214	Burdick Portable Crusher #2	0	0	0	0	no	no	0.164	0	0	0
4202236	Francis	0	0	0	0	no	no	0	0	0	0
4202264	Portable Crusher #3	0	0	0	0	no	no	0	0	0	0
4202267	Sorensen Pit	1	0	0	0	no	no	0.738	0	0	0
4202270	Cedar City Pit	0	0	0	0	no	no	0	0	0	0
4202278	Ft. Pierce	0	0	0	0	no	no	0	0	0	0
4202282	Nebo Pit	0	0	0	0	no	no	0	0	0	0
4202294	Ekins Pit	0	0	0	0	no	no	0	0	0	0
4202320	Hot Springs	1	0	0	0	no	no	0	0	0	0
4202348	Burdick Portable #3	0	0	0	0	no	no	0.774	0	0	0
4202354	Browns Canyon	0	0	0	0	no	no	0	0	0	0
4202363	Honeyville Pit	0	0	0	0	no	no	0	0	0	0
4202368	Daniel's Plant	0	0	0	0	no	no	0	0	0	0
4202373	Crusher #5 Fast Pack	0	0	0	0	no	no	0	0	0	0
4202381	West Valley Pit	0	0	0	0	no	no	0	0	0	0
4202397	Staker Parson Fast Pack	0	0	0	0	no	no	0.227	0	0	0
4202407	WR Portable # 4	0	0	0	0	no	no	0	0	0	0
4202430	Burdick Portable #4	1	0	0	0	no	no	0.725	0	0	0
4202440	Trenton Pit	0	0	0	0	no	no	0	0	0	0
4202459	Paria	0	0	0	0	no	no	0.179	0	0	0
4202460	Burdick Portable #5	0	0	0	0	no	no	0.391	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
4202462	Hales Portable	0	0	0	0	no	no	0	0	0	0
4202489	Elsinore Pit	0	0	0	0	no	no	0	0	0	0
4202490	Redmond Pit	0	0	0	0	no	no	0	0	0	0
4202501	Backus Pit	0	0	0	0	no	no	0	0	0	0
4202517	Beef Hollow	1	0	0	0	no	no	0.328	0	0	0
4202534	Crusher #6	0	0	0	0	no	no	0	0	0	0
4202558	Portable #4	0	0	0	0	no	no	0	0	0	0
4202561	Portable #3	0	0	0	0	no	no	0	0	0	0
4202708	Bear Lake Sand & Gravel	0	0	0	0	no	no	0	0	0	0
4202725	Ash Grove Tooele Plant	0	0	0	0	no	no	0	0	0	0
4300066	Pike Industries Inc (C612)	0	0	0	0	no	no	0	0	0	0
4300098	Cooley Sand Pit	0	0	0	0	no	no	0	0	0	0
4300105	Waterford Crushed Stone C603	0	0	0	0	no	no	0.147	0	0	0
4300185	New Haven Crushed Stone C600	0	0	0	0	no	no	0.147	0	0	0
4300213	La Fountain Pit	0	0	0	0	no	no	0	0	0	0
4300341	Hartland Pit 001658	0	0	0	0	no	no	0	0	0	0
4300488	PIKE INDUSTRIES, INC, (C613)	0	0	0	0	no	no	0	0	0	0
4300587	Pike Industries - C642	0	0	0	0	no	no	0	0	0	0
4300589	Portable Power Screen 01631	0	0	0	0	no	no	0	0	0	0
4300621	Portable Sand Screen C652	0	0	0	0	no	no	0	0	0	0
4300627	Pike Industries Inc - C632	0	0	0	0	no	no	0	0	0	0
4300628	Pike Industries Inc-C604	0	0	0	0	no	no	0	0	0	0
4300630	Pike Industries Portable Jaw	0	0	0	0	no	no	0	0	0	0
4300642	Pike Industries C601	0	0	0	0	no	no	0	0	0	0
4300643	Pike Industries Inc-Williamstown	0	0	0	0	no	no	0	0	0	0
4300649	Pike Industries-Power Screen	0	0	0	0	no	no	0	0	0	0
4300679	Pike Industries-Wash Plant 634	0	0	0	0	no	no	0	0	0	0
4300690	Pike Industries C654/664 Crusher	0	0	0	0	no	no	0	0	0	0
4300691	Pike Industries 654/664S Screen	0	0	0	0	no	no	0	0	0	0
4300697	Astec DS5162 Screen	0	0	0	0	no	no	0	0	0	0
4300715	Pike Industries Wash Screw-Danby	0	0	0	0	no	no	0	0	0	0
4400095	Pounding Mill Plant	0	0	0	0	no	no	0	0	0	0
4400096	Bluefield Plant	1	0	0	0	no	no	0.515	0	0	0
4400164	Glade Stone Plant	1	0	0	0	no	no	0	0	0	0
4400165	Castlewood Plant	0	0	0	0	no	no	0	0	0	0
4400234	Ewing Stone	0	0	0	0	no	no	0	0	0	0
4404924	Saltville Stone Plant	0	0	0	0	no	no	0	0	0	0
4405372	Rural Retreat Plant	0	0	0	0	no	no	0	0	0	0
4406371	Mouth of Wilson Plant	0	0	0	0	no	no	0.147	0	0	0
4407168	Dickensonville Plant	0	0	0	0	no	no	0	0	0	0
4407424	Castlewood	1	0	0	0	no	no	1.316	0	0	0
4500073	BASALT PLANT	0	0	0	0	no	no	0	0	0	0
4500359	Seattle Plant	22	0	0	0	no	no	351.473	5	8	6
4500560	Park Road Plant	0	0	0	0	no	no	0	0	0	0
4500572	Matheson Pit	0	0	0	0	no	no	0	0	0	0
4500593	FT. WRIGHT-PREMIX #2	0	0	0	0	no	no	0	0	0	0
4500594	Yardley Pit	0	0	0	0	no	no	0	0	0	0
---	---	---	---	---	---	---	---	---	---	---	---
4500604	Interstate Concrete and Asphalt-<br><br>Hawkins	0	0	0	0	no	no	0	0	0	0
4500631	Toppenish Facility	0	0	0	0	no	no	0	0	0	0
4500640	Sullivan Pit	0	0	0	0	no	no	0	0	0	0
4500727	East Selah Pit & Plant	0	0	0	0	no	no	0	0	0	0
4500730	Pasco Facility	0	0	0	0	no	no	0	0	0	0
4500764	ARP Portable Crusher #2	0	0	0	0	no	no	0	0	0	0
4500995	Yakima Crusher	0	0	0	0	no	no	0	0	0	0
4501118	Crestline Facility	0	0	0	0	no	no	0	0	0	0
4501237	Auburn Facility	0	0	0	0	no	no	0.843	0	0	0
4501752	D O E Pit No 1	0	0	0	0	no	no	0	0	0	0
4502137	No 5 Pit	0	0	0	0	no	no	0	0	0	0
4502205	Mead Pre-Mix #3	0	0	0	0	no	no	0	0	0	0
4502356	Odair Pit	0	0	0	0	no	no	0	0	0	0
4502709	Sullivan Road Facility	0	0	0	0	no	no	0	0	0	0
4502925	B P A Mead	0	0	0	0	no	no	0	0	0	0
4502999	P F R 76 Pit	0	0	0	0	no	no	0	0	0	0
4503032	IAC Portable Crusher	0	0	0	0	no	no	0	0	0	0
4503042	ARP Rock Island Plant	0	0	0	0	no	no	0	0	0	0
4503046	PORTABLE CRUSHER #2705	0	0	0	0	no	no	0	0	0	0
4503047	PLANT 2704	0	0	0	0	no	no	0	0	0	0
4503134	Basalt Pit	0	0	0	0	no	no	0	0	0	0
4503137	Iac Crusher #2	0	0	0	0	no	no	0	0	0	0
4503253	ARP Portable Crusher #1	0	0	0	0	no	no	0	0	0	0
4503343	PORTABLE PLANT #1	0	0	0	0	no	no	0	0	0	0
4503362	Yakima Wash Plant	0	0	0	0	no	no	0	0	0	0
4503384	Airway Sand & Gravel	0	0	0	0	no	no	0	0	0	0
4503391	ARP Portable Wash Plant #1	1	0	0	0	no	no	0	0	0	0
4503449	Elk Pit	0	0	0	0	no	no	0	0	0	0
4503452	ARP Prtbl Fabtech/Tidco	0	0	0	0	no	no	0	0	0	0
4503497	Whitcomb Quarry	0	0	0	0	no	no	0	0	0	0
4503498	Hanford Pit	0	0	0	0	no	no	0	0	0	0
4503537	Hospital Quarry	0	0	0	0	no	no	0	0	0	0
4503538	Kiona Quarry	0	0	0	0	no	no	0	0	0	0
4503554	ARP Portable Wash Plant #2	0	0	0	0	no	no	0	0	0	0
4503588	CDC Portable Recycler Crusher	0	0	0	0	no	no	0	0	0	0
4503623	ARP Prtbl Crusher WP/Kolberg	0	0	0	0	no	no	0	0	0	0
4503679	Berryman Quarry	0	0	0	0	no	no	0	0	0	0
4503684	IAC Portable Screen Plant	0	0	0	0	no	no	0	0	0	0
4503721	ARP Portable Wash Plant	0	0	0	0	no	no	0	0	0	0
4503744	East Valley	2	0	0	0	no	no	1.176	0	0	0
4503779	Hawthorne	0	0	0	0	no	no	0	0	0	0
4600001	Fort Spring Plant	0	0	0	0	no	no	0	0	0	0
4600005	MILL POINT QUARRY	0	0	0	0	no	no	0.294	0	0	0
4600044	Raleigh Quarry	0	0	0	0	no	no	0	0	0	0
4602793	Mercer Stone Plant	1	0	0	0	no	no	1.424	0	0	0
4602794	Lewisburg Plant	5	0	0	0	no	no	0.147	1	1	0
---	---	---	---	---	---	---	---	---	---	---	---
4603727	Kelly Mountain Quarry	0	0	0	0	no	no	0	0	0	0
4604327	Bowden Quarry	0	0	0	0	no	no	0	0	0	0
4605147	Beckley Plant	0	0	0	0	no	no	0	0	0	0
4801141	Evans No 1 Pit	0	0	0	0	no	no	0.42	0	0	0
4801189	Evans Wash Plant	0	0	0	0	no	no	0	0	0	0
4801275	133 Crusher H-K Portable Plant	0	0	0	0	no	no	0	0	0	0
4801371	Hakalo Quarry	0	0	0	0	no	no	0	0	0	0
4801392	#33 Crusher	0	0	0	0	no	no	0	0	0	0
4801547	Small Crusher #1330	0	0	0	0	no	no	0	0	0	0
4801735	Scale Number One	0	0	0	0	no	no	0	0	0	0
Total		246	2	3	1	-	-	1,036.858	27	31	23

(1)MSHA assigns an identification number to each mine or operation and may or may not assign separate identification numbers to related facilities. The

information provided in this table is presented by mine identification number.

(2)The definition of mine under Section 3 of the Mine Act includes the mine, as well as other items used in, or to be used in, or resulting from, the work of

extracting minerals, such as land, structures, facilities, equipment, machines, tools, and preparation facilities.  Unless otherwise indicated, any of these other

items associated with a single mine have been aggregated in the totals for that mine.

(3)Represents the total number of citations issued by MSHA, for violation of health or safety standards that could significantly and substantially contribute to a

serious injury if left unabated.  If MSHA determines that a violation of a mandatory health or safety standard is reasonably likely to result in a reasonably

serious injury or illness under the unique circumstance contributed to by the violation, MSHA will classify the violation as a “significant and substantial”

violation.

(4)Represents the total number of orders issued, which represents a failure to abate a citation under section 104(a) within the period prescribed by MSHA.

(5)Represents the total number of citations and orders issued by MSHA of the Mine Act for unwarrantable failure to comply with mandatory health or safety

standards. These violations are similar to those described above, but the standard is that the violation could significantly and substantially contribute to the

cause and effect of a safety or health hazard, but the conditions do not cause imminent danger, and the MSHA inspector finds that the violation is caused by

an unwarranted failure of the operator to comply with the health and safety standards.

(6)Represents the total number of imminent danger orders issued under section 107(a) of the Mine Act.  These orders are issued for situations in which MSHA

determines an imminent danger exists in the quarry or mine and results in orders of immediate withdrawal of all persons (except certain authorised persons)

from the area of the quarry or mine affected by its condition until the imminent danger and the underlying conditions causing the imminent danger no longer

exist.

(7)Represents whether a mine has received a written notice of a pattern of violations of mandatory health or safety standards that are of such nature as could

have significantly and substantially contributed to the cause and effect of our mine health or safety hazards under section 104(e) of the Mine Act.

(8)Represents whether a mine has received a written notice of the potential to have a pattern of violations of mandatory health or safety standards that are of

such nature as could have significantly and substantially contributed to the cause and effect of our mine health or safety hazards under section 104(e) of the

Mine Act.

(9)Total dollar value of proposed assessments from MSHA under the Mine Act.  These are the amounts of proposed assessments issued by MSHA with each

citation or order for the time period covered by the reports. Penalties are assessed by MSHA according to a formula that considers a number of factors,

including the mine operator’s history, size, negligence, gravity of the violation, good faith in trying to correct the violation promptly, and the effect of the penalty

on the operator’s ability to continue in business.

(10)Pending legal actions before the Commission as required to be reported by Section 1503(a)(3) of the Dodd-Frank Act. All 16 pending legal actions are

contests of proposed penalties referenced in Subpart C of 29 CFR Part 2700. There are no contests of citations and orders referenced in Subpart B of 29

CFR Part 2700; no complaints of discharge, discrimination or interference referenced in Subpart E of 29 CFR Part 2700; no complaints for compensation

referenced in Subpart D of 29 CFR Part 2700; no applications for temporary relief referenced in Subpart F of 29 CFR Part 2700; and no appeals of judges’

decisions or orders to the Federal Mine Safety and Health Review Commission referenced in Subpart H of 29 CFR Part 2700.